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do not overlap differ significantly (p<0.05). FC was significantly 
reduced using flexible rings. 
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FC results, in terms of mean ± 95% CI for either suture region, after 
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(p<0.05). R, rigid; S, semi-rigid (commercial); F, flexible; Ant, 




Ratio of anterior FC to posterior FC for each ring stiffness, averaged 
across suture positions and LVPmax levels. Left: mean ± SD. Right: 
mean ± 95% CI (after ANOVA 9). Pairs whose 95% CIs do not 
overlap differ significantly (p<0.05). R, rigid; S, semi-rigid 




Normalized half-width at half-maximum (HWHMnorm) for each 
suture region within a given ring stiffness. Larger HWHMnorm 
indicates a longer proportion of the cardiac cycle during which suture 
loading occurred. Left: mean ± SD. Right: mean ± 95% CI (after 





Residual Strength around the annular circumference, following use 
of each undersized ring in the Physio geometry (lower Residual 




Comparison of the hybrid ring (left) versus a fully flexible prototype 
in the same geometry (right). On left, rigid inserts along anterior 
(orange) and posterior (purple) are highlighted to reveal that they 





Fluoroscopic images of an implanted hybrid ring during diastole 
(left) and systole (right) of a single cardiac cycle. Cyclic changes in 




Preliminary FC results from undersized hybrid rings, shown 
alongside all prior undersized ring cohorts. Mean ± SD values are 
given at LVPmax = 125 mmHg. Red box: regional FC values enlarged 




Ratio of anterior FC to posterior FC, averaged across suture positions 
and LVPmax levels. Preliminary hybrid ring data is shown along with 




Residual Strength around the annular circumference, following use 
of each tested undersized ring design (lower Residual Strength 









Left: Representative plots of ΔP and PVL versus time from a single 
acquisition. The system was tuned to establish and hold each ΔP 
level, such that ΔP and PVL could be averaged over a 4 second 
interval (red lines). Right: Scatterplots of ΔP vs. PVL relationship 
from two acquisitions, using either the smallest circular device (C+0) 




ΔP vs. PVL curve fits. Each subplot includes seven curves from a 
single mock TMV plug. Each curve is fit to all data points collected 




ΔP vs. PVL curve fits. Each subplot includes an overall curve fit 
(black) with 95% confidence interval (red), from a single mock TMV 




PVLnorm results, in terms of mean ± standard deviation (SD) for each 
mock TMV plug type (included: individual devices, binned by 
shape, binned by size, and all shapes/sizes). Although trends are 
apparent, statistical significance of these trends cannot be assessed 
until after GLM 1 (see Figure 7-6 through Figure 7-8). Green line: 




PVLnorm results in terms of mean ± 95% confidence interval (CI) 
using either device shape (after GLM 1). Pairs whose 95% CIs do 
not overlap differ significantly (p<0.05). Green line: mean leakage 





PVLnorm results in terms of mean ± 95% CI using each device size 
(after GLM 1). Pairs whose 95% CIs do not overlap differ 
significantly (p<0.05). Green line: mean leakage across all samples. 





PVLnorm results in terms of mean ± 95% CI using each device shape-
size combination (after GLM 1). Pairs whose 95% CIs do not overlap 
differ significantly (p<0.05). Green line: mean leakage across all 
samples. The only circular device that did not exhibit significantly 




PVLnorm results, duplicated from Figure 7-5 through Figure 7-8. Top: 
mean ± SD for each mock TMV plug type (included: individual 
devices, binned by shape, binned by size, and all shapes/sizes). 
Bottom: mean ± 95% CI for each mock TMV plug shape, size, or 
shape-size combination (after GLM 1). Within each plot, pairs 
whose 95% CIs do not overlap differ significantly (p<0.05). Green 
line: mean leakage across all samples. Overall, shape was an equal 




sqrt(PVL) results after modeling ΔP as a continuous variable. Mean 
± 95% CI for each mock TMV plug at each of five key ΔP levels 





PVL results for the normotensive state (i.e., ΔP between 110-130 
mmHg), in terms of mean ± SD for each mock TMV plug type 
(included: individual devices, binned by shape, binned by size, and 
all shapes/sizes). Although trends are apparent, statistical 
significance of these trends cannot be assessed until after GLM 3 




PVL results for the normotensive state (i.e., ΔP between 110-130 
mmHg), in terms of mean ± 95% CI using either device shape (after 
GLM 3). Pairs whose 95% CIs do not overlap differ significantly 




PVL results for the normotensive state (i.e., ΔP between 110-130 
mmHg), in terms of mean ± 95% CI using each device size (after 
GLM 3). Pairs whose 95% CIs do not overlap differ significantly 
(p<0.05). The +6 size significantly reduced PVL as compared to +2, 




PVL results for the normotensive state (i.e., ΔP between 110-130 
mmHg), in terms of mean ± 95% CI using each shape-size 
combination (after GLM 3). Pairs whose 95% CIs do not overlap 
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differ significantly (p<0.05). Within either shape, no significant 
differences in PVL were detected due to size. The only circular 
device that did not exhibit significantly greater PVL than at least one 
of the D-shaped devices was C+6. 
Figure 
7-15 
PVL results, duplicated from Figure 7-11 through Figure 7-14. Top: 
mean ± SD for each mock TMV plug type (included: individual 
devices, binned by shape, binned by size, and all shapes/sizes). 
Bottom: mean ± 95% CI for each mock TMV plug shape, size, or 
shape-size combination (after GLM 3). Within each plot, pairs 
whose 95% CIs do not overlap differ significantly (p<0.05). Overall, 




Representative plots of force measured on each REFT arm from a 
single acquisition. With aortic pressure at approximately 120 mmHg, 
the arms were deployed to an expanded state, held, and retracted, 





FSL results in terms of mean ± SD for each expansion geometry 
(included: individual geometries, binned by shape, binned by size, 
and all shapes/sizes). Although trends are apparent, statistical 
significance of these trends cannot be assessed until after GLM 4 




FSL results in terms of mean ± 95% CI using either shape (after GLM 
4). Within each plot, pairs whose 95% CIs do not overlap differ 





FSL results in terms of mean ± 95% CI for each level of annular 
oversizing (after GLM 4). Within each plot, pairs whose 95% CIs do 
not overlap differ significantly (p<0.05). Each increase in oversizing 




FSL results in terms of mean ± 95% CI for each shape-size 
combination (after GLM 4). Within each plot, pairs whose 95% CIs 
do not overlap differ significantly (p<0.05). The D-shape was more 




FSL results, duplicated from Figure 7-17 through Figure 7-20. Top: 
mean ± SD for each expansion geometry (included: individual 
geometries, binned by shape, binned by size, and all shapes/sizes). 
Bottom: mean ± 95% CI for each shape, size, or shape-size 
combination (after GLM 4). Within each plot, pairs whose 95% CIs 
do not overlap differ significantly (p<0.05). Size was a stronger 





FIC results in terms of mean ± SD for each expansion geometry 
(included: individual geometries, binned by shape, binned by size, 
and all shapes/sizes). Although trends are apparent, statistical 
significance of these trends cannot be assessed until after GLM 4 




FIC results in terms of mean ± 95% CI using either shape (after GLM 
4). Within each plot, pairs whose 95% CIs do not overlap differ 





FIC results in terms of mean ± 95% CI for each level of annular 
oversizing (after GLM 4). Within each plot, pairs whose 95% CIs do 
not overlap differ significantly (p<0.05). Each increase in oversizing 




FIC results in terms of mean ± 95% CI for each shape-size 
combination (after GLM 4). Within each plot, pairs whose 95% CIs 
do not overlap differ significantly (p<0.05). The D-shape was more 




FIC results, duplicated from Figure 7-22 through Figure 7-25. Top: 
mean ± SD for each expansion geometry (included: individual 
geometries, binned by shape, binned by size, and all shapes/sizes). 
Bottom: mean ± 95% CI for each shape, size, or shape-size 
combination (after GLM 4). Within each plot, pairs whose 95% CIs 
do not overlap differ significantly (p<0.05). Size was a stronger 




Force eccentricity for each expansion geometry, expressed as mean 
± SD for FIC/FSL (included: individual geometries, binned by shape, 
binned by size, and all shapes/sizes). Green line: FSL=FIC. Although 
trends are apparent, statistical significance of these trends cannot be 




Force eccentricity for each shape, expressed as mean ± 95% CI for 
sqrt(FIC/FSL) (after GLM 4). Within each plot, pairs whose 95% CIs 
do not overlap differ significantly (p<0.05). Green line: FSL=FIC. 
Forces were eccentric for each shape (i.e., the 95% Cis did not 





Force eccentricity for each size, expressed as mean ± 95% CI for 
sqrt(FIC/FSL) (after GLM 4). Within each plot, pairs whose 95% CIs 
do not overlap differ significantly (p<0.05). Green line: FSL=FIC. 





Force eccentricity for each shape-size combination, expressed as 
mean ± 95% CI for sqrt(FIC/FSL) (after GLM 4). Within each plot, 
pairs whose 95% CIs do not overlap differ significantly (p<0.05). 
Green line: FSL=FIC. All shape-size combinations had 95% CI not 




Graphs duplicated from Figure 7-27 through Figure 7-30. Top: force 
eccentricity results for each expansion geometry, expressed as mean 
± SD for FIC/FSL (included: individual geometries, binned by shape, 
binned by size, and all shapes/sizes). Bottom: force eccentricity 
results for each shape, size, or shape-size combination, expressed as 
mean ± 95% CI for sqrt(FIC/FSL) (after GLM 4). Within each plot, 
pairs whose 95% CIs do not overlap differ significantly (p<0.05). 




Investigation of tissue thickness in the vicinity of the mitral annulus 
of a porcine heart. Top: photograph of heart. Bottom: multi-planar 
reconstruction of heart, obtained by micro-computed tomography. 
Blue border: annulus mid-plane. Green border: septal-lateral mid-
plane. Red border: inter-commissural mid-plane. LVOT: left 




Schematic depiction of two bounding scenarios describing the 
theoretical location/form of PVL gaps. In Scenario 1, all leakage 
emanates from a single circular orifice at an arbitrary position along 
the annular circumference. In Scenario 2, leakage emanates 




Illustration of a potential explanation for the finding that, although 
circular devices leaked more than D-shaped devices, the discrepancy 
was meaningfully reduced with use of C+6. At C+0 through C+4, 
the circular profile may fail to engage the commissural annulus, 
where the leaflets offer little contribution to sealing. The D-shaped 




Representative data used for FTD measurement. Sutures were tied 
first to the left trigone (LT), then the right trigone (RT), then 
clockwise from 11 o’clock. FTD was computed as the force 
differential immediately before/after tie-down (tie-down visible here 




Mean ± 95% CIs for each (A) surgeon, (B) suture position, or (C) 
suture position specific to the implanting surgeon. Model included a 
cohort of 11 Profile 3D cases split 5:6 among two surgeons. Within 
each plot, pairs whose 95% CIs do not overlap differ significantly 





Correlation between FTD and FC. 247 
Figure 
B-1 
(A-B) An annuloplasty ring, instrumented to record tensile forces on 
individual sutures, was implanted in the mitral valve of a healthy 
ovine subject using standard technique. (C) Implantation was 





The failed suture dehisced following a peak force of 16.7 N (red); 
5.7 N of this force shifted to the two adjacent sutures (black). 
Loading on all other sutures (green) either increased slightly (i.e. < 




Positions included in data collection. Suture pullout testing included 
all twelve positions. Fluoroscopic imaging included those positions 
with green circles. SAC, septal-anterior commissure; APC, anterior-




Representative image collected by two-photon autofluorescence, 
demonstrating the region of interest for colorimetric quantification 




Mean ± SD FP results, with ANOVA results depicted by symbol 
notation. *p<0.05 vs. 5 o’clock; **p<0.05 vs. 6 o’clock; @p<0.005 
vs. 5 o’clock; @@p<0.005 vs. 6 o’clock; $p<0.001 vs. 5 o’clock; 




Mean ± SD nMPI results, with ANOVA results depicted by symbol 




Linear regression of each position’s mean suture pullout force versus 
normalized mean pixel intensity (nMPI). Only positions subjected to 





Annular positions/regions tested. All positions were subjected to 
both suture pullout and collagen quantification testing. These are the 
same positions subjected to suture pullout testing in SA 1 and 
APPENDIX C. However, regional grouping is different in the 
present cohort, in support of a unified design between the MV and 
TV data. LT, left trigone; RT, right trigone; APC, anterior-posterior 





Mitral annulus sample from a donor heart, after preparation for 










Mean ± SD HYP results, with ANOVA results depicted by symbol 




Correlations of hydroxyproline fraction (a metric for collagen 
content) versus suture pullout force. Correlations are computed for 
each valve, both using every available data point and using mean data 
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Cyclic contracile Force (suture) 
Inter-Commissural Force (during radial expansion) 
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The range of implantable devices to correct mitral regurgitation (MR) is diverse 
and continually expanding. It consists mainly of annuloplasty rings, which restore native 
valve competency, and prosthetic valve replacements. Both attach to the mitral annulus via 
suture anchoring. Additionally, many transcatheter mitral valve (TMV) replacements, in 
which anchoring and sealing often rely on radial expansion against the mitral annulus, are 
now developing rapidly. The mechanical interactions of all such devices with the annulus 
remain poorly studied, yet are critical for device safety and performance.  
In this work, custom measurement techniques were applied to study device-annulus 
interactions in clinically and industrially relevant in vivo, ex vivo, and in vitro models. First, 
the impacts of mitral annuloplasty ring shape, size, and stiffness on suture dehiscence 
likelihood were assessed across 37 ovine subjects and a series of benchtop tests. A critical 
role of ring flexibility was uncovered, which suggested a promising new design concept to 
improve suture retention without compromising effectiveness. Second, TMV radial 
expansion forces and paravalvular leakage dynamics were quantified in explanted porcine 
hearts, as functions of the device’s profile. Findings quantitatively demonstrated key 
advantages of a non-circular TMV shape, implications of annular oversizing, and criteria 
for industrial TMV test system performance. Taken together, these studies yield significant 
new insights into best practices for MR device design, assessment, and usage. 
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CHAPTER 1. INTRODUCTION 
The four heart valves open and close in response to cyclic contraction and relaxation of the 
heart. By ensuring efficient, unidirectional blood flow, they each serve a vital role in 
cardiovascular function. However, due to the mechanical demands they face, in 
combination with genetic and other factors, a heart valve may become incapable of 
effective opening (valvular stenosis) or effective closure (valvular regurgitation). Among 
the four valves, the mitral valve (MV) faces the harshest mechanical environment due to 
its positioning between the left atrium and left ventricle. Mitral regurgitation (MR) is the 
most common form of clinically significant valve disease: the incidence of moderate or 
severe regurgitation in the US is 1.7% and rising.1  
 The MV is a complex structure, consisting of two asymmetric leaflets, a branching 
network of chordae tendineae that insert across the leaflets’ ventricular surfaces, and two 
papillary muscles that connect the chordae tendineae to the left ventricular wall. Further, 
the leaflets hinge from a ring of tissue referred to as the mitral annulus, whose non-circular 
and non-planar contour changes throughout the cardiac cycle. MR can result from any of a 
range of failures at the level of the leaflets, chordae tendineae, papillary muscles, annulus, 
or any combination thereof. This makes determining an optimal correction for a given MR 
phenotype a multi-faceted process.  
The landscape of prostheses to correct MR is diverse and steadily expanding. It 
consists mainly of annuloplasty rings that reshape the native tissue and prosthetic heart 
valves that replace native MV function. Despite overall positive outcomes using these 
surgically implantable devices, MR correction suffers from two major problems today. 
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First, whether correction is achieved by MV repair or replacement, post-operative failures 
persist. These include, but are not limited to, device migration, paravalvular leak, 
hemolysis, thrombosis, embolization, structural failure of the device (e.g., fracture), left 
ventricular outflow tract obstruction, and adverse ventricular remodeling.2-8 Second, an 
enormous sector of the MR patient population (with estimates ranging from 50-98%, 
depending upon the disease subtype9-11) is denied access to surgical correction altogether, 
largely due to operative risk. Inspired by the success of transcatheter aortic valve 
replacement (TAVR) in reaching otherwise-inoperable patients, development of novel 
devices for transcatheter mitral valve replacement (TMVR) is now an industry-wide 
goal.12-16 With no TMVR devices yet to achieve regulatory approval, the eventual success 
of TMVR will be dictated its ability to avoid myriad potentially critical modes of failure. 
 Among the various modes of failure known to undermine surgical MR correction, 
as well as those anticipated to challenge TMVR, many are attributable to events occurring 
at the device-annulus interface. In spite of a rich recent history of engineering research 
to understand MV mechanics and to optimize MR corrective techniques,17, 18 two such 
failure modes that stand out as markedly understudied are (a) annuloplasty ring 
suture dehiscence and (b) paravalvular leak (PVL) post-TMVR. 
In annuloplasty ring suture dehiscence, failure occurs in the sutures tie the 
annuloplasty ring to the MV annulus. When the force acting on one or more of these sutures 
exceeds the tissue’s suture holding strength, the suture tears out from the tissue. Studies of 
reoperation for failed annuloplasty-based MV repairs have reported the proportion of 
failures attributable to annular suture dehiscence to fall between 13-42%.19-21 Despite its 
prevalence, the factors contributing to dehiscence remain largely unclear. Although clinical 
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reports may be easily attributed to surgical error, multiple groups have questioned the 
extent to which dehiscence likelihood is determined systematically.22-24 Quantification of 
such systematic factors would offer two principal benefits. First, in a review of recent 
literature (with mean patient follow-up > 1 year), Khamooshian et al found insufficient 
evidence to establish any superior ring type, in terms of New York Heart Association class 
and ventricular function.25 Amidst such uncertainty, differences in anchoring performance 
would constitute a basis to discriminate among existing rings. Second, mechanistic 
description of the factors contributing to suture dehiscence would be instrumental in the 
development of controls and/or novel device designs to reduce its occurrence. 
Meanwhile, although the capacity for PVL post-TMVR has been demonstrated 
through early clinical experience,26-30 its eventual incidence upon wider use of TMVR 
remains to be determined. However, it is clear that PVL is (a) lethal in the TAVR setting, 
even when mild,31 (b) deadlier at the mitral than at the aortic position,32 (c) likely far more 
challenging to prevent in the TMVR setting than the TAVR setting, due to numerous 
biomechanical disadvantages,12-14 (d) difficult to diagnose, especially when mild or 
moderate,33 and (e) especially difficult to treat in surgically inoperable patients.34, 35 In light 
of the now-widespread use of TAVR and the rapid momentum of TMVR development,15 
a significant burden falls upon engineers, clinicians, standards bodies, and regulators to 
develop a rigorous understanding of TMVR PVL dynamics. Such understanding would 
support the continued development of existing and new TMVR systems toward optimal 
sealing against PVL.  
Presently, very little engineering research exists regarding the influences of MV 
annular mechanics and annuloplasty ring design parameters on suture dynamics. Despite a 
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wealth of clinical experience, carefully defining the mechanisms governing suture 
dehiscence remains a critical step before next-generation ring designs and usage techniques 
to prevent its occurrence can be developed. Similarly, very little engineering research exists 
regarding the influences of MV annular mechanics and TMV design parameters on PVL. 
Learning from surgical experience, TMVR outcomes may be improved prospectively by 
first characterizing the requirements for an optimal TMV-annulus seal. These are the goals 
of this thesis, as described herein.  
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CHAPTER 2. BACKGROUND 
2.1 The Circulatory System and the Heart 
2.1.1 The Circulatory System 
The circulatory system is a complex, pump-driven network of vessels that carry blood to 
and from the cells of the human body. Sustained flow of blood throughout the body is 
central to numerous fundamental aspects of physiology. The foremost of these is gas 
exchange between cells throughout the body and red blood cells suspended in the blood. 
Gas exchange entails collection of oxygen from (and delivery of carbon dioxide to) the 
alveoli within the lungs, and delivery of oxygen to (and collection of carbon dioxide from) 
all other tissues. Oxygen is a critical metabolic reagent (i.e. used in energy production 
within cells), and carbon dioxide is a metabolic waste. Other critical functions of the 
circulatory system include transport and delivery of immune cells, nutrients, and hormones 
across the body, as well as regulation of body temperature, pH, and water content. All cells 
in the body require oxygen as a fundamental reagent in the chemical processes that generate 
usable energy.  
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Figure 2-1 Overview of the circulatory system, highlighting the percentage of total 
blood in each part of the system (modified from Hall36) 
 
 At the center of the circulatory system sits the heart, a four-chambered pump that 
generates pressure to drive blood through the vasculature. It is described further in the 
following section. The right heart drives blood out through the pulmonary circulation: that 
is, through the pulmonary artery, into progressively smaller arteries and into capillary beds 
in the lungs, and back to the left heart via progressively larger veins ending with the 
pulmonary veins. The left heart drives blood to the systemic circulation: that is, through 
the aorta, into progressively smaller arteries and into capillary beds throughout the rest of 
the body, and back to the right heart via progressively larger veins ending with the vena 
cavae. The systemic circulation also includes the coronary circulation, a small network of 
vessels that branches from the aorta and delivers blood to the tissues of the heart itself. 
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2.1.2 The Heart 
Circulatory function requires the unidirectional flow of blood through the vasculature. This 
is made possible by the heart, a pump that generates pressure via rhythmic contraction and 
relaxation of its muscle to drive blood flow. The heart is composed of four chambers: the 
left and right atrium (LA and RA), and the left and right ventricles (LV and RV). The left 
and right sides deliver blood to the pulmonary and systemic circuits, as described above.  
 The pumping of the heart is referred to as the cardiac cycle, and can be broken into 
two distinct phases. In diastole, the ventricles expand and fill with blood. In systole, the 
ventricles contract, ejecting blood into the vasculature. Ventricular pressures rise and fall 
over large magnitudes, which on its own can cause blood to flow both forward and 
backward. However, to prevent backward flow, the ventricles are gated at their entry and 
exit points with four heart valves.  
The mitral and tricuspid valves (MV and TV) sit proximal to the left and right 
ventricle, respectively, and are also called the atrioventricular valves. The aortic and 
pulmonary valves (AV and PV) sit proximal to the aorta and pulmonary artery, 
respectively, and are also called the semilunar valves. All four heart valves open and close 
passively in response to oscillating pressure gradients across them. The atrioventricular 
valves open during diastole and close during systole; the opposite is true for the semilunar 
valves. The left heart’s valves face the largest pressure gradients: at healthy resting 
conditions, 120 mmHg at peak systole for the mitral valve, and 80 mmHg at peak diastole 
for the aortic valve. Immediately downstream of the AV are the coronary ostia, two entry 
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points into the coronary vasculature, which provides blood flow to the cardiac tissue itself. 
The coronary circulation drains into the right atrium. 
 
Figure 2-2 Long-axis view of the heart’s chambers, valves, and large vessel 
connections (image: biology-forum.com). Inset: Coronary arteries branching from 




Figure 2-3 Short-axis views of the heart during diastole (ventricular relaxation) and 
systole (ventricular contraction), revealing the opening and closure of the four heart 
valves (modified from prenhall.com). 
 
2.2 The Mitral Valve 
2.2.1 The Mitral Leaflets 
The anterior and posterior leaflets are the central components of the MV. Although the 
two leaflets differ in shape (with the posterior leaflet occupying the majority of the valve 
circumference, and the anterior leaflet being longer), their surface areas are similar.37 In 
total, their combined surface area is approximately twice that of the MV orifice.37 As such, 
MV closure during ventricular contraction exhibits redundant coaptation (leaflet-leaflet 
contact). This provides an effective seal against leakage from LV to LA (i.e. mitral 
regurgitation, MR). The anterior and posterior leaflets meet at two commissures. The 
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posterior leaflet is scalloped by two indentations, which divide it into the P1, P2, and P3 
segments. The anterior leaflet is not scalloped (see Figure 2-8 below). 
 In cross-section, the MV is the thickest of the four heart valves.38 The leaflets are 
roughly divided into three layers. In order from the atrial face (inflow) to the ventricular 
face (outflow), these are the atrialis, the spongiosa, and the fibrosa, with either side 
covered with endothelial cells.17 The major structural components of the leaflets are 
extracellular, namely collagen fibers, elastin fibers, glycosaminoglycans, and 
proteoglycans. At very low stretch levels, elastin provides the primary load-bearing 
function; under higher stretch, collagen does so. The deposition and alignment of these 
fibers varies across the three layers, as shown in Figure 2-4.   
 
Figure 2-4 (A) Histologic, cross-sectional image of the MV leaflet, highlighting its 
distinct layers (modified from Brazile et al38). (B-D) From left to right, histologic 
images of the atrialis, spongiosa, and ventricularis, with the leaflet until bi-axial 
stretch. In (B-D), green fibers are collagen and red fibers are elastin. R: radial 
direction; C: circumferential direction (modified images, originally courtesy of Dr. 





2.2.2 The Sub-Valvular Apparatus 
The sub-valvular apparatus is comprised of two papillary muscles that extend inward from 
the LV wall, and the chordae tendineae, a complex, branching network of chords that 
emanate from either papillary muscle and insert at numerous points across the ventricular 
faces of the leaflets. The precise branching structure of the chordae varies among 
individuals; branch taxonomy and the distinct functions of specific taxa are the subjects of 
ongoing research.39, 40 As a whole, the sub-valvular apparatus provides a critical function 
during systole. As left ventricular pressure (LVP) drives the MV leaflets basally (i.e. away 
from the heart’s apex), the chordae tendineae, combined with the contracting papillary 
muscles, exert tension on the leaflets. This tension restrains the leaflets from prolapsing 
into the LA, thereby holding them in a coapted state.  
 
Figure 2-5 Porcine (left) and ovine (right) MVs, manipulated in vitro to highlight the 
different sub-types of chordae tendineae and their complex, three-dimensional 




2.2.3 The Mitral Annulus 
The leaflets hinge around the mitral annulus, a region of myocardium, collagen, and other 
tissue that separates LA from LV. The boundaries of the annulus are not well defined, and 
the mere existence of the annulus as a coherent structure is debated. One clue comes from 
Angelini et al, who in 1988 described the presence of a “cord-like ring” at the intersection 
of the atrium, ventricle, and mitral leaflets.41 The completeness of, and the locations of 
gaps in, this ring were observed to vary widely among a cohort of 13 cadaveric hearts. 
More recently, Stephens et al illustrated that the distinct layers of the MV leaflets 
(especially the atrialis and fibrosa) may be considered to extend into the annulus.42 
Gunning et al, investigating collagen distribution in segments of the porcine mitral annulus, 
provided some evidence in favor of circumferential fiber alignment.43 These findings are 
depicted in Figure 2-6 and Figure 2-7. 
 
Figure 2-6 A 1988 illustration of the variability in the annular region among 




Figure 2-7 (A) Histologic illustration of the mitral leaflet and annulus, suggesting 
that the leaflet’s layered structure may be considered to extend into the annulus 
(modified from Stephens et al42). (B-C) Segmental analysis of the porcine aortic 
annulus. Segments shown in (B) were stained for collagen; representative segments 
shown in (C) suggest collagen is aligned circumferentially around the MV (modified 
from Gunning et al.43 
 
A few key characteristics of the MV annulus are functionally noteworthy. One arc 
of the annulus, centered at the mid-anterior annulus, sits in close proximity to the aortic 
valve. The region between the two valves is referred to as the aortic mitral curtain. At 
either end of the aortic mitral curtain, a few millimeters beneath the endocardial surface, 
are two dense fibrous structures, the left and right trigones. The right trigone is between 
the mitral, tricuspid, and aortic valves. Exterior from the trigones, the posterior annulus is 
surrounded by thick myocardium. Two major coronary vessels, the left circumflex artery 
and the coronary sinus, circumscribe the posterior annulus. Although Gunning et al 
reported that the anterior quadrant of the porcine annulus possessed over 8-fold greater 
collagen density than any other quadrant,43 Stephens et al found approximately 1/3 collagen 
reduction in the posterior annulus versus every other quadrant.42  
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Figure 2-8 Left: Illustration of the closed MV as viewed from the LA (dotted line: 
mitral annulus; modified from Carpentier et al37). Right: Illustration of key 
structures surrounding the mitral valve (modified from cthsurgery.com). 
 
The annulus is generally described as having a D-shaped projection, and a saddle 
shape when accounting for its three-dimensional shape.44, 45 Yet, the annulus changes 
significantly in size and three-dimensional shape throughout the cardiac cycle. In a study 
of ovine annular dynamics by Rausch et al,46 systolic contraction caused the septal portion 
of the annulus to increase in perimeter by 6%, while the lateral perimeter reduced by 7%. 
Annular area reduced by 15%, while eccentricity increased 14% (each based on its planar 
projection). Out-of-plane, the annular height increased by 65%. The accentuation of the 
saddle shape during systole is generally attributed to some combination of (a) lesser 
translation of the annulus toward the apex following to ventricular contraction in the inter-
trigonal region, due to aortic root tethering,47 and (b) expansion of the aortic root against 
this region due to the inflow of blood to the aorta.48, 49 
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Figure 2-9 Three-dimensional saddle shape of the MV annulus (modified from 
depts.washington.edu/cvrtc). 
 
2.3 Mitral Regurgitation 
A major study by Nkomo et al. identified the MV as the most common heart valve to 
experience hemodynamically significant disease in the United States.1 As with any heart 
valve, the two forms of dysfunction are mitral regurgitation (MR), in which it cannot close 
fully, and mitral stenosis (MS), in which it cannot open fully. MR is substantially more 
common than MS (estimated frequency among 2000 US adult population: 1.7% vs. 0.1%, 
respectively).1 Due to the increased demand on the left heart, chronic MR leads to LA 
and/or LV enlargement (hypertrophy) as a compensatory mechanism. Over time, further 
enlargement may not adequately address these demands, leading to reduced ejection 
fraction. MR and LA enlargement may also induce secondary arrhythmia.50 The resulting 
decompensated state may lead to patient fatigue, shortness of breath, and edema. 
The two major classes of MR are primary (or degenerative) and secondary (or 
functional). Less common, particularly in developed countries, are congenital, 
inflammatory, and infective subtypes. In primary MR, the valve tissue itself undergoes 
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adverse remodeling. Morphologic changes may include connective tissue deficiency (such 
as in Fibroelastic Deficiency) or excess (with overall enlarged leaflets, such as in Barlow’s 
disease).51 Annular dilation and/or disorganization are common throughout primary MR,52, 
53 and at the time of surgery, rupture or elongation of one or more chordae is also usually 
observed.52 Consequently, primary MR usually exhibits one or more sites of leaflet 
prolapse into the LA. In secondary MR, the MV leaflets and sub-valvular apparatus are 
generally regarded as biologically normal. Regurgitation occurs following an underlying 
annular and/or ventricular malfunction, which distorts leaflet geometry and inhibits 
coaptation. As such, secondary MR is often associated with significant comorbidities. In 
ischemic MR (IMR), ventricular remodeling follows from coronary disease, inducing 
papillary muscle displacement, annular dilatation, and restricted leaflet motion.54 
 
Figure 2-10 Examples of common mechanisms of MR (modified from Carpentier et 
al37). 
 
MR severity is commonly graded as “none,” “trace,” “mild,” “moderate,” or 
“severe.” Severity is also often referred to as “1+” (mild), “2+” (moderate), “3+” 
(moderate-to-severe), or “4+” (severe).55, 56 Grading is multi-factorial, and can account for 
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structural and fluid descriptors.57 One critical component of MR diagnosis is MR volume. 
Current American Heart Association guidelines classify primary MR or secondary MR as 
severe when regurgitant volume is ≥60 ml/stroke or ≥30 ml/stroke, respectively.57 This 
discrepancy reflects the generally lower tolerance for regurgitation among secondary MR 
patients, on account of their increased comorbidities. Note, following implantation of a 
replacement mitral valve, MR may also take a third form, known as paravalvular leakage 
(PVL; i.e., leakage through one or more gaps along the annulus-device interface). PVL is 
further described in Section 2.5.2.   
Overall, MR presents a sizeable clinical burden. MV prolapse can be surgically 
corrected, provided the patient is healthy enough for the operation. Yet, 45% of patients 
experience moderate or severe recurrent MR within ten years post-repair of degenerative 
MR.52 Ischemic MR, which affects an estimated 2.2 million Americans,58 has even poorer 
outcomes. Post-myocardial infarction patients have exhibited 1-year mortality rates of 11% 
with no MR, 22% with mild-to-moderate MR, and 52% with severe MR.58 Surgical 
intervention may initially correct the condition, but survival remains poor, with 28% 
recurrence of severe ischemic MR within 6 months post-repair.59  
 
2.4 Corrections for Mitral Regurgitation 
2.4.1 Surgical Approaches to MR Correction  
Surgical correction of MR centers around two paradigms: replacement and repair. In MV 
replacement, the native leaflets are removed, and a heart valve replacement implanted in 
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its place (the sub-valvular apparatus is often left intact60). Most surgical MV replacement 
devices feature three key components. First, leaflets replicate the function of the native 
leaflets. These are either bioprosthetic (i.e., derived from porcine or bovine leaflet or 
pericardium), or mechanical (commonly pyrolytic carbon). Second, a frame or housing 
secures the leaflets. Third, a suture cuff extending from the frame is tied directly to the 
native annulus. Whereas mechanical valves tend to outlast bioprosthetic valves, especially 
at the mitral position,61, 62 their greater thromboembolic risk also necessitates 
anticoagulation therapy. The choice of replacement type is therefore a function of patient 
health and potential to withstand reoperation. 
 
Figure 2-11 Left: The RegentTM (Abbott Laboratories, Chicago, IL) and 
PERIMOUNT (Edwards Lifesciences, Irvine, CA), examples of mechanical and 
bioprosthetic surgical heart valve replacement devices. Right: Suture-based 
implantation of the replacement valve into the native annulus.  
 
In MV repair, the objective is to restore function to the native tissue, avoiding many 
of the potential complications of a complex artificial valve. Repair techniques are diverse, 
and may address the leaflets (e.g. by plication, augmentation or resection), chordae (e.g. 
by cutting problematic chordae or implantation of artificial “neo-chordae”), or papillary 
muscles (e.g. by approximation).52, 58, 63-66 Nearly all of these techniques are used as 
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adjuncts to implantation of an annuloplasty ring. The ring generally consists of fabric 
wrapped around a solid core. Implantation is suture-based, similar to surgical valve 
replacement. Typically, a series of simple interrupted sutures is passed through the annulus 
and then the ring; the ring is then lowered down the sutures, and each suture is tied with 
multiple knot throws.  
 
Figure 2-12 Mitral valve ring annuloplasty (modified from Carpentier et al37) 
 
Ring annuloplasty aims to restore proper annular shape and size, while 
simultaneously opposing further remodeling. Adams et al. have described annuloplasty as 
a mainstay of all primary MR repair procedures, “regardless of the leaflet and chordal 
techniques employed.”67 It is similarly recommended for both idiopathic and ischemic 
secondary MR.63, 68 Numerous models are available commercially; specific device shapes, 
stiffnesses, materials, and sizes relative to the native annulus are frequently recommended 
for given MR etiologies.69-72 For example, complete, undersized, rigid or semi-rigid rings 
are frequently recommended for ischemic MR.63 
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Figure 2-13 Common annuloplasty rings. In addition to the evident diversity in 
shape, rings also vary in stiffness, and are each available in a range of sizes. 
 
2.4.2 Surgical Replacement vs. Repair – An Ongoing Debate 
Provision of the optimal correction to every MR patient is a fundamental clinical goal. One 
challenge is that the superiority of MV repair versus replacement, particularly for ischemic 
MR, remains controversial.5, 63, 73-75 Compounding this uncertainty, the likelihood of a 
surgeon electing MR repair has been shown to trend positively with the volume of 
operations they perform annually, likely due to the technical learning curve for repair.73 
This is a concerning statistic, given the median number of operations per surgeon per year 
is reportedly only five.76 Clearly, a significant gap exists between current practice and the 
goal of optimal treatment. 
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2.4.3 Catheter-based Approaches to Correct MR 
Furthering the gap between current practice and the goal of optimal treatment for all 
patients is the alarming fact that up to 50% of severe, symptomatic MR patients are denied 
surgery altogether, owing to high risk due to comorbidities.11 For ischemic MR, it is 
estimated that less than 2% of 2.4 million patients receive surgical correction.9, 10 To 
address this need, a wave of percutaneously delivered repair and replacement devices are 
currently in development.12-16 These so-called transcatheter devices avoid the need for 
sternotomy and cardiopulmonary bypass. They offer significant potential to treat patients 
who are prohibitively high-risk for surgery, and perhaps even to provide advantage over 
surgery for lower-risk groups.  
One repair device, MitraClip (Abbott Laboratories), was approved for United States 
use in degenerative MR in 2013. This device replicates the established surgical “edge-to-
edge repair” technique.77 The anterior and posterior MV leaflets are clipped together, 
easing their ability to coapt effectively. Presently, numerous important questions persist 
regarding MitraClip’s usage, including its suitability for secondary MR, and best practices 
to avoid introduction of stenosis.78, 79 It is also, in general, less effective than surgical 
techniques.80 Revealingly, the EVEREST II clinical trial for MitraClip established a 
primary endpoint that included freedom from MR > 2+ at 12 months. Thus, moderate 
residual MR was considered successful treatment. Even so, MitraClip’s primary endpoint 
rate (success rate) was significantly lower than that of surgical repair/replacement. A 
diverse range of other transcatheter MV repair devices are in development, aiming to 
replicate ring annuloplasty,81 annulus plication, neo-chordae implantation, and others.16  
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Meanwhile, numerous transcatheter mitral valve replacement (TMVR) devices are 
also under development. TMVR takes inspiration from the recent success of transcatheter 
aortic valve replacement (TAVR). Transcatheter aortic valve replacement (TAVR) was 
developed for use in a calcified, stenotic aortic valve. It was first attempted in humans in 
2002; 16 years later, multiple TAVR devices have received approval for sale in the United 
States and Europe. As of 2013, 27,000 new aortic stenosis (AS) patients were estimated to 
become TAVR candidates in North America and Europe annually.82 Since that time, 
TAVR has been further approved for use in intermediate-risk patients.83  
With substantially more patients suffering from MR than AS,1 so many of whom 
are unfit for surgery,11 the development of effective transcatheter mitral valves (TMVs) 
would have potentially transformative impact. Already, the TMVR procedure has found 
some early success for niche cases of mitral annular calcification (a subset of mitral 
stenosis)84 and reoperation for recurrent MR post-annuloplasty (termed valve-in-ring).85, 86 
In these settings, off-label use of a TAVR device has proven viable, due to the relatively 
well-defined and smaller annular landing zone. However, for the majority of MR patients, 
TMVR must overcome challenges for which TAVR devices were not designed. These 
include higher pressure gradients, a larger, D-shaped annulus, and much more flexible (i.e., 
non-calcified) annular tissue, with a lower profile as compared to the aortic sinus.12-14 
Nevertheless, recognizing the substantial opportunity, many novel, dedicated TMVR 
systems are under development. At least 10 have reached clinical trials, and at least 20 
others are in preclinical testing.15 None has yet achieved regulatory approval. 
Many common attributes exist among all TMV designs. In every case, a collapsible 
stent is fitted with bioprosthetic leaflets. The TMV is guided to the mitral annulus in 
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collapsed form via a catheter, and either self-expands or is expanded by a balloon. The 
deployed TMV anchors and seals without sutures, frequently relying on oversizing to 
generate radial force against the native annulus and some portion of the leaflets, along with 
some combination of additional features (flanges, cages, tethers, hooks, etc.).14 The annular 
region of the stent is often circular, however, various iterations of oval or D-shaped stents 
have also been developed, to improve congruence with the native annulus shape. 
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Figure 2-14 Top: Examples of publicly disclosed TMVs (modified from Carrel15). 
Bottom: Schematic depictions of some common modes of TMV anchoring/sealing. 
Green arrows indicate the annulus-contacting region, which is common to most 





2.5 Sub-Optimal Patient Outcomes  
Despite the sizable benefit of both annuloplasty rings and prosthetic valves (and the 
anticipated benefit of TMVR), a number of modes of device failure present ongoing 
challenges to clinicians and device designers. These include, but are not limited to, device 
migration, paravalvular leak, hemolysis, thrombosis, embolization, structural failure, left 
ventricular outflow tract obstruction (particularly after TMVR), and adverse ventricular 
remodeling.2-8 An important step in addressing these challenges is to characterize the 
underlying mechanisms at work. Improved understanding of the parameters governing 
such failures can inform advancements in device designs, standards, regulations, and usage 
techniques. 
 A common theme among many modes of MV device failure is adverse 
mechanical loading between the device and the native annulus. Although the 
biomechanics of the annulus have been increasingly studied in recent years,43, 46, 87, 88 many 
aspects of device/annulus interaction remain poorly understood. For the purposes of this 
thesis, two issues are of particular interest: (a) suture dehiscence from the annulus after 
ring annuloplasty, and (b) paravalvular leak after TMVR. These are described in the 
following sections. 
 
2.5.1 Annuloplasty Ring Suture Dehiscence   
In the event that excessive force is applied on the sutures used to tie the annuloplasty ring 
to the MV annulus (Figure 2-12), suture dehiscence, or detachment from the annulus, can 
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result. Although the incidence of ring dehiscence is not known, evidence of its prevalence 
as a mode of critical device failure is growing in the literature. Partial and complete 
dehiscence have been demonstrated with varying devices and patient groups. Various 
studies of reoperation for failed annuloplasty-based MV repairs have reported the 
proportion of failures attributable to annular suture dehiscence to fall between 13-42%.19-
21 Looking specifically at degenerative MR, Dumont et al reported an overall suture 
dehiscence rate below 1%,21 while Chitwood et al reported a rate of 2.3% among one 
center’s first 300 robotic repairs.89 _ENREF_83Kronzon et al reported 18 additional 
dehiscence cases across etiologies, encompassing 8 rings and 10 prosthetic valves.90 
Demonstrating that this risk extends to secondary MR repair, a large number of case studies 
have additionally been reported.7, 91-94  
While these data collectively highlight the potential for dehiscence even at high-
volume centers, its incidence may be greater at low-volume centers. Bolling et al reported 
that, among 1088 surgeons at 639 hospitals in the Society of Thoracic Surgeons Adult 
Cardiac Surgery Database, the median number of isolated MV operations per year was 5.76 
Further, it is likely that suture dehiscence is altogether underreported, given the common 
perception that it is purely a consequence of surgical error. 
Literature demonstrates that the consequences of dehiscence are severe, emergent, 
and often fatal.7, 89-99 However, little is known about what specific factors, if any, 
predispose to suture dehiscence. Interestingly, it is apparent that sutures most 
commonly dehisce from the posterior annulus (Figure 2-15 D-H). A mechanistic 




Figure 2-15 (A) Severe recurrent MR after ring dehiscence (modified from Jones-
Haywood et al7). (B) Fully-dehisced and embolized ring, lodged in the descending 
aorta (modified from Tsang et al94). (C) Dehisced ring, photographed 
intraoperatively during re-repair (modified from Derkx et al100). (D-H) Cases of 
dehiscence from the posterior annulus (modified from Derkx et al,100 Piatkowski et 
al,95 Levack et al93, Aggarwal et al96, and Ghadimi et al98). 
 
2.5.2 Paravalvular Leakage Post-TMVR 
Whether valve replacement is performed surgically or percutaneously, its effectiveness is 
predicated on a competent seal between its exterior edge/face and the native tissue.  Failure 
of this seal leads to regurgitation around the device periphery, known as paravalvular leak 
(PVL). Much like regurgitation through a faulty native MV, PVL hinders effective cardiac 
output. Further, another frequent consequence of PVL is hemolysis (red blood cell 
damage),32, 101 likely owing to high-velocity regurgitant jets flowing past non-native 
materials. PVL is a significant problem for surgical MV replacement. In general, 
visualization and quantification is challenging, especially at mild or moderate levels.33 
Mitral PVL has proven highly lethal, with Cho et al reporting an event-free survival rate 
of approximately 40% at two years post-surgical MV replacement.32 When PVL produces 
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symptoms of heart failure and/or hemolysis, correction is necessary.102 Indeed, PVL is one 
of the leading causes of reoperation after surgical valve replacement.6 For patients unfit for 
a second invasive surgery, PVL correction is challenging. Although percutaneous PVL 
closure is an emerging and promising field, it currently suffers from low reproducibility 
and from success rates reportedly as low as 60%.34, 35   
In the TAVR setting, PVL has also proven a difficult challenge that is a function of 
both annulus-device congruence and of procedure.103-105 Kodali et al demonstrated that 
PVL after TAVR significantly increases patient mortality, even when mild.31 PVL is 
widely predicted to present an even greater challenge post-TMVR than post-TAVR. One 
reason for this is biomechanical:49, 51, 97 the regurgitant mitral annulus is larger, less circular, 
more dynamic, and less rigid than the calcified, stenotic aortic annulus. The MV faces 
higher pressure gradients than the AV and the stent landing zone has a lower profile. 
Collectively, these factors challenge the TMV to generate sufficient radial force to seal 
against the native tissue around its full circumference. Another reason is experiential: 
mitral PVL is significantly more lethal than aortic PVL after surgical replacement.32 
 In limited publicly available information following animal and carefully selected 
human trials, early evidence of PVL post-TMVR has validated these concerns. In one 
instance, Ma et al reported significant PVL due to device-annulus mismatch.27, 28 
Sondergaard et al reported that the CardiAQ valve (Edwards Lifesciences) underwent 
design modifications from first- to second-generation to reduce PVL, which culminated in 
mild PVL in a first-in-man trans-femoral implantation.29, 30 The Tendyne valve (Abbott 
Laboratories), following incidents of PVL in its first-generation design testing, introduced 
second-generation modifications that included imitation of the native annulus’ D-shape.26, 
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27 Still, with no TMV yet to achieve regulatory approval, the eventual incidence of PVL 
upon wider TMVR usage remains to be determined. It is clear that a rigorous understanding 
of TMVR PVL dynamics will be necessary for device designers, regulators, and clinicians 
to effectively minimize its occurrence. Presently, very little engineering research exists 
regarding the influences of fundamental TMV design parameters on resultant PVL. 
 
Figure 2-16 Left: Post-TAVR, even mild PVL significant increases mortality (from 
Kodali et al31). Right: Post-surgical valve replacement, PVL is significantly more 
lethal at the mitral position (from Cho et al32). 
 
2.6 Investigations of MV Mechanics to Improve MR Treatment 
2.6.1 Precedent 
Large animal models and benchtop testers are well-established tools for the 
characterization of MV mechanics.17, 18 Assessment of valve performance across well-
controlled parameter spaces of interest (e.g. valve geometry, hemodynamic conditions, or 
repair type) is a fundamental approach toward the development and optimization of 
treatments for MR. One benefit of animal testing is the ability to employ high-fidelity 
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measurement tools that are too invasive, destructive, or high-risk for use in humans. 
Examples include trackable positional markers, radiographic imaging systems, pressure 
monitors, or force transducers. When the research question permits greater simplification, 
explanted mitral valves or whole hearts are may be mounted in benchtop cardiovascular 
simulators. These anatomic structures are integrated with various hardware components, 
including pumps, idealized anatomic replicas, and “lumped” resistance and compliance 
elements. Advantages of this testing format typically include an increased range of 
measurement equipment, rapid iteration among test conditions, and cost efficiency. 
Relevant studies of valve mechanics using these approaches include:  
 Description of MV annular motion during the cardiac cycle, using trackable, 
radiopaque markers in normal ovine subjects.46  
 Measurement of the MV annulus’ radial contractile forces in normal and IMR ovine 
subjects.106, 107 
 In vitro simulations of MV function following repairs or geometric alterations of 
interest, using explanted ovine or porcine valves mounted within an adjustable 
mock annulus/left heart. Optimization of leaflet augmentation patch dimensions to 
repair IMR,108 or quantification of leaflet chordal forces according to the annulus’ 
saddle height,45 are two successful examples.   
 Ex vivo recreations of passively beating, whole porcine hearts, with boroscopic or 
sonomicrometric tracking of leaflet kinematics.109, 110 Use of the whole heart may 
be critical for research questions that depend upon accurate representation of the 
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complex material behaviour of the structures surrounding the valve itself (e.g. the 
annulus or aortic root).  
 
Figure 2-17 Left: In vivo assessment of MV annular contractile forces in ovine 
subjects (modified from Siefert et al107). Right: Ex vivo assessment of tricuspid valve 
leaflet strain in an explanted, passively beating porcine heart (modified from Khoiy 
et al109). 
 
2.6.2 Potential for Impactful New Investigations 
As described in Section 2.5, it is clear that numerous failure modes following MR 
correction are attributable to events occurring at the device-annulus interface. Despite a 
rich recent history of engineering research to understand MV mechanics and to optimize 
MR corrective techniques, suture dehiscence post-annuloplasty and PVL post-TMVR 
stand out as two such failure modes that remain markedly understudied. Systematic 
descriptions of annuloplasty suture force dynamics and of TMVR PVL dynamics are 
expected to yield meaningful insights toward improved strategies for device design, 
standardization, regulation, and usage. In the present work, these dynamics are explored as 
functions of both the MV annulus’ material behavior and of fundamental device design 
parameters. The specific aims are described in the following chapter.  
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CHAPTER 3. HYPOTHESIS AND SPECIFIC AIMS 
The incidence of moderate-to-severe mitral valve (MV) regurgitation in the US is 1.7% 
and rising.1 The landscape of prostheses to correct mitral regurgitation (MR) is diverse and 
steadily expanding. These consist mainly of annuloplasty rings that reconstruct the native 
tissue, and prosthetic surgical heart valves that replace native MV function. 
Conventionally, these devices are implanted with interrupted sutures, which anchor the 
device to the MV annulus. Alternatively, a new wave of percutaneously implanted devices, 
which do not require sutures, are now in development, aiming to reach market throughout 
the next decade.111 Of these, a cohort of transcatheter mitral valve replacement (TMVR) 
devices are implanted by means of radial expansion against the native MV.13, 14 Among 
both surgical and transcatheter devices, nearly all rely on anchoring and/or sealing to the 
MV annulus, a D-shaped region of structurally and kinematically heterogeneous tissue. 
The mutual loading between annulus and device is a complex interplay between device 
design and tissue mechanics.  
Ideally, this loading allows for stable, durable anchoring/sealing, and helps to 
ensure freedom from recurrent MR. In contrast, either excessive suture force post-surgical 
implantation or insufficient radial force after transcatheter mitral valve (TMV) deployment 
can have disastrous consequences. These have included paravalvular leak (PVL), 
hemolysis, and device embolization,7, 90, 94, 99 all of which significantly increase 
morbidity/mortality rates. Trending with more frequent clinical reports of suture 
dehiscence,7, 89-96, 99 and with the growing clinical potential for TMVR, increased attention 
is being paid to these performance concerns by manufacturers, regulators, and the 
 33
International Standards Organization.112-114 Yet, limited publicly available work to date has 
systematically explored the impact of device design or physiology on the adequacy of 
annular anchoring/sealing, either for surgical (suture-based) or percutaneous devices. 
To aid the development of next-generation suture-based devices and implantation 
techniques to prevent dehiscence, defining the mechanisms governing its occurrence is 
critical. Learning from surgical experience, TMVR outcomes may be improved 
prospectively by similarly characterizing the requirements for an optimal TMV-annulus 
seal. This thesis hypothesized that improved understanding of the mechanical loading 
between the mitral valve device and the native annulus can reduce the risk of failure 
failure at their interface. This was be tested through the following Specific Aims:  
 
Specific Aim 1: Identify strategies to improve annuloplasty ring suture retention by 
describing the sensitivity of suture forces to ring design and annular biomechanics. 
First, the basic mechanism of annuloplasty ring suture dehiscence was characterized. 
Annular suture holding strength was measured in an ex vivo test system. Strength dynamics 
were linked to underlying tissue microstructure using two-photon excitation flouroscopy. 
Tensile forces acting on individual annuloplasty sutures in the beating heart were measured 
using custom, strain gage-based sensors.24 Transducers were manufactured, calibrated, and 
attached to a common commercial annuloplasty ring. The instrumented ring was implanted 
in healthy ovine subjects and cyclic contractile forces (FC) were recorded. Next, using this 
data as a reference, a parametric assessment of the impact of ring design on FC was 
conducted. Ring shape, ring sizing, and ring stiffness were systematically varied, and the 
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resulting FC distributions were analyzed. This effort relied on a novel system for the 
fabrication of rings of desired material properties. These results provide insight into the 
clinical potential for ring selection/sizing to affect suture tension around the annulus. 
Further, they motivate the development of putatively optimized ring design strategies to 
reduce suture dehiscence likelihood. One such novel ring was prototyped, and its FC 
dynamics preliminarily assessed in vivo.  
 
Specific Aim 2: Quantify the impact of TMV size and shape on PVL and radial 
expansion force. The importance of radial loading to prevent PVL post-transcatheter 
aortic valve replacement is well documented.103, 104, 115 At the MV position, the annulus’ 
complexity presents an added challenge to optimizing TMVR radial loading. The risk of 
PVL post-TMVR will depend on the mechanical interaction between stent and annulus 
(multiple stent shapes have been proposed, and sizing is poorly understood). A novel, 
whole-heart, steady flow simulator was developed. Using rigored porcine hearts, mock D-
shaped and circular TMV “plugs” (simulating closed TMVs) were implanted over a range 
of sizes. PVL was quantified under fixed pressures by ultrasonic flow probes.112 Further, a 
custom, strain gage-based force sensing system was developed and employed in porcine 
hearts, to provide direct assessment of the force required to radially expand each TMV 
design to the same oversizing levels studied in PVL testing. Comparison of TMV shapes 
and sizes in terms of PVL and radial expansion force will aid the development of optimized 
TMV geometries, to improve sealing performance and/or allow for lower-profile delivery.  
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The completion of this work has yielded extensive insights into (a) the hazards 
surrounding MV annulus-device interaction, and (b) associated design, testing, and 
usage strategies to improve device performance. 
 




Figure 3-2 Schematic for SA 2 experiments. 
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CHAPTER 4. MATERIALS 
Note that many custom components were used in this thesis. All computer aided design 
was performed in SolidWorks (Dassault Systemes, Waltham, MA). Computer aided design 
files have been uploaded to the Georgia Tech repository as a supplement to this thesis. 
Files for both individual parts and multi-component assemblies are included. For more 
information, refer to the supplement and/or APPENDIX H. This appendix also describes 
material and method used for fabrication. 
 
4.1 Specific Aim 1 Materials 
4.1.1 Test Subjects 
4.1.1.1 Ovine subjects used in in vivo testing 
In SA 1.A, 1.B, and 1.C, annuloplasty suture force dynamics were studied in the beating 
hearts of normal Dorsett hybrid sheep (a well-established model for heart valve 
research).116 These studies were conducted at the University of Pennsylvania, in 
collaboration with the Gorman Cardiovascular Research Group. The animals used in this 
work received care in compliance with protocols approved by the Institutional Animal Care 
and Use Committee at the University of Pennsylvania, in accordance with guidelines for 
humane care (National Institutes of Health Publication 85-23, revised 1996).  
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Figure 4-1 Left: Peri-operative image of surgical suite. Right: Ovine subject post-
thoracotomy and left atriotomy.  
 
4.1.1.2 Ovine annular tissue used in in vitro testing 
In SA 1.A, suture pullout and collagen quantification tests were conducted on mitral annuli, 
explanted from normal ovine hearts. These hearts, procured from a local market via 
Superior Farms (Sacramento, CA), were previously frozen; prior studies have established 
previously frozen MVs and annuli as suitable structural models for living tissue.117, 118  
 
4.1.2 Annuloplasty Rings 
4.1.2.1 Commercial Rings 
In vivo testing in SA 1 used five different annuloplasty rings, two of which were 
commercial products. These were the flat, semi-rigid Physio (Edwards LifeSciences, 
Irvine, CA) and the saddle-shaped, rigid Profile 3D (Medtronic, Dublin, Ireland). Sizes 24, 




Figure 4-2 Commercially available annuloplasty rings used in this work. 
 
4.1.2.2 Prototype Rings 
Three annuloplasty rings (used in SA 1.B and 1.C) were prototypes, based on the Physio 
or Profile 3D geometries. Each such ring was manufactured in sizes 24, 26, and 28. The 
methods by which these were produced and analysed are discussed in Section 5.1.2.  
The fully-rigid prototype ring was 3D printed from polycarbonate (Stratasys, Eden 
Prairie, MN) at Georgia Tech College of Architecture. The fully-flexible prototype ring 
was cast in-house from quick-curing, durometer 40A silicone putty (Quick-Sil, Castaldo, 
Franklin, MA). The hybrid ring consisted of two core segments of 3D printed Ti-6AL-4V 
titanium (Protolabs, Maple Plain, MN) overmolded with the same silicone used for the 
fully-flexible rings. Both the fully-flexible and hybrid rings were cast using specialized 
molds. These molds were 3D printed from VeroWhite (Stratsys) or GPCL02 (FormLabs, 
Somerville, MA), at the Georgia Tech Manufacturing Institute or at 3D Printing Tech 
(Atlanta, GA), respectively. These materials were selected because they could be printed 
at high resolution (each part was printed at 50 μm or better). 
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Figure 4-3 Top and side views of rigid (left) and flexible (right) prototype rings. 




Figure 4-4 Left: Hybrid prototype ring, with Profile 3D shown in background to 
illustrate matched geometry. Center: schematic CAD rendering of segmental 
material properties (black: rigid; white: flexible). Right: hybrid ring with portion of 






4.1.3 Suture Force Transducers 
4.1.3.1 Suture Force Transducer Materials 
Suture force measurements used previously designed and demonstrated transducers.24 
These were manufactured in-house, using the components listed in Table 4-1 and detailed 
further in Section 5.1.1. 
Table 4-1 Materials used for manufacturing Suture Force Transducers. 







3D printed spring element (316L 




Rosin flux 7799A11 
3 Loctite E-120HP epoxy 6430A24 
4 Heat shrink tubing 7856K33 
5 Electrical pins 69295K111 
6 Electrical sleeves 69295K115 
7 Electrical pin housing (12 pole) 69295K99 





M-Prep Conditioner A MCA-1 
10 M-Prep Neutralizer 5A MN5A-1 
11 Sandpaper SCP-3 
12 Surface wipes (gauze) GSP-1 
13 Strain gage installation tape PCT-2M 
14 Half-bridge strain gages 
EA-13-062TZ-
350/E 
15 M-Bond 200 adhesive and catalyst F006678 
16 M-Line Rosin Solvent RSK-1 
17 
Waterproofing sealant (nitrile 
rubber) F006688 
18 Eutectic solder 361A-20R-25  
19 
36 gage, etched PTFE-coated, three-




Figure 4-5 Left: CAD rendering of spring element. Middle: Printed spring element, 
prior to strain gage instrumentation. Right: Fully instrumented Suture Force 
Transducer. 
 
4.1.3.2 Suture Force Transducer Data Acquisition System 
Two identical data acquisition systems were used for all Suture Force Transducer-related 
testing (i.e. one each at Georgia Tech and at University of Pennsylvania). All system 
components and software were from National Instruments (Austin, TX). This system 
utilized a modular compact Data Acquisition System (cDAQ-9174), equipped with three 
strain gage input modules (NI-9237 DSUB) for strain gage signal recording, and, when 
applicable, one analog voltage input module (NI-9215) for left ventricular pressure (LVP) 
recording. LVP was measured using a high-fidelity pressure transducer (SPR-3505; Millar 




Figure 4-6 Left: Data Acquisition Hardware, including cDAQ chassis, input 
modules, and wiring. Right: Close-up view of a handsome man’s hand holding the 
plugs for connection to the strain gage-based transducers.  
 
4.1.4 Suture Pullout Testing 
In order to pull sutures from mitral annuli in Specific Aim 1.A, each annulus was first 
excised and mounted to a multi-layer test plate. The plate’s top layer was a sheet of rubber, 
to which the annulus was attached, as described in Section 5.1.3. The rubber was glued to 
a rigid acrylic plate, which in turn was fixtured to the upper-most of three aluminium layers. 
The aluminium layers were free to slide along one another in two orthogonal directions; 
the desired position could be fixed with lateral set screws. Testing was performed with an 
ElectroForce 3200 uniaxial tester (Bose Corporation, Eden Prairie, MN), equipped with a 




Figure 4-7 Suture pullout testing plate. Left, Center: CAD renderings of aluminum 
and acrylic layers, demonstrating the two degrees of lateral freedom the top layer 
achieves relative to the bottom. Right: As-manufactured test plate, with 
acrylic/rubber layer detached. Lateral set screws enabled locking to a desired 
position. 
 
4.1.5 Collagen Quantification 
Collagen quantification in Specific Aim 1.A used the native autofluorescence properties of 
the tissue under two-photon excitation. After slides were prepared for each sample (using 
30 μm thick slices of annulus tissue), they were imaged under a 10X objective (1.66 x 1.66 
μm resolution) using a laser scanning microscope (LSM 710 NLO; Zeiss, Oberkochen, 
Germany).  
 
4.2 Specific Aim 2 Materials 
4.2.1 Test Subjects 
All SA 2 experiments were conducted using porcine hearts, acquired the same day from a 
local slaughterhouse (Holifield Farms, Covington, GA), and tested 5-12 hours post-
mortem. Importantly, these hearts were in rigor mortis, a natural stiffening of muscle that 
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occurs after death due to the depletion of the molecule adenosine triphosphate.119 In the 
absence of adenosine triphosphate, strong actin-myosin bonds lock the muscle. Rigor may 
begin in under one hour and persist until tissue degradation induces a more relaxed state 
once again. Myocardial contraction during rigor mortis is reportedly 60-100% of normal 
systolic contraction in the beating heart.120, 121 Therefore, these hearts were intended to 
model a snapshot of a beating heart’s material properties during systole.  
Hearts were selected according to target dimensions of the MV annulus perimeter, 
as described in 5.2.1. Two key measurements of the mitral annulus were used as selection 
criteria: inter-trigonal distance and total annular perimeter.  
Following a preliminary assessment of the available hearts in terms of (a) the range 
of sizes commonly available, and (b) the correlation between annular perimeter and inter-
trigonal distance, specifications of inter-trigonal distance = 30 mm and annular perimeter 
≈ 108.4 mm were set. This assessment is detailed in Section 5.2.1. Inter-trigonal distance 
was measured using a Physio annuloplasty ring sizer set (Edwards LifeSciences).  
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Figure 4-8 Left: Porcine heart trimmed to expose mitral annulus for sizing. Right: 
Annuloplasty sizer set used for inter-trigonal distance measurement.  
 
4.2.2 Mock TMV Plugs (SA 2.A) 
In SA 2.A, TMVR paravalvular leak was investigated using “mock TMV plugs,” as 
opposed to commercial or pre-market TMV devices. These plugs, which were made in 
house, served to occlude the mitral orifice under trans-mitral pressure gradient (ΔP) 
between 50-210 mmHg, in a manner analogous to a TMV with perfectly sealed leaflets. 
After deploying a plug, any leakage across the mitral orifice was paravalvular (paravalvular 
leak, PVL).  
 Each plug was rapid-prototyped from ABS plastic (Stratasys) and acetone vapor-
polished. The region that contacted the mitral annulus was wrapped with a polyester fabric 
that is intended for use in cardiovascular implants (007831; C.R. Bard, Inc., Murray Hill, 
NJ). 
Eight plugs in total were used, including D-shaped and circular devices, each in 
four perimeter-matched sizes (termed +0, +2, +4, and +6). Their specific dimensions of 
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were selected based on a preliminary assessment of (a) the range of sizes commonly 
available from the slaughterhouse, and (b) the correlation between annular perimeter and 
inter-trigonal distance in these hearts. The details of this assessment, including the final 
dimensions, are provided in Section 5.2.1. Further details of plug design/function are 
provided in Section 5.2.2. An image of the plugs, and the handling funnel used to position 
and collect flow past them, is given in Figure 4-9. 
 
Figure 4-9 Eight mock TMV plugs used for PVL testing. At right, one plug is 
mounted to the handling funnel. Further details are provided in Section 5.2.2. 
 
4.2.3 Steady Back-Pressure Test System (SA 2.A) 
4.2.3.1 Flow Loop Materials 
PVL measurements used porcine hearts mounted in a novel flow loop, in which steady ΔPs 
of interest were generated. ΔP and trans-mitral leakage flow rate were monitored. The flow 
loop consisted of the components listed below. 
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Table 4-2 Materials used for the assembly of flow loop. 
  Supplier Item 
Supplier 
Serial Number 
1 Holifield Farms (Covington, GA) Porcine heart N/A 
2 QC Supply (Schuyler, NE) Small umbilical clamps 140899 
3 
Dayton Electric Manufacturing, Co.  
(Lake Forest, IL) Steady flow pump 12U596 
4 Powerstat (Bristol, CT) Variac transformer 3PN126 
5 Utah Medical Products (Midvale, UT) Pressure transducer 6199 
6 Transonic (Ithaca, NY) In-line flow meter ME25PXN 
7 VWR (Radnor, PA) Thermometer 89369-136 
8 
McMaster Carr (Atlanta, GA) 
Ball valves 4757K19 
9 Tubing and connectors various 
10 
Made in-house 
Apical port N/A 
11 Drill bit for apical port N/A 
 
The apical port was a two-part device, which was 3D printed from ABS plastic (Stratasys), 
acetone vapor-polished, and threaded. The inner component (shown in red in Figure 4-10) 
was passed through the mitral orifice and then its narrow tubular region was passed through 
a hole in the apex (ID = 0.3”, OD = 0.5”). The outer component (shown in blue in Figure 
4-10) was then screwed onto it until tight, such that apical tissue was sandwiched in 
between the flanges to create a robust seal. The apical hole was made using a custom hole-
cutting drill bit, lathed from aluminium (ID = 0.21”, OD = 0.25”, filed to a sharp edge). 
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Figure 4-10 (A-B) CAD renderings of apical port. Threading was added manually to 
each part after vapor polishing and is not shown. (C-D) Images of finished apical 
port and apical port drill bit.  
 
4.2.3.2 Flow Loop Data Acquisition System 
The data acquisition system used for PVL studies was the same as that used in SA 1 (see 
Section 4.1.3.2). However, in this case, strain modules (NI 9237) were not used; only the 
BNC analog voltage input module (NI 9215) was used for pressure and flow monitoring.  
 
4.2.4 Radial Expansion Force Transducer (SA 2.B) 
4.2.4.1 Transducer Materials 
TMV radial expansion force measurements used either of two variants of a novel force 
transducer, referred to as the Radial Expansion Force Transducer (REFT). These variants 
were the Circular REFT (C-REFT) and D-shaped REFT (D-REFT). Either transducer 
was deployed within the mitral annulus and expanded radially; the radially-inward force 
with which the tissue opposed this expansion was measured along the septal-lateral (SL) 
and inter-commissural (IC) axes via a network of strain gages. REFTs were manufactured 
in-house, using the materials listed in   
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Table 4-3 and described in detail in Section 5.2.4. 
 
Figure 4-11 Circular Radial Expansion Force Transducer (C-REFT).  
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Table 4-3 Materials used for manufacturing Radial Expansion Force Transducers. 







3D printed hubs (Form Labs Clear 
Resin) N/A 
2 
3D printed arms (Form Labs Clear 
Resin) N/A 
3 
3D printed wedges (Form Labs 
Clear Resin) N/A 
4 





Loctite 4014 Adhesive 1818A43 
6 
1/2"-20 Aluminum Threaded Rod, 
for machining 94435A533 
7 
Low-carbon steel sheet, for 
machining 2102T27 
8 Rosin flux 7799A11 
9 Loctite 3321 UV Curable Adhesive 6430A24 
10 Heat shrink tubing 7856K33 
11 Electrical pins 69295K111 
12 Electrical sleeves 69295K115 
13 Electrical pin housing (12 pole) 69295K99 





M-Prep Conditioner A MCA-1 
16 M-Prep Neutralizer 5A MN5A-1 
17 Sandpaper SCP-3 
18 Surface wipes (gauze) GSP-1 
19 Strain gage installation tape PCT-2M 
20 Half-bridge strain gages 
EA-13-062TZ-
350/E 
21 M-Bond 200 adhesive and catalyst F006678 
22 Eutectic solder 361A-20R-25  
23 
36 gage, etched PTFE-coated, three-




4.2.4.2 Transducer Calibration System 
To facilitate calibration of each REFT, a well-defined calibration apparatus was developed 
(Figure 4-12). Each apparatus had the ability to impose SL and IC forces, either 
independently or in tandem. Mechanical loading of each REFT arm within the apparatus 
was accomplished through a screw-piston-spring-pusher assembly, shown in detail in 
Figure 4-13. The springs (36066GS, Gardner Spring, Tulsa, OK) had spring constant of 
177.5 N/in. Each full turn of the screw (#6-40) compressed the spring by 0.025”, thereby 





Figure 4-12 (A-B) CAD renderings of the C-REFT and D-REFT mounted within 
their calibration apparatuses (the hub’s screw extender is not shown). (C-D) Top-
view and side-view of the actual D-REFT mounted within its calibration apparatus. 
Screw extender is visible in (D). (a) Septal-lateral loading mechanisms, (b) inter-
commissural loading mechanisms, (c) base plate, (d) screws mounting REFT to base 




Figure 4-13 Loading mechanism for calibration apparatus. (a) Screw, (b) piston, (c) 
precision spring, (d) pusher that contacts the REFT arm, (e) housing, (f) base plate, 
(g) REFT arm.  
 
4.2.4.3 Data Acquisition System 
The data acquisition system used for REFT studies was the same as that used in SA 1 (see 
Section 4.1.3.2). However, in this case, only one strain module (NI 9237, for four force 
measurement channels) and one BNC analog voltage input module (NI 9215, for pressure 
monitoring) were used. Data were monitored and recorded using a custom LabVIEW 
program.  
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4.2.4.4 Additional Experimental Materials 
SA 2.B experiments required various additional materials beyond the REFT devices and 
calibration apparatuses. The REFT was passed through the MV of a fresh porcine heart and 
out a hole cut through the ventricle, then secured to a base plate. The plate was mounted 
on a stand and the setup was submerged in a heated water bath. The aorta was pressurized 
using a simple hydraulic setup. These additional materials are listed in Table 4-4 and 
further detailed in Section 5.2.4. 
Table 4-4 Additional materials used for radial expansion force measurement 
studies. 









1/4" acrylic base plate with central 
1/2"-20 threaded hole 
machined from 
8560K354 
3 Acrylic stand for base plate 
machined from 
various 
4 Acrylic water tank 
machined from 
various 
5 Ball valves 4757K19 
6 Tubing and connectors various 
7 
Grainger (Lake 
Forest, IL) Super Lube Synthetic Grease 44N719 
8 
QC Supply 
(Schuyler, NE) Small umbilical clamps 140899 
9 
Dayton Electric 
Manufacturing, Co.  
(Lake Forest, IL) Steady flow pump 12U596 
10 
Powerstat (Bristol, 




UT) Pressure transducer 6199 
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CHAPTER 5. METHODS 
Note that many custom components were used in this thesis. All computer aided design 
was performed in SolidWorks. Computer aided design files have been uploaded to the 
Georgia Tech repository as a supplement to this thesis. Files for both individual parts and 
multi-component assemblies are included. For more information, refer to the supplement 
and/or APPENDIX H. This appendix also describes material and method used for 
fabrication. 
For MATLAB codes that were used for data processing and/or statistical analysis, refer to 
APPENDIX I. 
 
5.1 Specific Aim 1 Methods 
5.1.1 Suture Force Transducers: Concept, Production, and Characterization 
5.1.1.1 Basic Strain Gage Principles 
Fundamentally, a strain gage is an electrically conductive wire, configured in a specific 
shape to achieve desirable electrical properties. Strain gages are bonded to the surface of 
an object of interest to quantify the strain that the surface experiences, and/or the external 




Figure 5-1 An example of a wire strain gage (015DJ) sold by Micro-Measurements 
(Wendell, NC). 
 
The strain-sensitive pattern is a very fine metallic wire, which responds to being 
strained according to the fundamental equation for electrical resistance, R, of any 
physical object:  
 
 (1) 
Resistivity, ρ, is an intrinsic property of the material from which the wire is made. The 
wire’s length, L, and cross-sectional area, A, are extrinsic, i.e. they can be controlled. These 
dimensions change in response to mechanical loading. When the strain-sensitive pattern is 
tensioned or compressed, the resultant geometric change (i.e., strain) will tend to increase 




Figure 5-2 A strain gage bonded to a test specimen’s surface responds to surface 
strain (and to the force that caused it) by changing its electrical resistance. 
 
Thus, according to Ohm’s Law, which states:  
  (2) 
under a constant supplied current, i, any force that strains the gage, and thus induces a 
change in its resistance, will induce a corresponding change in the voltage, V, across the 
gage. By exploiting this principle, combined with other well-established mathematical 
relationships, measuring this voltage change allows one to calculate the directional surface 
strains in a test specimen. Alternatively, a constant of proportionality can be empirically 
determined (using a well-designed calibration apparatus) to link this same voltage change 
to the applied force acting on the specimen. In this case, the component to which the gage 
is attached is referred to as the spring element. Collectively, the spring element and gage 
function as a load cell or force transducer.  
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Whether the experimental endpoint is strain or force, the gage is wired into a 
Wheatstone bridge circuit, whose most important effect is to improve measurement 
sensitivity to as low as 1 με. If desired, two or four gages can be integrated into one bridge 
circuit, to achieve benefits such as further sensitivity to strain, insensitivity to temperature 
change, or isolation of bending vs. axial strains. For further information on the various 
multiple-gage configurations, the reader is referred to National Instruments’ white papers, 
especially 3642 (http://www.ni.com/white-paper/3642/en/#toc3).  
 
5.1.1.2 Suture Force Transducer Design 
In this work (and in SA 2.B), dedicated spring elements were designed, 3D printed, and 
instrumented with strain gages. The strains in these components were not, themselves, of 
interest. Instead, once instrumented with strain gages and calibrated, they served a critical 
function as force transducers, as described below. 
The Suture Force Transducer’s spring element is shown in Figure 4-5, and is further 
detailed in Figure 5-3 A below. The transducer utilized two strain gages, orthogonally 
aligned and wired in a half-bridge configuration (type I, as described in National 
Instruments white paper 3642; http://www.ni.com/white-paper/3642/en/#toc3). This 
configuration improved strain sensitivity and eliminated temperature sensitivity, as 
compared to a single gage in a quarter-bridge configuration). It featured an annuloplasty 
ring mounting bracket, such that it could be fixed directly to the ring by tying sutures 
through or around the ring and through the mounting holes. Transducers were attached to 
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ten positions per ring (Figure 5-3 B-C). Each transducer also featured a measurement arm, 
which was designed to replace the function of the ring’s own suture cuff.  
During implantation, simple interrupted sutures were passed through the valve 
annulus, through the implantation holes, and tied atop the measurement arm in the exact 
fashion used to secure sutures to a ring’s suture cuff during a normal annuloplasty 
procedure. Thereafter, any force applied to the suture would transfer to the transducer, 
generating a detectable signal response (Figure 5-3 D).  
As previously reported, these transducers exhibited a minimum measurable force 




Figure 5-3 A) CAD rendering of transducer, highlighting key functional features. B) 
Ten locations around the annular circumference in which Suture Force Transducers 
were placed (dotted line distinguishes anterior from posterior regions). C) Example 
of fully instrumented ring. D) Schematic of implanted ring with suture force 
inducing transducer deformation and detectable signal.  
 
5.1.1.3 Suture Force Transducer Fabrication 
Note, the strain gage manufacturer, Micro-Measurements (Wendell, NC), provides 
extensive documentation on strain gage installation best practices. The interested reader is 
referred to their website (http://www.vishaypg.com/micro-measurements/stress-analysis-
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strain-gages/appnotes-list/). The step-by-step installation process, as it was performed in 
this specific application, and using the materials listed in Table 4-1, is as follows. 
 
Step 1: Strain gage preparation. A clean acrylic surface was prepared by wiping with a 
few drops of M-Prep Conditioner A, then wiping with a few drops of M-Prep Neutralizer 
5A, then dried. Strain gages were extracted from their packaging with tweezers and laid on 
the clean surface. Excess gage backing material that extended beyond the bounds of the 
wiring was removed with a fresh razor blade. A piece of PCT-2M Gage Installation tape 
was laid over each gage (aligning the major axis of the gage with that of the tape) until 
further use. 
 
Step 2: Spring element surface preparation. The surface of the spring element was wetted 
with M-Prep Conditioner A, sanded with 400 grit sandpaper, and wiped dry with gauze. A 
few drops of M-Prep Neutralizer 5A were then added to the surface, and dried thoroughly 
with fresh gauze. Further physical handling of the spring element was avoided.  
 
Step 3: Strain gage alignment. The gage was lifted from the acrylic surface by delicately 
peeling the tape back from one edge. Next, the tape and gage were centered over the 
bonding area of the spring element, and the tape was “hinged” along the bottom edge of 
the spring element, such that the gage could be repeatably peeled back and returned to its 
proper position with ease.  For each set of 10 transducers, five each were made with the 
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solder terminals oriented to the left and to the right. This supported easier harnessing of the 
wires in preparation for attachment to the ring (described further in Step 9 and in Section 
5.1.1.4).  
 
Step 4: Strain gage adhesion. The tape was peeled back such that it remained hinged along 
the spring element’s edge, and the bonding surfaces of both spring element and gage were 
exposed. M-Bond 200 catalyst was lightly brushed in one continuous layer across the 
underside of the gage (after wiping the brush 8-10 times along the edge of the bottle to 
remove most of the liquid). After allowing ~30 seconds for the catalyst to air dry, one drop 
of M-Bond 200 adhesive was applied to the spring element’s bonding surface. As quickly 
and precisely as possible, the gage was laid back down over the adhesive, taking care to 
maintain proper alignment. The glued surfaces were pressed together under firm finger 
pressure for 5 minutes and left at rest to cure further for another 20 minutes or more. 
Finally, the tape was peeled straight back along the spring element’s surface, shearing 




Figure 5-4 From left to right: post-Step 3, post-Step 4. 
 
Step 5: Strain gage wiring. Each solder terminal was tinned, by first depositing a tiny drop 
of flux to the terminal, then depositing a round spot of solder. Next, a 5’ length of three-
stranded 336-FTE wire was slightly unwound and a miniscule length of outer Teflon 
coating was burned away to expose the metallic interior. One wire was bonded to each 
terminal. 
  
Step 6: Rosin removal. M-Line Rosin Solvent was used to remove excess rosin from the 





Step 7: Application of strain gage mechanical protectant. A thin layer (<0.5 mm) of Loctite 
E-120HP epoxy was applied over the entire spring element bonding face, covering gage, 
solder terminals, and a short span of each wire. Cure time was at least 36 hours. 
 
 
Figure 5-5 From left to right: Post-tinning (part of Step 5), post-Step 6, post-Step 7. 
 
Step 8: Application of strain gage moisture protectant. A thin layer of nitrile rubber sealant 
was applied directly atop the mechanical protectant layer. After 2 hours of curing, if any 
visible gaps were detected, a second coat was applied, with another cure time of 2 hours. 
 
Step 9: Final treatments for wiring. For each annuloplasty ring to be instrumented, two 
groups of five transducers were bundled within heat-shrink tubing. Each group’s 15 wires 
were drawn through a length of tubing, by transiently tying them with thin suture to a 0.5 
mm diameter braided metal wire, and carefully guiding the wire through the tubing. Note 
that, per Step 3, each transducer had wires extending to either its left or its right. Thus, one 
 66
group contained two left-facing and three right-facing transducers (or vice versa), and the 
other group contained the opposite. 
Next, the free ends of the wires were burned to expose ~2-3 mm of their metallic 
cores, and each wire was soldered into a pin or sleeve (corresponding to the gender of the 
plug to which it would ultimately be mated). Groups of pins or sleeves were inserted into 
their respective housings. Tubing was shrunk with a standard heat gun. The tubing end 
proximal to the gages was occluded with nitrile rubber, to prevent filling with blood during 
in vivo use. The backs of the electrical connector housings were covered with silicone to 
provide some mechanical cushion against accidental tugging.  
 
Figure 5-6 Left: Full set of 10 transducers after fabrication is complete. Center: 
Close-up of one transducer. Right: Electrical connectors for one set of transducers. 
 
5.1.1.4 Suture Force Transducer Attachment to Rings 
Ten Suture Force Transducers were attached to each annuloplasty ring of interest, at the 
positions shown in Figure 5-3 A) CAD rendering of transducer, highlighting key functional 
features. B) Ten locations around the annular circumference in which Suture Force 
Transducers were placed (dotted line distinguishes anterior from posterior regions). C) 
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Example of fully instrumented ring. D) Schematic of implanted ring with suture force 
inducing transducer deformation and detectable signal. B-C (i.e. 4 anterior, 6 posterior 
transducers). Using the method pictured in Figure 5-7, each transducer was tied around the 
ring’s minor circumference using 2-0 suture. Its position was secured either by passing the 
suture through the ring’s fabric suture cuff (for commercial rings) or by passing the suture 
around the ring and resting it in dedicated grooves, supported by a spot of cyanoacrylate 
glue to bond suture to ring (for prototype rings; see Section 0). Each mounting suture was 
tied with three knot throws, which were further secured with a spot of cyanoacrylate glue 
atop the knot. 
 
Figure 5-7 Method used to secure a Suture Force Transducer to Physio and Profile 
3D annuloplasty rings. Sutures passed through the fabric suture cuff to prevent 
slippage. Not shown: for prototype rings, which did not include a suture cuff, 
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sutures were instead passed around the ring’s minor circumference, along the same 
path shown. Sutures then rested in dedicated grooves to prevent slippage. 
 
5.1.1.5 Suture Force Transducer Calibration 
To calibrate the Suture Force Transducer, it was first detached from the annuloplasty ring. 
A loose loop of suture was passed through the transducer’s measurement arm and through a 
table with two holes positioned to match the device’s annular suture passages. The loop was 
knotted tightly to prevent any slippage. A small piece of tape secured the transducer’s ring-
mounting feature to the table. Five weights ranging from 0.5-10 N were each suspended from 
the suture loop beneath the table, three times apiece. The voltage vs. force curve was computed; 
R2 was greater than 0.99 in all instances.  
Note, transducers were calibrated before and after each in vivo use, to account for 
any changes in their sensitivity that may have occurred during use. When analyzing each 
in vivo data set, force values were generated according to the averaged calibration factors 
from before and after that experiment.  
 
5.1.2 Prototype Annuloplasty Rings: Concept, Production, and Characterization 
5.1.2.1 Reverse Engineering of Commercial Ring Geometry 
Step 1: Commercial ring imaging. Physio and Profile 3D rings (each of sizes 24, 26, and 
28) were subjected to micro-computed tomography imaging using a Siemens Inveon 
Scanner (Siemens Medical Solutions USA, Inc., Malvern, PA), tuned for metal 
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visualization (80 kV voltage, 500 mA, 500 msec integration time) at 43.29 μm isotropic 
voxel resolution. Raw output files were converted to DICOM format offline using Inveon 
Research Workplace (Siemens Medical Solutions).  
 
Step 2: Commercial ring geometry segmentation, triangulation, and refinement. DICOMs 
were segmented to yield the volume corresponding to the ring’s metallic core using 
InVesalius (São Paulo, Brazil). For the Physio ring, the multiple, closely packed Elgiloy 
strips were resolved as a single, closed tube. The resulting triangulated mesh was refined 
using Geomagic Studio 2014 (3D Systems, Cary, NC). Both global functions (Relax and 
Remove Spikes) and manual deletion of erroneous triangles were employed to generate a 
smooth ring surface. In preparation for Step 3, a short segment of the ring was deleted using 
the Trim With Sheet function, converting the surface from a closed tube to an open tube. 
The final geometry was saved as an .stl file.  
 
Step 3: Commercial ring centerline extraction and refinement. Next, the centerline 
describing this .stl file was computed using the Vascular Modeling Toolkit, or VMTK, and 
its GUI interface PypePad (www.vmtk.org). This was achieved using the following line of 
code: 
vmtksurfacereader -ifile InputFilePath/InputFileName.stl  --pipe vmtkcenterlines  
-seedselector openprofiles -ofile OutputFileName.dat 
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After re-importing the output data to Geomagic, the centerline data was further smoothed 
using the Reduce Noise function. In preparation for ring design, a coordinate system was 
defined based on the centerline’s transverse diameter and best-fit plane as shown below. 
At this point, the centerline was ready to be imported into SolidWorks for ring design. 
 
Figure 5-8 Reverse engineering of commercial ring geometry. From left to right: 
after micro-computed tomography scan; after surface triangulation; after surface 
refinement; after centerline extraction and refinement. 
 
5.1.2.2 Fully Rigid and Fully Flexible Ring Design 
To study the effect of ring stiffness on suture forces, fully rigid and fully flexible rings 
were produced in geometries exactly matching the Physio ring (sizes 24, 26, and 28). These 
were subsequently assessed in comparison to one another and to the semi-rigid commercial 
Physio ring.  
Prototype ring geometry consisted of a 3mm diameter circular profile swept around 
the centerlines that were computed as detailed above. Note, the rings were composed of a 
single material (see Section 4.1.2.2), without the fabric suture cuff that is found in 
commercial rings. Consequently, it was not possible to secure the transducers to the ring 
by passing suture through the ring. Therefore, pairs of grooves (0.6 mm wide, 3.7 mm 
apart, and approximately 0.3 mm deep) were positioned at the sites where each Suture 
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Force Transducer would be attached. These grooves, which occupied only the atrial/inner 
quadrant of the ring’s minor circumference, facilitated repeatable, secure transducer 
attachment, as described in Section 5.1.1.4.  
 
Figure 5-9 CAD Rendering of fully-rigid or fully-flexible ring prototypes fashioned 
in the Physio geometry. Sizes 24, 26, and 28 are shown. Suture grooves for 
transducer mounting are easily visible.  
 
5.1.2.3 Fully Rigid and Fully Flexible Ring Fabrication 
Rigid rings were 3D printed as described in Section 4.1.2.2. Flexible rings were cast from 
a fast-setting silicone with Shore hardness 40A (Quick-Sil; Castaldo; Franklin, MA), using 
the specialized molds described in Section 4.1.2.2. The mold’s cavity matched the 
commercial ring geometry, with a few additional tracts incorporated to aid escape of excess 
silicone during mold closure.  
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Figure 5-10 Left: CAD rendering of mold design. Center: Flexible ring immediately 
after opening mold, before flash removal. Right: Close-up of suture grooves in a 
finished flexible ring. 
 
5.1.2.4 Fully Rigid and Fully Flexible Ring Characterization 
The stiffness levels of rigid, semi-rigid (commercial), and flexible rings were characterized 
through mechanical compression in their septal-lateral directions. Compression testing was 
performed using an ElectroForce 3200 uniaxial tester (Bose Corporation) with 25 N in-line 
load cell (SMT1-22; Interface) with custom holders. Compression ended when the ring’s 
most septal and lateral points moved to within 75% of one their nominal distance (5 mm 
total deflection) or when a load of 7.5 N was reached. Each of these limits are conservative 
representations of in vivo annular function.46, 107 
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Figure 5-11 Mechanical characterization of prototype annuloplasty rings.  
 
5.1.2.5 Hybrid Ring Design 
Based on the findings of SA 1.A and 1.B, materially hybrid rings were designed to include 
rigid anterior and posterior segments, and flexible commissural segments. This putatively 
optimized design was intended to minimize suture dehiscence likelihood without 
compromise to repair efficacy. In light of the known and proposed benefits of saddle ring 
annuloplasty for repair efficacy,45, 122-128 hybrid rings were modelled after the saddle-
shaped Profile 3D geometry. Similar to the homogeneous prototype rings, these rings were 
constructed from a 3 mm circular profile sweep around a computed centerline, with the 




5.1.2.6 Hybrid Ring Fabrication 
Hybrid rings were fabricated via a molding technique similar to that used for the fully 
flexible rings. However, in this case, the two 1 mm diameter titanium inserts were 
embedded within the silicone at the desired locations, as shown in Section 4.1.2.2. 
 
5.1.3 Sample Preparation for In Vitro Studies 
5.1.3.1 Suture Pullout Force Studies  
Beginning with the ovine hearts described in Section 4.1.1.2, the left atrium was trimmed 
until approximately 1-2 cm of tissue superior to the leaflet hinge line remained. The left 
ventricle was removed; leaflets were left attached (with chords removed) to facilitate 
mounting to the test plate. To mount the annulus to the test plate, four simple interrupted 
sutures, followed by a running suture with Ford interlocking stitch, were first passed around 
its outer circumference and through the plate’s rubber layer. Next, ten Y-31 2-0 Ti∙Cron 
sutures (Medtronic) were passed through the same ten positions studied in vivo (see Figure 
5-3 B). Placement adhered strictly to published annuloplasty guidelines (1-2 mm above 
hinge line, 10 mm bite width, minimum 10° between needle and tissue).37 All sutures were 
placed by a single operator. Finally, another running suture with Ford interlocking stitch 
was passed around the inner circumference (i.e. mostly through the leaflet tissue) to further 
secure the annulus to the plate.  
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Figure 5-12 Left and Center: Mitral annulus, before and after explant from the 
heart. Right: Annulus mounted to test plate, after test suture passage (green 
sutures).  
 
5.1.3.2 Collagen Quantification Studies 
These tests again used the ovine hearts described in Section 4.1.1.2; note this was a distinct 
cohort of hearts than those used for suture pullout testing. Tissue sections were excised 
from the mitral annulus at each of four positions: LT, RT, 12 o’clock, and 6 o’clock. They 
were paraffinized, sectioned to 30µm (circumferential direction), and mounted on slides, 
all per standard protocol. Slices were roughly 5x3mm in the apical-basal and radial 




Figure 5-13 Region of the annulus subjected to collagen quantification testing. Left: 
30 μm thick slices were prepared as shown (blue plane). Right: Blue box highlights 
the same annular region in a histologic image (adapted from Angelini et al41). 
 
5.1.4 Experimental Protocols 
5.1.4.1 Cyclic Suture Force (In Vivo) Studies 
Normal Dorsett hybrid sheep were intubated, anesthetized, and ventilated with isofluorane 
(1.5-2%) and oxygen. Surface electrocardiogram and arterial blood pressure were 
monitored. 2D, 3D, 2D color Doppler, and pulsed-wave Doppler ultrasound imaging were 
used to assess mitral geometry and hemodynamics (iE33 ultrasound machine with x7-2 
matrix-array probe; Philips Health Tech, Andover, MA). After establishing 
cardiopulmonary bypass, a left atriotomy was performed. The annulus was sized and a ring 
was selected (either true-sized or undersized by two full ring sizes). Ten Y-31 2-0 Ti∙Cron 
sutures were passed through the annulus at the four anterior and six posterior positions 
shown in Figure 5-3 B (simple interrupted). Each suture was then passed through the 
implantation holes of the Suture Force Transducer at the appropriate position on the ring 
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of interest. Prior to tying the ring into the mitral annulus, all transducer signals were zeroed. 
Each suture was then tied, using six knot throws, in the following order: left trigone, right 
trigone, then clockwise from 11 o’clock.  
 Following left atrium closure and weaning from cardiopulmonary bypass, the 
pressure transducer was passed through the femoral artery to the left ventricle for 
continuous measurement of LVP. Surface electrocardiogram, LVP, and arterial pressure 
were monitored. All ultrasound image types were acquired upon re-establishment of 
baseline hemodynamics (100 mmHg peak LVP, 4.0 L/min cardiac output). To evaluate the 
effects of increasing afterload, peak LVP levels of 125 and 150 mmHg were subsequently 
achieved. Elevated peak LVP was achieved using a continuous infusion of neosynephrine 
and dobutamine. After data collection, the animal was euthanized via injection of 80 mEq 
KCl. The heart was explanted and examined to verify sutures were placed correctly and 
remained intact. 
 All suture force and LVP data was recorded at 1613 Hz. In the first 10 studies (SA 
1.A and part of 1.B), data was recorded only during key events. Thereafter, the data 
acquisition software was modified, such that this data could be recorded continuously from 
before suture tie-down until after ring removal.   
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Figure 5-14 Left: Ring being lowered into atrium. Top right, Bottom right: LA view 
and LV view, respectively, during ring inspection after euthanasia. 
 
5.1.4.2 Suture Pullout Force Studies  
The valve, mounted on the test plate, was loaded onto the uniaxial testing system. The 
fixture was attached to the lower testing arm in line with the load. Each suture was 
sequentially tied to the upper arm and pulled at 1 mm/sec until it tore through the tissue or 
until the upper arm reached its maximum displacement (13 mm). The test plate’s biaxial 
traverse enabled each suture to be positioned directly beneath the testing arm and pulled 
normal to the annulus. In terms of native MV geometry, this pulling was approximately 
radially inward, i.e. the approximate direction of suture tension following undersized 
annuloplasty in vivo. Throughout testing, MVs were kept topically hydrated with 0.75% 
saline spray.  
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Figure 5-15 Left: Patient CT scan (adapted from Cuéllar et al129), highlighting the 
annular orientation and the radially inward direction that an undersized ring would 
pull the annulus (red arrows). Center: Sketch demonstrating that the geometric 
transform associated with valve mounting for suture pullout testing re-orients this 
force to the upward direction. Right: Suture pullout testing in action. 
 
5.1.4.3 Collagen Quantification Studies 
Each sample was imaged via two-photon excitation, at 10X, using an 800 nm excitation 
wavelength. Collagen was detected in one channel at 390-420 nm via second harmonic 
generation from the fibers,130 while non-specific extracellular structures were detected in 
another channel at 485-700 nm. To maximize sensitivity and accuracy in assessing relative 
differences in microstructure, identical microscope acquisition settings (gain and offset) 
were used for each sample from a given MV. Among the four samples from each given 
MV, the sample with the strongest signal from either channel was identified. Settings were 




5.1.5 Data Processing and Experimental Endpoints 
5.1.5.1 Cyclic Suture Force (In Vivo) Studies 
Recorded data were processed offline using custom MATLAB scripts (MathWorks, 
Natick, MA). The primary endpoint was the cyclic contractile force (FC) on each suture. 
FC was computed as the difference between the minimum and maximum force recorded 
within a cardiac cycle (averaged over 10 consecutive cycles). Secondary endpoints across 
all studies included:  
 Trans-mitral pressure gradient increase:  Difference between gradient after ring 
implantation and gradient at baseline. This quantity was computed from Doppler 
ultrasound recordings for each experiment.  
 LVPmax: Peak LVP. LVPmax was averaged over 10 cardiac cycles for every FC data 
point. 
 Heart rate: 1/T, where T was the cardiac cycle length as measured in the associated 
LVP waveform.  Heart rates were averaged over 10 cardiac cycles for every FC data 
point. 
Two additional secondary endpoints were studied specifically during studies of ring 
stiffness (part of SA 1.B and SA 1.C). These were investigated due to their potential to 
uncover mechanisms underlying stiffness-related FC dynamics. They were: 
 FC,Ant/FC,Post: The ratio of mean anterior to mean posterior FC, computed at each 
LVPmax level for each experiment.  
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 HWHMnorm: An expression of the proportion of the cardiac cycle during which each 
suture experienced load increase. This proportion was studied as the leading half-
width at half-maximum (HWHM) force, normalized by cardiac cycle length, T: 
  (3) 
Here, t2 is the instant of maximum force, and t1 is the preceding instant of half-
maximum force.  This concept derives from full-width at half-maximum (FWHM), 
a well-established parameter for the description of peaks in waveforms that lack 
sharp edges.131, 132 HWHM is a modified parameter that is used to describe of one 
side of an asymmetric peak.133, 134 In this study, HWHMnorm refers to the leading 
half of the suture force wave; it thus describes the suture force response to 
ventricular contraction, while neglecting any minute increases in FC that may 
precede ventricular contraction. Larger HWHMnorm values indicated that FC takes 
a longer time to manifest. 
The following figure graphically describes many of the above quantities.  
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Figure 5-16 Graphical depiction of the experimental endpoints based on force and 
LVP recordings. 
 
5.1.5.2 Suture Pullout Force Studies  
The suture pullout force (FP), which can also be thought of as the suture holding strength 
of the tissue, was defined as the maximum recorded force. In the infrequent event that the 
testing arm reached maximum displacement before complete pullout occurred, the final 
(peak) load was used as FP; this provided a conservative approximation of the true FP.  
 To estimate suture dehiscence likelihood, a margin of safety, termed residual 
strength (RS), was computed for each suture position as the difference between mean FP 
and mean FC at LVPmax = 150 mmHg . This elevated LVPmax was chosen as a worst-case 





5.1.5.3 Collagen Quantification Studies 
Mean pixel intensity (MPI) in each channel was quantified over the entire sample area via 
a custom MATLAB code. Before averaging across samples, each MPI was normalized by 
the mean MPI from that valve. That is, for the normalized MPI (nMPI) from valve i, 







5.1.6 Statistical Analysis 
5.1.6.1 Analysis of Variance (ANOVA) Primer 
The central statistical tool used in SA 1 for evaluating the multi-factorial dynamics of the 
observed suture forces and tissue properties was Analysis of Variance (ANOVA). ANOVA 
is a form of hypothesis testing, with many similarities to the more well-known Student’s t-
test. However, whereas the t-test is only able to test differences between two groups, 
ANOVA has no such limit. A one-way ANOVA accounts for multiple levels of (i.e., 
categories within) a single factor. Multi-way ANOVA accounts for multiple levels of 
multiple factors, and may also test for significant interactions between factors. ANOVA 
determines the expected contributions to the observation due to each level of each factor.  
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For example, consider a two-way ANOVA model describing the sensitivity of FC 
to LVPmax (from the three possible levels tested here) suture position (from the ten positions 
tested here). If two-factor interaction is included, this model would be written as: 
 , 	 	  (5) 
FC,ijk refers to the kth FC observation having LVPmax level i and suture position j. FC,ijk is the 
sum of: μ0, the grand mean FC across all observations; αi, the contribution to FC due to 
LVPmax level i, βj, the contribution due to suture position j; (αβ)ij, the contribution due to 
interaction between LVPmax level i and suture position j; and εijk, the residual error in the 
observation.  
 The assessment of significance of each factor (as a whole) is made according to that 
factor’s F-value (a ratio of the variance between groups to the variance within groups) and 
accompanying p-value. Pairwise comparisons between any two levels of a single factor can 
also be made. However, this leads to the multiple-comparison problem: the larger the 
number of pairwise comparisons, the greater the risk of erroneous findings. A range of 
post-hoc corrections are commonly used to effectively compensate for this risk. It is also 
critical to note that ANOVA requires certain assumptions about the data to be met. These 
include normality of the model’s residuals, independence of observations, and 
homogeneity of variances among groups. For further information on ANOVA and related 




5.1.6.2 Analyses Used 
All statistical analyses were performed using MATLAB and/or Minitab (Minitab Inc., State 
College, PA). For hypothesis tests between two groups, Student’s t-test was used. 
However, as noted above, the central statistical tool was the one-way or multi-way 
ANOVA. FC, HWHMnorm, FP, RS, and nMPI were each treated as the dependent variable 
in various ANOVA models. Independent variables in these models included combinations 
of LVPmax, ring type, ring size, and suture position or suture region, as appropriate for the 
specific questions of interest. For multi-way ANOVAs, each model was run first without 
interaction terms to assess main effects, then with all possible two-factor interactions. 
Tukey’s Honestly Significant Difference post-hoc correction was used in all cases to test 
for pairwise differences. Each ANOVA model is detailed in Table 5-1. 
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Table 5-1 ANOVA models used in SA 1. 
Sub-aim Model 
Dependent 
Variables Independent Variables 
SA 1.A 
1 FC LVPmax, suture position 
2 FC LVPmax, suture region* 
3 FP suture position 
4 
nMPI (collagen),  
nMPI (non-specific 
fibers) suture position 
 
5 FC 
LVPmax, ring type, ring-annulus 
size, suture position 
6 FC 
LVPmax, ring type, ring-annulus 
size, suture region* 
SA 1.B 
7 FC 
LVPmax, suture position, ring 
stiffness 
8 FC 
LVPmax, suture region*, ring 
stiffness 
9 FC,Ant/FC,Post LVPmax, ring stiffness 
10 HWHMnorm 
LVPmax, suture region, ring 
stiffness 
*sutures grouped into regions as anterior (including left trigone, 11 o’clock, 1 o’clock, 
and right trigone) or posterior (including 3-9 o’clock). 
 
 Additionally, in order to test the causal relationship between collagen content and 
suture dehiscence likelihood, RS and nMPI were correlated. To facilitate this correlation, 
12 o’clock and 6 o’clock RS were estimated by averaging their two closest positions (11 




5.2 Specific Aim 2 Methods 
5.2.1 Establishment of Target Dimensions for Devices and Heart Selection Criteria 
Two key measurements of the mitral annulus were used as heart selection criteria 
throughout SA 2, for mock TMV plug dimensions, and for REFT dimensions: inter-
trigonal distance and total perimeter. These parameters were chosen for three primary 
reasons. First, each is an established descriptor of the mitral annulus for TMVR sizing.136, 
137 Second, inter-trigonal distance is also the standard annular dimension used for 
annuloplasty ring selection (and is therefore most relevant to SA 1).69, 138  Third, it was 
essential to control for perimeter in these studies, as they aimed to investigate phenomena 
occurring at the perimeter (i.e. paravalvular leak and radial force). 
To establish the specific inter-trigonal distances and perimeters of interest, a 
preliminary assessment of the available hearts was performed.  The assessment determined 
(a) the range of sizes commonly available from the slaughterhouse, and (b) the correlation 
between annular perimeter and inter-trigonal distance. Mitral annuli from 10 hearts were 
sized in terms of their perimeter (measured by photogrammetry using a ruler and 
MATLAB) and inter-trigonal distance (measured with an annuloplasty sizing tool from 
Edwards LifeSciences).  
A strong linear relationship was found (perimeter = 3.866*(inter-trigonal distance) 
– 7.548; R2 = 0.863). Using this relationship, it was determined that selected hearts would 
have mitral annuli with inter-trigonal distance of 30 mm, and perimeter as close as possible 
to 108.4 mm.  
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Accordingly, mock TMV plugs and REFTs were designed for true-sized and 
oversized geometries as given in Table 5-2. Another key aspect of these devices was the 
cross-sectional shape of their annulus-contacting regions. For circular devices this was 
trivial. For D-shaped devices this shape was based on published images of the Tiara TMV 
(Neovasc, Richmond, Canada; as shown in Figure 5-17). Its inter-commissural (IC) to 
septal-lateral (SL) diameter ratio was 1.30. Based on the best available images for Tendyne 
(Abbott Laboratories, Chicago, IL) another D-shaped TMV, its IC to SL diameter ratio is 
similar. 
 
















+0 108.4 30 34.5 28.8 37.5 
+2 116.2 32 37.0 30.8 40.2 
+4 123.9 34 39.4 32.9 42.9 




Figure 5-17 D-shaped profile design. Left: overlaid published images of the Tiara 
stent design139 and a manufactured Tiara valve.140 Right: Spline fit to Tiara profile. 
 
5.2.2 Mock TMV Plugs: Design and Fabrication (SA 2.A) 
5.2.2.1 Mock TMV Plug Design 
Mock TMV plugs were designed for use in PVL studies. These devices featured three key 
components, shown in Figure 5-17 and further explained below. 
 
Figure 5-18 CAD renderings of mock TMV plug (side and top views) and collection 
funnel used for handling plug and directing leakage flow toward a spill plate. a) 
Annulus-contacting region (with polyester fabric skirt, height 20 mm). b) 
Ventricular cage (height 23 mm, minimum OD 15 mm). c) Screw connection 
(threading not shown).  
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Annulus-contacting region. This was a straight, circular or D-shaped section, 20 mm in 
height. This height was selected for two reasons. First, 20 mm would slightly exceed the 
range of annular saddle heights (14-18 mm) anticipated based on prior experience with the 
same supply of hearts, allowing the device to contact the entirety of the annulus. Second, 
this height approximately matches that of some existing TMVR stent designs (e.g., 19 mm 
in a device originally reported by Young et al141). This region was wrapped with a polyester 
fabric designed for cardiovascular devices.  
 
Collection funnel. This additional tool was 3D printed, acetone vapor-polished, and 
threaded through the same techniques as the plugs themselves. It was designed to quickly 
screw into any given plug, and to serve two functions. First, it enabled easy handling of the 
plugs during deployment. Second, it captured the bulk of spray resulting from leakage flow, 
neatly routing it toward a spill tray. 
 
Ventricular cage. This region featured a wide-cell mesh that served to transiently prop the 
native leaflets open (rendering their seal incompetent) during device deployment. Its 
dimensions were empirically derived and held constant across all plug designs. As 
illustrated in Figure 5-19, this feature was necessary because the hearts used in this study 
were healthy, and the mitral leaflets, when closed, exhibited redundant coaptation length. 
In the absence of this cage, the leaflets extended far enough across the plug to maintain a 
seal. In this event, no PVL would occur because the annulus was not exposed to fluid at 
all. The cage held the leaflets open without pressing on the left ventricular wall. 
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Figure 5-19 Rationale for the ventricular cage feature in the mock TMV plugs.  
Cage transiently rendered the mitral leaflets incompetent, enabling fluid to reach 
the annulus-contacting region and thus enabling PVL quantification.  
 
5.2.2.2 Mock TMV Plug Fabrication 
After 3D printing and acetone vapor-polishing the plug, it was wrapped with laser-cut 
polyester fabric. The fabric was adhered using a thin layer of RTV silicone.  
 
5.2.3 Steady Back-Pressure Test System: Transducer Calibration 
5.2.3.1 Pressure Transducer Calibration 
The pressure transducer output a voltage in response to an applied pressure. It was 
calibrated by applying at least six known pressures ranging from -40 to 220 mmHg using 
a Delta-CalTM pressure transducer simulator/tester (650-950, Utah Medical) and recording 
the voltage response. This relationship was highly linear, with R2>0.99 in all instances.  
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5.2.3.2 Flow Transducer Calibration 
The flow probes output a voltage in response to an applied flow rate. They were calibrated 
by applying at least six known flow rates ranging from 2 to 200 ml/sec using a hydrostatic 
pressure head and recording the mean voltage response during this period. This relationship 
was highly linear, with R2 > 0.99 in all instances. 
 
Figure 5-20 Setup for flow probe calibration across a range of flow-rates. Known 
flow-rate was derived from measured flow-through volume and measured flow 
interval. Flow interval and transducer output voltage were both determined via 
MATLAB. 
   
5.2.4 Radial Expansion Force Transducers: Design, Fabrication, and Characterization 
(SA 2.B) 
Note, a review of basic strain gage principles is presented in Section 5.1.1.1. 
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5.2.4.1 Radial Expansion Force Transducer Design 
In this work, a dedicated force transducer was designed, manufactured, and instrumented 
with strain gages. As in the case of SA 1’s Suture Force Transducers, strains in this system 
were not, themselves, of interest. Instead, the system was calibrated such that forces of 
interest could be measured, as described below. 
The fundamental concept of the REFT was for a set of four arms, housed within a 
central hub, to be placed within the mitral annulus of an explanted porcine heart, then 
driven radially outward by a central piston. The radially inward, resistive force imparted to 
the arms by the tissue could be detected using strain gages installed on each arm. Arms 
were located at 12, 3, 6, and 9 o’clock (with 12 o’clock representing the mid-anterior 
annulus). By averaging of the signals at 12 and 6 o’clock or 3 and 9 o’clock, forces along 
the septal-lateral (SL) or inter-commissural (IC) axes were obtained. Arms would extend 
along a pre-determined path, tracing out either a circular or a D-shaped profile of the same 
dimensions studied in SA 2.A’s PVL experiments. The C-REFT and D-REFT designs were 
nearly identical, differing only as needed to generate the target profiles. The components 
of the assembly were as follows. Note, REFT performance is discussed in Section 7.2.2.1. 
 
Arms. Each arm was composed of an annulus-contacting pad and a straight shaft (Figure 
5-21). The pad’s height was 20 mm, matching the height of the annulus-contacting region 
in the mock TMV plugs used for PVL studies. The pad occupied 23.7 mm of annular 
perimeter. Thus, total contact area of each pad was 474 mm2. The shaft had a step region. 
This allowed application of strain gages, wiring, and coatings, without increasing the 
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shaft’s maximum height. This made it possible to pass the instrumented arms through the 
hub during initial assembly. The shaft’s piston-contacting face had a pitch matching that 
of the corresponding face on the piston.  
Each arm used four strain gages, two each on top and bottom, with each pair aligned 
orthogonally and wired in a full-bridge configuration (type III, as described in National 
Instruments white paper 3642; http://www.ni.com/white-paper/3642/en/#toc3). This 
configuration improved strain sensitivity, eliminated temperature sensitivity, and 
eliminated any response due to bending (thus isolating compression/extension).  
While all four arms were identical for the C-REFT, the asymmetry in the D-REFT 
profile led it to possess four unique arms. Also, because the 23.7 mm pad perimeter was 
held constant across all arms, the 3 and 9 o’clock arm shafts of the D-REFT were each 
rotated 13° posteriorly from the IC axis. The 13° rotation implied a 2.6% differential 
between measured forces at 3 or 9 o’clock and their components in the IC direction. This 
is an acknowledged design limitation, which is considered negligible in light of (a) the 
small magnitude of the differential, and (b) the likely similar resistive force facing the 
chosen arm design and a theoretical, alternate design in which the 3 and 9 o’clock arms 




Figure 5-21 From left to right: C-REFT arms, D-REFT arms, and one C-REFT arm 
from side view. Blue contours depict target profiles for +6 size; arms sat along this 
profile after piston was fully depressed. Arms were positioned at 12, 3, 6, and 9 
o’clock. 
 
Piston. The piston was comprised of a steel rod and a plastic wedge, which were 
permanently bonded together at a precise position to enable the desired annular oversizing 
levels. The user operated the REFT by depressing the piston toward the LV apex, which 
drove the wedge between the arms and slid them radially outward into the MV annulus. 
Four pinholes were cut in the rod. A pin could be passed through the cap and any hole in 
the rod to lock the REFT to the +0, +2, +4, or +6 configuration. The wedge’s total height 
was 25.9 mm (C-REFT) or 22.4 mm (D-REFT). The spacing between pinholes was 7.0 (C-
REFT) or 5.8 mm (D-REFT).  
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Figure 5-22 From left to right: C-REFT piston and D-REFT piston. The wedge 
(orange) was permanently bonded to the rod.  
 
Hub (with screw extender). 
The REFT hub’s key features were holes for each arm to slide through, a cavity that housed 
and stabilized the piston, and seats for the cap. Additionally, an aluminum screw extender 
was permanently bonded to the hub. As further explained in 5.2.5.2, the screw and tapered 
region of the hub were passed through the MV annulus, and the base plate was screwed 
onto the extender until flush with the LV’s cut surface. Further, the hub possessed tabs for 
mounting to the calibration apparatus.  
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Figure 5-23 From left to right: Full and section views of C-REFT hub, and full and 
section views of D-REFT hub. a) arm holes, b) taper to ease passage through MV 
and into LV, c) permanently bonded ½”-20 screw extender to secure REFT to base 
plate at optimal height for each heart, d) open channel for piston rod, with narrow 
entry to obstruct piston wedge from over-depression, e) seats for cap, f) mounting 
tabs for calibration apparatus.  
 
Cap. The cap’s function was to both stabilize the piston and provide a way to set the piston 
(and, in turn, the arms) to target positions. The piston was free to glide up or down through 
the cap, and a pin could be passed through the cap and any desired hole in the piston rod 
to establish +0, +2, +4, or +6 sizing. The cap was not permanently fixed to the hub, so that 
the piston could be removed and lubricant re-applied between uses. Strain gage wiring 
easily passed out of the hub between the spokes of the cap. 
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Figure 5-24 From left to right: C-REFT cap and D-REFT cap. The cap was pressed 
firmly onto the hub during use, held securely within seats in the hub. The piston 
could glide freely through the cap.  
 
 
Figure 5-25 Full and section views of the fully-assembled C-REFT (left) and D-
REFT (right) designs. 
 
5.2.4.2 Radial Expansion Force Transducer Fabrication 
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To assemble the REFT, the 1/2”-20 threaded aluminum rod was first prepared by drilling 
a 1.5” hole with a W bit on a lathe and cutting the total length to 2.5.”  The open end was 
bonded to the groove in the underside of the hub, using Loctite 4014 adhesive. Next, the 
piston rod was cut from the steel sheet using a water jet; lines were lightly etched to 
demarcate where the wedge would sit. Before bonding the wedge to the rod, the cap was 
passed onto the rod from the bottom, past the bonding site for the wedge. The wedge was 
carefully bonded into place using Loctite 4014 adhesive. Next, the strain gages were 
installed, using the protocol that follows. 
 
Steps 1-4: Strain gage preparation; spring element surface preparation; strain gage 
alignment; strain gage adhesion. These steps were identical to Steps 1-4 for Suture Force 
Transducer fabrication; see Section 5.1.1.3. After completing Steps 1-4 for the upper gages, 
Steps 1-4 were repeated for the lower gages. For correct strain measurement, it was critical 
that the solder terminals faced opposite directions for the top and bottom gages (this 
ensured that gages directly on top of one another had the parallel pattern alignment). 
  
Step 5: Strain gage wiring. Each solder terminal was tinned, by first depositing a tiny drop 
of flux to the terminal, then depositing a round spot of solder. Next, a 4’ length of three-
stranded 336-FTE wire was slightly unwound and a miniscule length of outer Teflon 
coating was burned away to expose the metallic interior. Wires were bonded to each 
terminal, using the pattern indicated by National Instruments for use with the strain sensing 
tool within LabVIEW (for Type III Full-Bridge configuration). The wires were oriented 
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backwards overtop of the gage; this allowed more of the wire to be trapped under the 
protective coating, and relieved strain on the solder terminals when passing the 
instrumented arm through the hub. 
 
Step 6: Application of strain gage dual protectant. Using a thin piece of steel wire as an 
applicator, a small amount of Loctite 3321 UV-curable adhesive was deposited atop one 
edge of the gage and immediately cured using a UV light wand. Care was taken to ensure 
the adhesive did not extend beyond the edges of the surface on which the gage was 
attached. More adhesive was applied and cured in additional small increments, until the 
gage and wire terminals were well-coated. This coating provided both mechanical and 
moisture protection. After completing Steps 5-6 for the upper gages, Steps 5-6 were 
repeated for the lower gages. 
 
Figure 5-26 Post-Step 6. Clear UV-curable adhesive was carefully applied to 
encapsulate each gage and wire terminal. 
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Step 7: Final treatments for wiring. Next, each arm was guided carefully into the hub and 
wires were externalized through its top. Each arm’s wires were carefully adhered to the 
wall of the hub using UV-curable adhesive. The 12 and 3 o’clock wires and the 6 and 9 
o’clock wires were each bundled within heat-shrink tubing. Their twelve wires were drawn 
through lengths of tubing, by transiently tying them with thin suture to a 0.5 mm diameter 
braided metal wire, and carefully guiding the wire through the tubing. 
Next, the free ends of the wires were burned to expose ~2-3 mm of their metallic 
cores, and each wire was soldered into a pin or sleeve (corresponding to the gender of the 
plug to which it would ultimately be mated). Groups of pins or sleeves were inserted into 
their respective housings. 
 
Figure 5-27 (A-B) Completed C-REFT and D-REFT, with cap and piston removed, 
and arms fully retracted, for clarity. (C-D) Completed C-REFT with cap and piston 




5.2.4.3 Radial Expansion Force Transducer Calibration 
To enable the measurement of TMV radial expansion forces within the MV annulus, the 
electrical outputs of the strain gages adhered to the REFT arms were calibrated within a well-
defined calibration apparatus (Figure 4-12). The REFT was first loaded into the calibration 
apparatus using four #3-48 screws passed through the hub’s dedicated mounting tabs and 
through the calibration apparatus. The assembly was submerged in a water tank heated to 
37 ± 2 °C.  The REFT piston was depressed to move the arms to the +6 position (helping 
the arms to engage the screw-piston-spring-pusher assembly shown in Figure 4-13). With 
the LabVIEW program running, each screw was tightened one full rotation past the point 
at which a strain response was first detected. This ensured each arm was fully engaged with 
its pusher. All strain signals were zeroed.  
Calibration was then performed as follows. Both arms along a given axis were 
calibrated simultaneously by alternately applying force on each arm. For example, when 
calibrating the 12 and 6 o’clock arms, the 12 o’clock screw was turned 360°, then the 6 
o’clock screw was turned 360°, then 12 o’clock, etc., until reaching 14 full turns (7 per 
screw). Each turn applied 4.44 N along the axis, thus, peak loading was 62.16 N (this 
loading range was determined based on preliminary testing). This process was repeated 
four times per axis, alternating which screw was turned first. The voltage vs. force curve 
was computed; R2 was between 0.976-0.999 in all instances. 
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Note, transducers were calibrated before and after use, to account for any changes 
in their sensitivity that may have occurred during use. During data analysis, force values 
were generated according to the averaged calibration factors from before and after use.  
 
5.2.5 Sample and Test System Preparation 
5.2.5.1 Paravalvular Leakage Studies 
Pre-selected hearts (with inter-trigonal distance 30 mm and perimeter approximately 108.4 
mm) were prepared as follows. 
Step 1: Remove unwanted structures. The pre-selected heart was trimmed to remove any 
pericardium, and any large vessels other than the aorta. The aorta was transected proximal 
to the brachiocephalic artery. Both atria were removed, taking care to leave a consistent 
length of tissue (~1-1.5 cm) superior to the mitral annulus.  
 
Step 2: Transect coronary circulation. Heart handling at the slaughterhouse and during 
experimental prep exposed many small coronary vessels which could leak significantly 
when the left ventricle and aorta were pressurized. To resolve this, the left and right main 




Step 3: Attach flow loop fittings. First, the apical port was connected by cutting a hole in 
the apex, passing the inner component through, and screwing on the outer component until 
tight (see Figure 4-10). Next, a barbed 0.75” ID connector tube was placed inside the aorta 
and secured with two cable ties. This tube was modified with a luer port on its side for 
pressure transducer attachment.  
 
Figure 5-28 From left to right: post-Step 2, post-Step 3. a) clamped left main; b) 
clamped right main; c) installed apical port; d) aorta with installed connector; e) 
right ventricle; f) left ventricle. 
 
The flow loop was then prepared as shown in Figure 5-29. R1 and R2 in this diagram were 
ball valves, whose degree of opening modulated LVP. The entire setup was arranged 
overtop a spill tray with drainage line. The apical port was gripped by a clamp 
approximately 24” above the tray, such that the heart was hanging by its apex in an inverted 
orientation. Note, with the ventricle pressurized and the atrial face of the mitral valve 




Figure 5-29 Schematic and photograph of steady back-pressure test system used for 
PVL studies. R1, R2: adjustable resistors; P: pressure transducer; Q1, Q2: flow 
transducers. Leakage flowrate was computed as the difference, Q1 – Q2.  
 
5.2.5.2 Radial Expansion Force Studies 
Pre-selected hearts (with inter-trigonal distance 30 mm and perimeter approximately 108.4 
mm) were prepared as follows. 
 
Step 1: Remove unwanted structures. The pre-selected heart was trimmed to remove any 
pericardium, and any large vessels other than the aorta. The aorta was transected proximal 
to the brachiocephalic artery. Both atria were removed, taking care to leave a consistent 
length of tissue (~2.5 cm) superior to the mitral annulus. 
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Step 2: Transect ventricle(s). A planar cut was made through the left ventricle (typically 
some amount of right ventricle was also cut). The cut was inferior to the papillary muscles 
to avoid disrupting any mechanical interaction between annulus and papillary muscles via 
the leaflets and chordae tendineae. It was also critical that the cut plane was parallel to the 
annulus mid-plane. 
 
Figure 5-30 Left ventricle transected after Step 2. 
  
Step 3: Implant and secure REFT. The heart was pre-assigned to receive either the C-REFT 
or D-REFT. The REFT was implanted by passing the screw through the MV and out the 
left ventricle opening. The acrylic base plate was screwed onto the hub and tightened until 
the LV was supported at optimal REFT positioning. Optimal REFT positioning was 
defined as having the mid-plane of the arms coincident with that of the annulus, and with 
the 12 o’clock arm centered between the left and right trigones. The base plate was then 
placed onto its stand.  
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Figure 5-31 Various views post-Step 3. The REFT has been positioned within the 
heart and then screwed onto the base plate. The base plate has been placed onto its 
stand. 
 
Step 4: Submerge in water bath and pressurize aorta. The heart was submerged in a water 
bath maintained at 37 ± 2 °C. A barbed 0.75” ID connector tube was placed inside the aorta 
and secured with two cable ties. This tube was modified with a luer port on its side for 
pressure transducer attachment. A steady flow loop, used to establish 120 mmHg aortic 
pressure, was prepared as shown in Figure 5-32. R1 and R2 in this diagram were ball 
valves, whose degree of opening modulated aortic pressure. The entire setup was arranged 




Figure 5-32 Schematic and photograph of full REFT setup. R1, R2: adjustable 
resistors; P: pressure transducer. Resistors were tuned to establish 120 mmHg 
aortic pressure. 
 
5.2.6 Experimental Protocols 
5.2.6.1 Paravalvular Leakage Studies (SA 2.A) 
The reservoir was filled with water heated to 37 ± 2 °C. The pump was turned on and held 
to a constant power (70% variac power throughout all experiments), which generated 
approximately 130 ml/sec output. Air bubbles were purged from the tubing, as they would 
otherwise interfere with flow transducer readings. The vertical offset distance between the 
pressure transducer and the MV mid-plane was measured; the associated hydrostatic 
pressure was computed. Within the LabVIEW program, this pressure was input as a 
correction offset, such that the pressure signal would then reflect the true ΔP driving 
leakage flow through the annulus. The annular saddle height at ΔP = 120 mmHg was 
measured. 
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 A repeatable approach for device placement/positioning was used, with a single 
operator performing every deployment. With the operator holding the collection funnel, 
the mock TMV plug was oriented such that the skirt’s seam aligned with the mid-point of 
the anterior annulus (12 o’clock). It was guided past the mitral orifice and into the LV, until 
the mid-planes of the annulus and of the device’s skirt were coincident. Coincidence was 
defined according to the 20 mm skirt height and the pre-measured annular saddle height. 
For example, for a 16 mm saddle, 2 mm of the skirt would extend below the annulus’ most 
basal points (i.e. 12 and 6 o’clock). Finally, the device was gently rocked about its 12 
o’clock to 6 o’clock axis until the maximum possible ΔP was achieved.  
PVL data collection was comprised of multiple “acquisitions.” One acquisition 
entailed deploying a single device with R1 completely closed (i.e., with LVP between 85-
95 mmHg), then toggling R1 and R2 to systematically attain five approximate ΔP targets: 
60 mmHg, 90 mmHg, 120 mmHg, 150 mmHg, and max LVP, i.e. the LVP produced by 
completely closing R1 and R2 (typically 160-200 mmHg). These targets were chosen based 
on ISO guideline 5840-3, which considers ΔP levels of 60, 120, 150, and 180 as the peak 
pressure differentials across a closed mitral valve corresponding to hypotensive, 
normotensive, mild hypertensive, or severe hypertensive states, respectively.112 These 
targets were intentionally only approximate, both to facilitate more rapid data collection, 
and to provide more robust input data to the General Linear Model used to analyze the 
system (see section 5.2.8). Each target LVP was held steady (i.e., the resistors were left 
untouched) for 8 seconds. To provide robustness against potential variation in deployment 
positioning, three acquisitions were collected for each of the eight mock TMV plugs. The 
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sequence of acquisitions was in order of increasing size, alternating circular (C) and D-
shaped (D) devices of each size according to a snaking pattern as shown below: 
Table 5-3 The sequence in which each of the 24 PVL data acquisitions was 
performed in each experiment. Each acquisition was performed with one device, 
having a given size and shape (e.g. D+0, etc). One acquisition consisted of five data 
points at target LVPs.  
Acquisition 1 2 3 4 5 6 … 19 20 21 22 23 24 
Size +0 +0 +0 +0 +0 +0 … +6 +6 +6 +6 +6 +6 
Shape (odd expts) D C C D D C … D C C D D C 
Shape (even expts) C D D C C D … C D D C C D 
 
Throughout the experiment, three key actions were performed at regular intervals. 
These were (a) hydration of the epicardial surface via a water spray bottle, (b) re-filling of 
the reservoir with water at 37 ± 2 °C, and (c) “baseline” recordings covering 5 or more 
LVPs ranging from 50-210 mmHg with no plug in place (so that baseline leakage through 
tubing and/or ports could later be offset from the PVL data, as detailed in Section 5.2.7.1). 
 
Figure 5-33 Representative images of paravalvular leakage experiment. Inset images 
are zoomed in on mock TMV plug extending out from the MV annulus. Left inset 
image is enhanced to improve visibility of leakage flow. Two time points are also 




Figure 5-34 Representative data from a single acquisition, which demonstrates the 
PVL experimental protocol. With the mock TMV plug in place, five ΔP levels were 
established and held as PVL rate was measured. Red lines: average ΔP and PVL 
values over a four-second interval.  
 
5.2.6.2 Radial Expansion Force Studies (SA 2.B) 
Throughout the experiment, the water tank was maintained at 37 ± 2 °C. The pump was 
maintained at a constant power (50-60% variac power); the ball valves were adjusted as 
needed to establish 120 mmHg aortic pressure. 120 mmHg was chosen to replicate the 
aortic pressure during peak systole.  
 Each acquisition began with the pin in place at the +0 size and proceeded as follows. 
After a five second recording, the pin was removed and the piston depressed to establish 
either the +2, +4, or +6 size. The pin was inserted and held in place for five seconds. The 
pin was removed and the piston drawn back to re-establish the +0 size. The pin was inserted 
and held in place for five seconds. 24 acquisitions were collected per heart: eight with 
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expansion to +2, followed by eight with expansion to +4, followed by eight with expansion 
to +6. 
 
Figure 5-35 Representative data depicting the REFT experimental protocol. (a) 
Force signals are zeroed with REFT at +0 size, (b) piston is depressed until the pin 
can be inserted to lock the REFT to the desired expanded size, (c) expanded size is 
maintained for five seconds, (d) +0 size is re-established, (e) +0 size is maintained for 
five seconds. 
 
 After completing all REFT experiments, one additional porcine heart was subjected 
to micro-computed tomography imaging to generate a clear depiction of the anatomical 
features that may underlie the observed force dynamics. The heart had its atria removed, 
and a ring of 20 small sand markers glued to the annular hinge line to delineate it clearly 
post segmentation. These markers and their usage have been described by Pierce et al.142 
Imaging used a Siemens Inveon scanner and Inveon Acquisition Workplace software 
(Siemens Medical Solutions USA, Inc., Malvern, PA), with settings optimized for soft 
tissue visualization (80 kV, 500 mA, 550 ms integration time). Volumes were composed 
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of 43.29 μm isotropic voxels. Following data acquisition, images were analyzed using 
Inveon Research Workplace. 
 
5.2.7 Data Processing and Experimental Endpoints 
5.2.7.1 Paravalvular Leakage Studies (SA 2.A) 
Recorded data were processed offline using custom MATLAB scripts. The primary 
endpoints were the trans-mitral pressure gradients (ΔP) established by adjusting the 
resistors, and their corresponding paravalvular leakage rates (PVL). Five (ΔP, PVL) data 
points were obtained from each acquisition. Each value was computed by averaging 4 
seconds of data.  
PVL values were then corrected for any incidental leakage through the apical, 
aortic, or other connections. This correction made use of the aforementioned baseline 
recordings that did not use a TMV plug. The series of (ΔP, PVL) points from each baseline 
recording were computed, and used to define an incidental leakage curve across the full 
ΔP range. This curve was computed using the Piecewise Cubic Hermite Interpolating 
Polynomial (PCHIP) method. The PCHIP is a “shape-preserving” form of the more 
common cubic spline fit. Unlike splines, PCHIPs enforce monotonicity of each piece. As 
a result, the curve has no overshoots beyond the range of the data points,143 and is thus a 
more conservative model of incidental leakage. Based on the average of the incidental 
leakage curves before and after each mock TMV plug acquisition, an incidental leakage 
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rate at the instant of each (ΔP, PVL) data point was estimated, and subtracted from the PVL 
value. 
Further, it is important to note that the flow probes used here each possessed an 
absolute accuracy of 4% (per manufacturer specifications). PVL was calculated from the 
difference between two flow probe measurements, thus, the theoretical worst case PVL 
uncertainty was 8% of the pump output (i.e., approximately 10 ml). Owing to this error, 
PVL values were occasionally near zero or slightly negative after incidental leakage 
correction. To correct for this, in any experiments for which the minimum PVL recording 
was below 1 ml/sec, all PVL samples from that experiment were offset uniformly, such 
that the minimum PVL recording became 1 ml/sec. 
One of the statistical models used to assess differences in sealing among device 
shapes and sizes did so in a pressure-normalized sense (see Section 5.2.8.2). To achieve 
this, each PVL observation, PVLi was first converted to a unitless quantity, referred to as 






PVLnorm was a key secondary endpoint, which quantified the percent change in pressure-
normalized leakage of each observation, relative to the average value across all 
observations. Results were reflective of the overall sealing performance of each device. 
For example, if PVLnorm for a given device type were 0.1, this would signify 10% more 
normalized leakage across all pressures using this device, as compared to the average 
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device. The use of (ΔP)2, rather than ΔP itself, was based on the empirically observed 
quadratic relationship between PVL and ΔP (described in detail in Section 7.2.1.2). 
PVLnorm enabled comparisons between each device as a whole, rather than specific to a 
given pressure level. 
Additional secondary endpoints included: 
 Inter-trigonal distance: Measured using an annuloplasty ring sizer set (Edwards 
LifeSciences), before and after all PVL measurements. 
 Annular 2-D perimeter and area: Measured by photogrammetry, before and after 
all PVL measurements (Figure 5-36). 
 SL diameter and IC diameter: Measured by photogrammetry, before and after all 
PVL measurements. Measurements were made per current recommendations for 
TMVR.144, 145 A line was first drawn between the trigones. A perpendicular line 
bisecting the inter-trigonal line defined the SL diameter. Another line, 
perpendicular to the SL diameter and passing through the annulus centroid (i.e., the 
SL midpoint), defined the IC diameter (Figure 5-36). 
 Annulus saddle height: Measured directly with a ruler, after mounting the heart and 
pressurizing to ΔP = 120 mmHg. 
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Figure 5-36 Left: Recommended approach for mitral annular sizing for TMVR 
(modified from Naoum et al145). Right: Representative MV used for PVL or REFT 
studies, after measuring relevant dimensions. 
 
5.2.7.2 Radial Expansion Force Studies (SA 2.B) 
Throughout all acquisitions, aortic pressure was maintained at 120 mmHg. Any 
acquisitions in which aortic pressure unintentionally deviated by more than 10 mmHg were 
noted during data processing and discarded. Recorded data were processed offline using 
custom MATLAB scripts.  
The primary endpoints were the septal-lateral and inter-commissural forces (FSL 
and FIC) during each acquisition. FSL was obtained by averaging the force signals at 12 and 
6 o’clock; FIC was obtained by averaging the force signals at 3 and 9 o’clock. Secondary 
endpoints included inter-trigonal distance, annular 2-D perimeter and area, SL diameter 




5.2.8 Statistical Analysis 
5.2.8.1 Further Comments on ANOVA and the General Linear Model (GLM) 
The fundamental concepts of ANOVA are described in Section 5.1.6.1, as an introduction 
to its extensive usage for SA 1. Two additional introductory comments are pertinent to the 
analyses used in SA 2.  
 First, it is important to note that ANOVA is only one instance of a broader statistical 
modeling format known as the General Linear Model (GLM). In ANOVA, the independent 
variables must be categorical. In contrast, the well-known counterpart to ANOVA, multiple 
linear regression, requires that independent variables are continuous. GLM allows for 
either categorical or continuous independent variables. GLM requires the same 
assumptions to be met as does ANOVA, but additionally, it assumes that the dependent 
variable is linearly related to each continuous independent variable. For further information 
on GLM, the interested reader is referred to Regression, ANOVA, and the General Linear 
Model: A Statistics Primer.146 
 Second, for both GLM and ANOVA, it is noted that in instances where model 
residuals are not normally distributed, and/or the relationships between dependent and 
continuous independent variables are non-linear, data transformations (such as log or 




5.2.8.2 Analyses Used 
All statistical analyses were performed using MATLAB and/or Minitab (Minitab Inc., State 
College, PA). To understand the correlation between ΔP and PVL, linear and quadratic 
regressions were each performed. For hypothesis tests between two groups, Student’s t-
test was used. The central statistical tool was the GLM, one instance of which was multi-
way ANOVA. PVLnorm, sqrt(PVL), PVL, FSL, FIC, and sqrt(FIC/FSL) were each treated as 
the dependent variable in various GLM or ANOVA models. Independent variables in these 
models included TMV shape, TMV size, and (for PVL studies) ΔP. Each model was run 
first without interaction terms to assess main effects, then with all possible two-factor 
interactions. For ANOVA, Tukey’s Honestly Significant Difference post-hoc correction 
was used to test for pairwise differences. Each model is detailed in Table 5-4. Further 
explanation of each model follows.  
Table 5-4 GLMs used in SA 2.  
Sub-aim Model Dependent Variables Independent Variables 
SA 2.A 
1 PVLnorm TMV shape, TMV size 
2 sqrt(PVL) TMV shape, TMV size, ΔP* 
3** PVL TMV shape, TMV size 
SA 2.B 4 FSL, FIC, sqrt(FIC/FSL) TMV shape, TMV size 
*continuous variable; **only included samples having ΔP between 110-130 mmHg. 
 To investigate differences in PVL dynamics between device types in SA 2.A, three 
complementary statistical methods were used: 
 GLM 1: compared across all pressures simultaneously, by converting leakage to a 
pressure-normalized term, PVLnorm. PVLnorm is defined in Section 5.2.7.1; it 
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reflected the proportion change in pressure-normalized leakage of any given 
observation relative to the average observation. For example, if PVLnorm for a given 
device type were 0.1, this would signify 10% more leakage using this device than 
the average device, across all pressures. This approach had the advantage of 
encapsulating data from all pressures simultaneously, but the disadvantage is that 
its units are relative. 
 GLM 2: accounted for ΔP as a continuous, independent variable, enabling 
generation of a 95% confidence interval for each device type at any ΔP. This 
approach had two advantages. First, it offered easy comparison among devices at 
any exact pressure level of interest (these were 60, 90, 120, 150, and 180 mmHg, 
per ISO guideline 5840-3112). Second it offered increased sensitivity relative to 
ANOVA, which would require binning of observations into pressure categories. 
However, its disadvantage was that the GLM assumes a linear relationship between 
the continuous independent and dependent variables. Due to the empirically 
observed quadratic relationship between PVL and ΔP (see Section 7.2.1.2), this 
assumption was satisfied by using the square root of PVL as the dependent variable. 
Thus, this model’s units, although absolute, may be less familiar for most readers. 
 GLM 3: compared within a narrow pressure range of interest by wholly neglecting 
the influence of pressure within that range. Due to the relevance of 120 mmHg as 
both the approximate mean ΔP in these experiments, and as the peak ΔP under 
normal physiologic conditions, GLM 3 included samples obtained in the 120 ± 10 
mmHg range. This approach had the advantage that it avoided the need to transform 
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PVL to sqrt(PVL), and thus its output was expressed in real-world units (ml/sec). 
Its disadvantage was reduced sensitivity relative to GLM 2.  
As a final note, GLM 4 from SA 2.B used sqrt(FIC/FSL) instead of FIC/FSL; this was 
necessary to satisfy the assumption of normally distributed residuals.  
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CHAPTER 6. RESULTS AND DISCUSSION – SPECIFIC AIM 1 
6.1 Introduction to Specific Aim 1 Results and Discussion 
For the reader’s convenience, the experimental schematic for Specific Aim 1 is reproduced 
here, followed by an experimental matrix: 
 




Table 6-1 Experimental matrix for SA 1. 







in vivo, ovine, w/ undersized Physio 5 10 3 150 
ex vivo, ovine, suture pullouts 12 10 N/A 120 
in vitro, ovine, multi-photon imaging 5 4 N/A 20 
SA 
1.B 
in vivo, ovine, w/ true-sized Physio 5 10 3 150 
in vivo, ovine, w/ undersized Profile 3D 6 10 3 180 
in vivo, ovine, w/ true-sized Profile 3D 7 10 3 210 
in vivo, ovine, w/ undersized rigid 
prototype 6 10 3 180 
in vivo, ovine, w/ undersized flexible 
prototype 5 10 3 150 
SA 
1.C 
in vivo, ovine, w/ undersized hybrid 
prototype 3 10 3 90 
 
The experimental designs for Specific Aims 1.B and 1.C were finalized according 
to the insights gained in the sub-aims preceding them. Therefore, in this chapter, brief 
comments are provided following the results of SA 1.A and SA 1.B (Sections 6.2.1.4 and 
6.2.2.4), in advance of a full discussion of the entire Aim (Section 6.3). 
 Note, many of the graphs that follow provide results in terms of both (a) mean ± 
standard deviation (SD), represented with bars, and (b) mean ± 95% confidence interval 
(CI) following ANOVA with Tukey’s post-hoc corrections, represented with dots. Text 
values are provided as mean ± SD. Also, orange or purple background in the following 
graphs denotes the anterior or posterior region of the annulus, respectively. For the reader’s 
convenience, Table 5-1, which summarized all ANOVA models used in SA 1, is 
reproduced here as Table 6-2. 
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Table 6-2 ANOVA models used in SA 1 (duplicated from CHAPTER 5). 
Sub-aim Model 
Dependent 
Variables Independent Variables 
SA 1.A 
1 FC LVPmax, suture position 
2 FC LVPmax, suture region* 
3 FP suture position 
4 
nMPI (collagen),  
nMPI (non-specific 
fibers) suture position 
 
5 FC 
LVPmax, ring type, ring-annulus 
size, suture position 
6 FC 
LVPmax, ring type, ring-annulus 
size, suture region* 
SA 1.B 
7 FC 
LVPmax, suture position, ring 
stiffness 
8 FC 
LVPmax, suture region*, ring 
stiffness 
9 FC,Ant/FC,Post LVPmax, ring stiffness 
10 HWHMnorm 
LVPmax, suture region, ring 
stiffness 
*sutures grouped into regions as anterior (including left trigone, 11 o’clock, 1 o’clock, 
and right trigone) or posterior (including 3-9 o’clock). 
 
6.2 Specific Aim 1 Results 
6.2.1 Specific Aim 1.A: Investigation of the Basic Mechanism of Suture Dehiscence 
A description of the sample populations used in SA 1.A is presented in Table 6-3. The F- 
and p-values from all ANOVA models used in SA 1.A are presented in Table 6-4. 
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Table 6-3 Data set summary for Specific Aim 1.A. 
In vivo - cyclic forces 
Sample size 5 
Positions tested 10 
Animal Weight (kg) 58.2 ± 12.4 
Annulus size 30 ± 0 
Ring size 26 
HR at LVPmax = 100 mmHg (bpm) 111 ± 14 
HR at LVPmax = 125 mmHg (bpm) 122 ± 13 
HR at LVPmax = 150 mmHg (bpm) 134 ± 15 
Ex vivo - pullout forces 
Sample size 12 
Positions tested 10 
Successful pullouts 112/120 
In vitro - microstructural 
analysis 
Sample size 5 
Positions tested 4 
 
Table 6-4 Results of all ANOVA models used in SA 1.A, before post-hoc analysis. 
ANOVA models are fully described in Table 6-2. 
      Factor F p 
Model 1 (FC) 
Main 
effects 
LVPmax 2.44 0.091 





Model 2 (FC) 
Main 
effects 
LVPmax 1.91 0.1515 
Suture region 23.93 <0.001 
Interactions LVPmax:Suture region 0.05 0.956 
Model 3 (FP) Main effect Suture position 3.98 <0.001 
Model 4 (nMPI 
for collagen) 
Main 
effects Suture position 7.86 0.002 








6.2.1.1 Cyclic Suture Force (In Vivo) Studies 
Instrumented Physio rings were successfully implanted in five healthy ovine subjects. In 
every case, the mitral annulus was size 30, and a size 26 ring was used. Cyclic contractile 
force (FC) was measured successfully at three target LVPmax levels as described in Section 
5.1.4.1. Under anesthesia, the Doppler-derived mean transmitral pressure gradient 
increased by 1.8 ± 2.1 mmHg after ring implantation (measured at resting heart rate and 
normotensive conditions, immediately before and after cardiopulmonary bypass). 
Representative suture force and LVP tracings are presented below. 
 
Figure 6-2 Representative, coupled tracings of annuloplasty suture forces and left 
ventricular pressure (LVP). Each force tracing corresponds to a single annuloplasty 
suture. Note, baseline pre-tension (i.e. the minimum absolute force in each tracing) 
has been zeroed to highlight the amplitude differences among the ten sutures. 
 
In Figure 6-2, the rise and fall in suture force throughout the cardiac cycle was 
closely coupled to LVP. Ventricular contraction and relaxation were clearly associated 
with sharp rises and falls in suture forces, with forces peaking near mid-systole. These 
observations were consistent across all experiments. 
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 The influences of LVP and suture position on FC were quantified through ANOVA 
model 1, and that of suture region was quantified through ANOVA model 2. The results of 
these models are presented in Figure 6-3 through Figure 6-7, and described in the text 
following Figure 6-7. 
 
Figure 6-3 FC results from undersized Physio rings, in terms of mean ± standard 
deviation (SD) for each suture position at each LVPmax. Although trends are 
apparent, statistical significance of these trends cannot be assessed until after 




Figure 6-4 FC results from undersized Physio rings, in terms of mean ± 95% 
confidence interval (CI) for each LVPmax (after ANOVA 1). Pairs whose 95% CIs do 




Figure 6-5 FC results from undersized Physio rings, in terms of mean ± 95% CI for 
each suture position (after ANOVA 1). Pairs whose 95% CIs do not overlap differ 
significantly (p<0.05). FC was significantly greater at either trigone than at 




Figure 6-6 FC results from undersized Physio rings, in terms of mean ± 95% CI for 





Figure 6-7 FC results from undersized Physio rings, duplicated from Figure 6-3 
through Figure 6-6. Top: mean ± SD for each suture position at each LVPmax. 
Bottom: mean ± 95% CI for each LVPmax and suture position (after ANOVA 1), or 
suture region (after ANOVA 2). Within each plot, pairs whose 95% CIs do not 
overlap differ significantly (p<0.05).  
 
The mean FC across all sutures was 2.2 ± 1.4 N. Among all 50 sutures, the absolute 
minimum and maximum FC were at 100 mmHg/4 o’clock and 150 mmHg/3 o’clock (0.2 
and 7.3 N, respectively). Averaged over all five subjects, the minimum and maximum FC 
were at 7 o’clock and RT (respectively, and in order of increasing LVP: 0.9 ± 0.4, 1.0 ± 
0.5, 1.1 ± 0.7 N, and 3.4 ± 1.6, 3.7 ± 1.6, 4.0 ± 1.8 N). 
Based on Figure 6-7, it is apparent that FC exhibited a positive, but statistically 
insignificant, trend versus LVPmax. Specifically, each successive 25 mmHg increase in 
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LVPmax caused a change in FC of 14 ± 16% (p=0.091). A series of significant differences 
between pairs of positions were also observed. Nearly all such differences in FC were 
between either LT or RT and a posterior position. When pooling FC by region, it was shown 
that anterior FC exceeded posterior FC by 1.0 N (mean ± SD: 2.8 ± 1.4 vs. 1.8 ± 1.2 N, 
p<0.001 by ANOVA model 2).  
 
6.2.1.2 Suture Pullout Force and Residual Strength Studies 
The influence of suture position or suture region on FP was quantified through ANOVA 
model 3 or two-sample t-test, respectively. Results are presented in Figure 6-8 through 
Figure 6-11, and described in the text following Figure 6-11. 
 
Figure 6-8 FP results in terms of mean ± SD for each suture position. Although 
trends are apparent, statistical significance of these trends cannot be assessed until 




Figure 6-9 FP results, in terms of mean ± 95% CI for each suture position (after 
ANOVA 3). Pairs whose 95% CIs do not overlap differ significantly (p<0.05). FP 
was significantly greater at each of various anterior positions than at each of 
numerous posterior positions. 
 
 
Figure 6-10 FP results, in terms of mean ± 95% CI for either suture region. FP was 




Figure 6-11 FP results, duplicated from Figure 6-8 through Figure 6-10. Top: mean 
± SD for each suture position. Bottom: mean ± 95% CI for each suture position 
(ANOVA 3), or suture region (t-test). Within each plot, pairs whose 95% CIs do not 
overlap differ significantly (p<0.05). 
 
The suture successfully pulled from the annulus in 93.3% of trials (Table 6-3). Each 
of the eight unsuccessful trials was due to the testing system’s arm reaching its 
displacement limit before pullout occurred; also, each trial was along the Ant aspect. The 
global mean ± SD for FP was 4.9 ± 2.8 N. Among all 120 sutures, the absolute minimum 
and maximum FP were 1.3 and 17.6 N (8 o’clock and RT, respectively). Among all 10 
positions, the weakest and strongest positions were, respectively, 7 o’clock (3.1 ± 1.3 N) 
and 1 o’clock (7.4 ± 3.7 N).  
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 The variation of FP by position was qualitatively observed to correlate with that of 
FC. However, whereas the two largest FC magnitudes were located at either trigone, the two 
largest FP magnitudes were between the trigones (with RT and LT the third- and fourth-
strongest locations). ANOVA revealed a series of differences between FP pairs. All 
significant differences were between 11 o’clock, 1 o’clock or RT and a posterior position. 
Pooled by region, anterior FP exceeded posterior FP by 2.5 N (6.4 ± 3.6 vs. 3.9 ± 1.6 N, p 
< 0.001). 
 Residual Strength (RS) at each suture position is given in Figure 6-12. Mean RS 
was 2.5 N; minimum and maximum RS were 1.1 and 5.4 N (LT and 1 o’clock, 
respectively). Despite the low LT value, the anterior annulus still exhibited greater mean 
RS than the posterior 1.4 N (3.3 ± 1.8 vs. 1.9 ± 0.3 N, p=0.104). The lack of significance 
of this finding is likely attributable to the fact that RS was computed from mean FC and 
mean FP at each position, leading to small sample sizes (four anterior and six posterior 
positions). Grouped differently, anterior sutures placed between the trigones (i.e. at 11 and 
1 o’clock) exhibited mean RS of 4.8 ± 0.9 N, versus 1.9 ± 0.5 N everywhere else (p<0.001). 
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Figure 6-12 Residual Strength (RS) at each position using undersized Physio rings. 
RS is defined for a given ring type as the difference between that position’s mean FP 
and its mean FC at LVP = 150 mmHg.   
 
6.2.1.3 Collagen Quantification Studies 
Annulus tissue microstructure was clearly visible by autofluorescence, without histologic 
staining. A sharply delineated collagenous band was typically located toward the 





Figure 6-13 Representative sections of each annulus position at sites of suture 
passage, under two-photon excitation fluoroscopic imaging. In each case, the 
endocardial surface is along the right edge, with the annular hinge point at bottom 
right. Green: collagen; red: non-specific fibers. 
 
 As shown in Figure 6-14, collagen nMPI ranged from 1.69 ± 0.37 (12 o’clock) to 
0.69 ± 0.23 (LT). The 12 o’clock position exhibited 92-145% greater collagen density than 
each other position (12 o’clock vs. each other position, p<0.05 following ANOVA model 
4). In contrast, non-specific fiber nMPI showed far less variation, ranging from 0.87 ± 0.25 
(LT) to 1.10 ± 0.62 (12 o’clock). No pairwise differences in non-specific fiber density 
existed among positions (ANOVA model 4). This supports the specificity of the collagen 
detection method and findings.  
 Collagen density correlated modestly to FP (R2 = 0.501, p = 0.293), and strongly to 
RS (R2 = 0.94, p = 0.033; Figure 6-15). Note, suture forces were not measured at 12 and 6 
o’clock. Therefore, RS at 12 or 6 o’clock were estimated by averaging 11 and 1 o’clock or 
5 and 7 o’clock, respectively. 
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Figure 6-14 Mean ± SD of nMPI for both collagen (green) and non-specific fibers 
(red). *p<0.05 vs. 12 o’clock; #p<0.005 vs. 12 o’clock; @p>0.05 for all pairs (95% CIs 
not shown). All statistics after ANOVA 4. 
 
 
Figure 6-15 Collagen density at a given suture position, indicated by nMPI, 
correlated to either pullout force or residual strength at that position.  
 
6.2.1.4 Comment 
Later in this chapter, SA 1.A is discussed fully. However, before SA 1.B results are 
presented, it is critical to highlight the key findings from SA 1.A, insofar as they guide SA 
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1.B’s experimental goals. It was found that, although FC was lower on the posterior annulus 
than the anterior, FP followed the same trend, by an even greater margin. As a net effect, 
RS was lower on the posterior annulus. From a biomechanical standpoint this implies a 
greater likelihood of suture dehiscence in this region, which is supported by the clinical 
predominance of posterior annular dehiscence.7, 89, 91-99 SA 1.A’s findings therefore 
motivate a goal of identifying annuloplasty ring design parameters that systematically 
reduce FC in the weaker posterior annulus. 
 
6.2.2 Specific Aim 1.B: Parametric Evaluation of Ring Design and Suture Forces 
6.2.2.1 Investigation of Ring Size and Shape 
A description of the sample populations used in SA 1.B’s investigations of ring size and 
shape (not including the undersized Physio samples already described) is presented in 
Table 6-5. Instrumented Physio and Profile 3D rings were successfully implanted in 18 
healthy ovine subjects, in addition to the 5 subjects receiving undersized Physio rings 
detailed in SA 1.A. Among all cases, mitral annulus sizes ranged between 26-32, and rings 
of size 26-30 were used (either true-sized to the annulus, or undersized by two sizes). 
Across all undersized or true-sized annuloplasty cases, the post-procedural increase in 
transmitral pressure gradient was 1.9 ± 1.6 mmHg for undersized rings or 0.9 ± 0.4 mmHg 
for true-sized rings (measured at resting heart rate and normotensive conditions, 
immediately before and after cardiopulmonary bypass). The F- and p-values from all 
ANOVA models used to analyze these rings are presented in Table 6-6. 
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Table 6-5 Data set summary for SA 1.B investigation of ring size and shape. 
  T-Ph U-3D T-3D 
Sample size 5 6 7 
Animal weight (kg) 58.2 ± 10.6 57.0 ± 5.8 57.4 ± 6.8 
Annulus size 28.8 ± 2.3 30.0 ± 0.0 27.7 ± 1.8 
Ring size 28.8 ± 2.3 26.0 ± 0.0 27.7 ± 1.8 
HR at LVPmax = 100mmHg (bpm) 106.0 ± 25.1 126.5 ± 24.6 136.0 ± 26.8 
HR at LVPmax = 125mmHg (bpm) 117.0 ± 25.0 130.2 ± 25.8 148.1 ± 23.4 
HR at LVPmax = 150mmHg (bpm) 126.2 ± 25.5 137.8 ± 33.2 159.3 ± 22.3 
 
Table 6-6 Results of all ANOVA models used in SA 1.B investigations of ring size 
and shape, before post-hoc analysis. ANOVA models are fully described in Table 
6-2. 





LVPmax 16.87 <0.001 
Ring type 1.12 0.29 
Ring-annulus sizing 11.56 0.001 
Suture position 14.74 <0.001 
Interactions 
LVPmax:Ring type 0.05 0.95 
LVPmax:Ring-annulus sizing 0.03 0.968 
LVPmax:Suture position 0.27 0.999 
Ring type:Ring-annulus sizing 4.05 0.045 
Ring type:Suture position 6.59 <0.001 





LVPmax 15.15 <0.001 
Ring type 0.93 0.334 
Ring-annulus sizing 10.66 0.001 
Suture region 42.72 <0.001 
Interactions 
LVPmax:Ring type 0.04 0.959 
LVPmax:Ring-annulus sizing 0.03 0.972 
LVPmax:Suture region 1.3 0.273 
Ring type:Ring-annulus sizing 3.41 0.065 
Ring type:Suture region 0.12 0.731 
Ring-annulus sizing:Suture region 8.28 0.004 
 139
 
The mean ± SD values for FC across these 23 animals (5 from SA1 and 18 additional 
here) are presented below, grouped two ways. First, Figure 6-16 reports FC for each cohort 
individually (i.e. undersized Physio, U-Ph, true-sized Physio, T-Ph, undersized Profile 3D, 
U-3D, and true-sized Profile 3D, T-3D). Next, Figure 6-17 reports the data parametrically 
(i.e. all Physio, all Profile 3D, all undersized, and all true-sized). In these and in all 
following figures reporting mean ± SD throughout the remainder of this chapter, only data 
from the intermediate LVPmax (i.e. 125 mmHg) is shown. Every trend visible in these 
graphs is consistent across each LVPmax level (with a shift down or up at 100 or 150 
mmHg). This trend is then quantified via the ANOVA plots. 
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Figure 6-16 FC results from undersized (U) or true-sized (T) Physio (Ph) or Profile 
3D (3D) rings. Mean ± SD values are given at LVPmax = 125 mmHg. Although trends 
are apparent, statistical significance of these trends cannot be assessed until after 




Figure 6-17 FC results from all Physio or Profile 3D rings, across sizes (top), and all 
undersized or true-sized rings, across types (bottom). Mean ± SD values are given at 
LVPmax = 125 mmHg. Although trends are apparent, statistical significance of these 
trends cannot be assessed until after ANOVAs 5 and 6 (see Figure 6-18 and Figure 
6-19). 
 
From Figure 6-16, true-sizing reduced FC, both for Physio and Profile 3D. In every 
ring type, the trigones exhibited the greatest or near-greatest FC. From Figure 6-17, it can 
be further noted that, although FC values for Physio and Profile 3D differ to varying degrees 
at each suture position, they agree closely both in the anterior and posterior regions. Lastly, 
it is noted that in Figure 6-17 that true-sizing reduced FC at 8/10 positions, including by 
0.5-0.8 N between 11 o’clock and RT, but by no more than 0.3 N elsewhere. 
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The influences of ring type (Physio vs. Profile 3D) and ring size (undersized vs. 
true-sized to the annulus) were quantified through ANOVA model 5. This model also 
accounted for LVP and suture position, which were found in SA 1.A to impact or 
potentially impact FC. ANOVA model 6 replicated model 5, but grouped sutures as anterior 
or posterior.   
 
Figure 6-18 Mean ± 95% CI for each LVPmax or suture position (after ANOVA 5). 
Within each plot, pairs whose 95% CIs do not overlap differ significantly (p<0.05). 
Increasing LVPmax significantly increased FC. FC was significantly greater at either 
trigone than at numerous other positions. 
 
Among all 23 animals, LVPmax showed similar trends to those seen in the five 
undersized Physio cases investigated in isolation in SA 1.A (Figure 6-7). That is, each 25 
mmHg increase in LVPmax led to a 0.2-0.3 N increase in FC. However, whereas this trend 
was not significant with N=5 subjects, in this larger cohort, each LVPmax level was 
significantly different from each other level (p<0.05). After accounting for all possible two-
factor interactions, it was noted that LVPmax did not significantly interact with any other 
factor, revealing that elevated LVPmax affected FC uniformly across ring type, ring size, or 
suture position. Suture position findings in ANOVA model 5 were very similar to those of 
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model 1 (Figure 6-7): nearly all pairwise significant differences were between either LT or 
RT and a posterior position. Further key results from ANOVA model 5 are shown in Figure 
6-19 A-C. Further key results from ANOVA model 6 are shown in Figure 6-19 D. 
 
Figure 6-19 Mean ± 95% CI for each (A) ring size, (B) ring type, (C) ring type of a 
given size, or (D) suture region within a given ring size. (A-C) after ANOVA 5, (D) 
after ANOVA 6. Within each plot, pairs whose 95% CIs do not overlap differ 
significantly (p<0.05). U, undersized; T, true-sized; Ph, Physio; 3D, Profile 3D; Ant, 
Anterior; Post, Posterior. 
 
True-sizing reduced FC by a statistically significant margin (undersized vs. true-
sized: 2.1 ± 1.2 vs 1.9 ± 1.0 N, p<0.001; Figure 6-19 A). In contrast, ring type did not 
significantly affect mean FC (Physio vs. Profile 3D: 2.0 ± 1.2 vs. 2.0 ± 1.1 N, p=0.290; 
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Figure 6-19 B). Ring sizing and ring type interacted: whereas, with Physio rings, true sizing 
conferred significant FC reduction (undersized Physio vs. true-size Physio: 2.2 ± 1.4 vs. 1.7 
± 0.9 N, p<0.001), undersized and true-sized Profile 3D rings did not differ significantly 
in FC (2.1 ± 1.1 vs. 2.0 ± 1.1 N, p=0.545; Figure 6-19 C). Significant interactions also 
existed between suture position and either ring type or ring-annulus sizing. However, these 
data are more clearly understood after grouping sutures by region.  
Thus, ANOVA model 6 replicated model 5, but grouped sutures as anterior or 
posterior. Comparable to the results of SA 1.A, anterior sutures endured greater FC than 
posterior (2.3 ± 1.3 vs. 1.8 ± 1.0 N, p<0.001). No significant interaction was observed 
between suture region and ring type (p=0.731). Interaction between suture region and ring-
annulus sizing was more complex (Figure 6-19 D). Anterior FC exceeded posterior, across 
sizes (undersized anterior vs. undersized posterior: 2.6 ± 1.3 vs. 1.8 ± 1.1 N, p<0.001; true-
sized anterior vs. true-sized posterior: 2.1 ± 1.2 vs. 1.7 ± 0.9 N, p=0.031). Importantly, the 
aforementioned capacity for true-sizing to relieve FC was driven exclusively by differences 
along the anterior annulus (undersized anterior vs true-sized anterior, p<0.001; undersized 
posterior vs true-sized posterior, p=0.812). 
Lastly, it was noted that when undersizing, use of the Profile 3D led to more 
uniform FC across positions. Pooled standard deviation was significantly higher for the 
undersized Physio than the undersized Profile 3D (0.9 vs. 0.5 N, p=0.036, Levene’s test). 




6.2.2.2 Development of Fully-Rigid and Fully-Flexible Ring Prototypes 
Next, the effect of ring stiffness was investigated, using the semi-rigid Physio ring and 
fully-rigid and fully-flexible ring prototypes designed to match the Physio geometry. 
Visual comparison shows that the Physio geometry was reproduced successfully (see 
Figure 4-3). Among multiple copies a given ring, stiffness exhibited coefficient of variation 
(standard deviation/mean) of approximately 20%. Force-deflection curves for each ring 
type were linear (Figure 6-20). Stiffnesses for the rigid, semi-rigid, and flexible designs 
were 10.12, 0.67, and 0.05 N/mm (all based on size 26 ring). That is, the rigid and flexible 
Physio prototypes were over one order of magnitude more or less stiff, respectively, than 
the semi-rigid (commercial) ring. 
 
Figure 6-20 Force-deflection data for each ring stiffness, under uniaxial compressive 




6.2.2.3 Investigation of Ring Stiffness 
A description of the sample populations used in SA 1.B’s investigations of ring stiffness 
(not including the undersized Physio samples already described) is presented in Table 6-7. 
Instrumented fully-rigid and fully-flexible prototype rings were successfully implanted in 
11 healthy ovine subjects, in addition to the 5 subjects receiving undersized Physio rings 
detailed in SA 1.A. Among all cases, mitral annulus sizes ranged between 30-34, and rings 
of size 26-30 were used (each undersized by two sizes relative to the annulus). The F- and 
p-values from all ANOVA models used to analyze these rings is presented in Table 6-8. 
Table 6-7 Data set summary for SA 1.B investigation of ring stiffness. 
  Fully-Rigid Fully-Flexible 
Sample size 6 5 
Animal weight (kg) 54.0 ± 6.0 63.6 ± 9.5 
Annulus size 32.4 ± 0.9 32.4 ± 1.7 
Ring size 28.4 ± 0.9 28.4 ± 1.7 
HR at LVPmax = 100mmHg (bpm) 118.5 ± 38.8 115.0 ± 22.6 
HR at LVPmax = 125mmHg (bpm) 119.2 ± 34.8 115.8 ± 26.3 




Table 6-8 Results of all ANOVA models used in SA 1.B investigations of ring 
stiffness, before post-hoc analysis. ANOVA models are fully described in Table 6-2. 
      Factor F p 
Model 7 (FC) 
Main 
effects 
LVPmax 9.23 <0.001 
Suture position 12.18 <0.001 
Ring stiffness 12.69 <0.001 
Interactions 
LVPmax:Suture position 0.09 >0.999 
LVPmax:Ring stiffness 0.24 0.917 
Suture position:Ring stiffness 3.32 <0.001 
Model 8 (FC) 
 Main 
effects 
LVPmax 8.56 <0.001 
Suture region 60.95 <0.001 
Ring stiffness 11.29 <0.001 
Interactions 
LVPmax:Suture region 0.3 0.74 
LVPmax:Ring stiffness 0.21 0.933 





LVPmax 0.04 0.9583 
Ring stiffness 10.66 <0.001 





LVPmax 1.93 0.146 
Suture region 9.87 0.002 
Ring stiffness 6.37 0.002 
Interactions 
LVPmax:Suture region 0.05 0.955 
LVPmax:Ring stiffness 0.21 0.933 




Figure 6-21 FC results from undersized rings in the Physio geometry, across three 
stiffnesses. Mean ± SD values are given at LVPmax = 125 mmHg. R, rigid; S, semi-
rigid (commercial); F, flexible. Although trends are apparent, statistical significance 
of these trends cannot be assessed until after ANOVAs 7 and 8 (see Figure 6-22 
through Figure 6-27). 
 
The mean ± SD values for FC across these 16 animals are presented in Figure 6-21, 
grouped by ring stiffness. It can be observed that for each ring type, FC was greatest at RT, 
and overall higher along anterior sutures than posterior sutures. Comparing among ring 
types, it is also notable that the rigid and semi-rigid rings experienced the highest FC at 
5/10 and 4/10 positions, respectively. Flexible rings experienced the lowest FC at 7/10 
positions, including 5/6 posterior positions.  
The influence of ring stiffness was quantified through ANOVA model 7. This 
model also accounted for LVP and suture position. ANOVA model 8 replicated model 7, 
but grouped sutures as anterior or posterior.  
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Figure 6-22 FC results, in terms of mean ± 95% CI for each LVPmax or suture 
position (after ANOVA 7). Within each plot, pairs whose 95% CIs do not overlap 
differ significantly (p<0.05). 
 
In this 16 animal cohort, LVPmax showed similar trends to those seen in Figure 6-7 
and Figure 6-18. That is, each 25 mmHg increase in LVPmax led to a 0.2-0.3 N increase in 
FC. In this cohort, FC at the lowest LVPmax (100 mmHg) was significantly reduced versus 
each higher level, but 125 vs. 150 mmHg did not achieve significance (p=0.233). 
Consistent with earlier cohorts, it was noted after accounting for two-factor interactions 
that LVPmax did not significantly interact with any other factor. Suture position findings in 
ANOVA model 7 were very similar to those of model 1 (Figure 6-7) and model 5 (Figure 
6-18): nearly all pairwise significant differences were between either LT or RT and a 
posterior position. However, here, RT was also significantly different from 11 and 1 
o’clock. Further key results from ANOVA model 7 are shown in Figure 6-23, Figure 6-26, 
and Figure 6-27 A and D. Further key results from ANOVA model 8 are shown in Figure 
6-24, Figure 6-25, and Figure 6-27 B-C. 
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Figure 6-23 FC results, in terms of mean ± 95% CI for each ring stiffness, after 
ANOVA 7. R, rigid; S, semi-rigid; F, flexible. Pairs whose 95% CIs do not overlap 
differ significantly (p<0.05). FC was significantly reduced using flexible rings. 
 
 
Figure 6-24 FC results, in terms of mean ± 95% CI for either suture region, after 
ANOVA 8. Pairs whose 95% CIs do not overlap differ significantly (p<0.05). FC was 




Figure 6-25 FC results, in terms of mean ± 95% CI for each ring stiffness/suture 
region combination, after ANOVA 8. Pairs whose 95% CIs do not overlap differ 




Figure 6-26 FC results, in terms of mean ± 95% CI for each ring stiffness/suture 
region combination, after ANOVA 7. Pairs whose 95% CIs do not overlap differ 
significantly (p<0.05). The reduction in FC using flexible rings occurred at most 




Figure 6-27 Mean ± 95% CI for each (A) ring stiffness, (B) suture region, (C) suture 
region within a given ring stiffness, or (D) suture position within a given ring 
stiffness, duplicated from Figure 6-23 through Figure 6-26. (A, D) after ANOVA 7; 
(B-C) after ANOVA 8. Within each plot, pairs whose 95% CIs do not overlap differ 
significantly (p<0.05). R, rigid; S, semi-rigid (commercial); F, flexible; Ant, 
Anterior; Post, Posterior. 
 
Relative to both semi-rigid and rigid rings, use of a flexible ring reduced mean FC 
by over 0.5 N (p<0.001; Figure 6-27 A). As previously seen with earlier cohorts (especially 
when undersizing), FC was significantly reduced along the posterior annulus (in this cohort 
by 0.9 N: anterior vs. posterior, 2.5 ± 1.4 vs. 1.6 ± 1.0 N, p<0.001; Figure 6-27 B).  The 
magnitude of this reduction depended on the selected ring’s stiffness. That is, posterior FC 
was less than anterior FC by 0.2, 1.0, and 1.3 N on average for rigid, semi-rigid, and flexible 
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rings, respectively. Suture region and ring stiffness interacted significantly (Figure 6-27 
C): whereas increasing flexibility was not found to affect anterior FC, it did reduce posterior 
FC (rigid, semi-rigid, and flexible: 2.0 ± 1.0, 1.8 ± 1.2, 1.0 ± 0.6 N, respectively; p<0.001). 
Ring stiffness also significantly influenced forces on individual sutures (Figure 6-27 D). 
Of note, flexible rings experienced a statistically significant reduction in FC only at the two 
positions immediately posterior of the trigones, i.e. at 3 o’clock (p=0.004 vs. semi-rigid) 
and 9 o’clock (p=0.005 vs. rigid). 
It was qualitatively observed that increasing ring flexibility affected the ratio of 
anterior FC to posterior FC. To quantify this observation, ANOVA model 9 investigated the 
ratio FC, Ant/FC, Post as a function of ring stiffness and LVPmax. Figure 6-28 demonstrates that 
this ratio scaled positively with increasing ring flexibility (rigid: (1.08 ± 0.46):1, semi-
rigid: (1.67 ± 0.66):1, flexible: (2.33 ± 1.18):1; p<0.001). 
It was hypothesized that the reduced posterior FC using flexible rings may relate to 
differences in the duration of suture loading in response to ventricular contraction. To test 
this hypothesis, ANOVA model 10 investigated HWHMnorm as a function of ring stiffness, 
suture region, and LVPmax. Figure 6-29 demonstrates that for anterior sutures, HWHMnorm 
did not show sensitivity to ring stiffness. However, for posterior sutures, HWHMnorm was 
significantly larger when a flexible ring was used (rigid: 0.08 ± 0.04, semi-rigid: 0.08 ± 
0.02, flexible: 0.13 ± 0.11; p<0.001 for flexible vs. rigid or semi-rigid).  
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Figure 6-28 Ratio of anterior FC to posterior FC for each ring stiffness, averaged 
across suture positions and LVPmax levels. Left: mean ± SD. Right: mean ± 95% CI 
(after ANOVA 9). Pairs whose 95% CIs do not overlap differ significantly (p<0.05). 
R, rigid; S, semi-rigid (commercial); F, flexible. 
 
 
Figure 6-29 Normalized half-width at half-maximum (HWHMnorm) for each suture 
region within a given ring stiffness. Larger HWHMnorm indicates a longer 
proportion of the cardiac cycle during which suture loading occurred. Left: mean ± 
SD. Right: mean ± 95% CI (after ANOVA 10). Pairs whose 95% CIs do not overlap 
differ significantly (p<0.05). 
 
Finally, the Residual Strength (RS) values for each ring stiffness were calculated. 
The resulting RS heat maps, shown below, are illustrative of the relative suture dehiscence 
risk for each ring. 
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Figure 6-30 Residual Strength around the annular circumference, following use of 
each undersized ring in the Physio geometry (lower Residual Strength implies 
greater suture dehiscence likelihood). 
 
6.2.2.4 Comment 
Later in this chapter, SA 1.B is discussed fully. However, before SA 1.C results are 
presented, it is critical to highlight the key findings from SA 1.B, insofar as they guide SA 
1.C’s experimental goals. It was shown that use of true-sized rings does indeed reduce FC 
as compared to undersized rings, but only on the anterior annulus. Use of larger rings (i.e. 
true-sized to the annulus) can therefore be rejected as a solution to the challenge of reducing 
dehiscence likelihood in the posterior annulus. Ring shape was not fully explored; a 
comparison of the flat Physio vs. saddle-shaped Profile 3D was confounded by the differing 
stiffness between the two rings. Nevertheless, no significant differences in posterior FC was 
observed between these rings. Meanwhile, use of more flexible rings reduced FC 
specifically on the posterior annulus, as desired. Given the known benefits in terms of 
resulting valve geometry and MR volume reduction of (a) undersized rings, (b) saddle-
shaped rings, and (c) semi-rigid or rigid rings, SA 1.B’s findings motivate materially 
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hybrid rings as one potential solution for reducing the likelihood of posterior 
annuloplasty ring suture dehiscence. 
 
6.2.3 Specific Aim 1.C: Development and Preliminary Assessment of a Novel Ring 
Design 
The successful manufacturing and implementation of the hybrid rings, with their rigid 
anterior and posterior segments and flexible commissural segments, is shown in Figure 
6-31. In these images, strings tied at 10 and 4 o’clock, and pulled radially outward, induced 
fully flexible ring prototypes to deform along their entire circumference. In contrast, the 
hybrid rings only deformed in their commissural segments. These rings were instrumented 
and successfully implanted in three ovine subjects. A description of SA 1.C’s hybrid ring 




Figure 6-31 Comparison of the hybrid ring (left) versus a fully flexible prototype in 
the same geometry (right). On left, rigid inserts along anterior (orange) and 
posterior (purple) are highlighted to reveal that they retain their shape under 
mechanical loading. 
 
Table 6-9 Data set summary for SA 1.C preliminary hybrid ring investigation. 
  Hybrid 
Sample size 3 
Animal weight (kg) 69.0 ± 8.5 
Annulus size 34.0 ± 0 
Ring size 30 
HR at LVPmax = 100mmHg (bpm) 111.1 ± 2.8 
HR at LVPmax = 125mmHg (bpm) 116.4 ± 9.3 






Figure 6-32 Fluoroscopic images of an implanted hybrid ring during diastole (left) 
and systole (right) of a single cardiac cycle. Cyclic changes in saddle height and 
angle are annotated.  
During in vivo use of all instrumented rings, the force transducer spring elements 
were easily visualized under fluoroscopic imaging. For the hybrid rings, this approach 
enabled tracking the spring element positions to reveal the extent of cyclic flexure. In the 
representative case shown in Figure 6-32, the ring’s saddle height and angle changed from 
4.19 mm and 162.3° during diastole to 8.92 mm and 136.5° during systole.  




Figure 6-33 Preliminary FC results from undersized hybrid rings, shown alongside 
all prior undersized ring cohorts. Mean ± SD values are given at LVPmax = 125 
mmHg. Red box: regional FC values enlarged for ease of viewing. 
 
Small sample size prohibited statistical analyses. However, a few observations from 
Figure 6-33 were noteworthy. First, across all sutures, FC using the hybrid ring (1.7 ± 1.1 
N) was most similar to the fully flexible ring. Second, although anterior FC using the hybrid 
ring (2.2 ± 1.3 N) was similar to that of each other ring type, posterior FC (1.4 ± 0.8 N) was 
most similar to the semi-rigid or flexible rings. Finally, using the hybrid ring, the 
concentration of FC at the intra-trigonal positions (i.e. 11 and 1 o’clock) is noted. The ratio 
of intra-trigonal to trigonal FC using the hybrid ring was 2.09:1; for each other ring type 
this quantity fell between 0.56:1 and 0.93:1. 
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In SA 1.B, it was demonstrated for rings in the Physio geometry that increasing 
flexibility increased the ratio of anterior to posterior FC. Figure 6-34 suggests a similar 
phenomenon with the hybrid ring. Its FC, Ant/FC, Post ratio ((1.65 ± 0.36):1) was greater than 
that of the fully-rigid Profile 3D ring ((1.65 ± 0.36):1 vs. (1.47 ± 0.61):1, respectively), and 
most similar to the semi-rigid Physio ring ((1.67 ± 0.61):1). Finally, in Figure 6-35, the RS 
heat maps generated in Figure 6-30 were extended to include the commercial Profile 3D 
and the hybrid rings. Hybrid rings showed the highest minimum RS at any one position of 
all tested rings. Its mean RS across all positions was higher than all but the fully-flexible 
ring.  
 
Figure 6-34 Ratio of anterior FC to posterior FC, averaged across suture positions 
and LVPmax levels. Preliminary hybrid ring data is shown along with all prior 




Figure 6-35 Residual Strength around the annular circumference, following use of 
each tested undersized ring design (lower Residual Strength implies greater suture 
dehiscence likelihood). 
 
6.3 Specific Aim 1 Discussion 
6.3.1 Specific Aim 1.A: Investigation of the Basic Mechanism of Suture Dehiscence 
Specific Aim 1.A utilized large animal and ex vivo models to explore the in vivo cyclic 
suture forces, in vitro suture pullout forces, and regional variation in microstructure within 
the mitral annulus. These studies successfully demonstrated how regional variations in 
collagen content impact the likelihood of suture dehiscence, seemingly through a combined 
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effect on in vivo suture forces in the beating heart and the forces necessary to tear sutures 
from the annular tissue. 
 Extending from an earlier pilot experiment,24 this work has provided measurements 
of cyclic suture forces (FC) for a common ring used for restrictive annuloplasty. At all 
suture positions, FC rose in systole, and fell in diastole (Figure 6-2). Three primary aspects 
of cardiac contraction likely contribute to this phenomenon. First, the native shape of the 
annulus is constrained to that of the flat, undersized ring. During systole, aortic root filling 
causes the central anterior annulus to rise, while ventricular contraction pulls the trigones 
apically. This accentuation of the annulus’ out-of-plane saddle shape is opposed by the 
annuloplasty ring, with the sutures absorbing the resulting tension. Second, when 
contracting myocardial fibers shorten along their length during systole, they also expand 
radially. This thickening will further tense the loops of suture, which are already tied taut 
around the fibers. Finally, systolic pressure on the leaflets has been shown to pull the 
annulus radially inward;148 this tension, which is greatest on the anterior aspect, likely 
propagates through the tissue to the sutures. As a net effect, FC was observed to trend 
positively with LVPmax, but to vary significantly with suture position.  
 The observation of greater anterior FC, when considered in isolation, appears to 
contradict the clinical predominance of annuloplasty suture dehiscence from the posterior 
annulus.7, 89, 91-99 Yet, ex vivo suture pullout force (FP) also varied by position, with 
significantly higher anterior suture FP. Taken together, the FC and FP data provided a 
margin of safety at each suture position, whose results supported clinical experience. This 
data is best represented by trigonal sutures exhibiting a RS approximately 2.5 fold higher 
than all other positions (Figure 6-12). 
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 Anchor detachment is a recognized mode of failure in ISO 5840-3 and FDA 
guidance for heart valve replacements and annuloplasty rings.112, 114, 149 This mode of 
failure, investigated in the present work for suture, recognizably extends to other anchor 
types (e.g. hooks, pledgets, or coils) that are common design features of minimally invasive 
or percutaneous MV repair devices. When such detachment potential is identified, pullout 
testing is recommended to determine the strength of annular anchoring. As current devices 
and anchoring methods vary widely,150 the justification of in vitro test methods and 
reference values becomes critical for anchor design validation and risk assessment.  
 Descriptions of such in vitro test methods and reference values for annular anchor 
pullout testing are limited in literature. Notably, in one study evaluating the safety of 
valvular prostheses for magnetic resonance imaging, annular suture pullouts were 
conducted.151 Among patients with varying valvular disease, single sutures were shown to 
tear from the annular tissue at 4.9 ± 3.6 N. These forces agree with the present FP values 
(4.9 ± 2.8 N). 
 The non-uniformity in RS in this investigation is most likely explained by the non-
uniformity in collagen around the annulus. Two-photon excitation autofluorescence 
revealed significantly denser collagen between the trigones (12 o’clock) than at the LT, 
RT, or 6 o’clock. This was tightly correlated to RS (R2 = 0.947); a 50% reduction in 
collagen from the 12 o’clock position to elsewhere was associated with a 3 N drop in RS. 
(Figure 6-15).  
Unexpectedly, nMPI correlated more weakly to FP (R2 = 0.501) than to RS. This 
suggests that mitral annular sutures more effectively engaged collagen fibers during cardiac 
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contraction (FC) than during in vitro suture pullout (FP). One plausible explanation for this 
is that at higher stress states (i.e., during pullout), collagen fibers rotate and/or become 
more uniformly aligned,152 making their alignment of greater consequence to FP than their 
density. In porcine mitral annuli, Gunning et al recently showed that unloaded collagen 
fibers are predominantly (though not completely) aligned in the circumferential direction.43 
This is parallel to the annuloplasty suture path; if these fibers become more uniformly 
aligned at high loads, this would inhibit the suture’s ability to engage their load-bearing 
capacity, potentially weakening the correlation between nMPI and FP. The relationship 
between annular collagen and FP is explored further in supplemental studies using ovine 
tricuspid valves and a small cohort of human mitral and tricuspid valves in APPENDIX C 
and APPENDIX D.  
Gunning et al further showed that annular collagen is the principal driver of porcine 
annular mechanical strength under circumferential stretch.43 Further, higher collagen 
content was observed on the anterior quadrant of the annulus. However, this colorimetric 
analysis used an atrial view of the entire quadrant, at relatively low spatial resolution. Thus, 
the critical zone of transition from high to low collagen density remained to be defined. 
Our data complement this work, suggesting the average location of this transition zone 
must be interior from either trigone. These findings provide motivation to consider annular 
heterogeneity in the development of catheter-based devices that do not use discrete 
anchors, as well. Transcatheter mitral valve replacements (TMVRs), for example, anchor 
and seal in part through radial expansion against the annulus. Specific Aim 2 investigates 
TMVR sealing mechanics as a function of device conformity to the annulus. 
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 The heightened FC at the trigones may be explained on a biomechanical basis. Both 
collagen and myocardium are viscoelastic;153, 154 under contractile loading, suture tension 
would induce these materials to strain in a time-dependent fashion, counteracting 
additional gains in tension. In contrast, the trigones do not possess such compliance. 
Sutures placed directly atop the trigones may therefore be expected to reach greater 
tensions more quickly, as systolic contraction tends to pull them radially inward and 
apically. Yet, the lower collagen density atop the trigones also adversely affects that 
region’s FP. In this way, the trigonal combination of high rigidity/moderate failure strength 
presents similar risk to the posterior aspect’s low rigidity/low failure strength. In contrast, 
the high-collagen inter-trigonal region (exclusive of the trigones themselves) features high 
failure strength and only moderate rigidity. It is thus uniquely established as an optimal 
suture anchoring zone, as evidenced by its superior margin of safety. These findings may 
explain the more common clinical observation of posterior device dehiscence. 
 These findings provide a first step in informing novel device design as well as 
improved surgical decision-making and technique, toward the ultimate reduction in the 
incidence of suture dehiscence. In a recent editorial titled “A Chain is Only As Strong as 
Its Weakest Link,” Dr. Patrick McCarthy emphasized that a network of annuloplasty 
sutures is only as strong as its weakest suture.155 In light of this concept, SA 1.A’s findings 
motivate a goal of identifying annuloplasty ring design parameters that systematically 
reduce FC in the weaker posterior annulus. Sections 6.2.2 and 6.2.3 describe findings 
from SA 1.B and 1.C, in pursuit of this goal. 
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6.3.2 Specific Aim 1.B: Parametric Evaluation of Ring Design and Suture Forces 
Clinical reports of suture dehiscence following mitral annuloplasty may be easy to dismiss 
as a result of mere surgical error. However, SA 1.A demonstrated that suture forces that 
may lead to dehiscence are influenced by annular position and left heart function. SA 1.B 
recapitulates this finding, and further establishes that suture forces further vary according 
to the properties of the selected ring (i.e. its size relative to the annulus, its shape, and its 
stiffness).  
 In the comparison among true-sized and undersized Physio and Profile 3D rings, 
use of a true-sized ring reduced FC. However, it was effective only by way of reducing 
anterior forces. As shown in Figure 6-11, mitral annular suture holding strength is greater 
on the anterior aspect, creating a higher likelihood of dehiscence from the posterior. Thus, 
although true-sizing certainly appears beneficial for anchoring stability as a whole, it does 
not directly affect the most pertinent anchoring region. Use of larger rings (i.e. true-sized 
to the annulus) can therefore be rejected as a solution to the challenge of reducing 
dehiscence likelihood in the posterior annulus. 
 Saddle-shaped annuloplasty rings have quantitatively demonstrated benefits over 
flat rings, including increased leaflet coaptation and curvature,122-125 reduced annular 
forces,128 and likely reduced leaflet and chordal stresses.45, 126, 127 A similar benefit to FC 
was hypothesized. Contrary to expectations, use of the saddle-shaped Profile 3D did not 
significantly relieve FC, as compared to the flatter Physio ring. Although the exact 
mechanical basis for this observation cannot be confirmed from this study, it is likely that 
the Profile 3D’s increased rigidity as compared to the “semi-rigid” Physio plays an 
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important role. A stiffer ring could increase FC overall by complying less with cyclic 
annular motion. Yet, it might also reduce variability between positions by more thoroughly 
transmitting force around its circumference. Based on this cohort, we speculate that when 
undersizing, the impact of the Profile 3D’s rigid, saddle-shaped design manifested as forces 
that are overall slightly reduced but significantly more balanced. However, the benefits of 
true-sizing were meaningfully diminished when using Profile3D, as the effects of its 
rigidity dominated. While these results provide a direct comparison between two prominent 
commercially-available rings, they do not decouple the distinct influences of ring shape 
and stiffness on cyclic suture force. 
 These findings were not sufficient to conclusively reject ring shape as an effector 
of FC on posterior annular sutures. However, they did implicate ring stiffness as a critical, 
and as-yet-unexplored, design parameter. This motivated the quantification of the isolated 
effects of ring material properties, presented in Section 6.2.2.3. FC dynamics were 
compared among the semi-rigid Physio ring and rigid and flexible ring prototypes of the 
same geometry. As demonstrated in earlier cohorts, anterior sutures endured greater FC 
than did posterior sutures. Importantly, whereas the earlier tests of ring design parameters 
that may relieve posterior suture forces were negative for ring size and inconclusive for 
ring shape, this study revealed for the first time that ring stiffness can preferentially 
affect suture forces in the posterior annulus. On the anterior side, no pairwise 
differences were detected. Figure 6-30 illustrates RS for the presently studied rings, based 
on FP data from SA 1.A. It is evident that increasing ring flexibility elevates the annulus’ 
Residual Strength both in the mean (across locations) and at its minimum (at any single 
location). 
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 Expressing the ring stiffness data differently, the anterior/posterior FC ratio became 
greater with increasing flexibility, with the mean ratio rising from 1.08:1 to 1.67:1 to 2.33:1 
(p<0.001 for rigid vs. flexible, but p>0.05 for semi-rigid vs. either other stiffness). These 
findings suggest a potential biomechanical mechanism whereby anatomic and physiologic 
factors local to the annulus initially apply greater force to anterior sutures than to posterior 
sutures. Specifically, systolic expansion of the aortic root (which sits adjacent to the 
anterior annulus), cyclic changes in the anterior saddle geometry,46 and the stiffer/more 
collagenous anterior annular tissue (as demonstrated by Gunning et al43 and in Figure 6-14) 
each likely contribute. Subsequently, when multiple annular sutures are connected via an 
annuloplasty ring or valve replacement, the device serves as a conduit that transfers forces 
around the suture network (i.e. higher anterior suture forces transfer to posterior sutures). 
Our data demonstrates that the efficiency of transfer depends on the device’s flexibility. 
Rigid annuloplasty rings appear to enable near-total equilibration of anterior and posterior 
FC. Increasing flexibility apparently serves to inhibit such equilibration. For posterior 
sutures specifically, HWHMnorm was 54% greater using flexible rings than either other ring. 
The observation that posterior sutures take longer to achieve their peak load when a flexible 
ring is used suggests that one mechanism by which flexible rings maintain lower posterior 
FC is by slowing down force transfer around the ring. 
 Independent of ring sizing or saddle shape, annuloplasty ring flexibility seems to 
offer a unique capacity to reduce forces on the annular region most clinically susceptible 
to dehiscence. However, these findings should not be taken to indicate that flexible rings 
are the superior option in all MR repairs. Notably, specifically in those cases in which a 
flexible ring is appropriate, the use of a running suture (rather than a series of interrupted 
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sutures as studied here) has been shown to offer further benefit to anchoring strength.23, 156 
However, for regurgitant valves exhibiting annular distortion (especially those with 
ischemic MR and/or annular dilation), semi-rigid and rigid rings remain important 
remodeling tools.63, 72_ENREF_23 Some degree of rigidity is also necessary for the ring to 
re-establish the anterior saddle. A design that retains critical features of both rigid and 
flexible annuloplasty rings could provide desirable performance from both a safety (suture 
retention) and efficacy (functional outcomes) standpoint. 
 Based on the collective findings of SA 1.A and 1.B, we propose materially hybrid 
rings as one potential solution for reducing the likelihood of posterior annuloplasty 
ring suture dehiscence. Such a design may feature rigid anterior and posterior regions, 
separated by short flexible segments near the commissures (approximately 3 and 9 
o’clock). This may disrupt FC transfer from anterior to posterior, while still allowing for 
well-defined anterior saddle curvature and posterior annular restriction.  Incidentally, these 
are the exact two positions for which the flexible ring offered significant FC relief (Figure 
6-27), which may further support such a hybrid configuration. SA 1.C consists of the 
development and preliminary testing of one such hybrid ring design (ring design shown in 
Figure 4-4). 
 
6.3.3 Specific Aim 1.C: Development and Preliminary Assessment of a Novel Ring 
Design 
Findings from SA 1.B showed that rigid rings, although known to offer the greatest benefit 
for annular remodeling and MR volume reduction, exhibited the highest posterior FC and 
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accordingly the highest suture dehiscence likelihood. Flexible rings, though lacking the 
material strength to effectively remodel the mitral annulus, exhibited significant FC 
reduction, and associated reduction in suture dehiscence likelihood. Thus, fully-rigid and 
fully-flexible rings within this study can be considered extreme ends of both the repair 
efficacy spectrum and the suture dehiscence likelihood spectrum. When assessing novel 
ring designs in terms of repair efficacy and suture retention, the ideal ring will possess the 
remodeling capacity of a rigid (and saddle-shaped) ring, and the low dehiscence likelihood 
of a flexible ring.  
 One such novel design was developed and preliminarily tested in SA 1.C. Note, its 
repair efficacy has not been investigated at this time; follow-up studies using an ovine 
model of ischemic mitral regurgitation are planned. However, FC dynamics were assessed 
in three cases using the healthy ovine model, with promising results. Anterior suture FC 
using the hybrid ring was similar to that of each other ring type. However, posterior FC 
using the hybrid ring was most similar to the flexible and semi-rigid rings (Physio 
geometry); the hybrid ring’s posterior FC was reduced by 24% relative to the rigid Profile 
3D, and by 27% relative to the rigid prototype in the Physio geometry. The 
anterior/posterior FC ratio using the hybrid rings was increased relative to either rigid ring, 
and was most similar to the semi-rigid Physio.  
 Two major implications appear likely based on the present hybrid ring data. First, 
they provide strong support for the force transmission hypothesis developed based on the 
first ring stiffness investigations. We proposed that anterior sutures are subjected to greater 
initial loading during cardiac contraction, and these forces are transmitted around the ring 
to less secure posterior sutures, with the completeness of this transmission scaling with the 
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ring’s rigidity. The hybrid rings, by offering 24% relief of posterior FC versus fully-rigid 
Profile 3D rings of matching geometry, validate the proposed mechanism of posterior FC 
elevation via anterior-to-posterior force transmission through a rigid ring conduit.  
 Further, the favorable FC dynamics establish early practical promise for the hybrid 
ring concept. The hybrid iteration tested here exhibited an excellent RS distribution, with 
the highest minimum RS at any one position of all tested rings. Its mean RS across all 
positions was higher than all but the fully-flexible ring. An unanticipated benefit using the 
hybrid rings was the concentration of FC at 11 and 1 o’clock, i.e. in the intra-trigonal region. 
Whereas all previously tested rings showed greater force at the trigones than between them 
(with FC,Intra-trigonal - FC,Trigonal differential ranging from -0.1 to -1.6 N), the opposite was true 
for the hybrid rings (+1.6 N). This differential aligns much more closely with the 
differential in FP (+1.2 N), and leads to a more uniform RS distribution in the anterior 
annulus (Figure 6-35). One likely mechanism leading to this observation is that the saddle 
shape’s benefit to FC becomes more pronounced when the saddle region is free to rotate 
about the flexible commissural “joints” (as shown by fluoroscopy in Figure 6-32). 
However, it may also be an artifact of small sample size.   
Additional testing will be necessary to assess the implications of this design, as 
further discussed in CHAPTER 8 (Conclusions and Future Work). It should also be noted 
that a different specific configuration of rigid and flexible segments may ultimately prove 
superior to the configuration tested here. Although posterior FC using hybrid rings (1.4 ± 
0.8 N) was reduced versus the rigid rings (rigid/Physio, 2.1 ± 1.1 N; rigid/Profile 3D, 1.9 
± 0.9 N), it was still not as low as in the fully-flexible/Physio case (1.0 ± 0.6 N). It is 
possible that larger flexible segments could further reduce posterior FC; the extent to which 
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any of these iterations would compromise repair efficacy remains unknown. The early 
success of the hybrid ring manufacturing techniques employed here establishes a viable 
approach for preparing any such future iteration. 
 
6.3.4 Integrated Specific Aim 1 Discussion 
With more than 20 mitral annuloplasty ring product lines commercially available in the 
United States, surgeons performing mitral annuloplasty must select from a range of ring 
sizes, shapes, and stiffnesses for a given patient lesion and etiology. The findings of SA 1 
demonstrate that these attributes systematically affect cyclic suture forces in the beating 
heart (FC), and suggest that suture dehiscence is not merely a consequence of technical 
error during ring implantation. An engineered approach to reduce suture dehiscence 
likelihood via improved device designs and usage strategies is a promising pursuit. 
 Important mechanistic insights surrounding annuloplasty suture retention dynamics 
have been uncovered through this work. The clinical predominance of suture dehiscence 
from the posterior mitral annulus is a likely consequence of both (a) the lesser suture 
holding strength along the posterior annulus relative to the anterior, and (b) the relative FC 
balance between the anterior and posterior annulus. Although FC was distributed 
asymmetrically toward anterior sutures in all tested ring types, the extent of this asymmetry 
was inadequate to compensate for the weaker posterior tissue. These dynamics were shown 
to likely derive, at least in part, from underlying annular collagen content, which was two-
fold higher at the mid-anterior annulus versus the mid-posterior or either trigone. In the 
assessment of ring flexibility as a potential means to reduce FC relative to anterior, 
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important suture force dynamics were uncovered. Greater initial loads on anterior sutures 
(likely arising from its material properties, aortic root expansion, and out-of-plane motion) 
are transmitted around the annuloplasty ring toward posterior sutures, tending to equilibrate 
anterior FC and posterior FC. The completeness of this equilibration scales with ring 
rigidity. The early experience with materially hybrid rings, in which short flexible 
commissural segments in an otherwise rigid ring led to reduced posterior FC, appears to 
validate this mechanism.  
 In the pursuit of better ring design and usage strategies, it was shown that use of 
true-sized rings does indeed reduce FC as compared to undersized rings, but only on the 
anterior annulus. Use of flat versus saddle-shaped rings was not fully explored; a 
comparison of the flat Physio vs. saddle-shaped Profile 3D was confounded by the differing 
stiffness between the two rings. Nevertheless, no significant differences in posterior FC was 
observed between them. Use of more flexible rings reduced FC specifically on the posterior 
annulus, as desired. Given the known benefits in terms of resulting valve geometry and 
MR volume reduction of (a) undersized rings, (b) saddle-shaped rings, and (c) semi-rigid 
or rigid rings, we propose that an “optimized” ring from a repair efficacy and suture 
retention standpoint would be undersized and saddle-shaped, and would possess both the 
repair benefits of rigidity and the retention benefits of a flexible ring. The materially hybrid 
ring concept developed and preliminarily tested here shows strong potential to achieve this 




6.3.5 Clinical and Engineering Implications 
Suture dehiscence is an increasingly reported, often catastrophic form of mechanical failure 
after ring annuloplasty, yet little engineering work has ever explored a basis for its 
occurrence. By demonstrating that both annular tissue properties and fundamental device 
design parameters systematically impact annuloplasty ring suture force dynamics, this 
study successfully established promising new inroads toward reducing the occurrence of 
dehiscence. This work showed that ring flexibility specifically reduced forces in the weaker 
posterior annulus, and further suggested that ring shape and size changes did not do so. An 
anterior-posterior suture force transfer mechanism was uncovered. This mechanism 
pointed toward the development of a novel, materially hybrid ring design, as a means to 
exploit the demonstrated benefits of ring flexibility for suture forces, without 
compromising the known benefits of ring rigidity for valve repair effectiveness. The 
eventual success of this design, or of any other related designs that derive from this work, 
may directly benefit patient outcomes.  
In parallel to the work included in this Specific Aim, a series of supplemental 
studies were also completed. These studies offered preliminary insights into the 
implications of suture tie-down force, suture placement error, and variation in suture 
pullout force between species (ovine vs. human) or valves (mitral vs. tricuspid); they are 
reported in APPENDIX A through APPENDIX D. Collectively, the studies included in SA 
1 and these supplemental studies have elicited six unique editorial responses to date from 
leading surgeons in the field.155, 157-161  The consensus opinions from these commentaries 
are that (a) the work has moved our field closer toward the identification of optimal ring 
designs and implantation techniques, (b) much additional work remains to be done toward 
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this end, and (c) the tools and techniques developed throughout these studies hold 
significant potential for such follow-up pursuits. 
Beyond guiding the development of new concepts in ring design and/or surgical 
practice, the data reported in these studies will provide a baseline for interpreting the impact 
of MV disease phenotypes on annuloplasty sutures. These data may be further applied as 
reference values for novel device comparison. Currently, annuloplasty rings may cleared 
for use in the U.S. market via the FDA’s 510[k] pathway. Among annuloplasty ring 510[k] 
submissions to date, suture pullout testing has been nearly ubiquitous. In effect, these 
comparisons aim to establish that the likelihood of dehiscence is substantially equivalent 
to existing devices. However, this work demonstrates that dehiscence likelihood for a given 
device may not be solely determined by pullout performance. The spatial distribution of 
suture forces generated during cardiac contraction varied significantly among the tested 
rings. Quantification of in vivo loading may prove an important criterion for device 
performance assessment; to that end, the present data may function as references for 
devices implanted using annular sutures. In vivo loading may also be important to assess 
in next-generation percutaneous devices, many of which utilize novel anchor types and 
placement patterns. 
It bears mentioning that anchor dehiscence is not solely a problem for suture-based 
device implantation. The significant variability in suture force dynamics observed in this 
work, coupled with the clinical experience with suture dehiscence, together serve as a 
cautionary tale for the next-generation of hopeful transcatheter mitral valve repair devices. 
Many of these devices rely on novel anchor types, such as hooks, pledgets, or coils. One 
such example is Cardioband (Edwards Lifesciences), a catheter-based annuloplasty band 
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that anchors to the annulus with a series of screw components, and which has CE Mark 
approval for commercial use in Europe. Notably, Cardioband underwent a recall in 
February 2018 due to “implant dehiscence” (https://www.tctmd.com/news/edwards-
voluntarily-recalls-cardioband-anchors-used-mitral-and-tricuspid-repair). Understanding 
of the loads that novel anchor types can withstand and/or can be expected to encounter 
during use may prove critical to their clinical success. 
An additional, direct application of the present data may be as an input to 
computational modeling for device design. Computational research is increasingly utilized 
in the medical device industry; recent reports by the FDA have embraced its importance in 
the design process.162, 163 Modeling of ‘virtual patients’ serves to enable simulation of 
complex in vivo dynamics, at times offering value to preclinical testing unmatched by in 
vitro, cadaver, or animal studies. Ground-truth data describing pullout forces and/or 
contractile loading of annular sutures may constitute critical boundary conditions and/or 
reference points to validate model performance. FP values, which exist independent of ring 
type, are likely applicable to a range of mitral implants. FC data should be applied to 




Several limitations of the present experimental materials and methods are noteworthy. 
First, although various data suggest overall comparable annular mechanics between sheep 
and humans,107 some differences are likely. One key difference which may favor higher FC 
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in humans is degree of systolic annular motion; systolic annular area reduction has been 
shown to be 10% in sheep, versus 26% in humans.37, 46 Also, although suture tie-down 
force (i.e. pre-tension) is not expected to impact FC, it may be an important component of 
total suture force, and may vary according to surgeon, patient anatomy, or other factors. 
Each of these aspects has been preliminarily investigated in studies supplemental to this 
work; these are reported in APPENDIX A through APPENDIX D. 
Three caveats must be acknowledged regarding comparisons among rings of 
different stiffnesses. First, the true Physio ring, although semi-rigid, is not materially 
homogeneous. Its greater anterior rigidity may be one reason the rigid and semi-rigid ring 
FC data agreed more closely than did the semi-rigid and flexible. Next, sensors were fixed 
to the prototype rings via a slightly different method than that for the true Physio, as shown 
in Section 5.1.1.4. However, the sensor’s range of motion relative to the ring was negligible 
in every case.  Finally, the rigid transducers likely had some consistent stiffening effect on 
all rings. Manual manipulation of the instrumented rings suggested that this effect was 
minor. Nevertheless, this may have subtly dampened the effect size across stiffnesses, 
suggesting the reported differences are conservative. 
During in vitro studies, use of previously frozen, post-rigor mortis hearts are 
expected not to have affected collagen content, but may have slightly compromised 
collagen strength. Fresh and/or living tissue is expected to be slightly more durable with 
respect to suture pullout. 
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In terms of statistical analysis, we note that, ANOVA testing among individual 
positions was less sensitive than other tests, due to limited sample size. It is possible that 
some true pairwise differences between suture positions went undetected.  
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CHAPTER 7. RESULTS AND DISCUSSION – SPECIFIC AIM 2 
7.1 Introduction to Specific Aim 2 Results and Discussion 
For the reader’s convenience, the experimental schematic for Specific Aim 2 is reproduced 
here, followed by an experimental matrix: 
 
Figure 7-1 Schematic of Specific Aim 2 Experiments (duplicated from CHAPTER 
3). 
 
Table 7-1 Experimental matrix for SA 2. 











ex vivo, porcine, 
PVL 7 2 4 3 5 840 
SA 
2.B 
ex vivo, porcine, 
C-REFT 6 1 3 8 1 144 
ex vivo, porcine, 
D-REFT 6 1 3 8 1 144 
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Note, many of the graphs that follow provide results in terms of both (a) mean ± 
standard deviation (SD), represented with bars, and (b) mean ± 95% confidence interval 
(CI), represented with dots. Text values are provided as mean ± SD. For the reader’s 
convenience, Table 5-4, which summarized all general linear models (GLMs) used in SA 
2, is reproduced here as Table 7-2. 
 
Table 7-2 GLMs used in SA 2 (duplicated from CHAPTER 5). 
Sub-aim Model Dependent Variables Independent Variables 
SA 2.A 
1 PVLnorm TMV shape, TMV size 
2 sqrt(PVL) TMV shape, TMV size, ΔP* 
3** PVL TMV shape, TMV size 
SA 2.B 4 FSL, FIC, sqrt(FIC/FSL) TMV shape, TMV size 
*continuous variable; **only included samples having ΔP between 110-130 mmHg. 
 
7.2 Specific Aim 2 Results 
7.2.1 Specific Aim 2.A: Parametric Evaluation of TMV Design and PVL 
7.2.1.1 Steady Back-Pressure System Performance 
The steady back-pressure system designed for use in SA 2.A was constructed successfully. 
Upon the installation of a fresh porcine heart having a competent MV, trans-mitral ΔP 
could be easily manipulated according to the fluid mechanics analog of Ohm’s Law. Under 
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these steady flow conditions, this equation states that LVP (equivalent to ΔP, because the 
MV’s atrial face was exposed to ambient air pressure) can be adjusted by changing either 
the flowrate through the LV and/or the resistance to said flow. As such, to increase ΔP 
required either (a) increasing the pump speed and/or closing the bypass valve (each of 
which increased rate of LV inflow through the apex) or (b) closing the downstream valve 
(which increased resistance to LV outflow through the aorta).  
Under nominal conditions (no mock TMV plug), ΔP was easily adjusted to between 
40-215 mmHg, and held steady within 1-2 mmHg. When a TMV plug was deployed, the 
resulting leakage gaps reduced the total resistance to LV outflow and reduced the 
maximum achievable ΔP. Nevertheless, even in the presence of mitral regurgitation 
exceeding 70 ml/sec, ΔP values above 160 mmHg were attained. Across all experiments, 
the system sealed effectively: incidental leak through apical, aortic, or other connections 
was 3.3 ± 3.0 ml/sec (this was quantified and detrended from PVL data, as described in 
Section 5.2.7.1). 
  
7.2.1.2 PVL Results 
Testing of each porcine heart for SA 2.A’s investigation of TMV design and PVL dynamics 
commenced 7-11 hours post-mortem. The saddle height, which was measured in each heart 
to guide mock TMV plug positioning as discussed in METHODS XXXX, had mean ± SD 
15.4 ± 1.6 mm. Additional key geometric descriptors of the hearts used are presented in 
Table 7-3. Metrics before and after PVL testing are included. As detailed in Section 5.2.1, 
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the selection criteria for these hearts included inter-trigonal distance of 30 mm and annular 
perimeter of approximately 108.4 mm.  
Table 7-3 Geometric descriptors for the hearts used in SA 2.A investigation of TMV 
design and PVL. 
  Pre-procedure Post-procedure 
Inter-trigonal distance (mm) 30.0 ± 0 31.3 ± 1.6 
Perimeter (mm) 105.9 ± 10.5 128.1 ± 7.8 
Area (cm2) 7.5 ± 1.6 11.9 ± 1.9 
DSL (mm) 23.5 ± 4.4 31.2 ± 4.8 
DIC (mm) 35.0 ± 5.9 41.3 ± 3.4 
DIC/DSL 1.54 ± 0.44 1.46 ± 0.34 
 
The PVL experimental protocol caused plastic deformation of the MV annulus. On 
average, the PVL protocol caused 20.9% increase in valve perimeter, 58.6% increase in 
valve area, 32.7% increase in DSL, and 18.0% increase in DIC. The implications of this 
stretch are discussed in Section 7.3.5. 
In total, 840 total leakage observations were collected (from 168 acquisitions). 
These were comprised of 3 acquisitions (5 pressure levels each), using each of 8 plugs, in 
each of 7 hearts. Across all samples, ΔP ranged from 52-209 mmHg and PVL ranged from 
1-88 ml/sec. The F- and p-values from all GLMs used in SA 2.A are presented in Table 
7-4. Representative ΔP and PVL data are presented in Figure 7-2. 
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Table 7-4 Results of all GLMs used in SA 2.A, before post-hoc analysis. GLMs are 
fully described in Table 7-2. 
  Factor F p 
Model 1 (PVLnorm) 
Main 
effects 
Shape 47.75 <0.001 
Size 7.70 <0.001 
Interactions Shape:Size 1.39 0.245 
Model 2 (sqrt(PVL)) 
Main 
effects 
Shape 56.44 <0.001 
Size 7.18 <0.001 
ΔP 1822.21 <0.001 
Interactions 
Shape:Size 2.16 0.091 
Shape:ΔP 9.83 0.002 
Size:ΔP 0.55 0.645 
Model 3 (PVL, for samples with 
ΔP between 110-130 mmHg) 
Main 
effects 
Shape 22.21 <0.001 
Size 3.75 0.012 
Interactions Shape:Size 0.05 0.984 
 
 
Figure 7-2 Left: Representative plots of ΔP and PVL versus time from a single 
acquisition. The system was tuned to establish and hold each ΔP level, such that ΔP 
and PVL could be averaged over a 4 second interval (red lines). Right: Scatterplots 
of ΔP vs. PVL relationship from two acquisitions, using either the smallest circular 
device (C+0) or the largest D-shaped (D+6) device.  
 
Two important observations can be made from Figure 7-2. As shown in the left 
panel, it was found that leakage rates as a whole exhibited oscillations with frequency of 
 184
approximately 1-2 Hz, and with amplitude of approximately 5-10 ml/sec. Nevertheless, 
leakage rates were stable in the mean, indicating that ΔP and PVL endpoints could be 
appropriately obtained from a 4 second window average.  
As shown in the right panel of Figure 7-2, changes to PVL in response to changes 
in ΔP were non-linear. This was qualitatively observed in real-time throughout all 
experiments, and was subsequently quantified across all acquisitions. Two sets of 
correlation coefficients were produced from each of the 168 acquisitions, using either linear 
or quadratic fits. For quadratic fits, a slope of 0 was enforced at ΔP = 0 (on the conservative 
assumption that leakage rates would not decrease as pressure increased). Mean ± standard 
deviation R2 values for linear and quadratic fits were, respectively, 0.826 ± 0.111 and 0.905 
± 0.082 (p<0.001 by paired Student’s t-test). Thus, a quadratic relationship between ΔP 
and PVL was concluded. 
Subsequent analyses were conducted accordingly. To visualize the ΔP vs. PVL 
relationship for each device, quadratic curves were fit to the data from each device in two 
ways. First, curves were fit to data collected with each device from each heart separately. 
These curves (56 total) are presented in Figure 7-3. Next, curves were fit to data collected 
with each device across all hearts (8 total). These curves, together with their 95% 
confidence intervals, are presented in Figure 7-4. 
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Figure 7-3 ΔP vs. PVL curve fits. Each subplot includes seven curves from a single 
mock TMV plug. Each curve is fit to all data points collected from a single heart 




Figure 7-4 ΔP vs. PVL curve fits. Each subplot includes an overall curve fit (black) 
with 95% confidence interval (red), from a single mock TMV plug. Each curve is 
derived from testing in all seven hearts. 
 
 Key observations from Figure 7-3 were as follows. First, for every device, mean R2 
across every heart was 0.702 or better, indicating a clear and consistent relationship 
between pressure and leakage. The diversity in the curves within each subplot indicates a 
variability in leakage dynamics among the seven hearts for every device. This variability 
was greater for some devices than others (e.g., the seven curves exhibit greater spread for 
the D+0 device than the D+6 device). Across all devices, PVL rates ranged from near 0 
ml/sec at ΔP = 60 mmHg (hypotension), to 30-90 ml/sec at ΔP = 180 mmHg (severe 
hypertension).  
From Figure 7-4, it is notable that each curve in Figure 7-4 was highly significant 
(p<0.001). This indicates that for each tested mock TMV plug, a real relationship existed 
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between pressure and leakage across hearts, even in spite of the variability between hearts. 
Across all devices, mean PVL rates ranged from near 0 ml/sec at ΔP = 60 mmHg 
(hypotension), to 45-75 ml/sec at ΔP = 180 mmHg (severe hypertension). 
In both Figure 7-3 and Figure 7-4, it appears that PVL rates were, in most instances, 
reduced for D-shaped devices and/or larger devices. However, significance of differences 
in leakage dynamics among the eight mock TMV plug designs cannot be assessed from 
these representations. To that end, three complementary statistical methods were 
employed. Each is detailed in full in Section 5.2.8.2. In brief, they were: 
 GLM 1: compared performances of each device as a whole, by converting leakage 
to the pressure-normalized term, PVLnorm. PVLnorm is defined in Section 5.2.7.1; it 
reflected the proportion change in leakage of any given observation relative to the 
average observation. For example, if PVLnorm for a given device type were 0.1, this 
would signify 10% more normalized leakage using this device than the average 
device, across all pressures. Results are presented in Figure 7-5 through Figure 7-9 
(and described in the text following Figure 7-9). 
 GLM 2: compared device performance in terms of sqrt(PVL) at each of 5 key 
pressure levels, by accounting for ΔP as a continuous independent variable. Results 
are presented in Figure 7-10. 
 GLM 3: compared device performance in terms of PVL, for all observations having 
normotensive ΔP (i.e., 110-130 mmHg). Results are presented in Figure 7-11 




Figure 7-5 PVLnorm results, in terms of mean ± standard deviation (SD) for each 
mock TMV plug type (included: individual devices, binned by shape, binned by size, 
and all shapes/sizes). Although trends are apparent, statistical significance of these 
trends cannot be assessed until after GLM 1 (see Figure 7-6 through Figure 7-8). 
Green line: mean leakage across all samples. 
 
 
Figure 7-6 PVLnorm results in terms of mean ± 95% confidence interval (CI) using 
either device shape (after GLM 1). Pairs whose 95% CIs do not overlap differ 
significantly (p<0.05). Green line: mean leakage across all samples. The D-shape 




Figure 7-7 PVLnorm results in terms of mean ± 95% CI using each device size (after 
GLM 1). Pairs whose 95% CIs do not overlap differ significantly (p<0.05). Green 
line: mean leakage across all samples. The +6 devices significantly reduced PVLnorm 
versus each other device size. 
 
 
Figure 7-8 PVLnorm results in terms of mean ± 95% CI using each device shape-size 
combination (after GLM 1). Pairs whose 95% CIs do not overlap differ significantly 
(p<0.05). Green line: mean leakage across all samples. The only circular device that 
did not exhibit significantly greater PVLnorm than at least one of the D-shaped 




Figure 7-9 PVLnorm results, duplicated from Figure 7-5 through Figure 7-8. Top: 
mean ± SD for each mock TMV plug type (included: individual devices, binned by 
shape, binned by size, and all shapes/sizes). Bottom: mean ± 95% CI for each mock 
TMV plug shape, size, or shape-size combination (after GLM 1). Within each plot, 
pairs whose 95% CIs do not overlap differ significantly (p<0.05). Green line: mean 
leakage across all samples. Overall, shape was an equal or greater effector of 
PVLnorm than size. 
 
The global mean ± SD for PVLnorm was 0 ± 0.558. The best-sealing device was D+6 
(-0.246 ± 0.481) and the worst-sealing device was C+0 (0.244 ± 0.529). These devices also 
exhibited the single best-sealing (-0.958) and worst-sealing (2.299) observations, 
respectively. PVLnorm differed substantially among device types. Across all device sizes, 
use of the D-shape offered significant reduction in PVLnorm versus the circular shape (-
0.127 ± 0.523 vs. 0.133 ± 0.564, p<0.001). Across all shapes, increasing size also 
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significantly reduced PVLnorm, but only when comparing the +6 size (-0.147 ± 0.521) to 
any smaller size (+0: 0.064 ± 0.563, p<0.001 vs. +6; +2: 0.084 ± 0.547, p<0.001 vs. +6; 
+4: 0.008 ± 0.576, p=0.012 vs. +6). Shape and size were found not to interact significantly 
as a whole (p=0.245, Table 7-4). Yet, it is notable that the D-shape outperformed the 
circular shape at all sizes; this was significant for each size except +2 (p=0.345). Further, 
it is notable that oversizing offered a significant advantage only when comparing +6 to +0 
(for circular shape; p=0.003) or +6 to +2 (for D-shape; p=0.019).  
 
Figure 7-10 sqrt(PVL) results after modeling ΔP as a continuous variable. Mean ± 
95% CI for each mock TMV plug at each of five key ΔP levels (after GLM 2). Pairs 
whose 95% CIs do not overlap differ significantly (p<0.05). 
 
It is evident from Figure 7-10 that, based on GLM 2, each 30 mmHg increase in ΔP 
significantly increased leakage. For any given device, no two 95% CIs from different ΔP 
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levels overlapped. When comparing leakage among devices, most trends found using 
PVLnorm (Figure 7-9) were mirrored at each single ΔP level. For example, the D-shape 
offered significant reduction in leakage versus the circular shape (for at least one pair of 
devices) at every pressure. The C+6 device exhibited significantly less leakage versus C+0 
at most pressures, as did the D+6 versus D+2.  
However, some important findings varied based on ΔP. For example, at 60 mmHg, 
no significant differences in leakage were detected between circular and D-shaped devices 
at matching sizes. But as ΔP increased, the annular sealing benefits of the D-shape became 
more pronounced. At 180 mmHg, D-shaped devices exhibited significantly less leakage 
than circular devices when holding size constant, at every size. While the effects of shape 
were most pronounced at 180 mmHg, the effects of size within each shape were least 
pronounced. Within all circular or all D-shaped devices, no significant differences were 
detected among sizes at 180 mmHg. 
 
Figure 7-11 PVL results for the normotensive state (i.e., ΔP between 110-130 
mmHg), in terms of mean ± SD for each mock TMV plug type (included: individual 
devices, binned by shape, binned by size, and all shapes/sizes). Although trends are 
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apparent, statistical significance of these trends cannot be assessed until after GLM 
3 (see Figure 7-12 through Figure 7-14). 
 
 
Figure 7-12 PVL results for the normotensive state (i.e., ΔP between 110-130 
mmHg), in terms of mean ± 95% CI using either device shape (after GLM 3). Pairs 
whose 95% CIs do not overlap differ significantly (p<0.05). The D-shape 
significantly reduced PVL. 
 
 
Figure 7-13 PVL results for the normotensive state (i.e., ΔP between 110-130 
mmHg), in terms of mean ± 95% CI using each device size (after GLM 3). Pairs 
whose 95% CIs do not overlap differ significantly (p<0.05). The +6 size significantly 




Figure 7-14 PVL results for the normotensive state (i.e., ΔP between 110-130 
mmHg), in terms of mean ± 95% CI using each shape-size combination (after GLM 
3). Pairs whose 95% CIs do not overlap differ significantly (p<0.05). Within either 
shape, no significant differences in PVL were detected due to size. The only circular 
device that did not exhibit significantly greater PVL than at least one of the D-




Figure 7-15 PVL results, duplicated from Figure 7-11 through Figure 7-14. Top: 
mean ± SD for each mock TMV plug type (included: individual devices, binned by 
shape, binned by size, and all shapes/sizes). Bottom: mean ± 95% CI for each mock 
TMV plug shape, size, or shape-size combination (after GLM 3). Within each plot, 
pairs whose 95% CIs do not overlap differ significantly (p<0.05). Overall, shape was 
an equal or greater effector of PVL than size. 
 
Averaged across all observations having ΔP between 110-130 mmHg, PVL was 
18.4 ± 11.0 ml/sec. Circular plugs leaked 51.2% more than D-shaped plugs (22.2 ± 11.8 
vs. 14.7 ± 8.8 ml/sec, p<0.001). Across shapes, again oversizing led to significant benefit, 
but only when comparing the +6 size (14.3 ± 9.9 ml/sec) to +2 (21.6 ± 12.8 ml/sec, 
p=0.008), or nearly when comparing to +0 (19.9 ±10.4, p=0.061). Within circular or within 
D-shaped devices, no significant differences were detected among sizes. Likewise, within 
each size, no significant differences were detected between shapes. The trends in these 
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comparisons mirror those in Figure 7-9 and Figure 7-10; the lack of significance likely 
reflects the reduced sensitivity of this approach. 
 
7.2.2 Specific Aim 2.B: Parametric Evaluation of TMV Design and Radial Expansion 
Force 
7.2.2.1 Qualification of REFT Performance 
The REFT design was completely novel. It was constructed from multiple high-precision, 
rapid prototyped components, with electronic sensors installed by hand. Its performance 
was systematically qualified according to the following criteria.  
 
Dimensional verification. The dimensions of the arms were measured in triplicate along its 
two major axes, at each of 4 sizes. Mean absolute error across all devices/sizes was 142 
µm. This was within the expected total error due to the 25 μm resolution of multiple printed 
parts, the water jet cutting process, and the steel piston rod’s thickness tolerance (127 μm).  
 
Linearity of voltage response. In each of the 8 REFT arms, the voltage response to applied 
force was linear throughout the full force range applied during calibration (R2: 0.976-
0.999). Further detail is provided in Section 5.2.4.3. 
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Validation of REFT force measurements. Once calibration values were obtained, 16 forces 
from across the calibration range were re-applied to the four REFT arms. The mean relative 
error between true and measured forces was 4.3%. 
 
Sensitivity. In general, a force transducer’s sensitivity is the smallest force magnitude that 
can be reliably resolved from any underlying noise in the system. For the REFT, it was 
observed that increments as small as 0.1 N could be easily detected.  
 
Drift. Each data acquisition was performed over approximately 30 seconds. Drift in the 
REFT signals over this time interval was approximately 0.05-0.1 N. To remove the 
influence of drift, the baseline force signal was taken as the average signal before and after 
REFT expansion (as descried in Section 5.2.6.2).    
 
Cross-talk between measurement arms. The design of the REFT featured orthogonal or 
near-orthogonal arm orientations, and also featured a central hub that dampened force 
transmission between arms. Both of these attributes were intended to minimize “cross-talk” 
between septal-lateral (SL) and inter-commissural (IC) force measurements. Nevertheless, 
it was observed that peak loading (62.1 N) along one measurement axis slightly influenced 
force detection on the perpendicular axis. Mean relative error between the true force 
applied on one axis and the force measured on the perpendicular axis was 1.1%.  
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Uncertainty estimation. The above noted 4.3% and 1.1% mean relative errors between true 
and measured forces propagate to a theoretical worst-case uncertainty of 5.4%. 
 
7.2.2.2 Radial Expansion Force Results 
Testing of each porcine heart for SA 2.B’s investigation of TMV design and radial 
expansion forces commenced 5-11 hours post-mortem. Key geometric descriptors of the 
hearts used are presented in Table 7-5. Metrics before and after REFT testing are included. 
As detailed in Section 5.2.1, the selection criteria for these hearts included inter-trigonal 
distance of 30 mm and perimeter of approximately 108.4 mm. 
  
 199
Table 7-5 Geometric descriptors for the hearts used in SA 2.B investigation of TMV 
design and radial expansion force. Each heart was assigned to receive either the C-
REFT or D-REFT; differences between sample populations were assessed by 
Student’s t-test. 
Pre-procedure 
  C-REFT D-REFT p (C vs. D) 
Inter-trigonal distance (mm) 30.0 ± 0 30.0 ± 0 - 
Perimeter (mm) 109.1 ± 4.0 108.7 ± 5.4 0.879 
Area (cm2) 8.5 ± 0.5 8.2 ± 0.9 0.513 
DSL (mm) 26.2 ± 2.4 25.1 ± 3.1 0.507 
DIC (mm) 35.1 ± 4.1 34.4 ± 4.3 0.784 
DIC/DSL 1.35 ± 0.24 1.40 ± 0.30 0.783 
Post-procedure 
  C-REFT D-REFT p (C vs. D) 
Inter-trigonal distance (mm) 30.0 ± 0 30.0 ± 0 ‐ 
Perimeter (mm) 121.8 ± 4.2 124.1 ± 9.0 0.575 
Area (cm2) 10.6 ± 0.8 10.9 ± 1.7 0.647 
DSL (mm) 29.2 ± 1.8 30.0 ± 4.4 0.693 
DIC (mm) 38.9 ± 3.7 40.3 ± 3.6 0.538 
DIC/DSL 1.34 ± 0.14 1.37 ± 0.25 0.800 
 
Importantly, no differences were detected between the shapes of the MV annuli 
assigned to the C-REFT and D-REFT groups. The REFT experimental protocol caused 
plastic deformation of the MV annulus, although to a lesser degree than did the PVL 
protocol (Table 7-3). On average, the REFT protocol caused 12.9% increase in valve 
perimeter, 28.7% increase in valve area, 15.9% increase in DSL, and 14.0% increase in DIC. 
The implications of this stretch are discussed in Section 7.3.5. 
In total, after discarding samples with aortic pressure below 110 or above 130 
mmHg, 262 acquisitions (48.9% using C-REFT) were collected from 12 hearts (50% using 
C-REFT). Aortic pressure across all acquisitions was 119.6 ± 3.1 mmHg. The F- and p-
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values from all ANOVA models used in SA 2.B are presented in Table 7-6. Representative 
data from one acquisition is presented in Figure 7-16. 
Table 7-6 Results of all ANOVA models used in SA 2.B, before post-hoc analysis. 
ANOVA models are fully described in Table 7-2. 
  Factor F p 
Model 4 (FSL) 
Main 
effects 
Shape 9.55 0.002 
Size 39.75 <0.001 
Interactions Shape:Size 5.45 0.0048 
Model 4 (FIC) 
Main 
effects 
Shape 9.72 0.002 
Size 95.67 <0.001 
Interactions Shape:Size 21.95 <0.001 
Model 4 (sqrt(FIC/FSL)) 
Main 
effects 
Shape 46.55 <0.001 
Size 1.09 0.338 
Interactions Shape:Size 5.99 0.003 
 
 
Figure 7-16 Representative plots of force measured on each REFT arm from a 
single acquisition. With aortic pressure at approximately 120 mmHg, the arms were 
deployed to an expanded state, held, and retracted, such that force and pressure 
could be averaged over a 1.5 second interval. 
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It is apparent from Figure 7-16 that the aortic pressurization system was effective 
in maintaining within 1-2 mmHg of the 120 mmHg target. Forces were stable over time, 
with minimal drift during either the retracted (true-sized to the annulus) or expanded (over-
sized) state. Accordingly, deriving ΔP and PVL endpoints from a 1.5 second window 
average was appropriate. Note, these data reflect the forces preliminarily measured on each 
arm. All force data is reported hereafter as septal-lateral force (FSL, from an average of the 
measurements at 12 and 6 o’clock) and inter-commissural force (FIC, from an average of 
the measurements at 3 and 9’oclock). 
 GLM 4 accounted for the effects of TMV shape and TMV size on each of three 
dependent variables. FSL findings are presented in Figure 7-17 through Figure 7-21 and 
described in the text following Figure 7-21. FIC findings are presented in Figure 7-22 
through Figure 7-26 and described in the text following Figure 7-26. Sqrt(FIC/FSL) findings 
are presented in Figure 7-27 through Figure 7-31 and described in the text following Figure 
7-31. Note, Figure 7-27 provides FIC/FSL data before square root transformation, because 
this figure presents mean ± SD only, prior to the statistical model, and thus the 
transformation was unnecessary at that point.  
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Figure 7-17 FSL results in terms of mean ± SD for each expansion geometry 
(included: individual geometries, binned by shape, binned by size, and all 
shapes/sizes). Although trends are apparent, statistical significance of these trends 
cannot be assessed until after GLM 4 (see Figure 7-18 through Figure 7-20). 
 
 
Figure 7-18 FSL results in terms of mean ± 95% CI using either shape (after GLM 
4). Within each plot, pairs whose 95% CIs do not overlap differ significantly 




Figure 7-19 FSL results in terms of mean ± 95% CI for each level of annular 
oversizing (after GLM 4). Within each plot, pairs whose 95% CIs do not overlap 
differ significantly (p<0.05). Each increase in oversizing significantly increased FSL. 
 
 
Figure 7-20 FSL results in terms of mean ± 95% CI for each shape-size combination 
(after GLM 4). Within each plot, pairs whose 95% CIs do not overlap differ 
significantly (p<0.05). The D-shape was more sensitive to degree of oversizing than 




Figure 7-21 FSL results, duplicated from Figure 7-17 through Figure 7-20. Top: 
mean ± SD for each expansion geometry (included: individual geometries, binned by 
shape, binned by size, and all shapes/sizes). Bottom: mean ± 95% CI for each shape, 
size, or shape-size combination (after GLM 4). Within each plot, pairs whose 95% 
CIs do not overlap differ significantly (p<0.05). Size was a stronger effector of FSL 
than shape. 
 
 The global mean ± SD for FSL was 18.6 ± 9.4 N. Averaged across all sizes, 13.9% 
more FSL was required using the C-REFT versus the D-REFT (19.8 ± 7.4 vs. 17.4 ± 10.8 
N, respectively; p=0.002). Averaged across shapes, increase in oversizing from +2 to +4, 
or from +4 to +6, required a 51.3% or 22.1% increase in FSL, respectively (+2 vs. +4 vs. 
+6: 12.7 ± 6.0 vs. 19.3 ± 7.8 vs. 23.5 ± 10.4 N, respectively; each pair p≤0.001).  
The effects of sizing on FSL were driven mostly by the D-REFT: whereas the C-
REFT required 44.7% more FSL to expand to +6 versus +2, the D-REFT required 166.6% 
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more FSL to do the same. Whereas every pair of sizes within the D-REFT differed 
significantly in required FSL (each p<0.001), no significant difference was detected 
between C+4 and C+6 (21.4 ± 6.6 vs. 22.8 ± 8.7 N, respectively; p=0.964). Also of note, 
significantly more FSL was required to establish the C+2 geometry than D+2 (15.8 ± 4.7 
vs. 9.0 ± 5.4 N, p=0.002).  
 
Figure 7-22 FIC results in terms of mean ± SD for each expansion geometry 
(included: individual geometries, binned by shape, binned by size, and all 
shapes/sizes). Although trends are apparent, statistical significance of these trends 




Figure 7-23 FIC results in terms of mean ± 95% CI using either shape (after GLM 
4). Within each plot, pairs whose 95% CIs do not overlap differ significantly 
(p<0.05). The D-shape led to a significant increase in FIC. 
 
 
Figure 7-24 FIC results in terms of mean ± 95% CI for each level of annular 
oversizing (after GLM 4). Within each plot, pairs whose 95% CIs do not overlap 




Figure 7-25 FIC results in terms of mean ± 95% CI for each shape-size combination 
(after GLM 4). Within each plot, pairs whose 95% CIs do not overlap differ 
significantly (p<0.05). The D-shape was more sensitive to degree of oversizing than 




Figure 7-26 FIC results, duplicated from Figure 7-22 through Figure 7-25. Top: 
mean ± SD for each expansion geometry (included: individual geometries, binned by 
shape, binned by size, and all shapes/sizes). Bottom: mean ± 95% CI for each shape, 
size, or shape-size combination (after GLM 4). Within each plot, pairs whose 95% 
CIs do not overlap differ significantly (p<0.05). Size was a stronger effector of FIC 
than shape. 
  
 The global mean ± SD for FIC was 34.3 ± 14.0 N. Averaged across all sizes, 14.6% 
less FIC was required using the C-REFT versus the D-REFT (31.5 ± 14.0 vs. 36.9 ± 16.2 
N, respectively; p=0.002). Averaged across shapes, increase in oversizing from +2 to +4, 
or from +4 to +6, required a 51.8% or 31.3% increase in FIC, respectively (+2 vs. +4 vs. 
+6: 22.7 ± 8.0 vs. 34.5 ± 10.6 vs. 45.2 ± 12.7 N, respectively; each pair p≤0.001).  
Similarly to FSL, the effects of sizing on FIC were driven mostly by the D-REFT: 
whereas the C-REFT required 56.8% more FIC to expand to +6 versus +2, the D-REFT 
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required 140.6% more FIC to do the same. Whereas every pair of sizes within the D-REFT 
differed significantly in required FIC (each p<0.001), no significant difference was detected 
between C+4 and C+6 (35.2 ± 10.5 vs. 36.9 ± 6.2 N, respectively; p=0.969). Also of note, 
significantly less FIC was required to establish the C+6 geometry than D+6 (36.9 ± 6.2 vs. 
52.2 ± 12.6 N, p<0.001).  
Although the FIC trends closely mirrored those of FSL, it was noted that FIC was 
consistently and substantially larger than FSL. Indeed, the ratio of the mean FIC to the mean 
FSL for each tested heart ranged from 0.94-3.26, and exceeded 1.00 for 11 of 12 hearts. To 
quantify force eccentricity, the ratio FIC/FSL was investigated. For the purposes of GLM 4, 
the square root of this ratio was used to satisfy the GLM assumption of normally distributed 
residuals. 
 
Figure 7-27 Force eccentricity for each expansion geometry, expressed as mean ± 
SD for FIC/FSL (included: individual geometries, binned by shape, binned by size, 
and all shapes/sizes). Green line: FSL=FIC. Although trends are apparent, statistical 
significance of these trends cannot be assessed until after GLM 4 (see Figure 7-28 




Figure 7-28 Force eccentricity for each shape, expressed as mean ± 95% CI for 
sqrt(FIC/FSL) (after GLM 4). Within each plot, pairs whose 95% CIs do not overlap 
differ significantly (p<0.05). Green line: FSL=FIC. Forces were eccentric for each 
shape (i.e., the 95% Cis did not intersect 1.0); eccentricity was significantly greater 
using the D-shaped profile. 
 
 
Figure 7-29 Force eccentricity for each size, expressed as mean ± 95% CI for 
sqrt(FIC/FSL) (after GLM 4). Within each plot, pairs whose 95% CIs do not overlap 
differ significantly (p<0.05). Green line: FSL=FIC. Size was not found to have any 




Figure 7-30 Force eccentricity for each shape-size combination, expressed as mean ± 
95% CI for sqrt(FIC/FSL) (after GLM 4). Within each plot, pairs whose 95% CIs do 
not overlap differ significantly (p<0.05). Green line: FSL=FIC. All shape-size 




Figure 7-31 Graphs duplicated from Figure 7-27 through Figure 7-30. Top: force 
eccentricity results for each expansion geometry, expressed as mean ± SD for 
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FIC/FSL (included: individual geometries, binned by shape, binned by size, and all 
shapes/sizes). Bottom: force eccentricity results for each shape, size, or shape-size 
combination, expressed as mean ± 95% CI for sqrt(FIC/FSL) (after GLM 4). Within 
each plot, pairs whose 95% CIs do not overlap differ significantly (p<0.05). Green 
line: FSL=FIC. 
 
The global mean ± SD for FIC/FSL was 2.21 ± 1.33. Averaged across all sizes, 
FIC/FSL was 35.3% lower using the C-REFT versus the D-REFT (1.73 ± 0.74 vs. 2.67 ± 
1.59, respectively; p<0.001 based on sqrt(FIC/FSL)). Averaged across shapes, no significant 
differences were detected based on the degree of oversizing.  
When investigating shape-size interaction, two findings were notable. First, each 
geometry exhibited a 95% CI entirely above 1, implying the observed force eccentricity 
was significant for each. Second, the D+2 geometry was notable, in that it had the greatest 
force eccentricity (3.23 ± 2.29), which significantly exceeded that of D+4 (2.30 ± 1.14; 
p=0.014 based on sqrt(FIC/FSL)). However, D+2 also exhibited greater than double the 
standard deviation in FIC/FSL versus every other geometry, suggesting some risk of a false 
positive in this comparison.  
 
7.2.2.3 Micro-Computed Tomography of Left Ventricle 
Following the observation that mean FIC exceeded mean FSL for both device shapes, for all 
device sizes, and in 11 of 12 hearts, a subsequent analysis of the porcine heart anatomy 
was conducted. The investigation sought to assess the approximate amount of tissue being 
displaced by a radially expanding TMV. A micro-computed tomography scan was 
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performed, using a lightly pressurized balloon to hold the aorta open and the anterior leaflet 
away from the ventricular septum. A series of high-contrast markers were applied to the 
mitral annulus to guide image processing. 
 
Figure 7-32 Investigation of tissue thickness in the vicinity of the mitral annulus of a 
porcine heart. Top: photograph of heart. Bottom: multi-planar reconstruction of 
heart, obtained by micro-computed tomography. Blue border: annulus mid-plane. 
Green border: septal-lateral mid-plane. Red border: inter-commissural mid-plane. 
LVOT: left ventricular outflow tract. 
  
It is evident from Figure 7-32 that the amount of tissue opposing a radially 
expanding TMVR varies circumferentially. Along the annulus mid-plane, the wall 
thicknesses at 3, 6, or 9 o’clock (13.5 mm or more) were each at least five-fold greater than 
was the wall thickness at 12 o’clock (2.7 mm). Further, it appeared that the basal ventricular 
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myocardium (i.e., the tissue immediately inferior to the annulus mid-plane) was thicker 
still than that of the annular mid-plane, for all positions except 12 o’clock. At 12 o’clock, 
there is no myocardium inferior to the annulus mid-plane, but rather, the left ventricular 
outflow tract. 
  
7.3 Specific Aim 2 Discussion 
7.3.1 Specific Aim 2.A: Parametric Evaluation of TMV Design and PVL 
Although the potential for PVL post-TMVR has been demonstrated through early clinical 
experience,26-30 its eventual incidence upon wider use of TMVR remains to be determined. 
However, it is clear that PVL is (a) lethal in the TAVR setting, even when mild,31 (b) 
deadlier at the mitral than at the aortic position,32 (c) likely far more challenging to prevent 
in the TMVR setting than the TAVR setting, due to numerous biomechanical 
disadvantages,12-14 (d) difficult to diagnose, especially when mild or moderate,33 and (e) 
especially difficult to treat in surgically inoperable patients.34, 35 In light of the wide 
diversity of TMV designs currently under development, and the paucity of existing 
engineering data in this scenario, SA 2.A sought to develop and employ a test system to 
evaluate PVL rates as a function of simple parametric TMV models.  
 The ex vivo test system, which utilized fresh, whole porcine hearts, was developed 
and implemented successfully. Trans-mitral pressure gradients as high as 215 mmHg could 
be easily established in the absence of mitral leak. As more PVL was introduced, the 
maximum possible gradient dropped, yet even in the presence of PVL over 70 ml/sec, ΔP 
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values above 160 mmHg were attained. Thus, it was routinely feasible to measure PVL 
at or near the five targeted trans-mitral ΔP values: 60, 90, 120, 150, and 180 mmHg. 
Based on ISO guideline 5840-3 for the testing of transcatheter heart valves,112 60, 120, 150, 
and 180 mmHg represented peak ΔP for hypotensive, normotensive, or mildly/moderately 
hypertensive, and severely hypertensive patients, respectively. 
For all 8 mock TMV plugs, the relationship between ΔP and PVL was empirically 
determined to obey an approximately quadratic relationship (Figure 7-2, Figure 7-3, Figure 
7-4). This relationship can be understood from a physical standpoint by considering the 
leakage flowrate, Q, as the product of velocity, v, and cross-sectional area, A, then 
considering the relationships between ΔP and either v or A. The Bernoulli equation states 
that, within the assumptions of laminar and inviscid flow along a streamline, v is 
proportional to sqrt(ΔP). Meanwhile, it can be expected that any increase in ΔP (which was 
achieved by increasing LVP) would increase the force being applied normal to the wall(s) 
of the leakage gap(s). This force would likely push the soft tissue outward, thereby 
increasing A.  
 Thus, increasing ΔP should induce both an increase in v and an increase in A. To 
understand whether these effects are indeed sufficient to generate a quadratic relationship 
between ΔP and Q, it is helpful to investigate the amount by which the gap dimensions 
would need to change to cause what was observed experimentally. This question depends 
on the specific gap shape(s), which is unknown, but a conservative range can be bounded 
as follows. Consider the following Scenario 1, in which all leakage emanates from a single 
circular orifice at an arbitrary position along the annular circumference. On the other 
 216
extreme, consider Scenario 2, in which leakage emanates uniformly from around the entire 
annular circumference: 
 
Figure 7-33 Schematic depiction of two bounding scenarios describing the 
theoretical location/form of PVL gaps. In Scenario 1, all leakage emanates from a 
single circular orifice at an arbitrary position along the annular circumference. In 
Scenario 2, leakage emanates uniformly from around the entire annular 
circumference. 
 





Here, we assume dynamic viscosity (of water at 37 °C), µ, is 0.0007 Pa*s, and leakage gap 
length, L, is 0.01 m.  
The radius, r, can then be calculated based on (ΔP, Q) pairs obtained from empirical 
data. Based on Figure 7-4, we utilize the representative values of (60 mmHg, 15 ml/sec), 
(120 mmHg, 45 ml/sec), and (180 mmHg, 90 ml/sec). Respectively, these correspond to 
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radii of 6.7, 7.4, and 8.0 mm. In Scenario 2, we can approximate the gap width by assuming 
an equivalent total leakage gap area to that in Scenario 1, and dividing the area by the 
device perimeter. The gap width would be smallest in the case of a +6 device, having 
perimeter 131.6 mm. For the same three (ΔP, Q) pairs analyzed in Scenario 1, Scenario 2 
would have gap widths of 1.1, 1.3, and 1.5 mm. So, when ΔP increased from 60 to 180 
mmHg, the gap’s diameter (Scenario 1) or thickness (Scenario 2) would have needed to 
increase by approximately 0.4-2.6 mm, depending on gap shape. The findings of SA 2.B 
shed further light on the likelihood that a 120 mmHg pressure increase would cause such 
expansion of the annulus. This is discussed further in Section 7.3.3. Provided that this tissue 
response is indeed plausible, this analysis demonstrates that the observed quadratic 
relationship between ΔP and PVL very likely derived from the combined effects of 
increasing velocity (per the Bernoulli equation) and increasing gap area.  
 As evident from Figure 7-3, even when holding device shape and size constant, the 
pressure-leakage curves varied substantially among hearts. Some portion of this variability 
can be attributed to procedure, as the TMV plug was positioned manually. This was 
partially compensated for through the use of a strict positioning protocol and repeated 
acquisitions within each heart. The remaining variability could be attributed to variation 
between hearts. Despite the careful heart selection process according key annular 
dimensions, some variability in these dimensions, and in other metrics such as ventricular 
mass, leaflet size, and tissue properties, was inevitable.  
 The range of measured leakage rates is noteworthy. Figure 7-3 reveals that even in 
the worst-sealing instances, leakage at 60, 90 120, 150, or 180 mmHg were approximately 
15, 25, 45, 60, or 90 ml/sec, respectively. Given a normal systolic period of approximately 
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0.3 sec, all of these instances would likely translate to mild MR (per the American Heart 
Association’s threshold for moderate MR of 30 ml/beat164). Under different circumstances, 
an upward shift in all PVL rates might be expected. Device positioning included a final 
step of carefully angulating it to maximize the initial ΔP (see Section 5.2.6.1). Further, the 
healthy porcine hearts possessed thick myocardium, which likely offered greater radial 
resistive force than would exist in frail/diseased hearts. These procedural and anatomic 
factors likely enhanced sealing.  
The specific TMV parameters modeled in this work were stent shape (circular 
versus D-shaped) and size (+0, +2, +4, and +6 mm oversizing, relative to the native 
annulus’ inter-trigonal distance). Significant differences in leakage were detected among 
mock TMV plug shapes and sizes. Irrespective of pressure level, or of specific statistical 
method used, D-shaped plugs exhibited significantly reduced leakage (for example, at 
120 mmHg, circular plugs leaked 51.2% more than D-shaped plugs). The superiority of the 
D-shaped devices was expected, as they more closely conformed to the shape of the native 
annulus. However, based on the data from SA 2.A alone, it remains unclear which of two 
potential mechanisms actually explain this phenomenon. It is plausible that this greater 
congruence equates to more uniform radial force when expanding a D-shaped device, 
rather than a circular device, into the annulus. Alternatively, it may be the case that a large 
proportion of TMV sealing fundamentally derives from stent-leaflet contact. The exception 
to this scenario would be near the commissures, where little-to-no leaflet tissue exists, and 
sealing must derive from stent-annulus contact. In this scenario, it would be plausible that 
the D-shape’s advantage derives merely from greater radial force near the commissures. 
SA 2.B offered further insights to this question, as discussed in the next sections. 
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Oversizing effects were also largely consistent across analysis methods. 
Oversizing led to no significant benefit until reaching +6 mm in inter-trigonal distance 
(23.2 mm in perimeter). For example, at 120 mmHg, the worst sealing oversizing level 
(+2) leaked 50.5% more than the +6 level. This may reflect the degree of oversizing 
necessary for the stents to adequately contact the commissural annular tissue. Alternatively, 
it may be a consequence of plastic stretch occurring within the myocardium during the 
experiment. Potential for tissue fatigue is a noted limitation of ex vivo whole heart testing, 
and is discussed further in Section 7.3.5.  
TMV designers must make decisions about both outer profile shape and intended 
approach for annular oversizing. A circular TMV is likely the simplest to develop, and is 
the most robust with regards to rotational orientation during implantation. Yet, circular 
designs may be expected to encounter greater PVL, as observed in the present study. 
Therefore, one relevant question is whether the potential trade-offs of a circular shape in 
terms of PVL can be compensated for through greater oversizing. In the present work, D-
shaped devices reduced mean normalized leakage by 12.7% versus average. C+0, C+2, and 
C+4 each increased mean normalized leakage by at least 8.7% versus average. C+6 
reduced normalized leakage by 2.0% versus average. Thus, within the limitations of the 
test system used here, even though the D-shaped plugs offered uniformly better sealing, 
the discrepancy was reduced by approximately half when C+6 was used. It is likely that +0 
through +4 circular devices were ineffective in establishing effective contact with the 
commissural regions of the annulus. This is depicted schematically in Figure 7-34. 
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Figure 7-34 Illustration of a potential explanation for the finding that, although 
circular devices leaked more than D-shaped devices, the discrepancy was 
meaningfully reduced with use of C+6. At C+0 through C+4, the circular profile 
may fail to engage the commissural annulus, where the leaflets offer little 
contribution to sealing. The D-shaped profile more easily reaches the commissural 
annulus, at every size. 
 
7.3.2 Specific Aim 2.B: Parametric Evaluation of TMV Design and Radial Expansion 
Force 
For any given TMV design, there exists some range of operating conditions that favor 
optimal performance. Two such conditions are its final shape and degree of oversizing 
(relative to the native annulus). Thus, the TMV stent’s fundamental design can be 
meaningfully informed by an understanding of the annular resistive forces it must 
overcome to achieve a target shape/size post-deployment. The Circular and D-shaped 
Radial Expansion Force Transducers (C-REFT and D-REFT) were developed for this 
purpose, with the goal to quantification of the resistive forces imparted by the porcine 
mitral annulus as the REFT arms extended radially along defined paths. Forces were 
quantified simultaneously along the septal-lateral and inter-commissural axes (FSL and 
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FIC), for either circular or D-shaped TMV profiles, each over a range of oversizing levels. 
Each device was designed, manufactured, calibrated, and implemented successfully.  
REFT performance fell within an acceptable range: signal drift was minimal, 
sensitivity was 0.1 N (0.38% of the mean recorded force), and theoretical worst-case 
uncertainty of 5.4%. REFTs were tested in rigored hearts, to mimic the geometry and 
material properties of the systolic, contracted state,120, 121 and thus to model the peak 
annular forces the TMV will encounter in the beating heart in a simple, inexpensive 
manner. 
Previous studies have reported select forces associated with novel TMV stent 
designs. For example, in Young et al’s report on a 19 mm tall “winged” stent design, a 
computational simulation found that 36.0 N radial force was required to fully expand a 
1/12th segment of the stent from its crimped state.141 More recently, Loger et al measured 
the force required to embolize stents of various designs after their fixation in the porcine 
annulus (finding an average of 23.4 N for D-shaped varieties or 27.7 N for oval 
varieties).165 However, to our knowledge, this is the first study to measure the radial forces 
necessary to deploy an oversized TMV or TMV-like device in the mitral annulus. The 
closest parallel comes from Siefert et al,107 who investigated in vivo the septal-lateral and 
inter-commissural forces associated with cardiac contraction. A rigid, D-shaped transducer 
was surgically affixed to the mitral annulus, in normal ovine subjects (implanted in the 
flaccid, cardioplegic heart). For the sake of comparison, it may be roughly considered to 
have oversized the systolic annulus to diastolic dimensions. Siefert et al reported a peak 
cyclic contractile force of 9.2 N (septal-lateral). Using the REFTs, the mean recorded 
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expansion force across all samples was 24.4 N, and the highest mean within any one 
configuration was 52.2 N (FIC, using D+6).  
Three main factors likely contributed to the present study’s higher forces. First, the 
in vivo transducer’s pads were under 3 mm in height, versus a REFT arm pad height of 20 
mm. Second, the porcine left ventricle is substantially greater in mass and wall thickness 
than the ovine left ventricle. Third, the normal ovine mitral annulus has been reported to 
contract approximately 12% by area throughout the cardiac cycle;46 the +6 profile tested 
here was 47% larger by area than the +0 profile. Thus, the relatively high force observed 
here likely derived from displacing a taller section of annular tissue, having greater 
wall thickness, by a greater distance, as compared to the prior work from Siefert et 
al.107 
Two other notable findings using the REFTs agreed with expectations. 
Fundamental mechanics suggests that greater radial expansion could only be achieved via 
greater applied radial force. Thus, the finding that both FSL and FIC scaled positively with 
degree of oversizing was expected. Similarly, the finding that the C-REFT required greater 
mean FSL and less FIC than the D-REFT, was expected. This is because, whereas with each 
oversizing step the circular profile expanded 2.46 mm along either axis, the D-shaped 
profile expanded 2.05 mm in the septal-lateral direction and 2.68 mm in the inter-
commissural direction (Table 5-2).  
Other findings were not expected. Across all shapes and sizes, the force 
eccentricity, FIC/FSL, was 2.21 ± 1.33. This represents a deviation from other aspects 
of annular mechanics. For example, Siefert et al’s in vivo transducer found lower 
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contractile forces on IC axis than the SL axis.107 Gunning et al reported the anterior 
quadrant of the annulus (which sits along the SL axis) to possess the greatest 
circumferential stiffness.43 SA 1 of this thesis found the anterior annulus to possess the 
greatest suture holding strength. The fact that SA 2.B observed greater force was needed 
to expand along the IC axis likely owes to the unique geometry under investigation in this 
scenario. Each of the aforementioned studies investigated phenomena within a few 
millimeters in height and/or depth of the leaflet hinge line. The REFT, meanwhile, applied 
force against a 20 mm tall ring of tissue, centered along the leaflet hinge line. Further, it 
functioned by radially displacing the entire thickness of the tissue emanating outward from 
its contact surface.  
In the annular plane of a representative porcine heart, the tissue’s radial thickness 
was at least five-fold greater at 3, 6, and 9 o’clock than at 12 o’clock (Figure 7-32). Sub-
annularly, the basal ventricular myocardium at 3-9 o’clock thickened even further, while 
at 12 o’clock only the anterior leaflet was present. On the contrary, expansion of the 
REFT’s 12 o’clock arm was further resisted by 120 mmHg aortic pressure. Yet, given the 
pad’s total contact area of 474 mm2, this pressure would impart a theoretical maximum of 
7.6 N resistive force (whereas even at +2 oversizing, mean FIC was 22.7 N). Altogether, 
this analysis reveals that the septal-lateral arms encountered far less resistance to 
expansion than did the inter-commissural arms, due to fundamental anatomic 
differences in the tissue region surrounding the region traditionally referred to as the 
“annulus,” namely the basal myocardium. Any TMV stent having a significant sub-
annular portion may encounter similar dynamics. This includes many of the leading TMVs 
currently in clinical trials, such as Intrepid (Medtronic, Dublin, Ireland), Tendyne (Abbott 
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Laboratories, Chicago, IL) and Tiara (Neovasc, Richmond, Canada), as well as earlier stage 
stent concepts reported in literature, such as those from Young et al141, Meredith et al,166 
or Loger et al.165 Effective stent design to achieve targeted levels of “annular” oversizing 
likely must account for the observed dynamics of this broader tissue region. 
Also unexpectedly, significantly greater eccentricity was observed between FSL and 
FIC with use of the D-REFT. The opposite was anticipated, on account of the D-shape 
conforming more closely to the native annular profile. This finding results from two of the 
aforementioned phenomena. As expected, the D-shape elevated FIC and reduced FSL 
relative to the circular shape. However, whereas this was expected to bring these 
orthogonal forces in closer proximity to one another, because the FIC unexpectedly 
exceeded FSL even with the circular shape, it instead drove them further apart. 
A final noteworthy finding was the D-REFT’s heightened sensitivity to sizing. The 
C-REFT required 45% greater FSL and 57% greater FIC to achieve +6 oversizing than +2; 
the D-REFT required 167% greater FSL and 140% greater FIC to do the same. As the two 
devices expanded in a perimeter-matched fashion, the D-shape required significantly less 
FSL to oversize to +2, but required significantly more FIC to oversize to +6. We hypothesize 
that, for +2 oversizing, the D-REFT required less force simply because it did less to distort 
the annulus from its nominal geometry. But, at progressively larger perimeters, the D-shape 
also expanded more quickly in the IC direction than did the circular shape. This effect 
apparently predominated at +6, where the DIC was 3.64 mm greater in the D-shaped profile 
than the circular profile (Table 5-2). 
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7.3.3 Integrated Specific Aim 2 Discussion 
SA 2 was successful in developing two ex vivo test systems (a steady back-pressure 
system for PVL quantification, and a radial expansion force transducer) to describe pre-
clinically and clinically relevant aspects of TMV-annulus interaction. First, complex 
dynamics were revealed in terms of the distinct influence of TMV shape, TMV size, and 
trans-mitral ΔP on PVL rates. Circular devices exhibited significantly greater leakage than 
D-shaped devices. Oversizing reduced leakage, as expected, but the effect was not 
significant until the final size level (+6 mm in inter-trigonal distance, or 23.2 mm in 
perimeter) was reached. For every device type, PVL exhibited a strong, quadratic 
relationship to ΔP.  
Subsequently, further dynamics were revealed in terms of the influence of TMV 
shape and size on the force necessary to expand radially against the annulus. As expected, 
expanding the D-shaped profile required more force along the inter-commissural annulus, 
but less on the septal-lateral axis, versus the circular profile. Interestingly, over 2 times 
more force was necessary to expand along the inter-commissural axis versus the septal-
lateral axis, across all observations. 
After analyzing the PVL findings, two key questions remained, which were further 
informed by the radial expansion force data. The first question regarded whether increasing 
trans-mitral ΔP from 60 to 180 mmHg (an increase of 120 mmHg) could press the soft 
tissue boundary of the leakage gap radially outward by a sufficient amount to explain the 
quadratic relationship that was observed between ΔP and PVL. Analysis of the relevant 
physics suggested that the tissue would need to displace radially by between 0.4-2.6 mm 
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(depending on the precise gap shape, which remains unknown). The REFT sheds light on 
this question. It was found that, for the D-REFT to expand by 2.0 mm along the SL axis, 
9.0 N force was required on average. For the C-REFT to expand by 2.5 mm along the IC 
axis, 23.5 N force was required on average. Given the area of two annular contacting pads 
was 948 mm2, these values equate to required pressure of 71.2-185.9 mmHg. It is therefore 
plausible that a 120 mmHg increase in ΔP could enlarge the gap area by 0.4-2.6 mm. In 
conclusion, the notion that the quadratic relationship between ΔP and PVL derives from a 
combination of increasing fluid velocity and increasing gap area is well-supported. 
The second remaining question after the PVL study regarded the underlying reason 
why the D-shape offered such a sizable sealing advantage. Was this because the D-shaped 
device applied force more uniformly along the annular circumference? Or, is it possible 
that TMV sealing derives largely from stent contact with the native leaflets, and thus at the 
commissures, where little-to-no leaflet tissue exists, the D-shape gains advantage by 
establishing greater contact with the annulus? Viewing the findings from both sub-aims 
simultaneously, an answer becomes apparent. It is notable that the forces were significantly 
less uniform for the D-REFT than the C-REFT. It is also notable that, whereas radial forces 
were much more greatly influenced by size than shape, PVL depended slightly more on 
shape.  
For devices such as the mock TMV plugs tested here, whose sealing is generated 
purely by contact between the tissue and a straight tubular section, these facts suggest that 
radial force is not the primary determinant of sealing. In turn, they imply that the D-shape's 
benefit for PVL indeed derives from the ability to better reach the commissural regions of 
the annulus, where leaflet tissue is scarce. The notion that leaflet tissue plays a central role 
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in TMV sealing supports the notion of fabric covering the TMV stent through the entire 
region of potential leaflet contact. Such is the case in most reported TMV designs,15 but 
not in Edwards Lifesciences’ Sapien, whose off-label use at the mitral position is of 
growing interest.84 The notion that expanding with more uniform force against the annulus 
is less effective way to improve sealing than merely expanding in the optimal position is 
profound and potentially impactful. This may indicate stent flexibility as a critical, as-yet-
unexplored variable to optimize sealing performance. Although specific stiffness data for 
leading TMV stent designs is not publicly available, some designs, such as Medtronic’s 
Intrepid, emphasize optimized stiffness to improve anchoring and sealing.27 
 
7.3.4 Clinical and Engineering Implications 
Among the wide range of TMVR systems currently in development, none has yet achieved 
regulatory approval for market use. Two critical challenges in the advancement of these 
systems are the lack of available mechanical data describing relationships between TMV 
design parameters and performance, and the lack of consensus on best practices for TMV 
testing. By developing and employing novel benchtop systems for the assessment of PVL 
rates and radial expansion forces as functions of TMV stent shape and size, the present 
study has attempted to address both of these challenges. 
Some TMVR systems have recently reported initial promise.167 For example, 
Tendyne reported positive outcomes in a 30 patient cohort, with only one patient exhibiting 
significant PVL.168 Clinical trials for Intrepid and Tiara are also currently recruiting, with 
estimated enrollment of 115 and 1380 patients, respectively (www.clinicaltrials.gov). 
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These mark meaningful milestones toward the goal of bringing TMVR to market. 
However, it is important to note the carefully selected patients in these trials. Muller et al 
emphasize that the 30 patients receiving Tendyne “were selected to maximize the 
likelihood of procedural success.”168 The Intrepid and Tiara trials include “anatomic 
contraindications” and “unsuitable cardiac structures,” respectively, as patient exclusion 
criteria. Thus, despite positive early clinical data, it remains uncertain at present what 
aspects of TMV design will prove effective amidst the anatomic variability of the larger 
MR population. In the present work, using an ex vivo system featuring porcine hearts whose 
annular dimensions were carefully selected, SA 2.A found substantial sealing variability 
within each mock TMV plug design (Figure 7-3), owing largely to anatomic factors. This 
finding clearly emphasizes that the conclusions drawn from such early, limited patient 
populations should remain conservative. TMVR performance is likely to vary widely upon 
broader clinical use.  
Despite the variability encountered in PVL rates between hearts, a decisive 
advantage in annular sealing was found using a rigid D-shaped design versus a rigid 
circular design. It was further shown that the performance discrepancy between shapes 
could be reduced by approximately half, by oversizing the circular stent to +6 mm in inter-
trigonal distance (23.2 mm in perimeter). Designers of new TMV devices, who may face 
choices between D-shaped and circular stent designs, should ultimately reconcile these data 
with other relevant criteria. These include, but are not limited to, ease of production and 
implantation, risk of inducing LVOT obstruction or coronary vessel compression, anchor 
retention, and robustness against misplacement (e.g., D-shaped devices must anchor in the 
 229
correct rotational orientation). These topics were not investigated in the present work; they 
remain poorly understood in the public domain.  
 Beyond merely determining the target degree of annular oversizing and post-
implantation shape and for a given TMV device, designers must ensure an ability to achieve 
these targets. This can derive from an understanding of the native tissue properties of the 
TMV landing zone, namely the annulus’ radial resistive force, which the expanding device 
must overcome. The present work revealed that these properties, in normal porcine hearts, 
are non-trivial. 1.7 fold greater radial force was required to expand along the inter-
commissural axis versus the septal-lateral axis, when enforcing a circular profile (for the 
D-shaped profile, this reached 2.2 fold). This radial expansion force data, much like the 
suture force data collected throughout SA 1, may also offer significant value to 
computational modeling (as discussed in Section 6.3.5). 
 The present investigations also serve as a testimonial on the suitability of whole 
porcine hearts as an ex vivo model for benchtop TMV performance assessment. ISO 
guideline 5840-3, which concerns the testing of transcatheter heart valve replacements, 
provides key test conditions that should be met, but does not specify the operational 
environments to achieve these conditions.112 Potential environments include rigid models 
(e.g, acrylic), flexible synthetic models (e.g., silicone), organic models (e.g., ovine, 
porcine, or human tissue), or combinations thereof. Using the present porcine model, 
challenges included the limited heart supply and tissue fatigue (as described in Table 7-3 
and Table 7-5). Synthetic models derived from imaging data could resolve each of these 
challenges, while also offering diseased and/or human anatomies. Yet, they would likely 
fall short in areas where the porcine heart excelled. Tissue material properties were 
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represented in terms of both bulk mechanics and surface-fluid interaction. Critically, 
geometrically and materially complex surrounding structures (e.g., the chordae tendineae, 
ventricular septum, and aorta), which may be difficult to fabricate, were intact. The porcine 
hearts proved effective, enabling the identification of clear differences in leakage and radial 
expansion forces according to device type. Ultimately, silicone and organic models will 
likely serve complementary roles in industry. A tester such as the REFT could prove an 
effective tool for silicone model validation, by establishing comparable radial expansion 
force behavior between the model and hearts of interest (e.g., cadaver). 
 The successes of the present work, outlined above, represent important first steps 
toward improved understanding of TMV design-performance relationships, and toward 
best practices for device assessment. Numerous important future directions exist on both 
fronts. These are discussed in Section 8.2.2. 
 
7.3.5 Limitations 
All experiments in Specific Aim 2 were conducted using healthy porcine hearts. 
The healthy porcine model is an established and appropriate tool for both benchtop ex vivo 
and preclinical in vivo testing of heart valve devices.165, 169, 170 While the observed relative 
trends are likely widely applicable across species including humans, absolute values for 
PVL and radial expansion forces may best represent what could be expected during 
preclinical TMV evaluation in porcine subjects. The thick, strong porcine myocardium 
may enhance annular sealing, and elevate radial expansion forces, relative to aged, human 
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hearts. These quantities are likely further influenced by disease morphologies, especially 
in the case of secondary mitral regurgitation results from annular remodeling.  
It must also be acknowledged that the PVL and REFT experimental procedures 
resulted in plastic stretch in the annulus (Table 7-3, Table 7-5). This is an inevitable 
consequence of mechanically loading explanted tissue. Due to the scarce supply of hearts 
with desired dimensions, each heart was tested across every oversizing level, in order of 
increasing size. This potentially exacerbated PVL and reduced radial forces at larger sizes. 
However, it likely influenced results across shapes, and across test methods, uniformly. 
Further testing using the methods employed in SA 2, but with only one oversizing level 
per heart, would offer additional insights.  
It is noteworthy that all testing was conducted with hearts in a rigored, contracted 
state, and that the basis for cardiac contraction, whether during rigor mortis or systole, is 
actin-myosin fiber interaction. The likely mode of plastic stretch in these experiments is 
that enforcing oversized and/or incongruous geometries disrupted actin-myosin bonds, 
which were then unable to generate tension. At this time, it is unclear the extent to which 
this phenomenon represents what should be expected in vivo. In vivo, stretch in a sarcomere 
(i.e., a functional actin-myosin unit) has been shown to affect the tension it generates during 
contraction according to sliding filament theory;171 in over-stretched sarcomeres, the 
myosin heads may fail to contact the actin fibers altogether.172 
PVL studies in SA 2.A used water as the working medium, rather than a fluid such 
as water-glycerine, which can be matched to the viscosity of blood (i.e., 1.8 times higher 
than water). This was necessary due to the high volume of fluid needed for each 
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experiment. Greater viscosity would be expected to uniformly reduce leakage flow rates, 
but would have no impact on relative differences between devices.  
One additional limitation specific to SA 2.B is noteworthy. The REFT’s four 
annulus-contacting pads were shaped to match the +0 profile, with 3.4 mm gaps between 
pads. Inevitably, when oversizing, these gaps grew larger, and the path described by the 
contact pads deviated from a true circle or a true D-shape at larger sizes. This deviation 
was considered negligible in terms of its impact on radial expansion force.  
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CHAPTER 8. CONCLUSIONS AND FUTURE WORK 
8.1 Specific Aim 1 
8.1.1 Conclusions 
 Suture Force Transducers were successful in detecting forces acting on individual 
annuloplasty sutures in the normal, beating ovine heart, using a range of 
annuloplasty ring designs.  
 Across all tested rings, cyclic contractile forces on annular sutures trended 
positively with peak LVP, and were greater on sutures in the anterior annulus than 
those in the posterior annulus. 
 Suture pullout force was also greater for sutures in the anterior annulus than those 
in the posterior annulus. This differential was larger for suture pullout force than 
for cyclic contractile force, indicating a lower margin of safety for suture 
dehiscence in the posterior annulus. 
 Annular collagen density was greater at the suture position corresponding to the 
mid-anterior annulus than at the suture position corresponding to either trigone or 
at the mid-posterior annulus.  
 As compared to undersized ring annuloplasty, true-sized ring annuloplasty 
conferred a cyclic contractile force reduction for anterior annulus sutures, only. 
 As compared to the semi-rigid/flat Physio ring, the rigid/saddle-shaped Profile 3D 
ring showed no effect on suture forces in the anterior region as a whole or on the 
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posterior region as a whole. When undersizing, Profile 3D did confer a reduction 
in force variability among individual positions. 
 Increasing ring flexibility conferred a cyclic force reduction to posterior annulus 
forces. 
 A novel hybrid ring design possessing rigid anterior and posterior segments 
interposed with small, flexible commissural segments appeared to yield the same 
effects on anterior-posterior balance of cyclic contractile forces as did the fully-
flexible design. Additional sample size is required.  
 The ring prototyping, force measurement, and force analysis techniques developed 
in this work, in combination with established echocardiography-based analysis of 
mitral valve function, comprise the means to further explore novel annuloplasty 
ring designs for the optimization of suture retention and repair effectiveness. 
 
8.1.2 Future Work 
SA 1 provided important research in pursuit of advanced strategies for the reduction in 
annuloplasty suture dehiscence rates. The most direct application of this research will be 
toward the subsequent development of improved ring designs. These designs may include 
the hybrid concept tested preliminarily in SA 1.C. Next steps in this development process 
should include: 
 Further testing of the current hybrid ring concept. Additional data points in normal 
ovine subjects would enable statistical testing. Studies in an ischemic MR model 
would clarify this design’s capacity to restore effective valve function. 
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 Development and testing of other hybrid design iterations. These may include 
altered positioning of flexible segments and/or varied material properties within the 
segments. 
 
Beyond ring design, other related questions regarding annular suture dehiscence 
remain. In parallel to the work included in SA 1, a series of additional studies have already 
been conducted, which highlight specific questions that demand further attention. These 
include: 
 Impact of suture tie-down force. From a large group of the animal studies conducted 
in SA 1, suture tie-down forces were also quantified. Significant differences were 
found in the force used between implanting surgeons, suggesting these practices 
may meaningfully impact dehiscence likelihood. These data are presented in 
APPENDIX A. Additional research is needed to assess the degree to which tie-
down force evolves post-operatively (on account of tissue viscoelasticity, weaning 
from cardiopulmonary bypass, and longer-term myocardial remodeling), and to 
work toward an eventual consensus on optimal suture tying techniques. 
 Robustness against suture mal-positioning. In one failed in vivo experiment 
investigating annuloplasty suture forces, a likely suture misplacement (too high 
above the annular hinge line) culminated in extreme force magnitudes on one 
suture, which ultimately dehisced at high LVP. This experience is described in 
APPENDIX B. Increased understanding of the implications of suture bite width, 
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depth, and location for suture dehiscence likelihood would significantly benefit the 
surgical training process.173 
 Tricuspid valve annular suture force dynamics. No longer the “forgotten valve,” 
the tricuspid valve is now the focus of steadily expanding device design efforts. 
Annuloplasty suture dehiscence is a noted problem for the tricuspid valve, as 
well.174, 175 We have measured suture holding strength and collagen content in ovine 
tricuspid annuli. The findings, presented in APPENDIX C, reveal a complex 
structure in need of further study. In vivo suture force measurements in the tricuspid 
annulus, akin to those performed in SA 1, would provide crucial information.  
 Discrepancies between normal ovine and diseased human annular mechanics. All 
experiments within SA 1 used normal ovine hearts. Although sheep are widely 
accepted as a model for human cardiac physiology, some differences between ovine 
and human mitral/myocardial mechanics are known.37, 46, 107 To begin to address 
this discrepancy, we have measured suture holding strength and collagen content 
in a cohort of six human mitral annuli (from donors aged 60-79, with no history of 
heart disease). This work is presented in APPENDIX D. Additional samples across 
a broader age range, and including valve disease, would be of value.  
 
Although SA 1 limited its investigations to surgical annuloplasty rings, related questions 
involving transcatheter technologies also deserve further attention. These include: 
 Mechanics of novel anchor types used with transcatheter repair devices. One such 
example is Cardioband (Edwards Lifesciences), a catheter-based annuloplasty band 
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that anchors to the annulus with a series of screw components, and which has CE 
Mark approval for commercial use in Europe. Notably, Cardioband underwent a 
recall in February 2018 due to “implant dehiscence” 
(https://www.tctmd.com/news/edwards-voluntarily-recalls-cardioband-anchors-
used-mitral-and-tricuspid-repair).  
 Valve-in-ring procedures using the hybrid ring concept. Off-label placement of a 
TAVR device within a mitral annuloplasty ring to correct recurrent MR is a 
growing research area. However, rigid and/or semi-rigid D-shaped rings may cause 
problematic distortion of the circular TAVR stent. If the hybrid ring developed in 
SA 1.C proves non-inferior to existing rigid or semi-rigid rings in terms of repair 
effectiveness, its utility for valve-in-ring procedures will warrant further 
investigation. It is likely that its three-dimensional shape and flexible commissural 
segments may enable it to “unfold” to better accommodate a circular stent.  
 
8.2 Specific Aim 2 
8.2.1 Conclusions 
 A steady back-pressure test system was successfully developed to investigate 
paravalvular leakage dynamics in fresh, rigored, normal porcine hearts, as a 
function of the shape and size of mock transcatheter mitral valve plugs.  
 Additionally, circular and D-shaped Radial Expansion Force Transducers were 
successfully developed to quantify the forces necessary to expand the rigored, 
normal porcine mitral annulus to shapes and sizes matching the plugs. 
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 PVL rates were proportional to the square of the trans-mitral pressure gradient. 
 D-shaped plugs offered significantly improved sealing against PVL compared to 
circular plugs. The performance discrepancy was reduced by approximately half 
when the circular plug was oversized to the annulus by +6 mm (inter-trigonal 
distance). 
 Unlike PVL dynamics, radial expansion force dynamics were much more sensitive 
to device sizing than to device shape. 
 Approximately two-fold more radial force was necessary to expand the annulus 
along the inter-commissural axis than the septal-lateral axis. 
 The forces necessary to oversize the annulus were less sensitive to the amount of 
oversizing when the shape of the device was circular rather than D-shaped.  
 For biomechanics research pertinent to TMVR development, the rigored, normal 
porcine heart is a relevant and convenient model for the anatomies and tissue 
properties encountered both in preclinical device testing and, to a lesser degree, in 
the clinic. An important limitation, however, is the capacity for plastic tissue 
deformation under sustained loads. 
 
8.2.2 Future Work 
SA2 developed two new test systems to investigate TMVR performance mechanics, and 
employed these systems to study clinically and industrially relevant implications of TMV 
shape and size. This represents one of the only studies to date to parametrically assess 
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relationships between TMV design and performance. Numerous additional future studies 
should follow to enhance, further, and/or complement the present work. These include: 
 Investigation of PVL and/or radial expansion force according to TMV stiffness. The 
circular and D-shaped devices used here represented final (post-implantation) TMV 
shapes. Notably, all stents possess some degree of flexibility, such that even a 
circular device may take on an oval, D-shaped, or other conformation post-
implantation. Two potential future ways to investigate this phenomenon are to vary 
stiffness of the mock TMV plug, or vary the geometries of the mock TMV plug 
(and/or REFT) to mimic alternative post-implant geometries of interest. 
 Further data acquisitions in additional hearts. Though cumbersome, additional 
tests using one size level per heart would largely address the noted limitation of 
plastic fatigue within the tissue. Also, testing in cadaver hearts would more closely 
represent the patient anatomies and tissue properties that a TMV would encounter.  
 Other steady back-pressure system and REFT system modifications. Specific to the 
steady back-pressure test system, modifications to accommodate pulsatile pressure 
waveforms (physiologic or pathophysiologic) would enable numerous other 
investigations of TMV performance dynamics. Specific to the REFT, it is 
noteworthy that, while all data in SA 2.B was collected with aortic pressure fixed 
to 120 mmHg, preliminary investigations suggest that radial expansion forces may 
vary with aortic pressure (data not shown). Further study could quantify this 
relationship across a wider range to represent hypotensive and hypertensive 
geometries. 
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 Parametric investigation of left ventricular outflow tract obstruction (LVOTO) 
dynamics. Likely important parameters include, but are not limited to, TMV shape, 
TMV size, and the anatomy of the ventricular septum and anterior leaflet, and aorto-
mitral angle. Integration of LVOTO and PVL data may inform best practices for 
device size and shape. 
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APPENDIX A. SUPPLEMENTAL STUDIES: ANNULOPLASTY 
SUTURE TIE-DOWN FORCES 
A.1 Introduction 
The in vivo studies conducted in Specific Aim 1 assessed the cyclic forces sutures 
experience in the beating heart (FC). In one subset of these studies, the force initially 
applied during implantation of each suture (i.e. tie-down force, FTD) was also recorded and 
analyzed, as described herein.  
 
A.2 Materials and Methods 
This study utilized the suture force transducers and normal ovine model described in 
Sections 4.1 and 5.1. Physio and Profile 3D rings were used. The experimental protocol 
was as described in Section 5.1.4.2. For each suture, FTD was computed as the difference 
in force immediately before and after its tie-down. Statistical analysis was as described in 
Section 5.1.6, using the specific ANOVA models listed below. 
Table A-1 ANOVA models used in this appendix.  
Model Dependent Variable Independent Variables 
1 FTD Ring type, ring-annulus sizing, suture position 
2 FTD* Surgeon, suture position 
*this model examined a subset of 11 Profile 3D cases, performed by either of two 




A description of the sample populations used in this supplemental study is presented in 
Table A-2 (note, each subject was also used in Specific Aim 1). In total, this cohort 
included 4 of 10 Physio cases and 13 of 13 Profile 3D cases (forces were not recorded 
during suture tie-down in the early cases using the Physio ring). Among all cases, mitral 
annulus sizes ranged between 26-32, and rings of size 26-30 were used (either true-sized 
to the annulus, or undersized by two sizes). Note, this sizing refers to the label size of the 
ring and its corresponding sizer, and is approximately equivalent to the inter-trigonal 
distance (in mm). 
Figure A-1 provides representative force data on each of ten sutures, covering a six-
minute period spanning from before the first suture tie-down to after the final suture tie-
down. The F- and p-values from all ANOVA models used to analyze these ring 
implantations is presented in Table A-3. 
Table A-2 Data set summary for this appendix. U: undersized; T: true-sized; Ph: 
Physio ring; 3D: Profile 3D ring 
  U-Ph T-Ph U-3D T-3D 
Sample size 3 1 6 7 
Surgeon 1 Frequency 0 0 1 5 
Surgeon 2 Frequency 0 0 3 2 
All Other Surgeons’ Combined 
Frequency 3 1 2 0 
Animal weight (kg) 49.7 ± 5.9 62 57.0 ± 5.8 57.4 ± 6.8 
Annulus size 30.0 ± 0.0 32 30.0 ± 0.0 27.7 ± 1.8 




Figure A-1 Representative data used for FTD measurement. Sutures were tied first 
to the left trigone (LT), then the right trigone (RT), then clockwise from 11 o’clock. 
FTD was computed as the force differential immediately before/after tie-down (tie-
down visible here as a series of quick spikes). 
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Table A-3 Results of ANOVA models used in this appendix, before post-hoc 
analysis. 




Ring type 0.76 0.385 
Ring-annulus sizing 2.08 0.152 
Suture position 1.93 0.051 
Interactions 
Ring type:Ring-annulus sizing 0.03 0.855 
Ring type:Suture position 1.67 0.101 




Surgeon 7.8 0.006 
Suture position 1.8 0.078 
Interactions Surgeon:Suture position 2.77 0.007 
 
Across all sutures, mean ± standard deviation FTD was 2.7 ± 1.4 N (range: 0.0-8.0 
N). On the basis of ANOVA model 1, it was found that ring type, ring-annulus sizing, and 
suture position did not significantly affect FTD. Furthermore, no significant pairwise 
interactions were found.  
 Next, noting that no significant differences due to ring type or ring-annulus sizing 
were found, and desiring to examine the impact of surgeon on FTD, ANOVA model 2 was 
applied to a subset of 11 Profile 3D cases. These were performed by either of two surgeons 
(5 or 6 each), whereas no other surgeon performed more than two cases for which FTD was 
collected. As shown in Figure A-2, independent of position, surgeon 2 applied 29% more 
FTD than surgeon 1 (2.9 ± 1.2 N vs. 2.2 ±1.4 N, p=0.006). Independent of surgeon, only 
one pairwise significant difference was found among positions: sutures at 1 o’clock 
endured greater FTD than those at 5 o’clock (3.6 ± 0.8 N vs. 1.9 ± 0.9 N, p=0.048).  In 
addition, 1 o’clock sutures nearly achieved significance versus multiple other positions. 
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Interaction between surgeon and position was observed; notably, the final 9 o’clock suture 
was subjected to greater FTD when implanted by surgeon 2 (3.9 ± 1.2 N vs. 1.3 ± 0.6 N, 
p=0.035).  
 
Figure A-2 Mean ± 95% CIs for each (A) surgeon, (B) suture position, or (C) suture 
position specific to the implanting surgeon. Model included a cohort of 11 Profile 3D 
cases split 5:6 among two surgeons. Within each plot, pairs whose 95% CIs do not 
overlap differ significantly (p<0.05). (B-C) Shown in order of suture implantation. 
 
 To understand the extent to which force used to tie down a suture dictates the 
eventual cyclic force on that suture during cardiac contraction (FC), correlation between 
 247
FTD and FC was assessed. Among all 170 sutures for which FTD was recorded, linear 
regression was conducted between FTD and the corresponding FC at LVPmax = 125 mmHg, 
revealing R2 = 0.003 (p=0.467).  
 
Figure A-3 Correlation between FTD and FC.  
 
A.4 Discussion 
Whereas clinical reports of suture dehiscence may be easily dismissed as a result of mere 
surgical error, Specific Aim 1 demonstrated that the force acting on annuloplasty sutures 
in the beating heart vary significantly as a function of the selected ring’s properties. The 
results of this appendix complement this finding by further demonstrating the significant 
variability in suture tie-down force among surgeons.  
 Specific Aim 1 pursued strategies to reduce annuloplasty suture forces in the 
beating heart (FC). The non-significance of the correlation between FTD and FC (Figure 
A-3) suggests that a more loosely tied knot is unlikely to relieve eventual FC. However, the 
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unexpectedly high FTD magnitudes, as compared with FC, suggest knot-tying force may 
meaningfully affect dehiscence likelihood. Across the 170 sutures in this cohort, mean FTD 
was 2.7 N, compared with 2.0 N FC (averaged across all three LVPmax levels). Still, the 
summed quantity, FTD + FC, cannot be assumed to represent the total suture force in the 
beating heart. We speculate that that FTD, measured immediately after suture tie-down, 
evolves postoperatively. Soft tissue viscoelasticity153 is known to facilitate stress relaxation 
and creep; its impact in this context remains unknown. Baseline myocardial tone also may 
change after weaning from cardiopulmonary bypass and recovery from anesthesia.176 
Longer term, soft tissue is also capable of active remodeling in response to changes in 
homeostatic mechanical stresses. Such phenomena warrant further investigation. 
 With respect to suture anchoring, three main variables can be influenced by the 
surgeon. Among these, neither suture selection not suture placement (bite width, bite depth, 
or height above the leaflet hinge line) was explored in the present study, although we have 
observed dehiscence to occur after likely suture misplacement (see APPENDIX B). The 
third variable, knot tying force (FTD), notably did not vary according to ring selection. 
However, it was shown to vary according to circumferential suture position. When 
exploring Profile 3D rings only, FTD at 1 o’clock was highest (36% above mean FTD), where 
it significantly exceeded that of 5 o’clock and nearly achieved significance versus multiple 
other positions. This may be explained by a combination of suture tie-down order (LT, then 
RT, then clockwise from 11 o’clock) and ring shape. The 1 o’clock and 9 o’clock sutures 
were unique in that they were each implanted after both of their respective adjacent sutures. 
At 1 o’clock, the higher annular collagen content (as reported in SA 1.A and by Gunning 
et al43) also might pose more resistance to suture knotting.  
 249
 Further, significant discrepancies in FTD were observed between the two primary 
implanting surgeons in these studies. Averaged across 6 or 5 procedures, respectively, 
surgeon 2 applied 29% more FTD overall, and 201% more FTD at 9 o’clock, than surgeon 
1. Currently, it remains unclear what suture tie-down strategy, if any, is optimal for 
anchoring durability. If subsequent investigations are able to identify such an optimum, 
standardizing to that strategy across surgeons could create substantial value within the 
scope of the applicable procedures. Recent commentary has highlighted the vital role of 
surgical training for accurate and precise suture placement as a means to minimize the 
likelihood of dehiscence.155 Surgical training may ultimately play a similar role in the 
context of knot-tying. 
  
A.5 Conclusion 
In this cohort of 17 annuloplasty ring implantations, suture tie-down force did not vary 
based on ring type or size, but varied significantly according to the suture position and/or 
the implanting surgeon. Tie-down force on a given suture exhibited no correlation to that 
suture’s eventual cyclic force in the beating heart. Although it remains unknown to what 
extent the force used during suture tie-down persists postoperatively, tie-down force may 
play a determining role in suture dehiscence likelihood.  
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APPENDIX B. SUPPLEMENTAL STUDIES: A LIVE-RECORDED 
CASE OF ANNULOPLASTY SUTURE DEHISCENCE 
B.1 Introduction and Background 
The in vivo experiments conducted in Specific Aim 1 sought to understand suture 
dehiscence mechanics by quantifying the forces acting on mitral annuloplasty sutures 
during cardiac contraction. These studies did not attempt to actually induce suture 
dehiscence. However, in the course of completing these experiments, one unexpected 
incident of suture dehiscence occurred; this is described herein.  
 
B.2 Materials and Methods 
This study utilized the suture force transducers and normal ovine model, and surgical 
procedures described in Sections 4.1 and 5.1. An instrumented Profile 3D ring (final size 
26 after accounting for transducers) was implanted in a size 30 annulus (subject weight, 45 
kg). The experimental protocol was as described in Section 5.1.4.2. However, in addition 
to the neosynephrine and dobutamine used to elevate left ventricular pressure (LVP), a 0.2 
µg intravenous bolus of epinephrine was also administered. Note, the forces reported in 
this appendix are absolute or peak forces, as indicated (i.e., not cyclic forces, FC, which 





It was noted that one suture, located at 11 o’clock, experienced peak force two-fold higher 
than any other suture, at all peak LVPs. The epinephrine bolus induced a rise in LVP to 
195 mmHg over 30 to 40 seconds. At an LVP of 188 mmHg, a dramatic decrease in force 
was observed at 11 o’clock, from 16.7 to 0.6 N. Simultaneously, peak forces increased at 
the two adjacent sutures, one by 3.1 N and the other by 2.6 N. Two other sutures 
experienced small increases (1.3 N and 0.3 N), but force decreased at all other sutures. 
After the animal was euthanized, visual examination revealed that the suture in question 
had torn through the annulus tissue, likely owing to technical misplacement above the 




Figure B-1 (A-B) An annuloplasty ring, instrumented to record tensile forces on 
individual sutures, was implanted in the mitral valve of a healthy ovine subject 
using standard technique. (C) Implantation was unremarkable. (D) Following LVP 




Figure B-2 The failed suture dehisced following a peak force of 16.7 N (red); 5.7 N of 
this force shifted to the two adjacent sutures (black). Loading on all other sutures 
(green) either increased slightly (i.e. < 1.3 N) or decreased. 
 
B.4 Discussion 
This case provides the first quantification of a tensile force responsible for annuloplasty 
ring suture dehiscence in the beating heart. After a 16.7 N load induced dehiscence, a 
combined 5.7 N shifted to the two adjacent sutures. This observation provides a likely 
mechanism whereby a single problematic suture could induce a cascade of dehiscence at 
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multiple anchor points, as observed clinically.99 A less eccentric redistribution of force 
across the remaining sutures may be preferable. 
 Greater suture loads may be expected along the anterior annulus in general, due to 
systolic expansion of the aortic root (which sits adjacent to the anterior annulus), cyclic 
changes in the anterior saddle geometry,46 and the stiffer/more collagenous anterior annular 
tissue (as demonstrated by Gunning et al43 and in SA 1.A). Nonetheless, it is noteworthy 
that the observed force distribution was so highly concentrated on the single failed suture, 
even at lower LVPs. This case was likely a consequence of misplacement of the suture in 
question; we believe that placement too high above the annular hinge heightened suture 
tension by adding an out-of-plane force component at that position. Ultimately, any steps 
during device selection, suture placement, and suture tie-down that minimize sharp force 
concentrations on single sutures will likely help to ensure prosthesis security. This case 
particularly highlights the importance of accurate suture positioning to that end; a more 
rigorous quantification of these effects is the subject of ongoing work.   
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APPENDIX C. SUPPLEMENTAL STUDIES: OVINE TRICUSPID 
ANNULAR MECHANICS 
C.1 Introduction and Background 
Functional tricuspid regurgitation (FTR) is the most common disease of the tricuspid valve 
(TV).177 In the past, FTR has often been ignored, and it continues to be undertreated.178, 179 
Patients are rarely referred for isolated tricuspid surgical repairs or replacements.178, 179 
Previous studies have asserted that FTR associated with left-heart conditions should be left 
to resolve itself after left-heart repair.180 However, more recent studies show that FTR does 
not, in fact, resolve itself after mitral-valve surgery,178, 181 and given that reoperation is 
risky and rarely performed,178, 182 it is important to address tricuspid regurgitation (TR) at 
the time of left-heart surgery.181, 183 Recent published opinions favor a more aggressive 
approach to correcting FTR,178, 181, 184, 185, and increased attention is now being given to the 
tricuspid disease, both in terms of volume of surgical treatments.183, 185 and breadth of 
corrective devices.182, 184, 186 Whenever possible, TV repair (largely centering around ring 
annuloplasty) is preferred over replacement 185. 
 TV repair is often triggered by an annulus diameter of greater than 40 mm, and an 
approach to sizing these cases may be to undersize by at least two ring sizes. However, the 
“normal” size of the tricuspid annulus is very close to 28 mm in all patients, suggesting 
that undersizing by two ring sizes may not be sufficient. Huffman examined patients who 
underwent mitral valve repair with an undersized, rigid, complete annuloplasty ring, and 
who concomitantly underwent TV repair using the same size TV annuloplasty ring.187 
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Findings suggest that the same ring size can be used for TR as was used for MR, without 
development of significant tricuspid stenosis or negative effects on right heart function. 
These findings were confirmed by three large clinical trials by Desai (USA), Mukherjee 
(USA), and Bertrand (Europe), which showed that the RV improves when functional TR 
is repaired.188, 189 Furthermore, this “normalize size” approach seems to prevent the 
recurrence of significant TR. Ghoreishi has shown that the application of a normal size 
tricuspid ring (28 mm) results in very little recurrent regurgitation and no stenosis.190 
 With respect to ring stiffness, there is currently little direct comparative evidence 
to discern between rigid and flexible options. However, similarly to functional MR, rigid 
rings are commonly considered more effective to treat FTR. In recent analyses of the 
existing literature, Rogers concluded the superiority of rigid or semi-rigid rings,185 owing 
to multiple clinical series.191-193 Zhu, meanwhile, noted that while flexible and rigid rings 
perform comparably in the short-term, rigid rings exhibit potential advantage in terms of 
sustaining postoperative TR grade.185, 194 
 Yet, as has been demonstrated in Specific Aim 1 of this thesis for the mitral valve, 
suture dehiscence is a potential drawback to rigid rings at the tricuspid position.194 
Tricuspid annuloplasty ring dehiscence data is currently limited, and its exact incidence 
varies from series to series. However, one revealing report comes from Pfannmuller, who 
reported a 4.8% dehiscence rate among 820 tricuspid annuloplasties performed for 
moderate-to-severe, non-organic TR.195 Within this cohort, flat rigid rings (Carpentier-
Edwards Classic, Edwards Lifesciences LLC, Irvine, CA) and flexible bands (Cosgrove-
Edwards, Edwards Lifesciences LLC) dehisced in 8.7% and 0.9% of cases, respectively. 
Dehiscence risk may become even more significant with the next generation of 
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transcatheter tricuspid repair devices, many of which anchor using unprecedented 
techniques.184 
 Specific Aim 1 showed significant variation in mitral annular collagen density, and 
an associated variation in suture holding strength. This suggested that shifting the 
distribution of annuloplasty suture forces more towards the anterior mitral annulus (i.e. 
towards the septum) could decrease the incidence of dehiscence. An analogous 
characterization of the tricuspid annulus could similarly inform anchor design in current 
and next-generation tricuspid devices. This study aimed to quantify the tricuspid annulus’ 
suture holding strength and its correlation to underlying collagen structure. 
 
C.2 Materials and Methods 
All testing was performed using fresh, never-frozen ovine hearts (Superior Farms, Dixon, 
CA). Suture pullout testing (N=15 hearts) was performed using the materials and methods 
described in Sections 4.1.4, 5.1.3.1, and 5.1.4.2. All sutures were placed by a single 
operator (note, this was a different operator than in SA 1.A suture pullout tests). Twelve 
sutures were tested per sample, at the positions shown in Figure C-1. Annular 
microstructure (i.e. collagen and non-specific fiber density) was quantified in a separate 
cohort of hearts (N=7) using the materials and methods described in Sections 4.1.5, 5.1.3.2, 
and 5.1.4.3. However, rather than excise small cubes of tissue prior to paraffinization, the 
entire tricuspid annulus was paraffinized. Sectioning and imaging were performed on 
larger regions of tissue, as shown in Figure C-2 below. Pixel intensities were then 
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quantified over a 2 x 3 mm region of interest extending superiorly and into the tissue, 
respectively, from the leaflet hinge. 
 
 
Figure C-1 Positions included in data collection. Suture pullout testing included all 
twelve positions. Fluoroscopic imaging included those positions with green circles. 





Figure C-2 Representative image collected by two-photon autofluorescence, 
demonstrating the region of interest for colorimetric quantification (white box). 
Green, collagen fibers; red, non-specific fibers. 
 
 Statistical analysis was performed using Minitab (Minitab, Inc., State College, PA) 
and MATLAB (MathWorks, Natick, MA). For suture pullout forces, a nested ANOVA 
model was used, with suture positions nested within regions (regions were defined as 
anterior leaflet, posterior leaflet, septal leaflet, and commissural). For normalized mean 
pixel intensity (nMPI), one-way ANOVA models accounting for each position were used.  
 
C.3 Results 
All 180 suture pullout attempts were successful. Across all suture positions, mean ± 
standard deviation FP was 6.5 ± 2.2 N. The absolute minimum FP was 1.9 N (SAC), and 
the absolute maximum value was 17.0 N (6 o’clock).  
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Figure C-3 Mean ± SD FP results, with ANOVA results depicted by symbol notation. 
*p<0.05 vs. 5 o’clock; **p<0.05 vs. 6 o’clock; @p<0.005 vs. 5 o’clock; @@p<0.005 
vs. 6 o’clock; $p<0.001 vs. 5 o’clock; $$p<0.001 vs. 6 o’clock; #p<0.001 vs. all other 
regions. 
 
The lowest average pullout force was 4.3 ± 1.3 N at the posterior aspect near the 
anterior-posterior commissure (1 o’clock), and the highest was 10.0 ± 4.1 N at the mid-
septal annulus (6 o’clock). Two positions in the septal annulus (5 and 6 o’clock) had 
significantly higher FP than nearly every other position. By region, the septal annulus (8.7 




Figure C-4 Mean ± SD nMPI results, with ANOVA results depicted by symbol 
notation. *p<0.005 vs. 6 o’clock; @p<0.005 vs. 6 o’clock. 
 
 Collagen nMPI peaked at 6 o’clock (1.26 ± 0.08) and decreased with progressive 
distance from the septum. ANOVA showed significant differences in nMPI between the 6 
o’clock and either 2 o’clock or APC. Non-specific myocardial fibers were also imaged; no 
significant variation in this signal was observed.  
 As shown below, a strong linear correlation was found between collagen density 
and suture holding strength (R2 = 0.82, p = 0.013).  No such correlation was found between 
non-specific fibers and suture holding strength (R2 = 0.02, p = 0.806), demonstrating the 





Figure C-5 Linear regression of each position’s mean suture pullout force versus 
normalized mean pixel intensity (nMPI). Only positions subjected to both 
measurements were included (i.e. each commissural and mid-leaflet position). 
 
C.4 Discussion 
The present study characterized the local suture holding strength around the annulus and 
the annular collagen density that may underlie it. It was observed that suture holding 
strength and collagen density were highest in the septal annulus. Each was also higher at 
positions above leaflet midpoints compared to commissures. Consistent with findings from 
SA1 at the mitral position, collagen density was found to be a strong predictor of tricuspid 
annular suture holding strength. It can be observed in Figure C-5 that an approximate 1/3 
decrease in TV annular collagen content equated to a 5 N decrease in holding strength. One 
implication of this finding is that, in forms of organic valvular regurgitation hallmarked by 
adverse collagen remodeling,53, 196 alternative suturing techniques may be preferable. In all 
disease states, care should also be taken to protect against dehiscence when tying the 
stitches in the least robust areas, and to avoid tying when there is over-distraction from 
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retraction. Reinforcing pledgetted sutures can also be used in areas of perceived or known 
weakness. 
 The increased suture holding strength in the septal annulus initially appears to 
contradict the clinical tendency toward suture dehiscence at the septal annulus.195 However, 
we note four possible explanations for this discrepancy. First, the report of predominantly 
septal dehiscence was following use of Carpentier-Edwards rings. Given the out-of-plane 
annular motion near the trigone,197 these planar rings may eccentrically load sutures along 
the septal annulus. Second, this report followed ring implantation in the beating heart; 
beating heart annuloplasty has shown a trend toward heightened dehiscence rates.198 The 
septal aspect of the ring is typically the last to be secured to the beating heart, which could 
predispose sutures in this region to misplacement and/or higher tie-down forces. Third, 
efforts taken to avoid damaging the atrioventricular node during tricuspid annuloplasty 
may result in too few sutures and/or too shallow bites being used along the septal aspect, 
causing diminished anchoring strength there. Finally, it is possible that higher contractile 
forces experienced along the septal annulus in vivo, independent of ring type and 
implantation method, may be sufficient to overcome its greater holding strength. 
 The notion that contractile forces at the tricuspid septum outweigh its superior 
tissue strength would represent a striking difference from the mitral valve, where the septal 
annulus is a superior anchor site.199 Yet it is plausible on the basis of the TV annulus’ 
dynamic motion. Even when dilated, the tricuspid annulus experiences a greater systolic 
reduction in circumference than the mitral annulus,197, 200 potentially elevating TV cyclic 
suture tension. Most FTR annular dilation occurs along the septal-lateral axis; rigid ring 
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annuloplasty most severely restricts motion along this axis,201, 202 suggesting that in vivo 
suture forces may be greatest near the septum or lateral wall. Further, the septal aspect, 
owing to the trigone and the heightened collagen content, is the TV annulus’ least 
compliant region and may thus experience uniquely high suture tension. 
In the pursuit of strategies to reduce dehiscence risk, this study highlights key 
differences between the MV and TV. A chain is only as strong as its weakest link203 –  that 
is to say, the most practical approach to minimizing dehiscence likelihood is to address the 
sutures with the lowest margin of safety between strength and loading. At the mitral 
position, SA1 showed that sutures placed in the septal annulus experience greater loading 
in vivo but also have the highest margin of safety. Thus, for the mitral valve, approaches 
that redistribute cyclic suture forces towards the septum are of interest to improve 
anchoring stability. On the other hand, at the tricuspid position, evidence suggests suture 
forces appear to be too high at the septal annulus, despite its superior strength. Thus, 
improved approaches for TV devices may involve a redistribution of cyclic suture forces 
away from the septum. For example, the use of nonplanar rings has been shown to be 
effective in treating tricuspid regurgitation without need for reoperation.204 Animal studies 
are necessary to fully characterize the force distribution on tricuspid annuloplasty sutures. 
 Although technically, undersized ring annuloplasty for FTR is relatively 
straightforward, careful attention should be given to surrounding structures. Specifically, 
in functional TR repairs, numerous annular stitches, even to the point of overlapping, 
should be utilized, as the annulus is usually “under-developed” as compared to the mitral 
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annulus and the distracting force from the geometric distortion of the RV must be 
counteracted. The annuloplasty sutures should be taken parallel with and travel in the 
annulus. One common source of failure of tricuspid annuloplasty is the dehiscence of the 
ring from inadvertently applying the stitches to the atrial wall or in the leaflet tissue. One 
general approach for FTR has been to place stitches only from 10 o’clock to 6 o’clock, 
avoiding the AV node, the lower septal area and the triangle of Koch. 
 The present data, though most directly applicable to existing surgical TV repair or 
replacement devices, have further implications for transcatheter devices. The field of 
transcatheter TV repair is growing rapidly, with MitraClip (Abbott Laboratories, 
Minneapolis, MN) already being used to achieve a percutaneous edge-to-edge-type repair 
of the TV, and with several additional devices in preclinical or clinical trials.184, 186 Many 
of these use novel mechanisms, such as corkscrews or foldable pledgets, to anchor to the 
annulus.205 Although the present reported force values are not necessarily representative of 
the exact annular strength in the presence of alternate anchor types, analogous positional 
heterogeneity likely exists for these devices. Ultimately, these novel mechanisms place 
unprecedented mechanical demands on the annulus that must be objectively characterized. 
Percutaneous delivery in the absence of direct visual access and without arresting the heart 
will likely challenge the precision of anchor placement.204 Anchor robustness in the 
presence of this variability is essential. The complexity of the TV annular tissue shown 
here, in combination with the increasing diversity in anchoring technology, creates a 




The septal region of the tricuspid annulus has an increased collagen density and increased 
suture holding strength. Both parameters were higher at positions above leaflet midpoints 
compared to commissures. For all positions tested, collagen density was a strong indicator 
of suture holding strength. The clinical tendency for dehiscence along the septal annulus195 
suggests that adverse suturing techniques in this region may be common, and/or that this 
region may experience higher cyclic forces in vivo. Further exploration of the factors 
influencing dehiscence risk and annular tissue failure are needed to improve device designs 
and implantation techniques.  
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APPENDIX D. SUPPLEMENTAL STUDIES: HUMAN MITRAL 
AND TRICUSPID ANNULAR MECHANICS 
D.1 Introduction and Background 
Investigations of suture pullout mechanics and collagen content were conducted in Specific 
Aim 1.A (for the mitral valve) and in APPENDIX C (for the tricuspid valve). As noted 
earlier, one limitation of these studies was the use of normal ovine tissue. This tissue’s 
material properties and composition may differ from the human tissue in which sutures are 
anchored in the clinical setting due to species,206 age,206, 207 and pathology.208  
A second limitation of these studies was that distinct cohorts of hearts were used 
for suture pullout testing and collagen quantification. Suture pullout testing, once complete, 
left the annular tissue disrupted to such an extent that accurate, in situ, quantitative imaging 
was not possible (in situ imaging is shown, for example, in Figure C-2). Although this in 
situ approach was cost-effective and provided spatial information about collagen 
concentrations within each section, it necessitated use of a separate cohort of hearts for 
collagen quantification. If the same samples were used for both tests, correlation of 
collagen content to suture pullout force (FP) would have been possible on a point-by-point 
basis; instead, only mean values at each suture position could be correlated.  
A third limitation was in the collagen quantification technique itself. The two-
photon excitation fluoroscopy technique was effective to assess relative differences in 
collagen content among multiple positions of a given valve annulus (with units of 
normalized mean pixel intensity, nMPI). Its effectiveness derived from the use of constant 
 268
imaging settings for all positions within each valve annulus. Because nMPI from a given 
sample signified collagen density in that sample, relative to the mean among all samples 
from that valve, the ovine mitral and tricuspid nMPI data cannot be compared to one 
another. Relatedly, two different operators were used for MV suture placement and TV 
suture placement, making direct comparison of FP values between the valves unreliable.  
 In an effort to address these limitations, an additional data series was collected. 
From a cohort of six human hearts age 60-79, both the MV and TV annuli were subjected 
to suture pullout testing (with all sutures placed by a single operator). Subsequently, the 
tissue from each tested suture position was subjected to a collagen quantification assay that 
used digested tissue. The tissue injury post-suture pullout that inhibited in situ annular 
imaging was of no concern for this digest-based assay. 
 
D.2 Materials and Methods 
D.2.1 Donor Criteria, Sample Preparation, and Positions Tested 
Hearts from donors with no history of heart disease (N=6) were acquired from Science 
Care, Inc. (Phoenix, AZ). Immediately upon receipt, mitral and tricuspid annular tissue 
were excised as described in Section 5.1.3.1. Each specimen was cryopreserved using a 
90% RPMI-1640 and 10% DMSO solution at -80 °C.209, 210 Before testing, specimens were 
thawed through incremental dilution of DMSO with 0.9% saline solution over the course 
of 40 minutes. 
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From each valve, ten positions (for MV) or twelve positions (for TV) were tested. 
Every sample was subjected to both suture pullout and collagen testing. These are the same 
positions for which suture pullout was conducted in SA 1 and in APPENDIX C. However, 
regional grouping is different in the present cohort, in support of a unified design between 
the MV and TV data. 
 
Figure D-1 Annular positions/regions tested. All positions were subjected to both 
suture pullout and collagen quantification testing. These are the same positions 
subjected to suture pullout testing in SA 1 and APPENDIX C. However, regional 
grouping is different in the present cohort, in support of a unified design between 
the MV and TV data. LT, left trigone; RT, right trigone; APC, anterior-posterior 
commissure; PSC, posterior-septal commissure; SAC, septal-anterior commissure. 
 
D.2.2 Suture Pullout Testing 
The valve annulus was mounted to the suture pullout test plate described in Section 4.1.4. 
Mounting and suture placement were performed as described in Section 5.1.3.1. All sutures 
were placed by a single operator. Mounted specimens were submerged in a 0.9% saline 
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solution at 37° C. Suture pullout was conducted with a TestResources 100Q Universal 
Testing Machine (Shakopee, MN). The axial force was measured using a 500 lbf load cell 
(TestResources SM-500-294) and recorded through a custom LabVIEW code. As in the 
earlier studies, the suture was tied to the upper arm and pulled at 1 mm/sec until it tore 
through the tissue. In terms of native MV or TV geometry, this pulling was approximately 
radially inward, i.e. the approximate direction of suture tension following undersized 
annuloplasty in vivo. 
 
Figure D-2 Mitral annulus sample from a donor heart, after preparation for suture 
pullout testing. 
 
D.2.3 Collagen Quantification Testing 
After all sutures from a valve were pulled out, tissue samples from each suture position 
were carefully excised. The excised section was a rectangular prism with boundaries 
approximately 1 mm beyond the suture path in all directions. Each sample was 
homogenized by grinding with submersion in liquid nitrogen. Each sample was then 
hydrolyzed at 120 °C for 3 hours, using 200 μl 6 M HCl per 10 mg sample mass.  
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The hydrolysate was tested for mass of hydroxyproline per unit volume, via a 
commercial assay (MAK008, Sigma-Aldrich, St. Louis, MO). Hydroxyproline is a major 
component of collagen, where it serves to stabilize the helical structure. Because it is 
largely restricted to collagen, the measurement of hydroxyproline levels is a standard 
metric for collagen content. Using a series of 96-well plates, the assay was performed for 
each sample in duplicate, according to the supplier’s protocol. Absorbance readings for 
each sample, in addition to three sets of hydroxyproline standards per plate, were obtained 
at 560 nm using a SynergyTM H4 plate reader (BioTek, Winooski, VT). 
 
D.2.4 Data Processing and Statistical Analysis 
FP values were the maximum recorded force during suture pullout testing. For collagen 
quantification testing, based on the absorbance readings from the hydroxyproline 
standards, a standard curve was computed for each plate (R2>0.98 in all cases). This curve 
was used to compute mg hydroxyproline per well, and in turn mg hydroxyproline per mg 
tissue (i.e. hydroxyproline mass fraction, HYP).  
 Statistical analysis was performed using Minitab (Minitab, Inc., State College, PA) 
and MATLAB (MathWorks, Natick, MA). For both FP and HYP, nested ANOVA models 
were used, with suture positions nested within regions as shown in Figure D-1. Tukey’s 
Honestly Significant Difference post-hoc correction was used to test for pairwise 
differences. Separate ANOVA models were used for MV and TV data. Although these 
ANOVA models exhibited normally distributed residuals, the FP or HYP results 
themselves were not normally distributed. Therefore, FP or HYP results were compared 
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between valves via Mann-Whitney U-test. Additional comparisons between valves were 
made after excluding the TV trigonal region. This is of interest because the atrioventricular 
node sits very close to this region, and surgeons often avoid placing sutures in this region 
to minimize risk of introducing cardiac rhythm defects. Additionally, in order to test the 
causal relationship between collagen content and suture holding strength, HYP and FP were 
correlated. Distinct correlations were assessed for each valve. Correlations were computed 
both on a point-by-point basis and on a positionally-averaged basis.    
 
D.3 Results 
Key donor descriptors are shown in Table D-1. 50% of donors were male. 
Table D-1 Descriptors of donor hearts (N=6). Post-mortem interval is the total time 
between donor death and tissue cryopreservation. 
    Min   Mean   Max 
Age 60 71 79 
Post-mortem interval (days) 3 5.7 8 
Body mass index 16.7 22.5 28.6 
 
D.3.1 Pullout Testing 
Pullout was successful for 58/60 mitral and 71/72 tricuspid sutures (with three failures due 
to experimental error). Among all MV or all TV positions, mean ± standard deviation FP 
was 7.8 ± 2.9 N or 8.2 ± 6.1 N, respectively. Median (inter-quartile range) FP was 7.4 (6.0-
9.1) N for MV or 6.6 (5.2-8.2) N for TV. These were not significantly different by Mann-
 273
Whitney U-test (p=0.115). Excluding the trigonal region, TV FP was 6.3 (4.6-7.6) N, which 
was significantly less than MV FP (p<0.001). Positional and regional analyses are presented 
below. 
Table D-2 ANOVA results for FP, before post-hoc analysis. 
  Factor F p 
Mitral 
Position (nested within region) 0.20 0.984 
Region 2.16 0.126 
Tricuspid 
Position (nested within region) 4.48 <0.001 




Figure D-3 Mean ± SD FP results, with ANOVA results depicted by symbol notation. 
#p<0.001. 
 
The weakest and strongest MV positions were 8 o’clock, in the posterior region, 
and 11 o’clock, in the anterior region (mean ± standard deviation, 6.9 ± 2.6 N and 10.3 ± 
4.7 N, respectively). The ANOVA model for MV FP did not detect significance in either 
position or region. Accordingly, no pairwise differences by position or region were found 
(although anterior sutures showed a trend toward higher FP, with p=0.130 or 0.201 versus 
posterior or trigonal sutures).  
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Whereas mean FP for every MV position fell within 3.3 N, pullout forces were more 
diverse for the TV. The weakest and strongest TV positions were 10 o’clock, in the anterior 
region, and SAC, in the trigonal region (mean ± standard deviation, 4.5 ± 1.6 N and 24.0 
± 9.3 N, respectively). 7 o’clock, also in the trigonal region, had FP of 10.8 ± 5.8 N; no 
other position had mean FP over 7.5 N. SAC was significantly stronger than every other 
position, and the trigonal region (FP=17.4 ± 10.1 N), was significantly stronger than every 
other region (each p<0.001).  
 
D.3.2 Hydroxyproline Fraction Testing 
HYP was successfully measured in 57/60 mitral and 71/72 tricuspid sutures (with failures 
due to experimental error either during the preceding suture pullout test or during tissue 
excision). Among all MV or all TV positions, mean ± standard deviation HYP was 8.4 ± 
4.1 mg/g or 5.0 ± 2.7 mg/g, respectively. Median (inter-quartile range) HYP was 6.8 (5.1-
11.2) mg/g for MV or 4.4 (3.3-6.1) mg/g for TV. Excluding the trigonal region, TV HYP 
was 4.2 (3.1-5.5 N). With or without the TV trigonal region, TV HYP was significantly 
less than MV HYP (p<0.001). Positional and regional analyses are presented below. 
Table D-3 ANOVA results for HYP, before post-hoc analysis. 
  Factor F p 
Mitral 
Position (nested within region) 1.31 0.265 
Region 6.93 0.002 
Tricuspid 
Position (nested within region) 0.96 0.480 




Figure D-4 Mean ± SD HYP results, with ANOVA results depicted by symbol 
notation. *p<0.05; @p<0.005; #p<0.001; $p<0.001 vs. SAC. 
 
 For the MV, the least and most dense HYP positions were 3 o’clock, in the posterior 
region, and 1 o’clock, in the anterior region (5.6 ± 2.7 mg/g and 13.6 ± 3.7 mg/g). 1 o’clock 
HYP was significantly greater than 3 o’clock (p=0.022); no significant differences were 
detected among suture positions, the posterior region (HYP=7.0 ± 3.3 mg/g) was less dense 
than each other region (p=0.006 vs. anterior, p=0.047 vs. trigonal). 
 For the TV, the least and most dense HYP positions were 9 o’clock, in the posterior 
region, and SAC, in the trigonal region (3.2 ± 1.5 mg/g and 10.3 ± 3.0 mg/g). Similarly to 
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FP results, 7 o’clock exhibited the second-highest HYP (7.3 ± 2.0 mg/g); no other position 
had mean HYP over 5.3 mg/g. SAC had significantly greater HYP than all other positions 
except for 7 o’clock (each p≤0.007). The trigonal region (HYP=8.8 ± 2.6 mg/g) had 
significantly greater HYP than either other region (each p<0.001). 
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D.3.3 Pullout Force and Hydroxyproline Fraction Correlation 
 
Figure D-5 Correlations of hydroxyproline fraction (a metric for collagen content) 
versus suture pullout force. Correlations are computed for each valve, both using 
every available data point and using mean data from each suture position. 
 
As shown in Figure D-5 no correlation existed between HYP and FP for the MV, however, 
a significant correlation existed for the TV. These findings were consistent whether 
accounting for all data points or mean values. It was also observed that data points from a 
given suture region tended to “cluster” together for the TV, but not for the MV.  
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D.4 Discussion 
This investigation measured both suture pullout forces (FP) and collagen content (in the 
form of hydroxyproline mass fraction, HYP) in mitral and tricuspid annuli from six donors 
age 60-79 with no history of heart disease. Both FP and HYP were measured from each 
tissue sample. Numerous phenomena observed here mirrored those in the earlier SA1 and 
APPENDIX C studies, which utilized multiple cohorts of ovine hearts, and which 
quantified annular collagen via colorimetric analysis of fluoroscopic images. Across all 
MV studies, FP was greatest for sutures placed in the anterior tissue, between the trigones. 
Across all TV studies, a strong FP peak was consistently exhibited approximately near the 
septum. Also, it was found in all TV studies that FP correlated strongly to collagen content. 
It is notable that, in the human tissue cohort, similar FP vs. HYP correlations were observed 
whether accounting for all individual data points or positional means (Figure D-5). This 
observation adds validity to the correlations based on positional means in SA 1 and 
APPENDIX C.  
Of equal importance, multiple findings from the present cohort differed from earlier 
findings obtained using ovine hearts. Firstly, although the human mitral annulus exhibited 
highest FP between the trigones, differences in FP were not significant among mitral suture 
positions or regions. In ovine tissue, the same trend was seen, but with statistical 
significance (Figure 6-11). Considering the similar physiologic surroundings for both the 
ovine and human inter-trigonal annulus (i.e. the cyclic rise and fall of the annular saddle, 
coupled to ventricular contraction and aortic root expansion), the lack of significance may 
reflect age-associated stiffening and/or calcification of these samples, which could impact 
FP irrespective of collagen density (some such calcification was noted qualitatively, 
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especially along the posterior annulus, however it was not evaluated quantitatively). 
Alternatively, it may be a reflection of the limited sample size of the human tissue cohort. 
In either case, additional analyses in a larger cohort of human tissue would offer 
clarification. 
Another distinct finding in the present data was the nature of the TV “spike” in FP. 
In APPENDIX C, the strongest position in the ovine TV annulus had mean FP=10.0 N, 
which was approximately 62% greater than all other positions (Figure C-3). In the human 
TV annulus, the strongest position had FP = 24.0 N, which was approximately 257% greater 
than all other positions. Interestingly, this spike was located at 6 o’clock (above the mid-
septal leaflet) in the ovine tissue, versus at the septal-anterior commissure in the human 
tissue. These positions were defined with respect to the leaflets and commissures. 
However, it is important to recognize that both of these positions were at or near the trigone. 
The shift in peak FP location with respect to the commissures may reflect a difference in 
the anatomy of the two species: namely, the ovine septal leaflet occupies a larger portion 
of the annulus than does its human counterpart, placing the ovine trigone closer to 6 
o’clock, as defined in this study. Rausch et al recently found that the septal leaflet occupied 
approximately 40-50% of the annulus in most ovine subjects.211 Meanwhile, Kawada et al, 
found the same quantity averaged 31% in humans.212 Regardless, the surprising strength of 
the human TV trigonal region adds further support to the notion that the heightened 
prevalence of tricuspid dehiscence from the septal annulus175 owes to sub-optimal suture 
placement in that region as a means to avoid injury to the atrioventricular node.  
Two unanticipated, likely related discrepancies were observed between the human 
mitral and tricuspid annuli. For the mitral annulus, collagen and FP showed no relationship 
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(although collagen did correlate moderately with FP and strongly with RS in ovine tissue; 
Figure D-5 and Figure 6-15). This is in contrast to the tricuspid annulus, where a strong 
correlation was observed in both species (Figure C-5). Meanwhile, although median TV 
FP was within 11% of median MV FP, median TV HYP was over 35% reduced versus 
median MV HYP.  In other words, although tricuspid annular collagen was substantially 
reduced versus mitral annular collagen, this did not translate to an equal reduction in suture 
holding strength. Taken together, these two findings suggest that some discrepancy 
between mitral and tricuspid collagen must better enable the latter to withstand suture 
tension. Such differences could include collagen fiber alignment, which is well-known to 
impact directional material properties in valve leaflets.213 In the setting of annular sutures, 
fiber alignment parallel to the suture path (i.e. circumferentially aligned) could inhibit the 
suture’s ability to engage the fibers’ load-bearing capacity, even if they are more densely 
packed. Another possible explanation is collagen sub-type. Strengths of different collagen 
sub-types are known to differ;214 the hydroxyproline assay does not distinguish among 
them.  
Both the limitations of this work, and its potential applications to device design and 
surgical practice, are as described earlier (see Sections 6.3.6 and C.4). In addition to the 
aforementioned follow-up studies that could shed further light collagen-suture holding 
strength relationships observed in this cohort of human valve annuli, further testing is 





FP and collagen distribution in mitral and tricuspid annuli from aged human donors largely 
paralleled those in ovine tissue, with two key exceptions. First, human mitral annular 
collagen showed no correlation to associated FP. Second, the peak in tricuspid FP near the 
trigone was far more pronounced in human tissue. These findings emphasize the 
importance of future anchor mechanics testing using larger cohorts of both normal and 
diseased human annuli. Also, tricuspid annular collagen content, although 35% less than 
mitral, correlated strongly with FP, leading to FP values only 11% less than mitral. These 
observations may be further explained through investigations into collagen type and/or 
alignment in either valve.  
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APPENDIX E. DATA TABLES FOR SPECIFIC AIM 1 
E.1 Specific Aim 1.A Data 
Table E-1 In vivo cyclic suture forces (N) using undersized Physio rings. 
Animal ID GTA2 GTA3 GTA6 GTA7 GTA11 




LT 4.16 3.88 2.26 1.48 3.51 
11 o'clock 1.97 2.12 1.66 1.97 1.52 
1 o'clock 2.58 2.79 0.63 0.38 1.79 
RT 3.38 4.37 1.53 5.61 2.24 
3 o'clock 1.15 1.36 5.30 1.20 2.00 
4 o'clock 0.17 2.69 2.68 1.62 1.43 
5 o'clock 1.35 1.99 0.78 1.50 1.17 
7 o'clock 0.81 0.26 1.13 1.48 0.97 
8 o'clock 0.85 1.58 0.57 2.26 1.26 




LT 4.64 4.38 2.56 2.13 3.92 
11 o'clock 2.39 2.39 1.91 2.19 1.69 
1 o'clock 3.21 2.94 0.84 0.60 2.00 
RT 4.15 5.03 1.71 5.22 2.24 
3 o'clock 1.42 1.52 6.56 1.78 1.88 
4 o'clock 0.27 3.10 3.47 1.86 1.49 
5 o'clock 1.68 2.18 1.01 1.89 1.16 
7 o'clock 1.00 0.36 1.04 1.66 0.87 
8 o'clock 0.99 1.80 0.90 2.34 1.37 




LT 4.81 4.86 2.73 2.34 4.52 
11 o'clock 2.80 2.75 2.17 2.79 1.92 
1 o'clock 3.28 3.00 0.90 0.65 2.16 
RT 4.78 5.65 1.79 5.22 2.40 
3 o'clock 1.43 1.72 7.25 2.00 2.37 
4 o'clock 0.19 2.07 3.94 2.45 1.71 
5 o'clock 1.90 2.45 1.07 2.16 1.36 
7 o'clock 0.81 0.55 1.11 2.27 0.98 
8 o'clock 1.06 2.12 0.91 2.31 1.62 
9 o'clock 3.57 3.94 0.62 1.39 1.74 
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Table E-2 Ex vivo suture pullout forces (N) from ovine mitral annuli. For italicized 
data points, terminal displacement was reached before pullout; maximum force 
recorded during trial is used. 
Heart ID Ov1 Ov2 Ov3 Ov4 Ov5 Ov6 
LT 4.76 4.72 1.91 2.48 3.06 3.20 
11 o'clock 2.55 8.13 8.77 9.79 2.44 6.53 
1 o'clock 4.16 10.70 7.72 12.03 2.63 5.42 
RT 10.32 5.11 3.80 12.64 2.45 2.68 
3 o'clock 4.28 4.53 3.83 3.62 4.26 5.56 
4 o'clock 2.93 5.87 3.92 2.98 5.32 3.26 
5 o'clock 1.46 6.43 2.23 4.88 5.48 3.42 
7 o'clock 2.28 5.46 3.67 2.42 1.73 4.91 
8 o'clock 1.84 6.08 4.16 1.95 4.42 1.34 
9 o'clock 3.51 9.27 4.78 3.61 6.93 1.71 
Heart ID Ov7 Ov8 Ov9 Ov10 Ov11 Ov12 
LT 2.88 7.35 7.43 10.58 8.09 3.50 
11 o'clock 4.76 6.38 6.09 6.21 12.38 4.86 
1 o'clock 2.46 13.52 8.46 5.31 5.66 10.85 
RT 3.76 17.57 5.42 6.57 3.16 5.00 
3 o'clock 3.92 4.85 4.55 6.29 4.54 5.10 
4 o'clock 3.17 2.09 5.29 3.97 4.23 2.47 
5 o'clock 2.37 1.60 5.97 7.40 4.47 2.97 
7 o'clock 2.83 4.18 2.03 3.68 3.03 1.36 
8 o'clock 3.52 2.13 3.05 3.91 3.90 3.41 




Table E-3 Mean Pixel Intensity, before and after normalization, from 
microstructural imaging of ovine mitral annuli. 






LT 3.91 16.57 8.14 6.47 12.51 
12 21.16 31.54 30.56 10.55 20.54 
RT 12.91 10.89 7.47 10.22 10.96 
6 3.45 35.31 11.76 4.52 6.80 
Myocardium 
LT 45.77 11.22 14.32 26.95 17.32 
12 30.27 10.78 9.14 41.87 65.96 
RT 49.00 11.50 16.22 55.07 17.79 







LT 0.38 0.70 0.56 0.81 0.98 
12 2.04 1.34 2.11 1.33 1.62 
RT 1.25 0.46 0.52 1.29 0.86 
6 0.33 1.50 0.81 0.57 0.54 
Myocardium 
LT 1.03 1.06 1.05 0.61 0.57 
12 0.68 1.02 0.67 0.95 2.16 
RT 1.11 1.09 1.19 1.24 0.58 




E.2 Specific Aim 1.B Data 
Note, in addition to the below, the data in Table E-1 was also used in Specific Aim 1.B. 
Also note, throughout the tables in Section E.2, missing FC data was due to peri-operative 
failure of Suture Force Transducers. Missing HWHMnorm data was due to low signal-to-
noise ratio, which rendered half-max localization unreliable.  
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Table E-4 In vivo cyclic suture forces (N) using true-sized Physio rings. 
Animal ID GTA4 GTA5 GTA8 GTA9 GTA10 




LT 2.03 2.43 1.26 0.96 1.93 
11 o'clock 1.35 1.56 2.26 1.51 0.50 
1 o'clock 1.94 0.48 1.00 1.72 0.33 
RT 1.49 0.47 2.25 3.39 1.40 
3 o'clock 1.50 2.13 1.58 1.43 2.41 
4 o'clock 1.38 1.97 1.76 1.55 1.95 
5 o'clock 0.92 1.49 2.28 1.74 1.12 
7 o'clock 0.60 0.81 1.45 0.86 0.57 
8 o'clock 0.89 0.98 1.39 0.70 0.72 




LT 2.37 2.87 1.87 1.29 2.11 
11 o'clock 1.60 1.82 1.78 2.10 0.45 
1 o'clock 2.42 0.53 1.41 2.08 0.29 
RT 1.70 0.62 3.12 4.23 1.61 
3 o'clock 1.59 3.17 2.56 1.77 2.94 
4 o'clock 1.76 2.40 2.48 1.88 2.27 
5 o'clock 1.19 1.73 2.12 2.17 1.36 
7 o'clock 0.87 0.88 1.59 1.15 0.67 
8 o'clock 1.22 1.13 1.90 0.83 0.75 
9 o'clock 2.94 2.79 1.48 1.68 0.48 
LVPmax  = 
150 
mmHg 
LT 2.91 3.29 2.20 1.56 2.30 
11 o'clock 1.87 1.84 2.12 2.34 0.52 
1 o'clock 3.13 0.62 1.74 2.42 0.28 
RT 2.11 0.93 3.87 4.87 1.88 
3 o'clock 1.77 3.23 2.95 2.02 3.39 
4 o'clock 1.86 2.80 2.73 2.19 2.47 
5 o'clock 1.51 1.99 2.39 2.46 1.55 
7 o'clock 0.78 0.78 1.69 1.33 0.78 
8 o'clock 1.29 1.27 2.14 0.94 0.64 




Table E-5 In vivo cyclic suture forces (N) using undersized Profile 3D rings. 
Animal ID GTA12 GTA18 GTA20 GTA26 GTA27 GTA28 




LT 0.75 0.66 2.48 1.45 3.39 1.25 
11 o'clock 1.81 1.07 2.04 1.75 0.65 1.50 
1 o'clock 1.77 2.87 3.97 2.21 1.65 2.43 
RT 4.27 1.16 2.69 2.90 1.08 2.09 
3 o'clock 1.93 1.99 1.54 3.52 1.53 1.37 
4 o'clock 2.05 1.35 1.45 3.34 0.90 0.58 
5 o'clock 3.04 1.17 1.64 3.13 0.95 0.91 
7 o'clock 1.72 1.36 1.68 1.59 1.69 1.10 
8 o'clock 1.34 2.41 1.48 2.13 1.99 0.48 




LT 1.03 0.94 3.36 2.01 4.14 1.55 
11 o'clock 2.01 1.33 2.89 1.33 0.92 1.87 
1 o'clock 2.05 3.76 5.05 2.63 2.04 2.41 
RT 4.97 1.57 3.57 3.43 1.33 2.65 
3 o'clock 2.21 2.32 1.73 3.98 1.66 1.61 
4 o'clock 2.42 1.55 1.72 3.98 1.33 0.74 
5 o'clock 3.94 1.38 2.00 3.50 0.96 1.21 
7 o'clock 2.03 1.48 2.00 1.60 1.90 1.41 
8 o'clock 1.66 2.63 1.78 2.29 2.35 0.36 
9 o'clock 2.19 1.37 0.84 2.97 0.48 0.80 
LVPmax  = 
150 
mmHg 
LT 1.23 1.15 4.44 2.40 4.38 1.84 
11 o'clock 2.39 1.50 2.82 2.31 0.99 2.91 
1 o'clock 2.34 4.68 5.22 3.39 2.39 2.96 
RT 5.14 1.86 4.01 3.83 1.63 3.80 
3 o'clock 2.17 2.49 1.71 4.24 1.71 1.66 
4 o'clock 2.75 1.87 1.87 4.14 1.14 0.71 
5 o'clock 4.21 1.71 2.40 4.49 1.02 1.26 
7 o'clock 2.06 1.62 2.32 1.99 1.80 1.40 
8 o'clock 1.80 2.94 1.97 2.81 2.49 0.28 
9 o'clock 2.52 1.51 1.13 2.90 0.67 0.85 
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LT 0.39 3.59 2.16 2.47 2.03 3.77 1.80 
11 o'clock 0.41 0.51 1.19 0.32 0.42 2.27 1.59 
1 o'clock 0.52 2.56 1.61 0.59 2.42 3.27 1.06 
RT 1.33 2.54 1.71 1.97 3.78 2.43 3.04 
3 o'clock 0.26 1.45 2.96  2.84 1.35 1.01 
4 o'clock 0.93 1.28 2.59 1.28 1.63 1.31 1.77 
5 o'clock 0.51 2.46 1.88 1.25 1.66 1.46 1.05 
7 o'clock 3.26 2.40 2.42 1.01 0.18 2.82 2.55 
8 o'clock 1.88 1.26 2.79 2.04 3.16 1.56 1.06 




LT 0.42 4.89 2.53 2.89 2.27 4.54 2.38 
11 o'clock 0.56 0.86 1.44 0.45 0.79 2.85 1.69 
1 o'clock 0.60 2.86 1.88 0.88 2.61 3.34 1.15 
RT 1.72 3.05 2.34 2.25 3.79 3.41 3.96 
3 o'clock 0.25 1.47 3.48 2.77 1.61 1.30 
4 o'clock 1.27 1.45 3.03 1.51 1.79 1.27 2.17 
5 o'clock 0.58 2.73 2.20 1.37 2.21 1.60 1.46 
7 o'clock 3.90 2.88 2.95 1.17 0.18 3.05 3.13 
8 o'clock 2.39 1.55 3.24 2.37 3.10 1.84 1.23 




LT 0.54 4.99 2.93 3.69 3.17 5.13 2.84 
11 o'clock 0.74 0.91 2.08 0.95 2.02 3.39 1.98 
1 o'clock 0.74 2.39 1.97 1.47 2.84 3.77 1.65 
RT 1.72 2.35 3.18 2.61 4.58 3.62 4.99 
3 o'clock 0.25 2.17 3.49  2.93 1.97 1.41 
4 o'clock 1.27 1.68 2.95 1.14 2.39 1.70 2.39 
5 o'clock 0.58 2.47 2.04 1.10 2.61 1.99 1.56 
7 o'clock 3.90 3.08 2.83 1.39 0.19 3.41 3.21 
8 o'clock 2.39 1.58 3.03 2.70 3.03 2.14 1.01 




Table E-7 In vivo cyclic suture forces (N) using undersized, rigid, Physio ring 
prototypes. 
Animal ID GTA34 GTA35 GTA36 GTA44 GTA45 GTA46 




LT 1.10 4.21 0.58 2.26 0.73 0.77 
11 o'clock 1.30 2.04 2.86 2.85 2.12 0.44 
1 o'clock 0.17 1.41 1.36 3.78 2.21 0.68 
RT 1.98 2.28 3.96 2.74   
3 o'clock 1.33 2.24 1.62 1.17 0.68 0.94 
4 o'clock 1.22 1.31 1.47  0.79 1.31 
5 o'clock 2.61 1.69 1.63  1.66 1.42 
7 o'clock 1.68 0.93 2.25 2.45 1.75 0.43 
8 o'clock 1.60 0.99 1.55 1.56 2.42 0.97 




LT 1.71 5.50 0.98 2.49 1.05 0.92 
11 o'clock 1.80 2.39 3.41 3.35 2.12 0.69 
1 o'clock 0.31 1.45 1.69 4.23 2.17 0.71 
RT 2.49 2.67 4.80 3.32   
3 o'clock 1.96 3.31 2.10 1.17 0.69 1.11 
4 o'clock 1.97 1.81 2.29  0.91 1.80 
5 o'clock 3.83 2.43 2.58  1.86 2.26 
7 o'clock 2.50 1.21 3.32 3.01 2.03 0.62 
8 o'clock 3.41 1.32 1.91 1.83 2.58 1.22 
9 o'clock 0.89 0.91 3.39 3.81 4.97 0.79 
LVPmax  = 
150 
mmHg 
LT 1.91 6.49 1.15 2.68 1.01 0.88 
11 o'clock 1.41 2.62 3.47 3.98 2.07 0.77 
1 o'clock 0.28 1.61 2.05 4.38 2.32 0.86 
RT 2.82 3.29 5.38 3.83   
3 o'clock 1.86 3.28 2.30 1.27 0.80 1.11 
4 o'clock 2.15 2.18 2.55  0.68 2.12 
5 o'clock 4.12 2.68 2.98  1.62 2.84 
7 o'clock 2.83 1.24 1.24 3.01 2.26 0.85 
8 o'clock 3.46 1.44 2.08 2.14 2.53 1.44 




Table E-8 In vivo cyclic suture forces (N) using undersized, flexible, Physio ring 
prototypes. 
Animal ID GTA33 GTA37 GTA38 GTA39 GTA40 




LT 0.74 1.90 2.94 0.55 3.98 
11 o'clock 0.15 2.80 1.11 1.48 2.68 
1 o'clock 0.74 2.40 3.18 1.09 1.96 
RT 0.93 1.32 3.08 2.64 4.69 
3 o'clock 0.79 0.64 0.97 0.56 0.50 
4 o'clock 0.74 1.57 0.68 0.41 0.79 
5 o'clock 1.69 0.47 0.52 1.53 1.49 
7 o'clock 0.75 0.36 0.35 1.13 0.60 
8 o'clock 0.83 1.60 1.47 0.99 2.35 




LT 0.79 2.05 3.35 0.71 4.67 
11 o'clock 0.26 3.20 1.62 1.91 2.78 
1 o'clock 1.04 2.37 3.58 1.29 2.85 
RT 0.87 1.20 3.65 2.83 5.85 
3 o'clock 0.98 0.66 1.36 1.08 0.60 
4 o'clock 0.80 1.73 0.82 0.48 0.99 
5 o'clock 1.99 0.51 0.73 1.78 1.57 
7 o'clock 0.91 0.46 0.36 1.37 0.79 
8 o'clock 0.98 1.53 1.81 1.22 2.68 
9 o'clock 0.31 0.11 0.18 1.27 1.11 
LVPmax  = 
150 
mmHg 
LT 0.76 2.57 4.48 0.93 6.12 
11 o'clock 0.29 3.98 2.22 2.48 3.51 
1 o'clock 1.04 2.90 4.22 1.70 3.50 
RT 0.94 1.18 4.00 2.98 6.01 
3 o'clock 0.83 0.61 1.08 0.83 0.80 
4 o'clock 0.90 1.67 0.90 0.49 1.71 
5 o'clock 1.93 0.52 0.74 1.74 3.05 
7 o'clock 0.91 0.39 0.56 1.48 1.25 
8 o'clock 1.03 1.92 2.21 1.23 3.37 




Table E-9 In vivo normalized half-width at half-maximum suture forces 
(HWHMnorm), using undersized, rigid Physio ring prototypes. 




LT 0.19 0.06 0.20 0.07 0.05 0.18 
11 o'clock 0.14 0.06 0.10 0.06 0.06 0.21 
1 o'clock 0.12 0.07 0.10 0.06 0.06 0.09 
RT 0.10 0.06 0.10 0.09   
3 o'clock 0.09 0.05 0.09 0.05 0.05 0.07 
4 o'clock 0.10 0.06 0.10  0.08 0.08 
5 o'clock 0.09 0.05 0.10  0.05 0.10 
7 o'clock 0.09 0.05 0.10 0.05 0.05 0.13 
8 o'clock 0.10 0.05 0.10 0.08 0.05 0.07 




LT 0.15 0.06 0.16 0.08 0.18 0.16 
11 o'clock 0.09 0.06 0.10 0.10 0.06 0.12 
1 o'clock 0.08 0.07 0.11 0.06 0.06 0.23 
RT 0.11 0.07 0.11 0.10   
3 o'clock 0.09 0.06 0.09 0.05 0.14 0.07 
4 o'clock 0.09 0.05 0.09 0.06 0.08 
5 o'clock 0.09 0.07 0.10 0.05 0.09 
7 o'clock 0.10 0.05 0.11 0.05 0.06 0.12 
8 o'clock 0.10 0.06 0.10 0.07 0.06 0.08 




LT 0.13 0.07 0.15 0.07 0.43 0.12 
11 o'clock 0.38 0.07 0.10 0.06 0.28 0.07 
1 o'clock 0.07 0.15 0.11 0.07 0.15 0.32 
RT 0.10 0.08 0.12 0.10   
3 o'clock 0.09 0.06 0.09 0.06 0.27 0.07 
4 o'clock 0.09 0.06 0.09  0.06 0.08 
5 o'clock 0.09 0.07 0.09  0.05 0.09 
7 o'clock 0.10 0.06 0.10 0.05 0.06 0.11 
8 o'clock 0.10 0.06 0.11 0.06 0.06 0.09 




Table E-10 In vivo normalized half-width at half-maximum suture forces 
(HWHMnorm), using undersized (commercial, semi-rigid) Physio rings. 




LT 0.06 0.08 0.11 0.49 0.11 
11 o'clock 0.07 0.09 0.11 0.07 0.14 
1 o'clock 0.07 0.13 0.09 0.06 0.12 
RT 0.06 0.07 0.27 0.07 0.10 
3 o'clock 0.06 0.07 0.09 0.06 0.10 
4 o'clock 0.04 0.07 0.09 0.06 0.07 
5 o'clock 0.05 0.06 0.07 0.06  
7 o'clock 0.05 0.05 0.07 0.08  
8 o'clock 0.05 0.06 0.08 0.08 0.08 




LT 0.07 0.08 0.10 0.50 0.11 
11 o'clock 0.07 0.08 0.10 0.08 0.11 
1 o'clock 0.09 0.08 0.09 0.07 0.11 
RT 0.08 0.08 0.28 0.08 0.10 
3 o'clock 0.06 0.07 0.10 0.07 0.09 
4 o'clock 0.06 0.07 0.09 0.07 0.06 
5 o'clock 0.05 0.06 0.07 0.07 0.07 
7 o'clock 0.06 0.06 0.07 0.14  
8 o'clock 0.05 0.06 0.08 0.08 0.08 




LT 0.11 0.07 0.11 0.49 0.11 
11 o'clock 0.11 0.08 0.11 0.07 0.10 
1 o'clock 0.10 0.08 0.10 0.07 0.11 
RT 0.10 0.08 0.33 0.09 0.10 
3 o'clock 0.09 0.07 0.11 0.07 0.10 
4 o'clock 0.06 0.06 0.09 0.07 0.07 
5 o'clock 0.09 0.06 0.08 0.07 0.07 
7 o'clock 0.09 0.05 0.15 0.08  
8 o'clock 0.08 0.06 0.09 0.08 0.08 
9 o'clock 0.13 0.11 0.10 0.09 0.13 
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Table E-11 In vivo normalized half-width at half-maximum suture forces 
(HWHMnorm), using undersized, flexible Physio ring prototypes. 




LT 0.11 0.08 0.08 0.18 0.07 
11 o'clock 0.17 0.08 0.07 0.26 0.07 
1 o'clock 0.19 0.07 0.08 0.26 0.07 
RT 0.12 0.07 0.07 0.08 0.07 
3 o'clock 0.08 0.05 0.15 0.17 0.05 
4 o'clock 0.08 0.07 0.09 0.05 0.06 
5 o'clock 0.10 0.05 0.06 0.11 0.06 
7 o'clock 0.09 0.10 0.17 0.08 0.09 
8 o'clock 0.12 0.07 0.07 0.09 0.07 




LT 0.11 0.09 0.08 0.44 0.07 
11 o'clock 0.18 0.09 0.07 0.10 0.07 
1 o'clock 0.28 0.08 0.08 0.17 0.07 
RT 0.13 0.18 0.07 0.08 0.08 
3 o'clock 0.08 0.06 0.10 0.09 0.05 
4 o'clock 0.07 0.08 0.07 0.05 0.07 
5 o'clock 0.09 0.17 0.06 0.21 0.07 
7 o'clock 0.08 0.13 0.14 0.08 0.29 
8 o'clock 0.12 0.08 0.07 0.23 0.08 




LT 0.12 0.11 0.09 0.30 0.09 
11 o'clock 0.10 0.09 0.07 0.14 0.08 
1 o'clock 0.13 0.09 0.08 0.13 0.09 
RT 0.12 0.20 0.08 0.10 0.08 
3 o'clock 0.07 0.06 0.08 0.18 0.57 
4 o'clock 0.29 0.08 0.07 0.06 0.05 
5 o'clock 0.09 0.44 0.06 0.18 0.07 
7 o'clock 0.09 0.13 0.10 0.11 0.09 
8 o'clock 0.12 0.09 0.08 0.11 0.09 




E.3 Specific Aim 1.C Data 
Note, in addition to the below, Table E-1, Table E-7, and Table E-8 were used in SA1.C.  
Table E-12 In vivo cyclic suture forces (N) using prototype hybrid rings. 
Animal ID GTA47 GTA48 GTA49 




LT 0.59 1.73 2.09 
11 o'clock 3.03 2.25 1.65 
1 o'clock 2.44 2.96 4.52 
RT 1.00 1.20 0.98 
3 o'clock 0.94 1.35 0.45 
4 o'clock 0.20 0.94 2.77 
5 o'clock 0.39 1.41 2.01 
7 o'clock 1.90 2.03 0.20 
8 o'clock 1.16 2.12 0.64 




LT 0.47 2.03 2.15 
11 o'clock 3.92 2.84 0.67 
1 o'clock 2.69 3.27 4.83 
RT 1.30 1.60 1.15 
3 o'clock 0.79 1.68 0.76 
4 o'clock 0.26 1.08 3.46 
5 o'clock 0.56 1.69 2.51 
7 o'clock 1.75 2.18 0.27 
8 o'clock 1.10 2.32 0.89 
9 o'clock 1.26 1.87 0.89 
LVPmax  = 
150 
mmHg 
LT 0.49 2.48 2.09 
11 o'clock 4.72 3.58 0.48 
1 o'clock 2.77 3.64 4.66 
RT 1.60 1.74 1.30 
3 o'clock 1.06 1.77 1.03 
4 o'clock 0.31 1.17 4.18 
5 o'clock 0.90 1.80 2.77 
7 o'clock 2.09 2.34 0.40 
8 o'clock 1.34 2.58 0.78 
9 o'clock 1.58 2.03 1.28 
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APPENDIX F. DATA TABLES FOR SPECIFIC AIM 2 
F.1 Specific Aim 2.A Data 
Note, in three instances (Porc2 D+4, Porc3 D+6, Porc7 D+6) substantial variability was 
noticed between acquisitions, in real-time. In these cases a fourth acquisition was collected. 
Also, in four instances (Porc1 D+2, Porc1 C+4, Porc3 C+4, Porc5 C+4), positioning errors 
were noticed only during post-processing (evidenced by a sharp shift in pressure and 
leakage in the middle of the acquisition); these acquisitions were discarded. 
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Table F-1 Paravalvular Leakage (PVL) and trans-mitral pressure gradient (ΔP) 




ΔP (mmHg) PVL (ml/sec) ΔP (mmHg) PVL (ml/sec) 
Porc1 
+0 
59.5 7.0 63.9 8.7 
97.6 17.1 73.9 9.7 
119.3 27.8 91.9 15.7 
145.0 35.8 122.3 26.0 
158.5 69.8 170.3 60.2 
61.7 8.7 61.5 6.0 
92.5 10.5 77.9 5.3 
120.0 18.8 90.7 20.8 
146.4 42.0 114.1 32.7 
166.0 65.9 157.6 73.9 
59.5 9.3 60.5 2.5 
71.3 11.7 95.4 7.0 
88.2 14.8 116.6 9.7 
116.5 36.1 133.0 23.7 
157.4 72.1 191.6 47.0 
+2 
58.0 6.4 
101.3 10.3   
125.7 29.6   
145.7 37.7   
174.3 59.1   
62.1 8.8 61.5 5.9 
89.8 8.4 96.9 7.9 
117.6 15.9 117.6 14.4 
151.5 60.2 135.0 43.6 
160.0 69.7 169.3 65.8 
61.7 9.7 61.6 2.9 
98.8 15.0 91.8 4.1 
126.7 14.9 122.0 18.7 
136.5 27.5 144.8 58.7 








ΔP (mmHg) PVL (ml/sec) ΔP (mmHg) PVL (ml/sec) 
Porc1 
+4 
    57.5 3.5 
    79.1 1.3 
    95.4 4.1 
    120.4 22.5 
    159.9 65.3 
63.8 6.4 52.5 2.6 
96.7 3.6 91.5 9.0 
120.2 13.1 127.1 21.1 
156.1 44.5 158.3 45.6 
177.3 53.7 171.8 62.5 
61.7 13.1 56.3 5.8 
89.3 22.2 80.9 7.6 
119.5 35.5 94.1 7.8 
142.5 46.7 116.2 13.5 
164.5 64.0 134.3 43.2 
+6 
55.5 6.8 59.7 5.9 
95.3 9.1 87.9 6.9 
123.9 18.8 122.3 8.0 
148.9 38.5 143.4 26.6 
162.0 69.2 163.2 67.7 
66.2 6.8 57.7 4.5 
86.9 8.8 95.6 4.9 
118.3 16.4 129.6 4.7 
155.5 31.0 156.1 24.4 
168.0 65.5 179.2 57.3 
59.0 5.6 62.2 5.9 
86.8 8.8 94.4 6.2 
121.3 16.8 124.5 10.1 
129.0 37.9 156.5 25.0 
155.1 50.5 168.8 64.3 
  
 299




ΔP (mmHg) PVL (ml/sec) ΔP (mmHg) PVL (ml/sec) 
Porc2 
+0 
59.6 3.6 63.3 6.6 
91.3 3.8 94.2 5.1 
119.4 5.9 124.5 3.7 
134.5 20.1 141.8 10.4 
172.3 64.2 184.4 55.5 
58.9 5.6 58.2 1.4 
93.8 9.2 93.6 3.7 
116.5 21.2 120.8 15.5 
140.3 63.0 145.0 51.6 
150.7 79.3 155.5 76.7 
60.1 5.3 57.1 1.0 
91.3 4.8 92.0 5.7 
121.9 15.5 123.5 6.4 
145.1 24.5 142.8 10.9 
175.0 64.9 191.7 45.8 
+2 
60.5 2.1 60.9 1.6 
91.2 2.5 93.9 4.1 
119.7 4.7 126.4 5.0 
145.0 8.8 146.5 9.7 
190.7 44.7 189.1 43.7 
58.8 1.3 63.6 1.7 
88.7 5.8 95.4 9.9 
120.6 13.2 118.9 10.8 
141.4 20.1 142.6 14.9 
189.8 42.7 195.4 31.3 
62.1 3.3 62.5 4.4 
87.4 9.2 90.1 8.8 
120.3 13.3 124.3 10.1 
137.3 22.0 146.4 9.1 
187.8 44.7 191.5 40.9 
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ΔP (mmHg) PVL (ml/sec) ΔP (mmHg) PVL (ml/sec) 
Porc2 
+4 
    60.1 8.1 
   89.7 7.3 
   120.9 7.0 
   144.7 7.3 
   201.6 21.3 
61.3 3.6 59.9 6.2 
93.3 10.5 94.1 8.0 
118.6 18.1 117.4 8.5 
141.4 30.8 146.3 6.9 
171.4 64.6 197.0 31.1 
63.2 5.6 60.1 2.2 
89.8 13.4 91.3 12.6 
116.3 31.2 121.0 32.3 
134.7 70.8 137.9 70.8 
141.6 86.0 143.3 88.1 
62.8 3.8 58.4 5.0 
91.8 12.0 92.6 9.2 
119.8 19.9 121.3 8.0 
145.7 57.0 141.8 12.3 
160.2 75.1 186.2 53.7 
+6 
59.9 3.9 62.2 1.0 
88.4 12.3 90.1 9.6 
119.4 33.0 120.3 10.5 
143.8 51.6 138.8 20.5 
152.3 81.7 150.8 86.1 
61.5 5.6 60.5 2.9 
93.5 9.4 89.9 11.2 
118.3 10.3 119.3 10.2 
142.1 22.2 142.1 16.8 
176.2 64.2 184.2 56.3 
60.6 7.8 60.4 1.2 
93.5 9.6 87.9 7.2 
123.5 10.2 118.0 11.3 
147.0 16.2 138.4 28.6 
188.5 52.5 161.1 79.7 
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ΔP (mmHg) PVL (ml/sec) ΔP (mmHg) PVL (ml/sec) 
Porc3 
+0 
58.8 3.8 57.8 4.2 
92.3 2.8 94.9 6.8 
117.0 7.3 120.4 3.4 
151.2 32.4 150.6 5.3 
179.1 66.5 202.7 43.2 
58.3 1.7 63.2 3.5 
90.9 9.5 93.5 2.1 
120.4 16.7 123.0 6.1 
148.0 47.5 153.2 9.5 
166.5 80.9 207.6 31.4 
61.0 7.0 59.7 7.1 
92.4 11.3 94.1 7.8 
122.1 22.4 119.7 9.9 
151.3 48.9 150.3 16.8 
173.5 76.8 193.2 52.0 
+2 
63.9 1.1 60.0 8.8 
90.1 3.0 90.6 8.1 
118.4 8.4 120.6 10.9 
149.2 21.4 148.7 23.2 
180.1 68.6 194.7 48.8 
58.5 2.8 65.5 3.5 
92.1 6.4 88.7 3.4 
125.9 34.7 116.0 10.3 
146.5 69.3 148.3 37.1 
165.8 82.3 174.6 73.1 
59.6 3.0 56.3 6.8 
89.2 2.7 96.5 8.2 
128.1 9.2 116.0 9.0 
153.6 42.6 154.6 35.7 
179.7 71.4 182.5 65.7 
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ΔP (mmHg) PVL (ml/sec) ΔP (mmHg) PVL (ml/sec) 
Porc3 
+4 
    57.1 3.9 
   90.2 5.7 
   116.8 9.8 
   157.6 17.1 
   194.9 52.3 
58.8 3.0 62.3 3.3 
93.4 3.9 93.6 2.0 
123.0 9.8 133.2 10.6 
148.2 55.7 151.3 44.1 
169.9 79.6 170.9 78.3 
59.0 3.0 57.9 2.2 
93.3 4.1 95.1 4.1 
119.8 6.0 121.9 16.7 
147.7 20.0 148.0 56.3 
191.8 54.8 177.7 71.8 
+6 
    59.0 1.0 
  92.8 2.4 
   122.7 9.2 
   145.7 21.0 
   180.9 69.3 
59.7 3.7 63.5 7.4 
92.6 7.9 88.9 6.2 
121.9 7.7 121.4 3.0 
149.8 10.2 152.0 10.1 
207.6 34.7 197.8 46.3 
57.9 1.9 60.4 7.0 
92.7 3.9 93.6 8.0 
122.7 2.9 121.8 6.0 
148.2 9.5 154.1 7.8 
208.7 30.7 193.4 49.0 
58.9 4.6 56.9 8.7 
93.0 9.7 92.5 8.3 
123.6 11.4 122.8 14.3 
150.3 25.4 149.4 17.6 
197.8 45.1 187.3 56.3 
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ΔP (mmHg) PVL (ml/sec) ΔP (mmHg) PVL (ml/sec) 
Porc4 
+0 
62.4 13.1 60.0 11.6 
92.6 17.4 92.0 19.1 
115.9 28.0 115.0 28.3 
147.2 54.6 143.0 43.7 
161.7 80.2 175.5 68.4 
59.6 18.1 59.2 13.1 
94.6 29.4 93.2 15.9 
120.7 40.9 117.0 24.8 
148.2 61.8 151.5 65.2 
161.1 79.3 168.8 74.9 
62.4 17.4 63.4 1.0 
92.8 22.1 91.4 13.2 
120.4 30.2 120.1 30.4 
146.8 54.6 148.9 59.5 
167.6 72.8 169.0 71.8 
+2 
62.8 8.7 63.6 8.6 
95.0 11.7 92.9 19.0 
116.1 18.1 121.6 29.5 
149.7 21.1 145.7 51.6 
181.4 64.2 168.1 76.6 
60.7 7.8 60.5 6.0 
94.3 8.2 92.4 14.3 
117.9 11.7 120.0 25.7 
142.4 42.3 148.8 54.1 
165.7 77.0 173.4 67.8 
61.3 8.9 57.9 4.8 
91.2 16.1 97.0 8.0 
120.0 48.7 121.5 7.8 
150.7 83.8 147.8 12.8 
155.9 82.0 204.4 36.9 
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ΔP (mmHg) PVL (ml/sec) ΔP (mmHg) PVL (ml/sec) 
Porc4 
+4 
58.3 5.7 60.6 5.1 
92.5 5.8 92.2 6.3 
119.0 18.6 118.6 3.5 
149.1 50.2 151.2 6.9 
167.3 75.3 196.7 48.0 
60.9 6.7 59.0 15.2 
92.2 13.3 92.0 12.2 
118.0 30.5 123.6 10.4 
148.3 55.7 150.1 11.6 
165.3 72.1 200.4 40.6 
59.8 3.1 59.9 8.3 
93.7 8.7 93.1 5.1 
123.3 14.4 122.4 4.5 
147.2 20.6 150.4 20.8 
189.6 53.8 179.0 64.1 
+6 
62.3 1.3 61.1 6.9 
94.1 7.9 93.2 3.0 
123.7 14.8 122.2 8.7 
147.2 28.3 149.6 21.5 
172.2 68.3 183.9 59.8 
59.2 7.9 59.0 7.1 
92.6 10.6 93.4 6.0 
123.6 17.9 119.8 11.4 
146.2 60.6 147.3 27.9 
159.1 83.2 176.9 68.3 
62.9 6.2 60.6 6.3 
91.8 4.3 92.3 4.5 
123.6 3.4 120.7 14.2 
150.9 13.2 148.8 34.6 
185.1 60.7 182.0 60.4 
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ΔP (mmHg) PVL (ml/sec) ΔP (mmHg) PVL (ml/sec) 
Porc5 
+0 
65.3 7.3 63.2 4.7 
93.7 16.7 95.0 1.8 
124.3 31.9 124.3 4.5 
153.0 46.6 154.6 9.3 
176.0 68.6 205.6 29.8 
62.1 6.4 63.9 11.5 
93.1 17.0 97.7 13.2 
124.4 39.5 125.1 25.9 
150.9 64.8 148.7 36.7 
169.9 73.2 181.1 64.3 
63.7 10.1 64.8 7.3 
93.7 12.4 95.2 8.9 
122.5 30.9 123.1 12.9 
151.5 46.7 152.9 26.9 
173.9 70.1 196.5 48.8 
+2 
66.9 9.8 64.1 11.6 
95.6 15.1 97.1 23.1 
127.4 34.5 124.4 35.4 
151.3 58.8 150.3 54.8 
167.7 74.5 180.0 64.9 
64.0 11.9 66.7 9.4 
91.1 16.0 92.4 16.3 
121.0 23.5 127.8 31.2 
149.2 34.2 153.2 48.5 
185.9 60.5 173.5 71.9 
66.1 10.7 65.7 7.5 
96.3 21.1 91.1 5.0 
124.3 53.4 123.3 10.8 
152.9 66.2 151.1 20.0 
166.2 76.7 197.5 45.2 
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ΔP (mmHg) PVL (ml/sec) ΔP (mmHg) PVL (ml/sec) 
Porc5 
+4 
    62.8 3.2 
    94.9 6.7 
    121.2 10.0 
    153.0 37.3 
    181.7 64.2 
62.3 7.1 62.8 4.4 
95.7 21.0 91.8 10.5 
121.6 40.5 120.8 30.4 
147.2 59.2 152.7 57.9 
164.4 77.2 170.6 71.5 
62.9 2.7 62.9 3.5 
93.4 7.1 96.1 3.2 
122.0 26.2 124.8 11.1 
149.2 65.5 149.2 21.5 
175.3 66.6 171.6 68.6 
+6 
62.5 7.8 66.1 4.9 
92.1 23.6 92.6 9.0 
122.4 41.4 125.7 19.7 
156.4 66.9 148.1 31.4 
164.3 75.6 177.1 62.7 
62.5 1.6 64.9 3.1 
94.8 6.9 93.8 6.3 
119.8 23.7 122.5 14.0 
148.4 63.4 152.4 32.1 
162.2 76.5 175.4 66.3 
64.9 1.1 63.0 1.2 
95.8 4.6 94.5 1.3 
123.8 21.2 123.5 1.0 
148.9 38.5 148.3 9.0 








ΔP (mmHg) PVL (ml/sec) ΔP (mmHg) PVL (ml/sec) 
Porc6 
+0 
62.5 6.7 61.8 1.5 
93.0 9.9 90.6 4.7 
122.3 18.0 120.5 9.4 
148.4 31.9 149.3 18.8 
189.6 53.9 202.2 38.3 
62.2 8.1 61.1 6.8 
93.2 13.9 91.1 10.1 
121.8 20.3 119.2 11.1 
146.5 31.5 150.2 17.9 
185.8 56.6 202.6 38.0 
60.5 9.5 60.8 6.7 
92.2 19.1 92.3 9.6 
119.8 28.9 120.0 14.4 
151.4 49.2 149.9 21.9 
172.2 68.6 192.1 49.5 
+2 
61.2 9.8 60.8 10.3 
93.1 20.5 94.0 17.7 
119.9 50.3 122.4 29.2 
153.6 68.2 150.5 35.7 
161.2 80.2 185.6 57.9 
65.0 10.3 62.5 7.8 
93.0 12.1 97.6 12.0 
115.3 13.2 124.9 21.1 
141.7 22.1 148.3 33.0 
195.7 44.9 196.3 50.3 
56.7 13.1 61.6 11.3 
92.1 15.8 89.9 12.4 
116.7 21.2 124.8 19.8 
142.7 30.7 146.3 31.0 
180.2 63.5 182.6 63.3 
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ΔP (mmHg) PVL (ml/sec) ΔP (mmHg) PVL (ml/sec) 
Porc6 
+4 
53.2 10.3 56.2 8.0 
94.8 12.3 93.8 14.8 
124.9 13.9 113.6 24.2 
148.7 26.0 154.4 50.0 
183.2 61.9 180.5 64.8 
59.9 9.7 60.8 6.0 
88.2 12.3 89.9 10.4 
120.2 22.7 125.1 14.1 
149.3 51.3 148.7 26.0 
172.7 72.3 180.6 64.6 
53.9 6.2 65.0 7.7 
88.1 10.1 95.0 11.0 
121.1 16.5 120.5 12.4 
151.2 35.1 149.8 31.4 
182.3 60.4 174.7 69.2 
+6 
62.8 5.0 56.9 7.3 
89.8 5.5 94.3 8.7 
119.5 7.3 121.4 8.9 
154.3 14.7 144.7 22.3 
197.0 45.9 191.7 52.1 
55.4 7.9 60.2 1.7 
96.5 9.9 94.0 5.4 
121.2 10.2 121.3 13.9 
151.4 24.1 153.6 32.2 
182.1 60.7 183.4 58.8 
58.8 7.0 59.0 3.2 
92.6 8.5 95.9 1.0 
127.2 7.9 123.0 3.8 
154.3 17.4 149.7 14.3 
180.6 59.9 191.0 50.1 
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ΔP (mmHg) PVL (ml/sec) ΔP (mmHg) PVL (ml/sec) 
Porc7 
+0 
61.5 3.3 61.9 8.1 
94.3 4.6 94.5 11.5 
123.0 17.9 118.8 30.4 
152.5 38.2 145.7 58.8 
180.6 64.6 161.3 81.6 
63.9 3.4 62.3 3.2 
90.5 7.8 91.3 4.5 
119.7 23.3 120.4 10.8 
148.0 44.3 151.9 44.0 
174.8 70.7 174.6 69.4 
63.5 3.8 60.8 4.3 
92.3 10.6 92.5 3.5 
122.1 25.4 120.4 11.1 
149.2 39.2 148.2 32.5 
166.0 75.2 169.0 69.4 
+2 
64.4 7.5 62.0 9.2 
91.7 21.0 92.2 15.4 
118.9 40.3 120.3 26.1 
149.6 62.4 148.0 71.2 
161.0 79.9 161.9 79.0 
62.9 4.1 59.3 3.6 
96.4 13.4 91.3 7.7 
119.0 18.3 121.6 16.8 
148.2 41.3 146.0 47.2 
177.7 61.1 162.2 78.3 
62.1 2.2 60.8 3.1 
89.4 11.9 94.8 4.9 
122.2 35.3 119.5 13.4 
149.1 54.0 150.9 40.7 
165.1 75.5 167.9 73.1 
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ΔP (mmHg) PVL (ml/sec) ΔP (mmHg) PVL (ml/sec) 
Porc7 
+4 
61.2 4.9 62.7 1.0 
89.9 13.5 91.8 2.0 
121.8 38.8 120.2 6.2 
147.0 65.0 149.9 26.3 
162.8 77.0 186.7 55.7 
59.6 7.0 60.9 3.5 
95.2 11.0 94.2 6.6 
118.8 30.7 117.3 14.4 
151.4 73.1 145.8 45.5 
152.1 86.2 171.3 67.1 
62.0 4.0 65.3 5.6 
91.3 4.9 94.5 7.0 
123.6 9.1 126.6 24.6 
145.7 36.9 147.8 61.9 
171.0 72.0 158.4 78.9 
+6 
    61.9 4.6 
  91.0 3.8 
   122.5 7.5 
   151.6 21.9 
   190.4 50.6 
60.3 2.0 61.3 1.0 
92.6 2.3 92.0 3.5 
117.6 17.2 126.8 5.4 
145.5 60.8 151.3 24.7 
160.4 78.5 180.0 59.7 
60.6 4.4 61.8 4.1 
90.1 10.8 92.4 5.2 
120.1 37.0 119.2 16.1 
149.1 69.7 148.7 64.7 
160.2 79.2 159.3 77.9 
63.0 8.5 59.2 3.3 
92.3 10.9 91.9 9.5 
122.4 24.9 125.5 32.1 
146.1 51.9 146.5 65.6 
163.5 76.2 166.9 73.6 
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F.2 Specific Aim 2.B Data 
Note, in some instances aortic pressure errors (i.e., outside of the 110-130 mmHg range) 
were identified only during post-processing; these acquisitions were discarded. 
Table F-2 Septal-lateral force (FSL) and inter-commissural force (FIC) data using the 




Circular   Heart 
ID Size 
Circular 
FSL (N) FIC (N)   FSL (N) FIC (N) 
Porc8 
+2 




13.6 11.3    
13.4 10.1  29.0 36.9 
14.1 10.9  24.6 35.1 
12.3 10.6  18.3 35.5 
13.8 10.8  15.8 35.2 
12.5 8.2 13.6 35.3 
12.2 11.0 15.1 31.2 
+4 
26.7 21.9  
+4 
  
20.4 19.9    
22.2 19.1    
24.4 21.8    
24.6 16.7  11.0 46.5 
26.8 20.8  11.9 43.4 
22.9 16.5  17.0 47.0 
21.9 19.3  10.7 30.9 
+6 
30.2 35.5  
+6 
  
30.7 34.0    
29.8 33.5    
29.7 29.1    
24.0 28.1    
27.8 28.4    
28.8 33.4    
27.9 28.3       
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Table F-2 continued 
Heart 
ID Size 
Circular   Heart 
ID Size 
Circular 
FSL (N) FIC (N)   FSL (N) FIC (N) 
Porc10 
+2 




19.9 29.3  18.8 31.8 
7.7 13.0  16.2 30.6 
9.0 19.6  18.9 34.1 
16.3 25.8  21.2 30.5 
10.4 14.1  20.7 31.1 
13.9 22.6  19.0 29.1 
9.1 12.9  17.9 33.7 
+4 
12.2 26.8  
+4 
  
32.6 41.7    
33.8 41.4  28.3 53.9 
35.2 44.3  25.3 47.9 
24.3 29.9  27.9 45.0 
31.1 36.8  24.1 36.9 
33.2 44.4 22.5 48.2 
29.4 34.3 20.3 47.6 
+6 
33.8 52.2  
+6 
24.8 47.8 
34.7 45.9  24.3 41.3 
39.2 43.2  27.5 40.5 
35.3 40.3  23.0 36.3 
26.9 35.4  22.6 42.4 
33.3 42.0  19.9 37.1 
37.0 43.8  20.6 37.8 
35.8 41.0   21.4 33.2 
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Table F-2 continued 
Heart 
ID Size 
Circular   Heart 
ID Size 
Circular 
FSL (N) FIC (N)   FSL (N) FIC (N) 
Porc12 
+2 




16.4 22.0  15.5 26.7 
19.6 18.0  11.7 30.1 
17.5 20.8  9.9 20.8 
17.2 17.8  14.9 34.8 
15.8 20.5  14.5 28.4 
18.8 22.6  7.5 14.8 
12.1 16.3  14.3 30.2 
+4 
20.7 38.6  
+4 
17.9 39.8 
11.6 32.8  21.6 51.6 
17.4 32.4  16.8 36.8 
12.3 26.1  20.5 47.1 
16.2 23.5  14.6 28.7 
17.3 29.9  20.0 43.7 
11.9 30.3 20.1 42.8 
20.5 31.9 18.4 40.0 
+6 
8.3 36.1  
+6 
17.9 41.5 
10.7 30.1  19.1 43.9 
16.1 29.5  15.4 37.8 
17.3 27.5  17.1 38.7 
8.7 29.5  15.7 38.4 
10.7 29.7  17.8 39.4 
6.8 30.9  15.0 42.2 
12.9 29.5   15.2 41.3 
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Table F-2 continued 
Heart 
ID Size 
D-shape   Heart 
ID Size 
D-shape 
FSL (N) FIC (N)   FSL (N) FIC (N) 
Porc14 
+2 




       
12.4 19.0    
5.8 18.9    
13.6 29.3    
10.4 22.0    
10.3 19.9    
7.0 19.3  17.0 35.8 
+4 
11.4 31.5  
+4 
29.4 55.4 
13.8 29.3  17.2 21.2 
8.0 29.4  30.7 52.1 
9.2 28.7  30.8 53.8 
9.6 28.4  29.7 53.8 
8.9 21.2  18.2 35.2 
5.4 29.5 30.2 54.2 
8.0 26.7 14.6 26.0 
+6 
9.0 42.8  
+6 
43.3 67.0 
8.2 37.5  39.2 66.8 
8.8 40.3  36.4 63.1 
11.2 38.5  36.1 64.8 
11.0 37.6  35.4 64.1 
12.4 39.6  35.2 65.9 
9.6 38.4  36.8 66.8 
10.5 36.6   32.8 64.6 
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Table F-2 continued 
Heart 
ID Size 
D-shape   Heart 
ID Size 
D-shape 
FSL (N) FIC (N)   FSL (N) FIC (N) 
Porc16 
+2 




5.3 26.8  12.7 28.0 
5.4 13.3  4.0 15.1 
3.1 13.2  5.8 9.6 
3.6 29.2  3.6 12.9 
4.5 14.4  5.0 16.2 
4.6 19.7  8.5 7.8 
4.0 22.5  8.3 24.2 
+4 
16.0 35.7  
+4 
18.2 13.3 
13.8 35.6  17.3 22.9 
13.5 32.5  15.4 24.6 
13.3 29.4  19.6 30.5 
8.1 31.9  21.5 32.9 
12.8 28.5  15.9 18.7 
12.1 39.3 15.6 11.9 
9.2 29.3 18.7 28.2 
+6 
21.7 46.6  
+6 
29.0 44.8 
17.7 46.5  27.8 41.5 
19.6 44.2  25.2 42.2 
17.4 43.3  23.9 44.1 
17.4 41.0  23.0 43.8 
16.1 36.6  20.0 27.9 
14.2 48.0  22.4 42.7 
16.7 38.2   21.7 43.1 
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Table F-2 continued 
Heart 
ID Size 
D-shape   Heart 
ID Size 
D-shape 
FSL (N) FIC (N)   FSL (N) FIC (N) 
Porc18 
+2 




20.2 33.2  6.3 21.4 
19.1 28.0  7.8 22.2 
11.8 29.5  6.3 22.1 
18.2 25.2  8.2 22.7 
5.1 16.8  9.9 20.0 
14.2 28.1  1.9 24.4 
18.3 28.7  2.4 20.2 
+4 
15.4 40.8  
+4 
12.3 41.2 
30.5 43.7  17.3 30.8 
30.2 40.5  17.2 43.5 
25.5 22.0  14.4 32.5 
26.0 24.0  6.8 24.7 
40.6 53.9  6.2 38.7 
26.7 36.9 11.4 42.3 
27.5 47.3 10.9 37.5 
+6 
34.1 69.7  
+6 
7.8 47.2 
40.4 64.6  10.7 51.3 
44.3 64.2  11.9 49.8 
45.0 69.5  29.1 58.8 
31.2 72.8  17.1 62.4 
30.2 75.8  17.5 58.7 
42.1 69.3  21.3 56.8 
48.3 64.1   14.0 60.9 
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APPENDIX G. DATA TABLES FOR APPENDICES A-D 
Table G-1 In vivo suture tie-down forces (N) using Physio and Profile 3D rings. 
Animal ID GTA5 GTA6 GTA7 GTA11 GTA12 GTA18 
Sizing true under under under under under 
Surgeon other other other other other 1 
Ring Ph Ph Ph Ph 3D 3D 
LT 4.47 0.57 0.00 2.21 2.66 0.54 
11 o'clock 4.37 5.56 5.70 1.42 2.35 0.88 
1 o'clock 3.03 1.61 1.51 2.02 2.40 4.59 
RT 2.99 2.38 3.09 0.83 2.54 3.37 
3 o'clock 4.57 2.54 6.68 2.32 0.73 2.71 
4 o'clock 2.33 7.24 5.93 2.37 1.19 3.49 
5 o'clock 1.78 2.53 2.09 1.36 2.18 1.41 
7 o'clock 1.81 0.22 1.20 3.02 3.56 2.30 
8 o'clock 2.65 1.17 2.54 2.15 2.41 1.47 
9 o'clock 3.15 3.47 4.41 2.92 1.64 2.08 
Animal ID GTA19 GTA20 GTA21 GTA22 GTA23 GTA25 
Sizing true under true true true true 
Surgeon 2 1 2 1 2 2 
Ring 3D 3D 3D 3D 3D 3D 
LT 2.60 1.74 3.48 2.95 1.98 3.51 
11 o'clock 2.74 1.45 1.40 2.03 3.73 3.05 
1 o'clock 1.16 1.96 0.84 1.84 2.90 5.09 
RT 2.62 4.13 3.91 4.83 3.83 3.84 
3 o'clock 1.12 3.50 3.93 0.24  4.23 
4 o'clock 0.76 2.82 2.86 3.67 2.95 2.74 
5 o'clock 0.09 1.72 3.11 0.77 2.17 2.36 
7 o'clock 2.39 1.32 1.82 2.05 3.55 5.72 
8 o'clock 2.74 0.95 1.82 2.12 4.48 5.17 
9 o'clock 3.54 0.42 5.71 1.49 3.10 4.50 
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Table G-1 continued 
Animal ID GTA26 GTA27 GTA28 GTA29 GTA30 
Sizing under under under true true 
Surgeon 2 1 other 2 1 
Ring 3D 3D 3D 3D 3D 
LT 2.97 0.45 0.00 2.23 0.21 
11 o'clock 1.83 1.86 7.98 2.92 1.35 
1 o'clock 1.02 1.27 5.73 2.45 6.79 
RT 2.50 3.02 4.93 3.50 3.94 
3 o'clock 1.99 4.07 3.26 3.67 3.82 
4 o'clock 3.08 3.87 3.56 3.04 1.43 
5 o'clock 2.67 1.16 1.48 2.56 2.85 
7 o'clock 3.00 2.40 2.03 1.85 2.92 
8 o'clock 3.19 1.65 6.27 2.59 2.11 
9 o'clock 4.10 0.98 3.04 2.27 1.46 
 
Note, in Table G-1, one missing data point was caused by temporary, peri-operative 
malfunction of the Suture Force Transducer. 
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Table G-2 Ex vivo suture pullout forces (N) from ovine tricuspid annuli. 
Heart ID Ov18 Ov19 Ov20 Ov21 Ov22 Ov23 Ov24 Ov25 
1 o'clock 4.55 4.40 4.16 3.37 2.14 3.91 3.50 3.17 
2 o'clock 5.83 6.62 3.85 6.44 2.01 3.70 6.52 2.86 
3 o'clock 5.56 7.14 6.87 2.38 4.08 8.54 6.43 3.31 
PSC 4.92 4.94 6.64 4.59 5.12 9.33 5.31 4.11 
5 o'clock 7.22 3.98 13.99 7.87 8.69 9.86 9.85 5.48 
6 o'clock 16.32 6.11 4.57 5.78 13.63 17.01 9.50 7.42 
7 o'clock 9.29 3.95 7.25 6.05 3.61 3.36 9.24 10.47 
SAC 7.57 3.29 3.84 4.00 1.88 4.28 4.54 9.85 
9 o'clock 6.93 9.28 4.14 6.37 2.39 3.97 6.92 4.94 
10 o'clock 6.70 7.62 6.78 8.38 3.96 7.60 5.87 4.87 
11 o'clock 10.764 3.77 5.721 5.363 6.086 6.424 4.678 5.315 
APC 3.683 10.088 2.478 2.088 2.864 5.971 3.445 4.41 
Heart ID Ov26 Ov27 Ov28 Ov29 Ov30 Ov31 Ov32  
1 o'clock 2.30 6.31 5.48 4.83 6.47 5.94 4.57  
2 o'clock 5.16 7.63 5.19 7.05 3.99 3.50 7.08  
3 o'clock 9.62 7.27 5.84 6.02 7.00 8.72 8.22  
PSC 5.26 4.88 8.64 6.99 9.19 6.01 7.82 
5 o'clock 9.74 6.69 9.55 15.58 10.13 8.46 10.25 
6 o'clock 7.95 10.73 8.40 6.13 14.92 8.26 13.30  
7 o'clock 10.89 4.81 6.24 5.70 8.39 6.19 8.83  
SAC 7.25 8.30 8.28 5.90 3.06 5.82 7.50  
9 o'clock 6.79 6.46 8.45 6.27 5.71 6.90 5.47  
10 o'clock 8.16 4.92 8.42 8.18 7.21 5.46 3.19  
11 o'clock 8.26 5.83 4.92 4.18 6.80 5.10 5.78  




Table G-3 Mean Pixel Intensity, before and after normalization, from 
microstructural imaging of ovine tricuspid annuli. 





PL 2.98 2.84 1.05 2.93 3.24 7.68 6.39 
PSC 3.26 3.59 1.35 4.32 3.30 7.96 10.17 
SL 3.65 4.24 1.69 6.08 5.62 7.84 12.44 
SAC 4.22 3.62 1.94 2.44 6.06 7.84 4.78 
AL 4.23 2.83 1.28 4.90 4.11 8.10 5.85 
APC 3.33 3.31 1.15 4.20 3.64 6.17 8.93 
Myocard
-ium 
PL 19.48 13.60 4.44 8.05 15.48 39.60 31.21 
PSC 25.48 37.51 4.19 14.95 8.74 22.28 33.10 
SL 22.56 14.94 2.71 24.15 15.36 30.35 20.50 
SAC 10.28 12.48 5.57 5.27 14.38 26.61 17.78 
AL 20.04 13.13 5.03 15.72 25.84 29.62 17.72 






PL 0.83 0.83 0.75 0.71 0.75 1.01 0.79 
PSC 0.90 1.05 0.95 1.04 0.76 1.05 1.26 
SL 1.01 1.24 1.20 1.47 1.30 1.03 1.54 
SAC 1.17 1.06 1.37 0.59 1.40 1.03 0.59 
AL 1.17 0.83 0.91 1.18 0.95 1.07 0.72 
APC 0.92 0.97 0.82 1.01 0.84 0.81 1.10 
Myocard
-ium 
PL 1.02 0.71 0.95 0.65 0.94 1.30 1.19 
PSC 1.33 1.95 0.90 1.20 0.53 0.73 1.26 
SL 1.18 0.77 0.58 1.94 0.94 1.00 0.78 
SAC 0.54 0.65 1.19 0.42 0.88 0.88 0.68 
AL 1.04 0.68 1.08 1.26 1.58 0.98 0.68 




Table G-4 Summary data and ex vivo suture pullout forces (N) from human mitral 
and tricuspid annuli. 
Heart ID Hu1 Hu2 Hu3 Hu4 Hu5 Hu6 
Gender F F F M M M 
Body Mass Index 16.72 27.46 24.63 28.58 20.09 17.79 
Age 79 68 60 73 74 70 
Post-mortem interval 8 7 6 4 3 6 
Mitral 
LT 7.42 10.43 5.34 5.02 9.59 5.53 
11 o'clock 16.63 6.19 7.09 15.94 8.12 7.78 
1 o'clock 12.96  7.17 8.15 6.29 8.90 
RT 11.15  4.65 2.99 9.21 8.64 
3 o'clock 6.47 6.24 6.16 6.03 11.62 8.28 
4 o'clock 5.62 2.95 9.03 8.00 11.26 8.88 
5 o'clock 6.19 4.96 5.69 7.46 9.48 9.13 
7 o'clock 4.51 5.23 8.19 7.23 9.04 14.61 
8 o'clock 4.75 3.44 6.16 7.86 8.94 10.35 
9 o'clock 6.29 9.92 5.06 6.37 6.01 11.32 
Tricuspid 
APC 6.61 7.95 7.33 8.64 7.33 7.17 
1 o'clock 4.67 10.93 7.07 5.57 8.48 7.45 
2 o'clock 3.96 8.47 6.77 4.45 9.72 7.16 
3 o'clock 4.00 6.01 6.82 5.61 11.38 8.55 
PSC 4.04 12.26 5.17 4.46 6.74 7.76 
5 o'clock 5.30 9.15 6.07 6.92 3.48 6.32 
6 o'clock 7.41 6.32 4.92 7.86 7.47 4.13 
7 o'clock 5.96 6.54 19.74 6.05 15.81 10.70 
SAC 29.85 6.49 30.75 30.28 24.25 22.60 
9 o'clock 4.00 6.89  2.83 4.11 5.45 
10 o'clock 5.27 4.43 1.72 4.25 6.55 4.66 




Table G-5 Hydroxyproline content (mg/g wet weight) in human mitral and tricuspid 
annuli.   
Heart ID Hu1 Hu2 Hu3 Hu4 Hu5 Hu6 
Mitral 
LT 19.09 11.44 12.55 7.83 11.41 7.85 
11 o'clock 6.79 11.19 9.13 12.70 5.55 6.41 
1 o'clock 14.64 16.08 8.68 17.63  11.16 
RT 15.64  3.73 11.06  4.73 
3 o'clock 6.87 10.47 3.23 3.42 5.07 4.60 
4 o'clock 11.35 10.93 3.30 4.92 6.63 5.80 
5 o'clock 5.53 10.01 10.03 6.15 4.27 3.61 
7 o'clock 12.08 10.52 4.24 4.52 5.34 5.35 
8 o'clock 16.87 13.15 4.82 6.35 5.44 6.63 
9 o'clock 3.85 12.13 7.36 6.58 3.95 6.24 
Tricuspid 
APC 3.31 2.25 4.21 2.54 5.69 7.76 
1 o'clock 2.78 5.50 3.80 2.01 5.17 6.07 
2 o'clock 3.54 4.72 4.41 4.14 5.58 6.03 
3 o'clock 3.91 4.67 6.48 3.29 7.69 3.25 
PSC 4.27 6.17 6.19 0.68 3.32 5.54 
5 o'clock 1.20 6.23 4.66 1.14 3.71 4.26 
6 o'clock 10.48 7.20 4.15 1.80 4.21 3.89 
7 o'clock 5.10 7.22 9.73 5.28 7.67 9.42 
SAC 14.52 5.96 10.92 9.96 8.23 11.95 
9 o'clock 5.85  1.86 2.52 3.02 2.73 
10 o'clock 3.89 7.78 1.63 1.07 3.66 4.47 
11 o'clock 4.21 5.38 3.06 1.49 4.73 4.17 
 
 
Note, in Table G-4 and Table G-5, missing data was due to experimental error and/or thin 
boundary between mitral and tricuspid annuli making it impossible to fully separate them 
for testing. Also note, the tricuspid leaflets in Hu1 and Hu2 were highly non-uniform in 
size. In order to maintain 12 total sutures in these cases, 2 sutures were placed in the 
shortest segment (i.e., Hu1 tricuspid posterior, Hu2 tricuspid septal) and 4 in the longest 
(i.e., Hu1 tricuspid anterior, Hu2 tricuspid posterior). Whether 2, 3, or 4 sutures were 
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placed in a given annular segment, their spacing was uniform. To enable positional 
comparison, when 2 or 4 sutures were placed, a three-suture arrangement was 
approximated by averaging values from the two adjacent positions. For example, in Hu1, 
the final 1 o’clock values were derived from the average of the anterior-most posterior 




APPENDIX H. GUIDE TO SUPPLEMENTARY COMPUTER 
AIDED DESIGN FILES 
Attached to this thesis, a set of supplementary files has been uploaded within SMARTech 
(the Georgia Tech repository for theses and other scholarly works). All supplementary files 
are Computed Aided Design (CAD) files for components and assemblies that were used in 
this thesis. All files were produced in Solidworks 2016 or earlier (Dassault Systemes, 
Waltham, MA). For every .sldprt file except for 2_P41_D-
profileForPlugsAndREFT.sldprt, a duplicate file has been provided in .stl format. The .stl 
format is more readily suited for 3D printing, and may prove easier to read in the future, in 
the event the .sldprt format becomes obsolete. In addition to an accompanying README 
file, the interested reader may refer to the following table for a description of these files.  
 






































1.A Laser Cutter 
Acrylic 
sheet 
Suture pullout test plate, 
top acrylic layer for 
rubber sheet attachment 
1_A1_SuturePullouts
System.sldasm 1.A - - - 
2_P1_Funnel.sldprt 2.A 
3D printing 
(250 um) + 
vapor polish ABS 





(250 um) + 
vapor polish ABS 





(250 um) + 
vapor polish ABS 





(250 um) + 
vapor polish ABS 





(250 um) + 
vapor polish ABS 





(250 um) + 
vapor polish ABS 





(250 um) + 
vapor polish ABS 





(250 um) + 
vapor polish ABS 





(250 um) + 
vapor polish ABS 













(250 um) + 
vapor polish ABS 





(250 um) + 
vapor polish ABS 

































rt 2.B Water jet Steel Sheet 






























































rt 2.B Water jet Steel Sheet 
bonded to wedge after 
machining 
2_P25_REFTHubScr




hollowed out threaded 




herPad.sldprt 2.B 3D printing ABS for 12, 3, 6, and 9 oclock 
2_P27_C-





herPad12.sldprt 2.B 3D printing ABS for 12 oclock only 
2_P29_D-
REFTCalModulePus
herPad3.sldprt 2.B 3D printing ABS for 3 oclock only 
2_P30_D-
REFTCalModulePus
herPad6.sldprt 2.B 3D printing ABS for 6 oclock only 
2_P31_D-
REFTCalModulePus














uleHousing.sldprt 2.B Mill Acrylic bar - 
2_P34_REFTCalMod




uleSpring.sldprt 2.B OEM OEM 
OD 0.36", 0.042" wire, 
7/16" free length, 49 lb. 
spring rating 
2_P36_REFTCalMod




eScrew.sldprt 2.B OEM OEM 
1-1/4" 6-40 socket cap 
screw 
2_P38_REFTCalLarg
eNut.sldprt 2.B OEM OEM for 6-40 screw 
2_P39_REFTCalSma
llScrew.sldprt 2.B OEM OEM 
1/2" 3-48 socket cap 
screw 
2_P40_REFTCalSma
llNut.sldprt 2.B OEM OEM for 3-48 screw 
2_P41_D-
profileForPlugsAndR
EFT.sldprt 2 N/A N/A 
2-D sketch only. An 
included equation called 
"Scale Factor" allows 
user to generate all sizes 
based on perimeters only. 
2_A1_LVApicalPort.
sldasm 2.A - - - 
2_A2_C-
REFT.sldasm 2.B - - - 
2_A3_D-










ule.sldasm 2.B - - - 
2_A5_C-
REFTCal.sldasm 2.B - - - 
2_A6_D-




APPENDIX I. MATLAB CODES 
The following MATLAB codes (MathWorks, Natick, MA) are included: 
 multiway_anova.m - a generic code used for all ANOVA models in both Specific 
Aims. 
 Fc_processing_part1.m - enabled selection of 10-cardiac cycle periods for 
subsequent computation of cyclic force (FC) in in vivo studies throughout  
SA 1. 
 Fc_processing_part2.m - computed FC throughout SA 1. 
 HWHM.m - computed normalized half-width at half maximum force data 
(HWHMnorm) for SA 1.B. 
 Ftd_processing.m - produced a graph for subsequent, manual extraction of tie-down 
force (FTD) in APPENDIX A.  
 annular_measurements.m - computed all photogrammetry-based annular 
dimensions throughout SA 2. 
 PVL_processing_part1.m - computed the PCHIP curves representing incidental 
leakage rates through apical, aortic, or other connections, as a function of ΔP, in 
SA 2.A. 
 PVL_processing_part2.m - computed the ΔP and PVL values from each acquisition 
in SA 2.A. 






%Description: This code runs a one-way or multi-way ANOVA, followed by 
%Tukey's post-hoc. This was used for many different data sets but is shown 
%with a two-way ANOVA sample from SA 1 (ANOVA model 9). It is meant to be 
%run one section at a time. This way, the model can first be tested without 
%interactions (for main effects), and then with interaction. 
  
close all; clear all; clc 
  
%% Initialize  
%All input data has been previously put in .mat format 
load stiffness_apratio.mat 
  
apratio = stiffness_apratio(:,1); 
stiffness = stiffness_apratio(:,2); 
LVP = stiffness_apratio(:,3); 
  
%% Run without interaction  
[p tab stats terms] = anovan(apratio, {stiffness, LVP}a,... 
    'varnames', {'stiffness','LVP'},... 
    'model','linear'); 
for i=1:2 
    figure; 
    [comps{i} mean_se{i} h gnames] = multcompare(stats,'dimension',i); 
end 
  
%% Run with interaction 
[p tab stats terms] = anovan(apratio, {stiffness, LVP},... 
    'varnames', {'stiffness','LVP'},... 
    'model','interaction'); 
for i=1:2 
    for j=2:2 
        if i==j 
        elseif i>j 
        else 
            figure;  
            [comps{i,j} mean_se{i,j} h gnames] = 
multcompare(stats,'dimension',[i j]); %this is doing Tukey's 
        end  






%This code reads in the recorded forces, then prompts the use to select a 
%start and and end point. These two points were always chosen for 10 
%consecutive cardiac cycles. Based on an average from the ten cycles, heart 
%rate and peak left ventricular pressure are computed. Output files are 
%produced, which are force and LVP data over the chosen range. 
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close all; clear all; clc 
  
%% User input section 
%these inputs cover where the files are located, and how the outputs will 
%be named. 
hdir = 'C:\Users\epierce7\Dropbox\Documents\Lab\Research - Thesis\1 - Aim 1-2 - 
Gorman NIH Grant\Animal Raw and Processed Data\'; 
Expt = 'GTA52'; %pulls data from this folder and applies this prefix to output 
files 
Acquisition = '31'; %pulls data from this folder and applies this prefix to 
output files 
Event = 'LVP100'; %applies this prefix to output files 
  
  
%% Analyze data to identify cycles of interest 
cd(strcat(hdir,Expt,'\',Expt,' Processed\',Acquisition)) 
  
%Read in data files 
for i=1:10 








    hold on 






%prompt user for the start and endpoints 
pause=0; 
while pause==0 
    hold off 
    figure(2) 
    set(gcf,'units','normalized','outerposition',[0 0 1 1]) 
    plot(x,LVP) 
    xlabel('indexed time') 
    ylabel('LVP [mmHg]') 
    start=input('what would you like the start point to be?'); 
    disp('') 
    finish=input('what would you like the end point to be?'); 
     
    %% 
    [pks,locs] = findpeaks(LVP(start:finish), 'minpeakdistance', 400, 
'minpeakheight', 80); 
     
    %Calculate Heart Rate 
    for i=2:length(locs) 
        HR(i-1)=locs(i)-locs(i-1); 
    end 
    HR=60./(HR/1613); 
    MeanPeakLVP=mean(pks); 
    StdDevPeakLVP=std(pks); 
    MeanHeartRate=mean(HR); 
    StdDevHeartRate=std(HR); 
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    close Figure 2 
    figure(2) 
    plot(x(start:finish),LVP(start:finish)) 
    hold on 
    plot(x(locs)+start,pks+5,'k^','markerfacecolor',[1 0 0]); 
    title(strcat(['LVP = ' num2str(MeanPeakLVP) ' +/- ' num2str(StdDevPeakLVP) 
... 
        '; HR = ' num2str(MeanHeartRate) ' +/- ' num2str(StdDevHeartRate)])); 
     
    figure(3) 
    set(gcf,'units','normalized','outerposition',[0 0 1 1]) 
    hold off 
    for i=1:10 
        subplot(2,5,i); plot(x(start:finish),ch(start:finish,i)) 
    end 
     
    pause=input('LVP and HR OK? (0=redo, 1=OK)') 
end 
  
%% Export selected data 
%store the selected data into a matrix A 
for i=1:10 

















%This code extracts cyclic forces from the cycles selected in part 1. The 
%code first attempts to identify min and max forces automatically. The user 







%% User input section 
%these inputs cover where the files are located, and how the outputs will 
%be named. 
hdir = 'C:\Users\epierce7\Dropbox\Documents\Lab\Research - Thesis\1 - Aim 1-2 - 
Gorman NIH Grant\Animal Raw and Processed Data\'; 
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Expt = 'GTA52'; %applies this prefix to output files 
Acquisition = '31'; %applies this prefix to output files 
Event = 'LVP100'; %applies this prefix to output files 
  
%% Import data 
cd(strcat(hdir,Expt,'\',Expt,' Processed\')) 
disp('  ')%spacer 
disp('reading in txt file of the forces.....') 
disp('  ') %spacer 
Force=dlmread(strcat(Expt,'_Acq',Acquisition,'_',Event,'_','CyclicForcesToBeEva
luated.txt')); 
[M N]=size(Force);%calculates the size of the column vector1 
x=1:M; 
  
%% Analyze data 
for w=1:N 
    Signal=Force(:,w); 
  
    fifty=prctile(Signal,70); 
    [pks,locs] = findpeaks(Signal, 'minpeakheight', fifty, 
'minpeakdistance',400); 
    SignalInverted=Signal*-1; 
    fiftyInverted=prctile(SignalInverted,70); 
    [pks2,locs2] = findpeaks(SignalInverted, 'minpeakheight', fiftyInverted, 
'minpeakdistance',400); 
    pks2=pks2*-1; 
    if length(pks2)>10 
        pks2(11)=[]; 
        locs2(11)=[]; 
    end 
     
    plot(x,Signal); hold on; 
    plot(x(locs),pks+0.05,'k^','markerfacecolor',[1 0 0]); 
    plot(x(locs2),pks2-0.05,'k^','markerfacecolor',[1 0 0]); 
    hold off 
    set(gcf, 'Position', get(0,'Screensize')); 
    title('Invert forces? (keep=1, flip=2)', 'fontsize', 16) 
    answer1=input('Invert forces? (keep=1, flip=2)'); 
         
    if answer1==1 
    elseif answer1==2 
        Signal=Signal.*-1; 
        clear('pks','pks2','locs','locs2'); 
        fifty=prctile(Signal,70); 
        [pks,locs] = findpeaks(Signal, 'minpeakheight', fifty, 
'minpeakdistance',400); 
        SignalInverted=Signal*-1; 
        fiftyInverted=prctile(SignalInverted,70); 
        [pks2,locs2] = findpeaks(SignalInverted, 'minpeakheight', 
fiftyInverted, 'minpeakdistance',400); 
        pks2=pks2*-1; 
        if length(pks2)>10 
            pks2(11)=[]; 
            locs2(11)=[]; 
        end 
        plot(x,Signal,x,LVP./10,'r'); hold on; 
        plot(x(locs),pks+0.05,'k^','markerfacecolor',[1 0 0]); 
        plot(x(locs2),pks2-0.05,'k^','markerfacecolor',[1 0 0]); 
        hold off 
        set(gcf, 'Position', get(0,'Screensize')); 
         
    end 
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    title('Did you find all the peaks you wanted? (yes=1, no=2)','fontsize',16) 
    answer2=input('did you find all the peaks you wanted? (yes=1, no=2)'); 
     
    if answer2==1 
        AbsoluteLow(:,w)=pks2; 
        AbsolutePeaks(:,w)=pks; 
        PeakValues(:,w)=pks-pks2; 
        MeanValue(w,1)=mean(PeakValues(:,w)); 
        StandardDeviation(w,1)=std(PeakValues(:,w)); 
        PercentageOfMean(w,1)=100*StandardDeviation(w,1)/MeanValue(w,1); 
    end 
     
    if answer2==2 
        title('pick points on graph (min, max, min, max...etc), click enter key 
when all have been selected','fontsize',14) 
        [a b]=ginput; 
        a=round(a); 
        %Values=Signal(a); 
        k=100; 
        j=1; 
        for i=1:2:length(a)-1 
            if a(i)<k 
                low(j)=min(Signal(1:a(i)+k)); 
            else 
                low(j)=min(Signal(a(i)-k:a(i)+k)); 
            end 
            j=j+1; 
        end 
         
        j=1; 
        for i=2:2:length(a) 
            if a(i)+k>length(Signal) 
                high(j)=max(Signal(a(i)-k:end)); 
            else 
                high(j)=max(Signal(a(i)-k:a(i)+k)); 
            end 
            j=j+1; 
        end 
         
        AbsoluteLow(:,w)=low; 
        AbsolutePeaks(:,w)=high; 
        PeakValues(:,w)=high-low; 
        MeanValue(w,1)=mean(PeakValues(:,w)); 
        StandardDeviation(w,1)=std(PeakValues(:,w)); 
        PercentageOfMean(w,1)=100*StandardDeviation(w,1)/MeanValue(w,1); 
         
    end 
    close all 
end 
  



















%% USER INPUT SECTION 
%these inputs cover where the files are located 
hdir = 'C:\Users\Eric\Dropbox\Documents\Lab\Research - Thesis\1 - Aim 1-2 - 
Gorman NIH Grant\Animal Raw and Processed Data\'; 
Expt = 'GTA11'; %applies this prefix to output files 
Acquisition = '11'; %applies this prefix to output files 
Event = 'LVP100'; %applies this prefix to output files 
  





%% Plot each file and identify maxes 
major_count=1; %necessary in case there were any busted transducers and some 
channels must be skipped 
for channel=[1:10] 
    close all 
    if channel==110%|channel==5 
        check=1; 
    else 
        %auto-find peaks 
        height_cutoff=prctile(force(:,channel),70); 
        [max_force{major_count},max_t{major_count}] = 
findpeaks(force(:,channel), 'minpeakheight', height_cutoff, 
'minpeakdistance',550); 
        [min_force{major_count},min_t{major_count}] = 
findpeaks(force(:,channel).*-1, 'minpeakheight', height_cutoff*-1, 
'minpeakdistance',550); 
        min_force{major_count}=min_force{major_count}.*-1; 
         
        %clean up list of found peaks 
        if min_t{major_count}(1)>max_t{major_count}(1) 
            max_t{major_count} = max_t{major_count}(2:end); 
            max_force{major_count} = max_force{major_count}(2:end); 
        end 
        if length(max_force{major_count})>10 
            max_force{major_count} = max_force{major_count}(1:10); 
            max_t{major_count} = max_t{major_count}(1:10); 
        end 
        if length(min_force{major_count})>10 
            min_force{major_count} = min_force{major_count}(1:10); 
            min_t{major_count} = min_t{major_count}(1:10); 
        end 
        if length(max_force{major_count})>length(min_force{major_count}) 
            max_force{major_count} = 
max_force{major_count}(1:length(min_force{major_count})); 
        end 
        if length(max_force{major_count})<length(min_force{major_count}) 
            min_force{major_count} = 
min_force{major_count}(1:length(max_force{major_count})); 
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        end 
         
        for i = 1:size(max_force{major_count},1) %find half-width locations 
            subset = force(min_t{major_count}(i):max_t{major_count}(i), 
channel); 
            targetHW = (subset(1)+subset(end))/2; 
             
            [resid,HW_t{major_count}(i)]=min(abs(subset-targetHW)); 
            HW_force{major_count}(i) = subset(HW_t{major_count}(i)); 
            HW_t{major_count}(i) = HW_t{major_count}(i)+ min_t{major_count}(i); 
        end 
         
        plot(force(:,channel)); hold on; 
        set(gcf, 'Position', get(0,'Screensize')); 
        scatter(max_t{major_count}, max_force{major_count}, 'kv', 
'markerfacecolor', 'r'); 
        scatter(min_t{major_count}, min_force{major_count}, 'k^', 
'markerfacecolor', 'r'); 
        scatter(HW_t{major_count}, HW_force{major_count}, 'ko', 
'markerfacecolor', 'g'); 
         
        title('Manual Correction Required?? Press enter to proceed; type 1 to 
correct manually') 
        check=input('Press enter to proceed; type 1 to correct manually'); 
    end 
    while check==1 
        close all 
        clear a b 
        min_t{major_count}=[]; 
        max_t{major_count}=[]; 
        min_force{major_count}=[]; 
        max_force{major_count}=[]; 
        HW_t{major_count}=[]; 
        HW_force{major_count}=[]; 
         
        plot(force(:,channel)); hold on; 
        set(gcf, 'Position', get(0,'Screensize')); 
        title('pick min/max/min/max/etc. on graph, then click 
enter','fontsize',14) 
         
        [a,b]=ginput; 
        a=round(a); 
        minor_count=1; 
        for i=1:2:length(a)-1 
            [min_force{major_count}(minor_count), 
min_t{major_count}(minor_count)] = min(force(a(i)-25:a(i)+25, channel)); 
            
min_t{major_count}(minor_count)=min_t{major_count}(minor_count)+a(i)-25; 
            minor_count=minor_count+1; 
        end 
        minor_count=1; 
        for i=2:2:length(a) 
            [max_force{major_count}(minor_count), 
max_t{major_count}(minor_count)] = max(force(a(i)-25:a(i)+25, channel)); 
            max_t{major_count}(minor_count) = 
max_t{major_count}(minor_count)+a(i)-25; 
            minor_count=minor_count+1; 
        end 
         
        for i = 1:length(max_force{major_count}) %find half-width locations 
            subset=force(min_t{major_count}(i):max_t{major_count}(i),channel); 
            targetHW = (subset(1)+subset(end))/2; 
             
 338
            [resid,HW_t{major_count}(i)]=min(abs(subset-targetHW)); 
            HW_force{major_count}(i) = subset(HW_t{major_count}(i)); 
            HW_t{major_count}(i) = HW_t{major_count}(i)+ min_t{major_count}(i); 
        end 
         
        scatter(max_t{major_count}, max_force{major_count}, 'kv', 
'markerfacecolor','r'); 
        scatter(min_t{major_count}, min_force{major_count}, 'k^', 
'markerfacecolor','r'); 
        scatter(HW_t{major_count}, HW_force{major_count}, 'ko', 
'markerfacecolor','g'); 
        title('Redo Required?? Press enter to proceed; type 1 to redo') 
        check=input('Press enter to proceed; type 1 to redo'); 
    end 
     
    for k=1:length(max_t{major_count})-1 
        cyc_len{major_count}(k) = (max_t{major_count}(k+1)-
max_t{major_count}(k))./1613; 
    end 
    for k=1:length(max_t{major_count}) 
        finalHW{major_count}(k) = (max_t{major_count}(k)-
HW_t{major_count}(k))./1613; 
    end 




% get the mean length of every cycle, averaged across each suture's 
% recording (this is redundant but whatever) 
for i=1:major_count 




% express the half-width interval in normalized time, then average across 
% cycles for each suture 
for i=1:major_count 
    finalHW_norm{i}=finalHW{i}./avg_cyc_len; 










%This code generates a large plot of all ten force channels, ranging from 
%before tie-down began to after it completed. The user then manually 
%selects time points before and after each suture's tie-down, and computes 
%the force differential. Note, for proper color visualization as used 
%below, the published function rgb.m should be downloaded. 
  
clear all; close all; clc 
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    '5' 
    'RT' 
    '4' 
    'LT' 
    '8' 
    '7' 
    '9' 
    '3' 
    '11'  }; %each row corresponds to the channel, ie row1=ch0, etc. 
  
acqstart = 1; %the acq when tie-down began 
acqfinish = 4; %the acq when tie-down ended 
%% Initial info 
TiedownOrder={'LT','RT','11','1','3','4','5','7','8','9'}; 
%Get channel(+1) of ith suture that was tied down 
for i=1:10; ch_loc(i)=find(strcmp(TiedownOrder{i},PositionMap)); end 
  
datadir=strcat(['C:\Users\Eric\Dropbox\Documents\Lab\Research - Thesis\1 - Aim 
1-2 - Gorman NIH Grant\Animal Raw and Processed Data\' expt '\' expt ' 
Processed\']); 
hdir=cd; 
%% Load ALL data, concatenate into long runs 
for h=acqstart:acqfinish 
% for h=[2 4] 
    cd(strcat(datadir,num2str(h))) 
    for i=1:10; 
        ch(:,i)=load(strcat('ch',num2str(i-1),'.txt')); 
    end 
    if exist('Whole_ChOrder')==0 
        Whole_ChOrder=ch; 
    else 
        Whole_ChOrder=vertcat(Whole_ChOrder,ch); 
    end 
%     acqsize(h-TiedownTimes(1,1)+1)=size(ch,1); 
    clear ch 
end 
  
%Re-order all data to be in order of tie-down instead of channel 
for i=1:10 
    Whole_TieOrder(:,i)=Whole_ChOrder(:,ch_loc(i)); 
end 
  
%% Offset and plot data 
for i=1:10 
    Whole_TieOrder(:,i)=Whole_TieOrder(:,i)-5*(i-1); 




ColorOrder = {'OrangeRed';'Black';'ForestGreen';'FireBrick';'RoyalBlue';... 
    'Purple';'Brown';'DarkKhaki';'Sienna';'HotPink';... 




set(gcf, 'Position', get(0,'Screensize')); 
set(gca,'fontsize',14) 
for i=1:10 
    hold on 
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    plot(x,Whole_TieOrder(:,i),'color',rgb(ColorOrder{i}),'linewidth',1.25) 
  
    set(gca,'fontsize',14) 
    if i<10 
         set(gca, 'XTick', []) 






% AnnularMeasurements.m  
  
%This code will first measure annular perimeter and area, defined as 
%follows: perimeter is measured with arclength.m, a publicly available 
%function (fits spline through selected points). Area is measured using 
%polyarea (fits polygon through selected points). Next, it will measure SL 
%and CC diameters, defined as follows: The two trigones are defined. Then, 
%a perpendicular from their mid-point to the posterior annulus defines SL. 
%Then, based on the SL diameter, a perpendicular passing through its 
%midpoint to the annulus (which is roughly at the commisures) defines the 
%CC diamter. 
  
clear all; close all; clc 
  
%% User input data 
  
file = 'IMAGE.jpg'; 
  
CalDist = 50; %distance you will select for calibration scale, in units 
outlined below 
unit = 'mm'; 
  
CalibrateFlag = 1; %1 if yes, 0 if no (no is unlikely) 
getPerimAreaFlag = 1; %1 if yes, 0 if no 
getDiametersFlag = 1; %1 if yes, 0 if no 
  
%% Calibrate 
if CalibrateFlag == 1 
     
    M = imread(file); %import photo 
    imshow(M); %show photo 
    set(gcf, 'Position', get(0,'Screensize')); %set image to full-screen 
    title('Set zoom for calibrating and measuring, then press ENTER.', 
'fontsize',16) 
    input('Press enter when zoom complete.') 
     
    % calibrate the image 
    title(['Select two calibration points equal to ' num2str(CalDist) ' ' unit 
'.'], 'fontsize',16) 
    cal = ginput(2); %select two points 
    CalDist_Pixel = sqrt( (cal(2,1)-cal(1,1))^2 + (cal(2,2)-cal(1,2))^2 ); 
%find # pixels between points 
    ScaleFac = CalDist/CalDist_Pixel; 
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end 
%% Get area and perimeter 
if getPerimAreaFlag ==1 
     
    title('Select ~30 points around annulus then press enter (start and end on 
same spot).', 'fontsize',16) 
    [p_x, p_y] = ginput(); % select points for perimeter 
    hold on 
    scatter (p_x,p_y, 'go', 'filled') 
     
    [pixelPerim,seglen] = arclength(p_x,p_y,'spline'); 
    realPerim=pixelPerim*ScaleFac; 
    disp(['Perimeter is ' num2str(realPerim) ' ' unit]) 
     
    pixelArea = polyarea(p_x,p_y); 
    realArea = pixelArea*ScaleFac^2; 
    disp(['Area is ' num2str(realArea) ' ' unit '^2']) 
     
end 
%% Get SL and CC diameters 
if getDiametersFlag == 1 
     
    %find trigones 
    title('Select LT and RT.', 'fontsize',16) 
    [tt_x, tt_y] = ginput(2); % select points for trigones 
    SLAnt_x=mean(tt_x); 
    SLAnt_y=mean(tt_y); 
    hold on 
    scatter (tt_x, tt_y, 'ro', 'filled') 
    scatter(SLAnt_x,SLAnt_y,'co','filled') 
    plot(tt_x,tt_y,'r','LineWidth',1.5) 
     
    %find 6 o'clock and SL diameter 
    slope_trig = (tt_y(2)-tt_y(1))/(tt_x(2)-tt_x(1)); 
    slope_SL = -1/slope_trig; 
    SL_yint = SLAnt_y-slope_SL*SLAnt_x; %use known slope and TT midpoint to 
define b in y=mx+b 
     
    SLAxis_arb_x = SLAnt_x + SLAnt_x/3; 
    SLAxis_arb_y = slope_SL*SLAxis_arb_x + SL_yint; 
    SLAxis_arb_x(2) = SLAnt_x - SLAnt_x/3; 
    SLAxis_arb_y(2) = slope_SL*SLAxis_arb_x(2) + SL_yint; 
    scatter(SLAxis_arb_x,SLAxis_arb_y,'co') 
     
    plot(SLAxis_arb_x,SLAxis_arb_y,'c','LineWidth',1.5) 
    title('Select the point where the SL axis crosses the posterior 
annulus.','fontsize',16) 
    [SLPost_x, SLPost_y] = ginput(1); 
    PixelSLDist = sqrt((SLAnt_x-SLPost_x)^2 + (SLAnt_y-SLPost_y)^2); 
    RealSLDist = PixelSLDist * ScaleFac; 
    disp(['SL Diameter is ' num2str(RealSLDist) ' ' unit]) 
     
    %find CC diameter 
    scatter(SLPost_x,SLPost_y,'co','filled') 
    SLMid = [mean([SLAnt_x SLPost_x]) mean([SLAnt_y SLPost_y])]; 
    scatter(SLMid(1),SLMid(2),'yo') 
     
    %find 3 and 9 oclock 
    CC_yint = SLMid(2)-slope_trig*SLMid(1); %use known slope and TT midpoint to 
define b in y=mx+b 
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    CCAxis_arb_x = SLMid(1) + SLMid(1); 
    CCAxis_arb_y = slope_trig*CCAxis_arb_x + CC_yint; 
    CCAxis_arb_x(2) = SLMid(1) - SLMid(1); 
    CCAxis_arb_y(2) = slope_trig*CCAxis_arb_x(2) +CC_yint; 
    scatter(CCAxis_arb_x,CCAxis_arb_y,'yo') 
     
    plot(CCAxis_arb_x,CCAxis_arb_y,'y','LineWidth',1.5) 
    title('Select the points where the CC axis crosses the 
annulus.','fontsize',16) 
    [CC_x, CC_y] = ginput(2); 
    scatter(CC_x,CC_y,'yo','filled') 
    PixelCCDist = sqrt((CC_y(2)-CC_y(1))^2 + (CC_x(2)-CC_x(1))^2); 
    RealCCDist = PixelCCDist * ScaleFac; 
    disp(['CC Diameter is ' num2str(RealCCDist) ' ' unit]) 








%This code computes PCHIP curves representing the incidental leakage across 
%the full pressure range, at every timepoint for which incidental leakage 
%data was acquired throughout a single experiment. Each acquisition is 
%imported, the user selects a set pressure-leakage pairs, and the 
%coefficients and constants describing each PCHIP are stored in a .mat 
%file for use in PVL_processing_part2.m. 
  
clear all; close all; clc 
  
%% User input section 
%these inputs cover where the files are located. 
Path = 'C:\Users\Eric\Dropbox\Documents\Lab\Research - Thesis\2 - Aim 3 - 
TMVR\PVL Testing\Data\Expt 7\19-07-2017\'; %file path 
Prefix = 'Expt7'; %from file names 
Date = '19-07-2017'; %from file names 
WinSize = 5; %number of seconds upstream of the final pressure instant to be 
used in average; default is 4 
  
FiltFlag = 1; %set to 1 if you want to apply low-pass filter, 2 if not 
FiltCutoff = 4; %low-pass filter cutoff to use if filtering; default is 4 
DwnsmpFac = 8; %downsample factor to use if filtering; ignore this otherwise; 
default is 8 
  











]; %baseline (false leakage) files to be read 
  
%% Initialization 
if FiltFlag==2; DwnsmpFac=1; end 
SampleFreq = round(1613/DwnsmpFac);  
addpath(Path); 
  
%% Read in, massage, and filter data 
for i=1:length(BaseFileNumbers) 




Data = cell(length(FileNames),1); %create empty cell 
for i=1:length(FileNames) 
    Path_File = strcat(Path, FileNames{i}); 
    Data{i} = textread(Path_File,'',-1,'delimiter',' ','headerlines',18); %read 
in file 
     
    if FiltFlag==1 
        %downsample data to support low-pass filter 
        for j=1:size(Data{i},1)/DwnsmpFac 
            Data_Dwn(j,:)=mean(Data{i}(DwnsmpFac*(j-1)+1:DwnsmpFac*j,:),1); 
        end 
         
        %design and apply filter to downsampled data 
        conv_filter = fir1(floor(size(Data_Dwn,1)/3)-
1,FiltCutoff/SampleFreq,'low'); 
        Data_Filt=filtfilt(conv_filter,1,Data_Dwn); 
         
        %replace data with downsampled/filtered data 
        Data{i} = []; 
        Data{i} = Data_Filt; 
        clear Data_Dwn Data_Filt 
    end 
     
    Data{i} = [Data{i}(:,4) Data{i}(:,5)-Data{i}(:,6)]; %discard all LVP and 
Flow; subtract AoFlow from ApFlow to get PVL 
    Data{i} = [linspace(0,size(Data{i},1)/SampleFreq,size(Data{i},1))' 
Data{i}(:,1:2)]; %add a new 1st column for time 
end 
  
PtsSumm = []; %set up to populate later 
for i = 1:length(FileNames) 
     
    proceed = 2; %enables while loop 
    while proceed==2; 
        close all 
        clear MeanData 
         
        %% Plot data 
        figure(1) 
        set(gcf,'units','normalized','outerposition',[0 0 1 1]) 
        hAx = plotyy(Data{i}(:,1), Data{i}(:,2),... 
            Data{i}(:,1), Data{i}(:,3)); 
        xlabel('time [sec]') 
        ylabel(hAx(1),'LVP (mmHg)') % left y-axis 
        ylim(hAx(1), [0 1.05*max(Data{i}(:,2))]) 
        set(hAx(1), 'YTick', 0:25:200) 
        ylabel(hAx(2),'PVL (ml/sec)') % right y-axis 
        ylim(hAx(2), [-20 1.05*max(Data{i}(:,3))]) 
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        title('LVP and PVL vs. time. Select FINAL points for each pressure. 
Code will average over 5 seconds prior. Press enter when done!') 
         
        figure(2) 
        plot(Data{i}(:,2),Data{i}(:,3)) 
        xlabel ('LVP (mmHg)') 
        ylabel ('PVL (ml/sec)') 
        title ('PVL vs. LVP') 
         
        %% Take measurements 
        figure(1) 
        Endpoints=ginput(); %select terminal point of each pressure level 
        Endpoints_IndexedTime=round(Endpoints.*SampleFreq); %convert to indexed 
time 
         
        for h=1:size(Endpoints,1) 
            if Endpoints_IndexedTime(h,1)-SampleFreq*WinSize<1 
                MeanData(h,1) = mean(Data{i}(1:Endpoints_IndexedTime(h,1),2)); 
                MeanData(h,2) = mean(Data{i}(1:Endpoints_IndexedTime(h,1),3)); 
            else 
                MeanData(h,1) = mean(Data{i}(Endpoints_IndexedTime(h,1)-
SampleFreq*WinSize:Endpoints_IndexedTime(h,1),2)); 
                MeanData(h,2) = mean(Data{i}(Endpoints_IndexedTime(h,1)-
SampleFreq*WinSize:Endpoints_IndexedTime(h,1),3)); 
            end 
            %plot means on top of raw data; get confirmation to proceed 
            figure(1) 
            hold(hAx(1), 'on') 
            plot([Endpoints(h,1)-WinSize Endpoints(h,1)],[MeanData(h,1) 
MeanData(h,1)],'g','linewidth',2) 
            hold(hAx(2), 'on') 
            plot([Endpoints(h,1)-WinSize Endpoints(h,1)],[MeanData(h,2) 
MeanData(h,2)],'k','linewidth',2,'Parent',hAx(2)) 
            title('Proceed? (Enter 1 to proceed, 2 to repeat selections.)') 
        end        
         
        %%  PCHIP fit 
        MeanData=sortrows(MeanData); %curve fit requires sequential x-coords 
        int=linspace(MeanData(1,1),MeanData(end,1),2000); 
        curve=pchip(MeanData(:,1),MeanData(:,2),int); 
        figure(3) 
        plot(MeanData(:,1),MeanData(:,2),'ob'); hold on 
        plot(int,curve,'r') %review this looks reasonable 
         
        proceed=input('Proceed? (Enter 1 to proceed, 2 to repeat 
selections.)'); 
    end 
     
    %% Summarize selected points and pchip equations 
    for h=1:size(Endpoints,1) 
        TempSumm = [BaseFileNumbers(i) Endpoints_IndexedTime(h,1)-
SampleFreq*WinSize... 
            Endpoints_IndexedTime(h,1) MeanData(h,:)]; %.lvm#, start pt, end 
pt, LVP, leak 
        PtsSumm = vertcat(PtsSumm, TempSumm); %stick the selected point at the 
bottom of the aggregate list 
    end 
     
    BaseSumm{i} = pchip(MeanData(:,1),MeanData(:,2)); 




save(strcat([Prefix '_Baseline.mat']),'BaseSumm') %write data to a .mat file 





%This code generates PVL and trans-mitral delta_P values for each 
%acquisition. Uses the .mat file produced by PVL_processing_part1.m. The 
%variable AcqFileNumbers (i.e., the set of files to be analyzed) must only 
%include files acquired between two consecutive incidental leak files. In 
%other words, all acquisitions should have the same two incidental leak 
%files as their before and after points. All data is output as two 
%matrices, ProcessedDataLeft and ProcessedDataRight, which can then be 
%stored in an Excel spreadsheet. 
  
clear all; close all; clc 
  
%% User input: DO NOT EDIT BELOW THIS SECTION 
%these inputs cover where the files are located. 
Path = 'C:\Users\Eric\Dropbox\Documents\Lab\Research - Thesis\2 - Aim 3 - 
TMVR\PVL Testing\Data\Expt 6\10-07-2017\'; %file path 
Prefix = 'Expt6'; %from file names 
Date = '10-07-2017'; %from file names 
  
WinSize = 4; %number of seconds upstream of the final pressure instant to be 
used in average; default is 4 
FiltFlag = 1; %set to 1 if you want to apply low-pass filter, 2 if not 
FiltCutoff = 4; %low-pass filter cutoff to use if filtering; default is 4 
DwnsmpFac = 8; %downsample factor to use if filtering; ignore this otherwise; 
default is 8 
  








41]; %baseline (incidental leakage) files to be read 
  
AcqFileNumbers = [21 22 23]; %acquisition files to be read 
  
%% Initialization 
if FiltFlag==2; DwnsmpFac=1; end 
SampleFreq = round(1613/DwnsmpFac);  
addpath(Path); 
  
%% Read in and massage all data 
FileNames=cell(length(AcqFileNumbers),1); %create empty cell 
%then populate it with full File Names 
for i=1:length(FileNames) 





Data = cell(length(FileNames),1); %create empty cell 
for i=1:length(FileNames) 
    Path_File = strcat(Path, FileNames{i}); 
    Data{i} = textread(Path_File,'',-1,'delimiter',' ','headerlines',18); %read 
in file 
     
    if FiltFlag==1 
        %downsample data to support low-pass filter 
        for j=1:size(Data{i},1)/DwnsmpFac 
            Data_Dwn(j,:)=mean(Data{i}(DwnsmpFac*(j-1)+1:DwnsmpFac*j,:),1); 
        end 
         
        %design and apply filter to downsampled data 
        conv_filter = fir1(floor(size(Data_Dwn,1)/3)-
1,FiltCutoff/SampleFreq,'low'); 
        Data_Filt=filtfilt(conv_filter,1,Data_Dwn); 
         
        %replace data with downsampled/filtered data 
        Data{i} = []; 
        Data{i} = Data_Filt; 
        clear Data_Dwn Data_Filt 
    end 
     
    Data{i} = [Data{i}(:,4) Data{i}(:,5)-Data{i}(:,6)]; %discard all LVP and 
Flow; subtract AoFlow from ApFlow to get PVL 
    Data{i} = [linspace(0,size(Data{i},1)/SampleFreq,size(Data{i},1))' 
Data{i}(:,1:2)]; %add a new 1st column for time 
end 
  
load(strcat([Prefix '_Baseline.mat'])); %loads baseline data as BaseSumm, a 
cell of structures 
  
%% Plot and analyze data 
colors=['r','g','b','c','k']; 
  
for i = 1:length(FileNames) 
     
    proceed = 2; 
    while proceed==2; 
        close(figure(1),figure(2)) 
         
        %plot data 
        figure(1) 
        set(gcf,'units','normalized','outerposition',[0 0 1 1]) 
        hAx = plotyy(Data{i}(:,1), Data{i}(:,2),... 
            Data{i}(:,1), Data{i}(:,3)); 
        xlabel('time [sec]') 
        ylabel(hAx(1),'LVP (mmHg)') % left y-axis 
        ylim(hAx(1), [0 1.05*max(Data{i}(:,2))]) 
        set(hAx(1), 'YTick', 0:25:200) 
        ylabel(hAx(2),'PVL (ml/sec)') % right y-axis 
        ylim(hAx(2), [-5 1.05*max(Data{i}(:,3))]) 
        title('LVP and PVL vs. time. Select FINAL points for each pressure. 
Code will average over 5 seconds prior. Press enter when done!') 
         
        figure(2) 
        plot(Data{i}(:,2),Data{i}(:,3)) 
        xlabel ('LVP (mmHg)') 
        ylabel ('PVL (ml/sec)') 
        title ('PVL vs. LVP') 
         
        %select spans of interest 
        figure(1) 
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        Endpoints=ginput(); %select terminal point of each pressure level 
        Endpoints_IndexedTime=round(Endpoints.*SampleFreq); %convert to indexed 
time 
         
        for h=1:size(Endpoints,1) 
            %compute mean LVP's and PVL's 
            meanLVP(h) = mean(Data{i}(Endpoints_IndexedTime(h,1)-
SampleFreq*WinSize:Endpoints_IndexedTime(h,1),2)); 
            meanPVL(h) = mean(Data{i}(Endpoints_IndexedTime(h,1)-
SampleFreq*WinSize:Endpoints_IndexedTime(h,1),3)); 
             
            %plot means on top of raw data 
            figure(1) 
            hold(hAx(1), 'on') 
            plot([Endpoints(h,1)-WinSize Endpoints(h,1)],[meanLVP(h) 
meanLVP(h)],'g','linewidth',2) 
            hold(hAx(2), 'on') 
            plot([Endpoints(h,1)-WinSize Endpoints(h,1)],[meanPVL(h) 
meanPVL(h)],'k','linewidth',2,'Parent',hAx(2)) 
            title('Proceed? (Enter 1 to proceed, 2 to repeat selections.)') 
             
            %% correct for incidental leakage 
            %find file numbers and piecewise intervals of the correct 
            %baseline leakage recording 
            [x file_before] = min(abs(BaseFileNumbers-min(AcqFileNumbers))); 
            [err bk_bef] = min(abs(BaseSumm{1,file_before}.breaks-meanLVP(h))); 
            if BaseSumm{1,file_before}.breaks(bk_bef)>meanLVP(h) 
                bk_bef=bk_bef-1; 
            end 
             
            [x file_after] = min(abs(BaseFileNumbers-max(AcqFileNumbers))); 
            file_after = file_before + 1; 
            [x bk_aft] = min(abs(BaseSumm{1,file_after}.breaks-meanLVP(h))); 
            if BaseSumm{1,file_after}.breaks(bk_aft)>meanLVP(h) 
                bk_aft=bk_aft-1; 
            end 
             
            %find incidental leakage at meanLVP(h) based on before/after 
            %baseline recordings 
            offset_before(h) = ... 
                BaseSumm{1,file_before}.coefs(bk_bef,1)*(meanLVP(h)-
BaseSumm{1,file_before}.breaks(bk_bef))^3 +... 
                BaseSumm{1,file_before}.coefs(bk_bef,2)*(meanLVP(h)-
BaseSumm{1,file_before}.breaks(bk_bef))^2 +... 
                BaseSumm{1,file_before}.coefs(bk_bef,3)*(meanLVP(h)-
BaseSumm{1,file_before}.breaks(bk_bef)) +... 
                BaseSumm{1,file_before}.coefs(bk_bef,4); 
             
            offset_after(h) = ... 
                BaseSumm{1,file_after}.coefs(bk_aft,1)*(meanLVP(h)-
BaseSumm{1,file_after}.breaks(bk_aft))^3 +... 
                BaseSumm{1,file_after}.coefs(bk_aft,2)*(meanLVP(h)-
BaseSumm{1,file_after}.breaks(bk_aft))^2 +... 
                BaseSumm{1,file_after}.coefs(bk_aft,3)*(meanLVP(h)-
BaseSumm{1,file_after}.breaks(bk_aft)) +... 
                BaseSumm{1,file_after}.coefs(bk_aft,4); 
             
            offset(h)=fudge*mean([offset_before(h) offset_after(h)]); 
             
            %correct for incidental leakage 
            meanPVL(h) = meanPVL(h) - offset(h); 
             
            %populate summary data 
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            ProcessedDataLeft(5*(i-1)+h,:) = [AcqFileNumbers(i) 
Endpoints_IndexedTime(h,1)-SampleFreq*WinSize Endpoints_IndexedTime(h,1) 
offset(h)]; 
            ProcessedDataRight(5*(i-1)+h,:) = [i meanLVP(h) meanPVL(h)]; 
        end 
         
        %visualize baseline offset values 
        figure(3) 
        hold on 
        scatter(meanLVP,offset_before,colors(i),'x') 
        scatter(meanLVP,offset_after,colors(i),'o') 
        scatter(meanLVP,offset,colors(i),'^','filled') 
         
        %confirm OK to proceed 
        proceed=input('Proceed? (Enter 1 to proceed, 2 to repeat 
selections.)'); 
        if proceed == 2 
            close(figure(3)) 
        end 
    end 
end 
  




    
a=linspace(BaseSumm{1,file_before}.breaks(k),BaseSumm{1,file_before}.breaks(k+1
),100); 
    plot(a,... 
        BaseSumm{1,file_before}.coefs(k,1).*(a-
BaseSumm{1,file_before}.breaks(k)).^3 +... 
        BaseSumm{1,file_before}.coefs(k,2).*(a-
BaseSumm{1,file_before}.breaks(k)).^2 +... 
        BaseSumm{1,file_before}.coefs(k,3).*(a-
BaseSumm{1,file_before}.breaks(k)) +... 




    
a=linspace(BaseSumm{1,file_after}.breaks(k),BaseSumm{1,file_after}.breaks(k+1),
100); 
    plot(a,... 
        BaseSumm{1,file_after}.coefs(k,1).*(a-
BaseSumm{1,file_after}.breaks(k)).^3 +... 
        BaseSumm{1,file_after}.coefs(k,2).*(a-
BaseSumm{1,file_after}.breaks(k)).^2 +... 
        BaseSumm{1,file_after}.coefs(k,3).*(a-BaseSumm{1,file_after}.breaks(k)) 
+... 











%This code imports a set of REFT acquisitions, enables the user to select 
%time points of interest, and outputs the forces on each arm associated 
%with the each REFT acquisition. All data is output as finaloutput, which 
%can then be stored in an Excel spreadsheet. 
  
clear all; close all; clc 
  
%% User input section 
%these inputs cover where the files are located. 
RootPath = 'C:\Users\Eric\Dropbox\Documents\Lab\Research - Thesis\2 - Aim 3 - 
TMVR\REFT Testing\Data\'; %file path 
Expt = 'C6'; 
Prefix = 'plus2'    ; %from file names 
Date = '24-01-2018'; %from file names 
  
AcqFileNumbers = [1 
    2 
    3 
    4 
    5 
    6 
    7 
    8]; 
  
calfac = [-160076.3146 
    -167705.9941 
    -152129.8866 
    -182690.8505];%calibration factors for each arm 
%% Import and prep data 
TCR = 5; %total channels recorded. INDEX FROM 1. 
SampleFreq = 1613; 
  
Path = (strcat(RootPath,Expt,'\',Date,'\')); 
  
FileNames=cell(length(AcqFileNumbers),1); %create empty cell 
%then populate it with full File Names 
for i=1:length(FileNames) 




data = cell(length(FileNames),1); %create empty cell 
for i=1:length(FileNames) 
    Path_File = strcat(Path, FileNames{i}); 
    data{i} = textread(Path_File,'',-1,'delimiter',' ','headerlines',26); %read 
in file 
    time = linspace(0,size(data{i},1)/SampleFreq,size(data{i},1)); 
    filtereddata{i} = data{i}(:,TCR+1:end); 
     
    %% Plot data 
    proceed = 2; 
    while proceed==2; 
        hold off 
        figure(1); 
        set(gcf,'units','normalized','outerposition',[0 0 1 1]) 
        subplot(2,1,2); 
        plot(time,filtereddata{i}(:,5)) 
 350
        hold on 
        plot([0 time(end)],[115 115],'r--',[0 time(end)],[125 125],'r--') 
        set(gca,'position',[0.07 0.1 0.88 0.33]) 
        xlim([0,time(end)]) 
        ylim([100,140]) 
        xlabel ('Time (sec)') 
        ylabel ('Aortic Pressure (mmHg)') 
         
        colororder=['k','r','y','b']; 
         
        subplot(2,1,1); 
        for j=1:4 
            plot(time,filtereddata{i}(:,j).*calfac(j),colororder(j)) 
            hold on 
        end 
        legend('12','3','6','9') 
        xlim([0,time(end)]) 
        ylabel('Strain') 
        set(gca,'XTick',[]) 
        set(gca,'position',[0.07 0.45 0.88 0.5]) 
         
        %% select points, review selections 
        title(strcat(['TRIAL ' num2str(i) '. Select endpoints for 1) before, 2) 
during, and 3) after deployment.'])) 
        Endpoints = ginput(3); 
        Endpoints_IndexedTime=round(Endpoints.*SampleFreq); %convert to indexed 
time 
         
        WinSize = 1.5; %number of secs beforethe final instant to be averaged 
         
        %compute mean AoPs and Forces 
        for j = 1:3 
            meanAoP(j) = mean(filtereddata{i}(Endpoints_IndexedTime(j,1)-
SampleFreq*WinSize:Endpoints_IndexedTime(j,1),5)); 
            for k = 1:4 
                meanStrain(j,k) = 
mean(filtereddata{i}(Endpoints_IndexedTime(j,1)-
SampleFreq*WinSize:Endpoints_IndexedTime(j,1),k)); 
                plot([Endpoints(j,1)-WinSize Endpoints(j,1)],[meanStrain(j,k) 
meanStrain(j,k)],'g','linewidth',2) 
            end 
        end 
        title(strcat(['TRIAL ' num2str(i) 'Proceed? (Enter 1 to proceed, 2 to 
repeat selections.)'])) 
         
        %confirm OK to proceed 
        proceed=input('Proceed? (Enter 1 to proceed, 2 to repeat 
selections.)'); 
        if proceed == 2 
            close(figure(1)) 
        end 
    end 
     
    %get final force and pressures from that trial 
    finaloutput(i,1:6) = [AcqFileNumbers(i) Endpoints_IndexedTime(:,1)' WinSize 
mean(meanAoP)]; 
    for k = 1:4 
        finaloutput(i,6+k) = meanStrain(2,k) - mean(meanStrain(3,k)-
meanStrain(1,k)); 
        finaloutput(i,6+k) = meanStrain(2,k) - mean(meanStrain(3,k)-
meanStrain(1,k)); 
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